8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

 the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 14, 2017

Brighthouse Life Insurance Company

(Exact name of registrant as specified in its charter)

Delaware	033-03094	06-0566090
(State of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
11225 North Community House Road, Charlotte, North Carolina		28277
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code

(980) 365-7100

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the

registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 under the Exchange Act (17 CGR 240.12b-2).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 8.01 Other Events

Brighthouse Life Insurance Company is filing this Current Report on Form 8-K to reflect the impact on its previously filed financial statements and other disclosures included in Brighthouse Life Insurance Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (the “2016 Annual Report”) filed with the U.S. Securities and Exchange Commission (“SEC”) of actions taken with respect to Brighthouse Life Insurance Company and its subsidiaries (collectively, the “Company” or “Brighthouse Insurance”) by MetLife, Inc., the Company’s former parent company, in the second quarter of 2017 as described below.

Beginning with the second quarter of 2017, MetLife, Inc. implemented certain reporting changes related to the change in the ownership of the Company in connection with the separation of a substantial portion of MetLife, Inc.’s former U.S. retail business. These changes have been applied retrospectively effective January 1, 2014. These changes included the following:

•the contribution by MetLife, Inc. of certain affiliated reinsurance companies and Brighthouse Life Insurance Company of NY to Brighthouse Life Insurance Company; and

•the merger of these affiliated reinsurance companies with and into Brighthouse Reinsurance Company of Delaware, a licensed reinsurance subsidiary of Brighthouse Life Insurance Company.

See Note 3 of the Notes to the Consolidated Financial Statements included within Item 8 of Part II in Exhibit 99.1 to this Current Report on Form 8-K for the effects of the retrospective application of these changes.

The following items of the 2016 Annual Report (collectively, the “Revised Sections”) are being revised as and to the extent reflected in Exhibit 99.1 to this Current Report on Form 8-K:

•Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and

•Part II, Item 8. Financial Statements and Supplementary Data.

The Revised Sections are being filed as Exhibit 99.1 to this Current Report on Form 8-K and it is hereby incorporated by reference herein. The disclosures filed as Exhibit 99.1 supersede the corresponding portions of the 2016 Annual Report, as specified in such Exhibit 99.1. No Items of the 2016 Annual Report other than those identified above are being revised by this filing. Information in the 2016 Annual Report is generally stated as of December 31, 2016 and this filing does not reflect any subsequent information or events other than the changes described above and those reflected in the Overview included within Item 7 of Part II and Note 18 of the Notes to the Consolidated Financial Statements included within Item 8 of Part II in Exhibit 99.1 to this Current Report on Form 8-K. Without limitation of the foregoing, this filing does not purport to update the Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the 2016 Annual Report for any information, uncertainties, transactions, risks, events or trends occurring, or known to management, other than the events described above. More current information is contained in Brighthouse Life Insurance Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31 and June 30, 2017 (the “Quarterly Reports on Form 10-Q”) and our other filings with the SEC. This Current Report on Form 8-K should be read in conjunction with the 2016 Annual Report, the Quarterly Reports on Form 10-Q and other filings made by Brighthouse Life Insurance Company with the SEC.

Item 9.01 Financial Statements and Exhibits

Exhibit No.	Description of Exhibit
23.1	Consent of Deloitte & Touche LLP.
99.1	Revised items in 2016 Annual Report on Form 10-K: Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Part II, Item 8. Financial Statements and Supplementary Data
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRIGHTHOUSE LIFE INSURANCE COMPANY
By	/s/ Lynn A. Dumais
	Name:	Lynn A. Dumais
	Title:	Vice President and Chief Accounting Officer

Date: September 14, 2017

Exhibit Index

Exhibit No.	Description of Exhibit
23.1	Consent of Deloitte & Touche LLP.
99.1	Revised items in 2016 Annual Report on Form 10-K: Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Part II, Item 8. Financial Statements and Supplementary Data
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.

EX-23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-209162, 333-209163, 333-208664, 333-207091, 333-201861, 333-201860, 333-201864, 333-216485, 333-217507, 333-217509, and 333-218126 on Form S-3 of our report dated March 28, 2017 (September 14, 2017, as to the effects of the change in reporting entity described in Note 3 and as to Note 18), relating to the consolidated financial statements and financial statement schedules of Brighthouse Life Insurance Company (formerly MetLife Insurance Company USA) and subsidiaries for the year ended December 31, 2016, appearing in this Current Report on Form 8-K.

/s/ Deloitte & Touche LLP

New York, NY

September 14, 2017

EX-99.1

EXHIBIT 99.1

Brighthouse Life Insurance Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (the “2016 Annual Report”) is being revised to reflect the implementation of certain reporting changes related to the contribution to Brighthouse Life Insurance Company by MetLife, Inc. of certain affiliated reinsurance companies and Brighthouse Life Insurance Company of NY, as described in Item 8.01 of the accompanying Current Report on Form 8-K. The 2016 Annual Report is revised as follows:

• The information previously set forth in the following sections under the heading “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the 2016 Annual Report is replaced in its entirety by the information set forth below in this Exhibit 99.1 in the corresponding sections under the heading of “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”:

– Overview

– Results of Operations

• The information previously set forth under the heading “Part II, Item 8. Financial Statements and Supplementary Data” in the 2016 Annual Report is replaced in its entirety by the information set forth below in this Exhibit 99.1 under the heading “Part II, Item 8. Financial Statements and Supplementary Data.”

Other than as set forth herein, the 2016 Annual Report remains unchanged. Those sections of the 2016 Annual Report which have not been revised as set forth herein are not materially impacted by the actions taken described in this Exhibit 99.1 and the accompanying Current Report on Form 8-K and/or have already been updated through the Quarterly Reports on Form 10-Q forthe quarters ended March 31 and June 30, 2017 (the “Quarterly Reports on Form 10-Q”), including Risk Factors and the Note Regarding Forward Looking Statements contained in the Quarterly Reports on Form 10-Q, and are not included in this Exhibit 99.1. Accordingly, the revised information set forth in this Exhibit 99.1 should be read in conjunction with the 2016 Annual Report and the Quarterly Reports on Form 10-Q.

1

Part II

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Page
Overview	3
Results of Operations	4

2

Overview

“Brighthouse Insurance” and the “Company” refer to Brighthouse Life Insurance Company (formerly, MetLife Insurance Company USA, “MetLife USA”), a Delaware corporation originally incorporated in Connecticut in 1863, and its subsidiaries. Brighthouse Life Insurance Company is a wholly-owned subsidiary of Brighthouse Holdings, LLC, which until July 28, 2017 was a direct wholly-owned subsidiary of MetLife, Inc. (MetLife, Inc., together with its subsidiaries and affiliates, “MetLife”).

We offer a range of individual annuities and individual life insurance products. We are licensed and regulated in each U.S. jurisdiction where we conduct insurance business. Brighthouse Insurance is licensed to issue insurance products in all U.S. states (except New York), the District of Columbia, the Bahamas, Guam, Puerto Rico, the British Virgin Islands and the U.S. Virgin Islands. Our insurance subsidiary, Brighthouse Life Insurance Company of NY (“Brighthouse NY”), is only licensed to issue insurance products in New York. In anticipation of the separation from MetLife, in the third quarter of 2016, the Company reorganized its businesses into three segments: Annuities, Life and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other. See “— Other Key Information — Segment Information” and Note 2 of the Notes to the Consolidated Financial Statements for further information on the Company’s segments and Corporate & Other. See also “— Other Key Information — The Separation” for information on the separation from MetLife. Management continues to evaluate the Company’s segment performance and allocated resources and may adjust related measurements in the future to better reflect segment profitability.

Other Key Information

Segment Information

In anticipation of the separation from MetLife, in the third quarter of 2016, the Company reorganized its businesses as follows:

• The businesses in the Company’s former Retail segment are reflected in two new segments, Annuities and Life.

• The Retirement and Income Solutions business (which represents most of the segment formerly known as MetLife’s Corporate Benefit Funding segment) is reflected in a new segment, Run-off. Further, beginning in the fourth quarter of 2016, we report our ULSG business in this segment.

• Corporate & Other remains unchanged.

These and certain other presentation changes were applied retrospectively and did not have an impact on total consolidated net income or operating earnings in the prior periods. See Note 2 of the Notes to the Consolidated Financial Statements for further information on the Company’s segments.

The Separation

On January 12, 2016, MetLife, Inc. announced its plan to pursue the separation of a substantial portion of its former U.S. retail business (the “Separation”). Additionally, on July 21, 2016, MetLife, Inc. announced that the separated business would be rebranded as “Brighthouse Financial.” Effective March 6, 2017, and in connection with the Separation, the Company changed its name from MetLife Insurance Company USA to Brighthouse Life Insurance Company.

On October 5, 2016, Brighthouse Financial, Inc., which until the completion of the Separation on August 4, 2017 was a wholly-owned subsidiary of MetLife, Inc., filed a registration statement on Form 10 (as amended, the “Form 10”) with the U.S. Securities and Exchange Commission (“SEC”) that was declared effective by the SEC on July 6, 2017. The Form 10 disclosed MetLife, Inc.’s plans to undertake several actions, including an internal reorganization involving its U.S. retail business (the “Restructuring”) and include, among others, Brighthouse Life Insurance Company, Brighthouse NY, New England Life Insurance Company, Brighthouse Investment Advisers, LLC (formerly known as MetLife Advisers, LLC) and certain affiliated reinsurance companies in the separated business, and distribute at least 80.1% of the shares of Brighthouse Financial, Inc.’s common stock on a pro rata basis to the holders of MetLife, Inc. common stock. In connection with the Restructuring, in April 2017 following receipt of applicable regulatory approvals, MetLife, Inc. contributed certain affiliated reinsurance companies and Brighthouse NY to Brighthouse Insurance (the “Contribution Transactions”). The affiliated reinsurance companies were then merged into Brighthouse Reinsurance Company of Delaware (“BRCD”), a licensed reinsurance subsidiary of Brighthouse Life Insurance Company. See Note 3 of the Notes to the Consolidated Financial Statements for further information.

3

Additionally, in June 2017 in connection with the Separation: (i) MetLife, Inc. forgave the $750 million principal amount of 8.595% surplus notes issued by Brighthouse Life Insurance Company; and (ii) Brighthouse Holdings, LLC (“Brighthouse Holdings”) contributed $600 million in cash to Brighthouse Life Insurance Company. On July 28, 2017, MetLife, Inc. contributed Brighthouse Holdings to Brighthouse Financial, Inc., resulting in Brighthouse Life Insurance Company becoming an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. On August 4, 2017, MetLife, Inc. completed the Separation through a distribution of 96,776,670 of the 119,773,106 shares of the common stock of Brighthouse Financial Inc, representing 80.8% of MetLife Inc.’s interest in Brighthouse Financial Inc., to holders of MetLife, Inc. common stock.

On August 10, 2017 and September 8, 2017, the Company received capital contributions of $400 million and $100 million in cash from Brighthouse Holdings.

On April 28, 2017, BRCD entered into a new financing arrangement with a pool of highly rated third party reinsurers and a total capacity of $10.0 billion. This financing arrangement consists of credit-linked notes that each have a term of 20 years. At September 14, 2017, there were no drawdowns on such notes and there was $8.1 billion of funding available under this arrangement.

In July 2016, MetLife, Inc. completed the sale to Massachusetts Mutual Life Insurance Company (“MassMutual”) of MetLife’s U.S. retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MetLife’s affiliated broker-dealer, MetLife Securities, Inc., a wholly-owned subsidiary of MetLife, Inc. (the “U.S. Retail Advisor Force Divestiture”). MassMutual assumed all of the liabilities related to such assets that arise or occur at or after the closing of the sale. As part of the transactions, MetLife, Inc. and MassMutual entered into a product development agreement under which MetLife’s U.S. retail business would be the exclusive developer of certain annuity products to be issued by MassMutual. In the MassMutual purchase agreement, MetLife, Inc. agreed to indemnify MassMutual for certain claims, liabilities and breaches of representations and warranties up to limits described in the purchase agreement.

Subsequent Events

For additional information regarding subsequent events, see Note 18 of the Notes to the Consolidated Financial Statements.

Results of Operations

Consolidated Results

Business Overview.Annuity sales declined 23% primarily due to the suspension of sales by a major distributor and discontinuance of sales of ourguaranteed minimum income benefits (“GMIBs”)rider products. Life sales declined 28% primarily due to the U.S. Retail Advisor Force Divestiture. While overall sales declined, we did experience increases in certain products including our newest universal life product,our index-linked annuities and our latest generation variable annuity withdrawal guarantee product.

A significant portion of our net income is driven by separate account balances, particularly in our variable annuity business. Most directly, these balances determine asset-based fee income, but also impact deferred policy acquisition cost (“DAC”) amortization and asset-based commissions. Separate account balances are driven by sales, movements in the market, surrenders, withdrawals, benefit payments, transfers and policy charges. Average separate account balances declined in 2016 compared to 2015 due to unfavorable equity market impact and negative net flows as surrenders, withdrawals and benefits have exceeded new sales. While overall equity market performance was positive during 2016, the timing of a significant market decline in the third quarter of 2015 resulted in lower average balances during 2016. In 2016, we experienced positive net flows in the general account.

4

	Years Ended December 31,
	2016			2015
	(In millions)
Revenues
Premiums	$	1,180		$	1,637
Universal life and investment-type product policy fees	3,097			3,293
Net investment income	3,111			3,001
Other revenues	709			433
Net investment gains (losses)	(67		)	5
Net derivative gains (losses)	(5,770		)	(497		)
Total revenues	2,260			7,872
Expenses
Policyholder benefits and claims	3,738			3,087
Interest credited to policyholder account balances	1,131			1,224
Goodwill impairment	381			—
Capitalization of DAC	(330		)	(399		)
Amortization of DAC and VOBA	(225		)	673
Interest expense on debt	130			137
Other expenses	1,900			1,985
Total expenses	6,725			6,707
Income (loss) before provision for income tax	(4,465		)	1,165
Provision for income tax expense (benefit)	(1,690		)	247
Net income (loss)	$	(2,775	)	$	918

The table below shows the components of our net income (loss), in addition to operating earnings for the years ended December 31, 2016 and 2015.

	Years Ended December 31,
	2016			2015
	(In millions)
GMLB Riders	$	(3,180	)	$	(602	)
Amortization of DAC and VOBA	4			(3		)
Other derivative instruments	(2,015		)	(156		)
Net investment gains (losses)	(67		)	5
Other adjustments	(481		)	2
Operating earnings before provision for income tax	1,274			1,919
Income (loss) before provision for income tax	(4,465		)	1,165
Provision for income tax expense (benefit)	(1,690		)	247
Net income (loss)	$	(2,775	)	$	918

Year Ended December 31, 2016 Compared with the Year Ended December 31, 2015

Income (loss) before provision for income tax decreased $5.6 billion ($3.7 billion, net of income tax) for the year ended December 31, 2016. In addition to lower operating earnings, this decrease was primarily due to unfavorable results from GMLB Riders, unfavorable changes in other derivative instruments, and a charge for goodwill impairment. Excluding the impact of the annual actuarial assumption review, income (loss) before provision for income tax decreased $3.4 billion ($2.2 billion, net of income tax).

GMLB Riders.Results from GMLB Riders reflect (i) changes in the carrying value of guaranteed minimum living benefits (“GMLBs”) liabilities, including GMIBs, guaranteed minimum withdrawal benefits (“GMWBs”) and guaranteed minimum accumulation benefits (“GMABs”); (ii) changes in the fair value of the hedges and reinsurance of the GMLB liabilities; (iii) the fees earned from the GMLB liabilities; and (iv) the related DAC offsets to each of the preceding components (collectively, the “GMLB Riders”).

5

GMLB Riders decreased income (loss) before provision for income tax by $2.6 billion ($1.7 billion, net of income tax), as our annual actuarial assumption review resulted in changes to assumptions regarding policyholder behavior which significantly increased the carrying value of the liabilities combined with unfavorable market factor impacts on our hedges. This was partially offset by the favorable impacts on the liabilities due to the same market factors as well as higher fee income and favorable impacts to DAC amortization. See “— GMLB Riders — Year Ended December 31, 2016 Compared with the Year Ended December 31, 2015.”

Amortization of DAC and VOBA. Lower DAC and value of business acquired (“VOBA”) amortization, excluding the amounts in GMLB Riders and operating earnings, increased income (loss) before provision for income tax by $7 million ($5 million, net of income tax), primarily due to lower profits resulting from net investment gains (losses) and net derivative gains (losses) related to life and annuity products.

Other Derivative Instruments.We have other derivative instruments in addition to the hedges and embedded derivatives included in GMLB Riders, for which changes in fair value are recognized in net derivative gains (losses). The change in fair value of other derivative instruments decreased income (loss) before provision for income tax by $1.9 billion ($1.2 billion, net of income tax).

We have freestanding derivatives that economically hedge certain invested assets and insurance liabilities. The majority of this hedging activity is focused in the following areas:

• use of interest rate swaps when we have duration mismatches where suitable assets with maturities similar to those of our long-dated liabilities are not readily available in the market; and

• use of foreign currency swaps when we hold fixed maturity securities denominated in foreign currencies that are matching insurance liabilities denominated in U.S. dollars.

In 2016, in connection with the planned separation, we entered into additional interest rate swaps in order to protect the statutory capital of the company against further declines in interest rates.

The market impacts on the hedges are accounted for in net income (loss) while the offsetting economic impact on the items they are hedging are either not recognized or recognized through other comprehensive income in equity.

Changes in the fair value of freestanding derivatives decreased income (loss) before provision for income tax by $1.7 billion ($1.1 billion, net of income tax), primarily due to the unfavorable changes in our receive fixed interest rate swaps and interest rate total return swaps resulting from long-term interest rates increasing in 2016, compared to decreasing in 2015.

Changes in liability values of our index-linked annuity products that result from changes in the underlying equity index are accounted for as embedded derivatives. Unfavorable changes in the fair value of embedded derivatives decreased income (loss) before provision for income tax by $179 million ($116 million, net of income tax), primarily due to the unfavorable impact of an increase in equity index levels on our index-linked annuity liabilities.

Net Investment Gains (Losses).Unfavorable net investment gains (losses) decreased income (loss) before provision for income tax by $72 million ($47 million, net of income tax), primarily due to gains on sales of real estate joint ventures recognized in 2015 and impairments recognized in 2016. These decreases from real estate joint ventures were partially offset by lower impairments and net losses on sales of fixed maturity securities as well as gains on mortgage loans in 2016.

Other Adjustments. Other adjustments to determine operating earnings decreased income (loss) before provision for income tax by $483 million ($371 million, net of income tax), primarily due to an impairment of goodwill in our run-off business. See Note 11 of the Notes to the Consolidated Financial Statements for additional discussion of the goodwill impairment.

Income Tax Expense (Benefit). Income tax benefit for the year ended December 31, 2016 was $1.7 billion, or 38% of income (loss) before provision for income tax, compared to income tax expense of $247 million, or 21% of income (loss) before provision for income tax, for the year ended December 31, 2015. Our effective tax rates differ from the U.S. statutory rate of 35% typically due to dividend received deductions and tax credits. Our 2016 results include a $381 million ($305 million, net of income tax) non-cash charge for goodwill impairment. The tax benefit on this charge was limited to $76 million on the associated tax goodwill. Our 2016 results also include a $78 million benefit due to a deferred tax adjustment related to goodwill.

6

Operating Earnings. We use operating earnings, which does not equate to net income (loss) as determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”) , to analyze our performance, evaluate segment performance, and allocate resources. We believe that the presentation of operating earnings, as we measure it for management purposes, enhances the understanding of our performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings allows analysis of our performance and facilitates comparisons to industry results. This financial measure focuses on our primary businesses principally by excluding the impact of market volatility, which could distort trends, and revenues and costs related to non-core products and businesses. Operating earnings should not be viewed as a substitute for net income (loss). The following are excluded from total revenues, net of income tax, in calculating operating earnings: (1) net investment gains (losses); (2) net derivative gains (losses) except: (i) earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment Hedge Adjustments”); and (ii) earned income on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment (“PAB Adjustments”); (3) amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees (“GMIB Fees”); (4) certain amounts related to securitization entities that are variable interest entities (“VIEs”) consolidated under GAAP; and (5) revenues from divested businesses. Additionally, the following are excluded from total expenses, net of income tax, in calculating operating earnings: (1) amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”); (2) amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); (3) amortization of DAC and VOBA related to (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments; (4) recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance; (5) expenses of divested businesses; (6) amounts related to securitization entities that are VIEs consolidated under GAAP; (7) goodwill impairment; and (8) costs related to: (i) implementation of new insurance regulatory requirements and (ii) acquisition and integration costs. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Non-GAAP and Other Financial Disclosures” included in the 2016 Annual Report for additional information on how each component of operating earnings is calculated from the GAAP statement of operations line items.

Operating earnings before provision for income tax decreased $645 million ($474 million, net of income tax) for the year ended December 31, 2016. Operating earnings is discussed in greater detail below.

Reconciliation of net income (loss) to operating earnings

	Years Ended December 31,
	2016			2015
	(In millions)
Net income (loss)	$	(2,775	)	$	918
Add: Provision for income tax expense (benefit)	(1,690		)	247
Net income (loss) before provision for income tax	(4,465		)	1,165
Less: GMLB Riders	(3,180		)	(602		)
Less: Amortization of DAC and VOBA	4			(3		)
Less: Other derivative instruments	(2,015		)	(156		)
Less: Net investment gains (losses)	(67		)	5
Less: Other adjustments (1)	(481		)	2
Operating earnings before provision for income tax	1,274			1,919
Less: Provision for income tax (expense) benefit	341			512
Operating earnings	$	933		$	1,407

__________________

(1) See “—Year Ended December 31, 2016 Compared with the Year Ended December 31, 2015 — Operating Earnings” for a listing of other adjustments to net income (loss).

7

Consolidated Results – Operating

	Years Ended December 31,
	2016			2015
	(In millions)
Fee income	$	3,577		$	3,346
Net investment spread	1,507			1,443
Insurance-related activities	(1,187		)	(464		)
Amortization of DAC and VOBA	(1,012		)	(691		)
Other expenses, net of DAC capitalization	(1,611		)	(1,715		)
Operating earnings before provision for income tax	1,274			1,919
Provision for income tax expense (benefit)	341			512
Operating earnings	$	933		$	1,407

Year Ended December 31, 2016 Compared with the Year Ended December 31, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Overview. The $474 million decrease in operating earnings primarily resulted from charges recognized in our universal life with secondary guarantees (“ULSG”) business, higher costs related to guaranteed minimum death benefits (“GMDBs”), and unfavorable underwriting experience in our ULSG and life businesses, partially offset by higher fee income. Excluding the impact of the annual actuarial assumption review, operating earnings decreased $389 million.

In the second quarter of 2016, we refined our actuarial model which calculates reserves for our ULSG products (“ULSG Model Change”). This change resulted in a one-time charge to operating earnings of $349 million, when compared to 2015. Of this one-time charge, $171 million was due to higher insurance-related liabilities combined with unfavorable adjustments related to unearned revenue and DAC. The change also resulted in a reduction of expected future gross profits, which drove our loss recognition margins negative, resulting in an increase in DAC amortization of $158 million and an additional increase in insurance-related liabilities of $20 million.

In the fourth quarter of 2016, we decided to cease sales of all ULSG products effective in early 2017. In conjunction with this decision, we moved the ULSG business out of the Life segment and into the Run-off segment so that the business can be separately managed from the remaining Life businesses by the Run-off segment manager (“ULSG Re-segmentation”). In accordance with our accounting policies, the move to a different segment required us to separately evaluate and test the ULSG business for loss recognition without being able to offset losses with future earnings from the variable and universal life business remaining in the Life segment. The re-segmentation and related loss recognition testing resulted in a decrease in both net income (loss) and operating earnings of $95 million, primarily from the write-off of DAC. There will be additional one-time charges when the current affiliated captive reinsurance companies are merged with and into BRCD.

As a further result of the lower expected future gross profits in our ULSG products, we expect future recurring increases in insurance-related liabilities for which $34 million was recognized in the third and fourth quarters of 2016, in addition to the one-time charges discussed above. The recurring amounts may increase when the current affiliated captive reinsurance companies are merged with and into BRCD.

Fee Income. Higher fee income increased operating earnings by $150 million, primarily due to:

• a gain of $197 million from the recapture from an affiliate of a reinsurance agreements for certain single premium deferred annuity contracts (“SPDA Recaptures”); and

• a gain of $83 million from the recapture of several ceded and assumed reinsurance agreements for certain traditional life products; partially offset by

• a decrease of $93 million due to lower asset-based fees resulting from the lower separate account balances in our variable annuities business; and

• a decrease of $16 million in our ULSG business resulting from an adjustment to unearned revenue in connection with the ULSG Model Change.

Excluding the impact of the annual actuarial assumption review, higher fee income increased operating earnings by $146 million.

8

Net Investment Spread. Higher net investment spread increased operating earnings by $42 million as higher net investment income and lower interest credited expense were partially offset by lower interest credited income on the reinsurance receivable related to the SPDA Recaptures. Net investment income increased primarily due to a higher average invested asset base, higher income on interest rate and currency derivatives, and higher returns on other limited partnership interests. These increases in net investment income were partially offset by lower yields on the reinvestment of fixed maturity securities and mortgage loans as well as lower returns on real estate joint ventures and other limited partnership interests. The average invested asset base increased primarily due to the SPDA Recaptures and positive general account net flows from our life businesses, partially offset by funding agreement repayments in our run-off business. Interest credited expense decreased primarily due to lower average crediting rates in our annuities business in connection with the low interest rate environment.

Insurance-Related Activities. Insurance-related activities decreased operating earnings by $470 million, primarily due to:

• a $205 million increase in insurance-related liabilities resulting from the ULSG Model Change combined with the impacts from the related loss recognition and additional recurring liability increases;

• a $109 million increase in insurance-related liabilities driven by GMDB costs related to higher claims, hedge losses and the liabilities increasing at a higher rate; and

• a $105 million increase in insurance-related liabilities from unfavorable underwriting experience due to (i) higher frequency and severity of claims in our ULSG and life businesses and (ii) the incremental increase in secondary guarantee liabilities subsequent to the implementation of the refinements to the actuarial valuation model in the second quarter of 2016. .

Excluding the impact of the annual actuarial assumption review, insurance-related activities decreased operating earnings by $453 million.

Amortization of DAC and VOBA. Higher DAC and VOBA amortization decreased operating earnings by $209 million, primarily due to:

• an increase in amortization of $216 million due to the ULSG Model Change and ULSG Re-segmentation, net of the impact of lower operating amortization recognized in 2016 compared to 2015, as a result of the loss recognition write-offs;

• an increase in amortization of $78 million due to the net impact from recapture activity related to several ceded and assumed reinsurance agreements for certain traditional life products;

• an increase in amortization of $67 million from changes in actuarial assumptions related to our variable annuity business discussed below; partially offset by

• a decrease in amortization of $71 million from a recovery of DAC related to the SPDA Recaptures;

• a decrease in amortization of $63 million from lower actual margins or profits resulting from lower asset-based fees earned on the lower average separate account balances, which exceeded the inverse effect on amortization from lower expected future margins or profits due to the same decrease in asset-based fees; and

• a decrease in amortization of $24 million due to lower profits earned on a closed block of universal life policies acquired through a prior acquisition.

Excluding the impact of the annual actuarial assumption review, higher amortization of DAC and VOBA decreased operating earnings by $139 million.

Other Expenses, Net of DAC Capitalization. Lower expenses increased operating earnings by $68 million, primarily due to the impacts from the U.S. Retail Advisor Force Divestiture, lower project-related costs and impacts from reinsurance recapture activities. These decreases were partially offset by higher software amortization as certain projects were completed and placed into service in 2016.

Actuarial Assumption Review. The results of our actuarial assumption review, which are included in the amounts discussed above, decreased operating earnings by $83 million, primarily due to:

9

• a decrease of $70 million from unfavorable DAC amortization mostly related to our variable annuity business due to assumption changes related to rider utilization, separate account growth, market volatility and lapse rates; and

• a decrease of $27 million due to GMDB liabilities resulting from assumption changes related to rider utilization assumptions; partially offset by

• an increase of $10 million due to lower liabilities resulting from assumption changes related to lapse rates in our universal and traditional life businesses.

Income Tax Expense (Benefit). Income tax expense for the year ended December 31, 2016 was $341 million, or 27% of income (loss) before provision for income tax, compared to income tax expense of $512 million, or 27% of income (loss) before provision for income tax, for the year ended December 31, 2015. Our effective tax rate differs from the U.S. statutory rate of 35% typically due to dividend received deductions and tax credits.

GMLB Riders

The following table presents the overall impact to income (loss) before provision for income tax from the performance of GMLB Riders for (i) changes in carrying value of the GAAP liabilities, (ii) the mark-to-market of hedges and reinsurance, (iii) fees, and (iv) associated DAC offsets for the years ended December 31, 2016 and 2015, respectively.

	Years Ended December 31,
	2016			2015
	(In millions)
Directly Written Liabilities	$	(2,477	)	$	(1,162	)
Assumed Reinsurance Liabilities	(34		)	(63		)
Total Liabilities	(2,511		)	(1,225		)
Core Hedges	(2,022		)	(86		)
Macro Overlay Hedges	(777		)	(162		)
Ceded Reinsurance	51			70
Total Hedges and Reinsurance	(2,748		)	(178		)
Directly Written Fees	825			759
Assumed Reinsurance Fees	21			21
Total Fees (1)	846			780
GMLB Riders before DAC Offsets	(4,413		)	(623		)
DAC Offsets	1,233			21
Total GMLB Riders	$	(3,180	)	$	(602	)

______________

(1) Excludes living benefit fees of $75 million and $74 million, included as a component of operating earnings, for the years ended December 31, 2016 and 2015, respectively.

Year Ended December 31, 2016 Compared with the Year Ended December 31, 2015

Unless otherwise noted, all amounts in the following discussion are net of income tax.

GMLB Riders decreased income (loss) before provision for income tax by $2.6 billion ($1.7 billion, net of income tax). Of this amount, an unfavorable change of $3.5 billion ($2.3 billion, net of income tax) was recorded in net derivative gains (losses). Excluding the impact of the annual actuarial assumption review, GMLB Riders decreased net income (loss) before provision for income tax by $320 million ($208 million, net of income tax).

GMLB Riders Liabilities

GMLB Riders liabilities represent our obligation to protect policyholders against the possibility that a downturn in the markets will reduce the specified benefits that can be claimed under the base annuity contract. Any periods of significant and/or sustained downturns in equity markets, increased equity volatility, or reduced interest rates could result in an increase in the valuation of our GMLB Riders liabilities. An increase in these liabilities would result in a decrease to our net income, which could be significant.

10

The change in the carrying value of GMLB Riders liabilities decreased income (loss) before provision for income tax by $1.3 billion ($836 million, net of income tax), primarily due to changes in actuarial assumptions related to rider utilization, partially offset by a favorable change from higher equity markets and higher interest rates. Excluding the impact of the annual actuarial assumption review, the change in the carrying value of the GMLB Riders liabilities increased income before provision for income tax by $1.7 billion ($1.1 billion, net of income tax).

GMLB Riders Hedges and Reinsurance

We enter into freestanding derivatives, and to a lesser extent reinsurance, to hedge the market risks inherent in GMLB Riders liabilities. However, certain of the risks inherent in GMLB Riders liabilities are unhedged, including the adjustment for non-performance risk. Generally, the same market factors that impact the fair value of GMLB Riders liabilities impact the value of the hedges, though in the opposite direction. However, due to the complex nature of the business and any unhedged risks, the changes in fair value of GMLB Riders liabilities and GMLB Riders hedges and reinsurance are not always in an equal amount.

The unfavorable change in the fair value of GMLB Riders hedges and reinsurance decreased income (loss) before provision for income tax by $2.6 billion ($1.7 billion, net of income tax). This unfavorable change in value was primarily due to impacts from higher equity markets as well as the effect on the hedges of long-term interest rates increasing in 2016 compared to decreasing in 2015.

GMLB Riders Fees

We earn fees on our GMLB Riders liabilities, which are calculated based on the notional amount used to calculate the owner’s guaranteed benefits (“Benefit Base”). In market downturns, fees calculated based on the benefit base are more stable, as compared to fees based on the account value, because the Benefit Base excludes the impact of a decline in the market value of the policyholder’s account value. We use the fees directly earned from GMLB Riders to fund the reserves, future claims and costs associated with the hedges of market risks inherent in GMLB Riders liabilities. For GMLB Riders liabilities accounted for as embedded derivatives, the future fees are included in the fair value of the embedded derivative liabilities, with changes recorded in net derivative gains (losses). For GMLB Riders liabilities accounted for as insurance, while the related fees do affect the valuations of these liabilities, they are not included in the resulting liability values, but are recorded separately in universal life and investment-type product policy fees.

Higher GMLB Riders fees increased income (loss) before provision for income tax by $66 million ($43 million, net of income tax), primarily due to the impact from the roll-up of the average benefit base on which fees are assessed.

DAC Offsets

DAC offsets related to the impact of changes in each of the individual components of the GMLB Riders discussed above increased income (loss) before provision for income tax by $1.2 billion ($788 million, net of income tax). The DAC offset related to each component of the directly written GMLB Riders is determined by the same factors that impact the respective component, but generally in the opposite direction. There is no DAC related to assumed reinsurance and, accordingly, no DAC offset. Excluding the impact of the annual actuarial assumption review, DAC offsets increased income (loss) before provision for income tax by $505 million ($328 million, net of income tax).

GMLB Riders Actuarial Assumption Review

The annual assumption review, which is included in the amounts discussed above, resulted in an unfavorable impact for the year ended December 31, 2016, decreasing income (loss) before provision for income tax by $2.3 billion ($1.5 billion, net of income tax), primarily due to the following:

• a decrease of $3.0 billion ($1.9 billion, net of income tax) recognized in net derivative gains (losses), mainly related to changes in rider utilization assumptions; partially offset by

• an increase of $707 million ($460 million, net of income tax) from the favorable impact to DAC amortization, which is inversely related to the assumption changes above.

11

Item 8. Financial Statements and Supplementary Data

Index to Consolidated Financial Statements, Notes and Schedules

	Page
Report of Independent Registered Public Accounting Firm	13
Financial Statements at December 31, 2016 and 2015 and for the Years Ended December 31, 2016, 2015 and 2014:
Consolidated Balance Sheets	14
Consolidated Statements of Operations	15
Consolidated Statements of Comprehensive Income (Loss)	16
Consolidated Statements of Stockholder's Equity	17
Consolidated Statements of Cash Flows	18
Notes to the Consolidated Financial Statements	20
Note 1 — Business, Basis of Presentation and Summary of Significant Accounting Policies	20
Note 2 — Segment Information	35
Note 3 — Organizational Changes	40
Note 4 — Disposition	41
Note 5 — Insurance	42
Note 6 — Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles	47
Note 7 — Reinsurance	51
Note 8 — Investments	57
Note 9 — Derivatives	76
Note 10 — Fair Value	88
Note 11 — Goodwill	105
Note 12 — Debt	107
Note 13 — Equity	108
Note 14 — Other Expenses	112
Note 15 — Income Tax	113
Note 16 — Contingencies, Commitments and Guarantees	116
Note 17 — Related Party Transactions	119
Note 18 — Subsequent Events	121
Financial Statement Schedules at December 31, 2016 and 2015 and for the Years Ended December 31, 2016, 2015 and 2014:
Schedule I — Consolidated Summary of Investments — Other Than Investments in Related Parties	123
Schedule II — Condensed Financial Information (Parent Company Only)	124
Schedule III — Consolidated Supplementary Insurance Information	129
Schedule IV — Consolidated Reinsurance	131

12

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholder of

Brighthouse Life Insurance Company:

We have audited the accompanying consolidated balance sheets of Brighthouse Life Insurance Company (formerly MetLife Insurance Company USA) and subsidiaries (the "Company") as of December 31, 2016 and 2015, and the related consolidated statements of operations, comprehensive income (loss), stockholder's equity, and cash flows for each of the three years in the period ended December 31, 2016. Our audits also included the financial statement schedules listed in the Index to the Consolidated Financial Statements, Notes and Schedules. These consolidated financial statements and financial statement schedules are the responsibility of the Company's management. Our responsibility is to express an opinion on the financial statements and financial statement schedules based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Brighthouse Life Insurance Company and subsidiaries as of December 31, 2016 and 2015, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly in all material respects the information set forth therein.

DELOITTE & TOUCHE LLP

New York, New York

March 28, 2017

(September 14, 2017 as to the effects of the change in reporting entity described in Note 3 and as to Note 18)

13

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Consolidated Balance Sheets

December 31, 2016 and 2015

(In millions, except share and per share data)

	2016			2015
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $57,289 and $59,852, respectively, includes $0 and $3,194, respectively, relating to variable interest entities)	$	59,899		$	62,121
Equity securities available-for-sale, at estimated fair value (cost: $280 and $432, respectively, includes $0 and $48, respectively, relating to variable interest entities)	300			457
Mortgage loans (net of valuation allowances of $40 and $36, respectively; includes $136 and $172, respectively, at estimated fair value, relating to variable interest entities)	9,290			7,404
Policy loans	1,093			1,266
Real estate and real estate joint ventures (includes $0 and $5, respectively, of real estate held-for-sale)	215			628
Other limited partnership interests	1,639			1,846
Short-term investments, principally at estimated fair value (includes $344 and $35, respectively, relating to variable interest entities)	1,272			1,796
Other invested assets, principally at estimated fair value (includes $0 and $50, respectively, relating to variable interest entities)	5,029			6,129
Total investments	78,737			81,647
Cash and cash equivalents, principally at estimated fair value (includes $3,078 and $47, respectively, relating to variable interest entities)	5,057			1,507
Accrued investment income (includes $1 and $1, respectively, relating to variable interest entities)	668			585
Premiums, reinsurance and other receivables	13,853			18,104
Deferred policy acquisition costs and value of business acquired	6,339			5,777
Current income tax recoverable	736			226
Goodwill	—			381
Other assets, principally at estimated fair value	689			862
Separate account assets	105,346			106,527
Total assets	$	211,425		$	215,616
Liabilities and Stockholder’s Equity
Liabilities
Future policy benefits	$	32,752		$	30,508
Policyholder account balances	36,579			36,725
Other policy-related balances	2,712			2,802
Payables for collateral under securities loaned and other transactions	7,371			10,622
Long-term debt (includes $23 and $48, respectively, at estimated fair value, relating to variable interest entities)	1,904			1,936
Deferred income tax liability	2,451			3,935
Other liabilities (includes $1 and $1, respectively, relating to variable interest entities)	5,445			3,925
Separate account liabilities	105,346			106,527
Total liabilities	194,560			196,980
Contingencies, Commitments and Guarantees (Note 16)
Stockholder’s Equity
Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding	75			75
Additional paid-in capital	18,461			16,850
Retained earnings (deficit)	(2,919		)	117
Accumulated other comprehensive income (loss)	1,248			1,594
Total stockholder’s equity	16,865			18,636
Total liabilities and stockholder’s equity	$	211,425		$	215,616

See accompanying notes to the consolidated financial statements.

14

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Consolidated Statements of Operations

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Revenues
Premiums	$	1,180		$	1,637		$	1,451
Universal life and investment-type product policy fees	3,097			3,293			3,610
Net investment income	3,111			3,001			2,984
Other revenues	709			433			520
Net investment gains (losses):
Other-than-temporary impairments on fixed maturity securities	(19		)	(23		)	(6		)
Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss)	(3		)	(8		)	(8		)
Other net investment gains (losses)	(45		)	36			(475		)
Total net investment gains (losses)	(67		)	5			(489		)
Net derivative gains (losses)	(5,770		)	(497		)	294
Total revenues	2,260			7,872			8,370
Expenses
Policyholder benefits and claims	3,738			3,087			3,198
Interest credited to policyholder account balances	1,131			1,224			1,245
Goodwill impairment	381			—			33
Amortization of deferred policy acquisition costs and value of business acquired	(225		)	673			1,069
Other expenses	1,700			1,723			1,757
Total expenses	6,725			6,707			7,302
Income (loss) before provision for income tax	(4,465		)	1,165			1,068
Provision for income tax expense (benefit)	(1,690		)	247			261
Net income (loss)	$	(2,775	)	$	918		$	807

See accompanying notes to the consolidated financial statements.

15

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Consolidated Statements of Comprehensive Income (Loss)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Net income (loss)	$	(2,775	)	$	918		$	807
Other comprehensive income (loss):
Unrealized investment gains (losses), net of related offsets	(535		)	(1,681		)	2,270
Unrealized gains (losses) on derivatives	27			89			245
Foreign currency translation adjustments	(3		)	(29		)	(50		)
Other comprehensive income (loss), before income tax	(511		)	(1,621		)	2,465
Income tax (expense) benefit related to items of other comprehensive income (loss)	165			593			(813		)
Other comprehensive income (loss), net of income tax	(346		)	(1,028		)	1,652
Comprehensive income (loss)	$	(3,121	)	$	(110	)	$	2,459

See accompanying notes to the consolidated financial statements.

16

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Consolidated Statements of Stockholder’s Equity

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	Common Stock			Additional Paid-in Capital			Retained Earnings (Deficit)			Accumulated Other Comprehensive Income (Loss)			Total Stockholder's Equity
Balance at December 31, 2013	$	86		$	16,700		$	(469	)	$	970		$	17,287
Redemption of common stock	(11		)	(895		)	(484		)				(1,390		)
Capital contributions from MetLife, Inc.				933									933
Dividends paid to MetLife, Inc.							(155		)				(155		)
Returns of capital				(40		)							(40		)
Net income (loss)							807						807
Other comprehensive income (loss), net of income tax										1,652			1,652
Balance at December 31, 2014	75			16,698			(301		)	2,622			19,094
Capital contributions from MetLife, Inc.				202									202
Dividends paid to MetLife, Inc.							(500		)				(500		)
Returns of capital				(50		)							(50		)
Net income (loss)							918						918
Other comprehensive income (loss), net of income tax										(1,028		)	(1,028		)
Balance at December 31, 2015	75			16,850			117			1,594			18,636
Capital contributions from MetLife, Inc.				1,637									1,637
Dividends paid to MetLife, Inc.							(261		)				(261		)
Returns of capital				(26		)							(26		)
Net income (loss)							(2,775		)				(2,775		)
Other comprehensive income (loss), net of income tax										(346		)	(346		)
Balance at December 31, 2016	$	75		$	18,461		$	(2,919	)	$	1,248		$	16,865

See accompanying notes to the consolidated financial statements.

17

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Consolidated Statements of Cash Flows

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Cash flows from operating activities
Net income (loss)	$	(2,775	)	$	918		$	807
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization expenses	56			25			31
Amortization of premiums and accretion of discounts associated with investments, net	(231		)	(233		)	(173		)
(Gains) losses on investments and from sales of businesses, net	66			(5		)	489
(Gains) losses on derivatives, net	6,998			1,321			1,255
(Income) loss from equity method investments, net of dividends or distributions	26			110			(17		)
Interest credited to policyholder account balances	1,131			1,224			1,245
Universal life and investment-type product policy fees	(3,097		)	(3,293		)	(3,610		)
Goodwill impairment	381			—			33
Change in accrued investment income	(35		)	10			107
Change in premiums, reinsurance and other receivables	45			(403		)	(879		)
Change in deferred policy acquisition costs and value of business acquired, net	(555		)	273			690
Change in income tax	(1,830		)	724			762
Change in other assets	2,152			2,231			2,376
Change in future policy benefits and other policy-related balances	2,404			2,283			1,103
Change in other liabilities	(590		)	(206		)	1,562
Other, net	(15		)	13			(20		)
Net cash provided by (used in) operating activities	4,131			4,992			5,761
Cash flows from investing activities
Sales, maturities and repayments of:
Fixed maturity securities	45,460			38,341			22,990
Equity securities	224			308			98
Mortgage loans	1,560			1,083			2,456
Real estate and real estate joint ventures	446			512			28
Other limited partnership interests	417			425			255
Purchases of:
Fixed maturity securities	(39,097		)	(43,502		)	(28,056		)
Equity securities	(58		)	(273		)	(89		)
Mortgage loans	(2,847		)	(2,560		)	(353		)
Real estate and real estate joint ventures	(75		)	(109		)	(209		)
Other limited partnership interests	(203		)	(233		)	(345		)
Cash received in connection with freestanding derivatives	707			224			788
Cash paid in connection with freestanding derivatives	(2,764		)	(869		)	(1,991		)
Cash received under repurchase agreements	—			199			—
Cash paid under repurchase agreements	—			(199		)	—
Cash received under reverse repurchase agreements	—			199			—
Cash paid under reverse repurchase agreements	—			(199		)	—
Sale of business, net of cash and cash equivalents disposed of $0, $0 and $251, respectively	—			—			451
Sales of loans to affiliates	—			26			520
Receipts on loans to affiliates	50			—			—
Net change in policy loans	109			(72		)	52
Net change in short-term investments	596			(343		)	3,491
Net change in other invested assets	7			(55		)	(598		)
Net cash provided by (used in) investing activities	$	4,532		$	(7,097	)	$	(512	)

See accompanying notes to the consolidated financial statements.

18

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Consolidated Statements of Cash Flows — (continued)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Cash flows from financing activities
Policyholder account balances:
Deposits	$	10,040		$	20,269		$	18,947
Withdrawals	(12,292		)	(21,078		)	(21,853		)
Net change in payables for collateral under securities loaned and other transactions	(3,251		)	3,121			704
Long-term debt issued	—			175			—
Long-term debt repaid	(26		)	(235		)	(1,379		)
Financing element on certain derivative instruments and other derivative related transactions, net	(1,011		)	(97		)	(414		)
Redemption of common stock	—			—			(906		)
Common stock redemption premium	—			—			(484		)
Dividends paid to MetLife, Inc.	(261		)	(500		)	(155		)
Capital contributions from MetLife, Inc.	1,688			406			476
Net cash provided by (used in) financing activities	(5,113		)	2,061			(5,064		)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	—			(2		)	(45		)
Change in cash and cash equivalents	3,550			(46		)	140
Cash and cash equivalents, beginning of year	1,507			1,553			1,413
Cash and cash equivalents, end of year	$	5,057		$	1,507		$	1,553
Supplemental disclosures of cash flow information
Net cash paid (received) for:
Interest	$	130		$	137		$	171
Income tax	$	150		$	(463	)	$	(471	)
Non-cash transactions:
Returns of capital	$	26		$	50		$	40
Capital contributions	$	69		$	181		$	457
Transfer of fixed maturity securities from affiliates	$	4,030		$	—		$	—
Transfer of mortgage loans from affiliates	$	662		$	—		$	—
Transfer of short-term investments from affiliates	$	94		$	—		$	—
Transfer of fixed maturity securities to affiliates	$	346		$	—		$	804
Transfer of mortgage loans to affiliates	$	—		$	—		$	94
Reduction of other invested assets in connection with affiliated reinsurance transactions	$	676		$	—		$	863
Transfer of policyholder account balances to affiliate	$	—		$	—		$	528

See accompanying notes to the consolidated financial statements.

19

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements

1. Business, Basis of Presentation and Summary of Significant Accounting Policies

Business

“Brighthouse Insurance” and the “Company” refer to Brighthouse Life Insurance Company (formerly, MetLife Insurance Company USA, “MetLife USA”), a Delaware corporation originally incorporated in Connecticut in 1863, and its subsidiaries. Brighthouse Life Insurance Company is a wholly-owned subsidiary of Brighthouse Holdings, LLC, which until July 28, 2017 was a direct wholly-owned subsidiary of MetLife, Inc. (MetLife, Inc., together with its subsidiaries and affiliates, “MetLife”). The Company offers a range of individual annuities and individual life insurance products.

On January 12, 2016, MetLife, Inc. announced its plan to pursue the separation of a substantial portion of its former U.S. retail business (the “Separation”). Additionally, on July 21, 2016, MetLife, Inc. announced that the separated business would be rebranded as “Brighthouse Financial.” Effective March 6, 2017, and in connection with the Separation, the Company changed its name from MetLife Insurance Company USA to Brighthouse Life Insurance Company.

On October 5, 2016, Brighthouse Financial, Inc. (together with its subsidiaries and affiliates, “Brighthouse”), which until the completion of the Separation on August 4, 2017, was a wholly-owned subsidiary of MetLife, Inc., filed a registration statement on Form 10 (as amended, the “Form 10”) with the U.S. Securities and Exchange Commission (“SEC”) that was declared effective by the SEC on July 6, 2017. The Form 10 disclosed MetLife, Inc.’s plans to undertake several actions, including an internal reorganization involving its U.S. retail business (the “Restructuring”) and include Brighthouse Insurance and certain affiliates in the planned separated business and distribute at least80.1%of the shares of Brighthouse Financial, Inc’s common stock on a pro rata basis to the holders of MetLife, Inc. common stock. In connection with the Restructuring, effective April 2017, following receipt of applicable regulatory approvals, MetLife, Inc. contributed certain affiliated reinsurance companies and Brighthouse Life Insurance Company of NY (“Brighthouse NY”) to Brighthouse Insurance (the “Contribution Transactions”). The affiliated reinsurance companies were then merged into Brighthouse Reinsurance Company of Delaware (“BRCD”), a licensed reinsurance subsidiary of Brighthouse Life Insurance Company. SeeNote 3for further information on this change, which was applied retrospectively. On July 28, 2017, MetLife, Inc. contributed Brighthouse Holdings, LLC to Brighthouse Financial, Inc., resulting in Brighthouse Life Insurance Company becoming an indirect wholly-owned subsidiary of Brighthouse Financial, Inc.On August 4, 2017, MetLife, Inc. completed the Separation through a distribution of 96,776,670 of the 119,773,106 shares of the common stock of Brighthouse Financial, Inc., representing 80.8% of MetLife Inc.’s interest in Brighthouse Financial, Inc., to holders of MetLife, Inc. common stock.

In anticipation of the Separation, in the third quarter of 2016, the Company reorganized its businesses intothreesegments: Annuities, Life and Run-off. SeeNote 2for further information on the reorganization of the Company’s segments in the third quarter of 2016, which was applied retrospectively.

In November 2014, MetLife Insurance Company of Connecticut re-domesticated from Connecticut to Delaware, changed its name to MetLife Insurance Company USA and merged with its subsidiary, MetLife Investors USA Insurance Company (“MLI-USA”), and its affiliates, MetLife Investors Insurance Company (“MLIIC”) and Exeter Reassurance Company, Ltd. (“Exeter”). See Note 3 for further information on the merger transactions and the prior periods’ adjustments.

Basis of Presentation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.

Consolidation

The accompanying consolidated financial statements include the accounts of Brighthouse Life Insurance Company and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.

Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.

20

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Discontinued Operations

The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. Effective January 1, 2014, the Company adopted new guidance regarding reporting of discontinued operations for disposals or classifications as held-for-sale that have not been previously reported on the consolidated financial statements. A disposal of a component is reported in discontinued operations if the disposal represents a strategic shift that has or will have a major effect on the Company’s operations and financial results. See “— Adoption of New Accounting Pronouncements.”

Separate Accounts

Separate accounts are established in conformity with insurance laws. Generally, the assets of the separate accounts cannot be used to settle the liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if:

• such separate accounts are legally recognized;

• assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities;

• investments are directed by the contractholder; and

• all investment performance, net of contract fees and assessments, is passed through to the contractholder.

The Company reports separate account assets at their fair value, which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line on the statements of operations. Separate accounts credited with a contractual investment return are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses and the accounting for these investments is consistent with the methodologies described herein for similar financial instruments held within the general account.

The Company’s revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees on the statements of operations.

Reclassifications

Certain amounts in the prior years’ consolidated financial statements and related footnotes thereto have been reclassified to conform with the current year presentation as discussed throughout the Notes to the Consolidated Financial Statements.

Summary of Significant Accounting Policies

The following are the Company’s significant accounting policies with references to notes providing additional information on such policies and critical accounting estimates relating to such policies.

Accounting Policy	Note
Insurance	5
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles	6
Reinsurance	7
Investments	8
Derivatives	9
Fair Value	10
Income Tax	15
Litigation Contingencies	16

21

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Insurance

Future Policy Benefit Liabilities and Policyholder Account Balances

The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid, reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions that are in accordance with GAAP and applicable actuarial standards. The principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, policy renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. These assumptions are established at the time the policy is issued and locked in and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality, morbidity and interest rates are locked in upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation. To assess whether or not a premium deficiency exists, the Company groups insurance contracts based on the manner acquired, serviced, and the measurement of profitability. In applying the profitability criteria, groupings are limited by segment.

Liabilities for universal and variable life secondary guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the contract period based on total expected assessments. The assumptions used in estimating the secondary guarantee liabilities are consistent with those used for amortizing deferred policy acquisition costs (“DAC”), and are therefore subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of the appropriate underlying equity indices, such as the Standard & Poor’s Global Ratings (“S&P”) 500 Index. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios.

The Company regularly reviews its assumptions supporting its estimates of actuarial liabilities for future policy benefits. For universal life and annuity product guarantees, assumptions are updated periodically, whereas for traditional life products, such as term life and non-participating whole life insurance, assumptions are established and locked in at inception but reviewed periodically to determine whether a premium deficiency exists that would trigger an unlocking of assumptions. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur.

Policyholder account balances relate to contracts or contract features where the Company has no significant insurance risk.

See “— Variable Annuity Guarantees” for additional information on the Company’s variable annuity guarantee features that are accounted for as insurance liabilities and recorded in future policy benefits, as well as the guarantee features that are accounted for at fair value as embedded derivatives and recorded in policyholder account balances.

Other Policy-Related Balances

Other policy-related balances primarily include assumed affiliated reinsurance payables, affiliated deferred experience refunds, policy and contract claims and unearned revenue liabilities.

The assumed affiliated reinsurance payable relates primarily to reinsurance for certain universal life business assumed from an affiliate, net of other reinsurance. 

The affiliated deferred experience refunds relate to the repayment of acquisition costs under an affiliated reinsurance agreement and represent part of the net cost of reinsurance for the business reinsured. The deferred experience refund is being amortized consistent with the DAC methodology on the underlying contracts.

22

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

The liability for policy and contract claims generally relates to incurred but not reported death, disability and long-term care claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company’s estimated ultimate cost of settling all claims. The Company derives estimates for the development of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made.

The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product’s estimated gross profits, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees.

Recognition of Insurance Revenues and Deposits

Premiums related to traditional life and annuity contracts with life contingencies are recognized as revenues when due from policyholders. When premiums are due over a significantly shorter period than the period over which policyholder benefits are incurred, any excess profit is deferred and recognized into earnings in proportion to insurance in-force or, for annuities, the amount of expected future policy benefit payments.

Premiums related to non-medical health and disability contracts are recognized on a pro rata basis over the applicable contract term.

Deposits related to universal life-type and investment-type products are credited to policyholder account balances. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which policyholder benefits and expenses are incurred. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related policyholder account balances.

Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance.

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles

The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include:

• incremental direct costs of contract acquisition, such as commissions;

• the portion of an employee’s total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed;

• other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and

• the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits.

All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred.

Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections.

23

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

DAC and VOBA are amortized as follows:

Products:		In proportion to the following over estimated lives of the contracts:
•	Nonparticipating and non-dividend-paying traditional contracts (primarily term insurance)		Actual and expected future gross premiums.
•	Participating, dividend-paying traditional contracts		Actual and expected future gross margins.
•	Fixed and variable universal life contracts		Actual and expected future gross profits.
•	Fixed and variable deferred annuity contracts

See Note 6 for additional information on DAC and VOBA amortization.

The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated on the financial statements for reporting purposes.

The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a specified percentage of the customer’s deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements (“DSI”) to determine the recoverability of the asset.

Value of distribution agreements acquired (“VODA”) is reported in other assets and represents the present value of expected future profits associated with the expected future business derived from the distribution agreements acquired as part of a business combination. Value of customer relationships acquired (“VOCRA”) is also reported in other assets and represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business. The VODA and VOCRA associated with past business combinations are amortized over useful lives ranging from 10 to 40 years and such amortization is included in other expenses. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews VODA and VOCRA to determine whether the asset is impaired.

Reinsurance

For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims.

For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC when there is a gain at inception on the ceding entity and to other liabilities when there is a loss at inception. The net cost of reinsurance is recognized as a component of other expenses when there is a gain at inception and as policyholder benefits and claims when there is a loss and is subsequently amortized on a basis consistent with the methodology used for amortizing DAC related to the underlying reinsured contracts. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums and ceded (assumed) premiums, reinsurance and other receivables (future policy benefits) are established.

Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance.

24

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. The Company withholds the funds rather than transferring the underlying investments and, as a result, records funds withheld liability within other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio.

Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to guaranteed minimum income benefits (“GMIBs”), a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in net derivative gains (losses).

If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. Certain assumed non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”), guaranteed minimum accumulation benefits (“GMABs”) and GMIBs are also accounted for as embedded derivatives with changes in estimated fair value reported in net derivative gains (losses).

Variable Annuity Guarantees

The Company issues directly and assumes from an affiliate through reinsurance certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. In some cases, the benefit base may be increased by additional deposits, bonus amounts, accruals or optional market value step-ups.

Certain of the Company’s variable annuity guarantee features are accounted for as insurance liabilities and recorded in future policy benefits while others are accounted for at fair value as embedded derivatives and recorded in policyholder account balances. Generally speaking, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. Alternatively, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize, that is, the policyholder can receive the guarantee on a net basis. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Further, changes in assumptions, principally involving behavior, can result in a change of expected future cash outflows of a guarantee between portions accounted for as insurance liabilities and portions accounted for as embedded derivatives.

Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits (“GMDBs”), the life contingent portion of the GMWBs and the portion of the GMIBs that require annuitization, as well as the life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value.

These insurance liabilities are accrued over the accumulation phase of the contract in proportion to actual and future expected policy assessments based on the level of guaranteed minimum benefits generated using multiple scenarios of separate account returns. The scenarios are based on best estimate assumptions consistent with those used to amortize DAC. When current estimates of future benefits exceed those previously projected or when current estimates of future assessments are lower than those previously projected, liabilities will increase, resulting in a current period charge to net income. The opposite result occurs when the current estimates of future benefits are lower than those previously projected or when current estimates of future assessments exceed those previously projected. At each reporting period, we update the actual amount of business remaining in-force, which impacts expected future assessments and the projection of estimated future benefits resulting in a current period charge or increase to earnings.SeeNote 5for additional details of guarantees accounted for as insurance liabilities.

25

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Guarantees accounted for as embedded derivatives in policyholder account balances include the non-life contingent portion of GMWBs,GMABs,and for GMIBs the non-life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value, as well as the Guaranteed Principal Option.

The estimated fair values of guarantees accounted for as embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees. At policy inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees. In valuing the embedded derivative, the percentage of fees included in the fair value measurement is locked-in at inception.

The projections of future benefits and future fees require capital market and actuarial assumptions including expectations concerning policyholder behavior. A risk neutral valuation methodology is used to project the cash flows from the guarantees under multiple capital market scenarios to determine an economic liability. The reported estimated fair value is then determined by taking the present value of these risk-free generated cash flows using a discount rate that incorporates a spread over the risk-free rate to reflect our nonperformance risk and adding a risk margin. For more information on the determination of estimated fair value,seeNote 10Fair Value.

Investments

Net Investment Income and Net Investment Gains (Losses)

Income from investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein.

Fixed Maturity and Equity Securities

The Company’s fixed maturity and equity securities are classified as available-for-sale (“AFS”) and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) (“OCI”), net of policy-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis.

Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for mortgage-backed and asset-backed securities (“ABS”) considers the estimated timing and amount of prepayments of the underlying loans. See Note 8 “Investments — Fixed Maturity and Equity Securities AFS — Methodology for Amortization of Premium and Accretion of Discount on Structured Securities”. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Dividends on equity securities are recognized when declared.

The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 8 “— Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities.”

For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment (“OTTI”) is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in OCI.

26

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security’s cost and its estimated fair value.

Mortgage Loans

The Company disaggregates its mortgage loan investments into three portfolio segments: commercial, agricultural and residential. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 8.

Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts.

Also included in mortgage loans are commercial mortgage loans held by consolidated securitization entities (“CSEs”) for which the fair value option (“FVO”) was elected, which are stated at estimated fair value. Changes in estimated fair value are recognized in net investment gains (losses) for commercial mortgage loans held by CSEs.

Policy Loans

Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy.

Real Estate

Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Rental income is recognized on a straight-line basis over the term of the respective leases. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable and exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, which is generally computed using the present value of expected future cash flows discounted at a rate commensurate with the underlying risks.

Real estate for which the Company commits to a plan to sell within one year and actively markets in its current condition for a reasonable price in comparison to its estimated fair value is classified as held-for-sale. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated.

Real Estate Joint Ventures and Other Limited Partnership Interests

The Company uses the equity method of accounting for investments (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, while the cost method is used when the Company has virtually no influence over the investee’s operations. The Company generally recognizes its share of the equity method investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period; while distributions on cost method investments are recognized as earned or received.

The Company routinely evaluates such investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value (“NAV”). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired.

27

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Short-term Investments

Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. Short-term investments also include investments in affiliated money market pools.

Other Invested Assets

Other invested assets consist principally of the following:

• Freestanding derivatives with positive estimated fair values which are described in “— Derivatives” below.

• Tax credit and renewable energy partnerships which derive a significant source of investment return in the form of income tax credits or other tax incentives. Where tax credits are guaranteed by a creditworthy third party, the investment is accounted for under the effective yield method. Otherwise, the investment is accounted for under the equity method.

• Leveraged leases which are recorded net of non-recourse debt. Income is recognized by applying the leveraged lease’s estimated rate of return to the net investment in the lease. The Company regularly reviews residual values for impairment.

• Investments in an operating joint venture that engages in insurance underwriting activities which are accounted for under the equity method.

• Funds withheld which represent a receivable for amounts contractually withheld by ceding companies in accordance with reinsurance agreements. The Company recognizes interest on funds withheld at rates defined by the terms of the agreement which may be contractually specified or directly related to the underlying investments.

Securities Lending Program

Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with securities lending transactions may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the Company’s financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary throughout the duration of the loan. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income.

Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.

28

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:

Statement of Operations Presentation:	Derivative:
Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
Net investment income	•	Economic hedges of equity method investments in joint ventures

Hedge Accounting

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:

• Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in estimated fair value of the hedged item attributable to the designated risk being hedged.

• Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).

The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported on the statement of operations within interest income or interest expense to match the location of the hedged item.

In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

29

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Embedded Derivatives

The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:

• the combined instrument is not accounted for in its entirety at estimated fair value with changes in estimated fair value recorded in earnings;

• the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and

• a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.

See “Variable Annuity Guarantees” for additional information on the accounting policy for embedded derivatives bifurcated from variable annuity host contracts.

Such embedded derivatives are carried on the balance sheet at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses), except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation.

Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition.

Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities.

Income Tax

Brighthouse Life Insurance Company and its includable subsidiaries join with MetLife, Inc. and its includable subsidiaries in filing a consolidated U.S. life and non-life federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended. Current taxes (and the benefits of tax attributes such as losses) are allocated to Brighthouse Life Insurance Company and its subsidiaries under the consolidated tax return regulations and a tax sharing agreement. Under the consolidated tax return regulations, MetLife, Inc. has elected the “percentage method” (and 100% under such method) of reimbursing companies for tax attributes e.g. net operating losses. As a result, 100% of tax attributes are reimbursed by MetLife, Inc. to the extent that consolidated federal income tax of the consolidated federal tax return group is reduced in a year by tax attributes. On an annual basis, each of the profitable subsidiaries pays to MetLife, Inc. the federal income tax which it would have paid based upon that year’s taxable income. If Brighthouse Life Insurance Company or its includable subsidiaries has current or prior deductions and credits (including but not limited to losses) which reduce the consolidated tax liability of the consolidated federal tax return group, the deductions and credits are characterized as realized (or realizable) by Brighthouse Life Insurance Company and its includable subsidiaries when those tax attributes are realized (or realizable) by the consolidated federal tax return group, even if Brighthouse Life Insurance Company or its includable subsidiaries would not have realized the attributes on a stand-alone basis under a “wait and see” method.

30

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

The Company’s accounting for income taxes represents management’s best estimate of various events and transactions.

Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse.

The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established against deferred tax assets when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination the Company considers many factors, including:

• the nature, frequency, and amount of cumulative financial reporting income and losses in recent years;

• the jurisdiction in which the deferred tax asset was generated;

• the length of time that carryforward can be utilized in the various taxing jurisdiction;

• future taxable income exclusive of reversing temporary differences and carryforwards;

• future reversals of existing taxable temporary differences;

• taxable income in prior carryback years; and

• tax planning strategies.

The Company may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, the effect of changes in tax laws, tax regulations, or interpretations of such laws or regulations, is recognized in net income tax expense (benefit) in the period of change.

The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded on the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made.

The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax expense.

Litigation Contingencies

The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company’s financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected on the Company’s financial statements.

Other Accounting Policies

Cash and Cash Equivalents

The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value.

31

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Property, Equipment, Leasehold Improvements and Computer Software

Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, as appropriate. Estimated lives generally range from five to 10 years for leasehold improvements, and from three to seven years for all other property and equipment. The net book value of the property, equipment and leasehold improvements was insignificant at both December 31, 2016 and 2015.

Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $248 million and $266 million at December 31, 2016 and 2015, respectively. Accumulated amortization of capitalized software was $142 million and $110 million at December 31, 2016 and 2015, respectively. Related amortization expense was $39 million, less than $1 million and $3 million for the years ended December 31, 2016, 2015 and 2014, respectively.

Other Revenues

Other revenues primarily include, in addition to items described elsewhere herein, fee income on financial reinsurance agreements and broker-dealer fees.

Employee Benefit Plans

Through December 31, 2016, Metropolitan Life Insurance Company (“MLIC”) provided and the Company contributed to defined benefit pension and postemployment plans for its employees and retirees. MLIC also provides and the Company contributes to a postretirement medical and life insurance benefit plan for certain retired employees. The Company accounts for these plans as multiemployer benefit plans and as a result the assets, obligations and other comprehensive gains and losses of these benefit plans are not included on the consolidated balance sheet. Within its consolidated statement of operations, the Company has included expense associated with its participants in these plans. These plans also include participants from other affiliates of MLIC. The Company’s participation in these plans ceased December 31, 2016.

Defined Contribution Plans

Through December 31, 2016, MLIC provides and the Company contributes to a defined contribution plan sponsored by MLIC for substantially all employees under which a portion of employee contributions are matched. The Company’s participation in this plan ceased on December 31, 2016.

Foreign Currency

Assets, liabilities and operations of a foreign affiliate (owned in 2014) are recorded based on functional currency. The determination of the functional currency is made based on the appropriate economic and management indicators. The local currencies of foreign operations are the functional currencies. Assets and liabilities of this foreign affiliate are translated from the functional currency to U.S. dollars at the exchange rates in effect at each year-end and revenues and expenses are translated at the average exchange rates during the year. The resulting translation adjustments are charged or credited directly to OCI, net of applicable taxes. Gains and losses from foreign currency transactions, including the effect of re-measurement of monetary assets and liabilities to the appropriate functional currency, are reported as part of net investment gains (losses) in the period in which they occur.

Goodwill

Goodwill represents the future economic benefits arising from net assets acquired in a business combination that are not individually identified and recognized. Goodwill is calculated as the excess of cost over the estimated fair value of such net assets acquired, is not amortized, and is tested for impairment based on a fair value approach at least annually or more frequently if events or circumstances indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event.

32

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

The impairment test is performed at the reporting unit level, which is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income.

On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company’s reporting units to assess whether any goodwill impairment exists.

Adoption of New Accounting Pronouncements

Effective January 1, 2016, the Company adopted guidance relating to short-duration contracts. Upon adopting the new guidance, the Company updated the disclosure for the rollforward of the liability of the unpaid policy and contract claims to include incurred and paid long-duration life claims that are settled within one year. The Company’s liability for unpaid policy and contract claims includes incurred but not reported claims, as well as claims which have been reported but not yet settled. The net incurred and paid claims within the Company’s tabular rollforward are principally comprised of death benefits on long-duration life contracts. The adoption did not have an impact on the consolidated financial statements and given the Company’s minimal extent of short-duration insurance contracts did not require any other expanded disclosures.

Effective January 1, 2016, the Company retrospectively adopted new guidance relating to the consolidation of certain entities. The objective of the new standard is to improve targeted areas of the consolidation guidance and to reduce the number of consolidation models. The new consolidation standard provides guidance on how a reporting entity (i) evaluates whether the entity should consolidate limited partnerships and similar entities, (ii) assesses whether the fees paid to a decisionmaker or service provider are variable interests in a VIE, and (iii) assesses the variable interests in a VIE held by related parties of the reporting entity. The new guidance also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. The adoption of the new guidance did not impact which entities are consolidated by the Company. The consolidated VIE assets and liabilities and unconsolidated VIE carrying amounts and maximum exposure to loss as of December 31, 2016, disclosed in Note 8, reflect the application of the new guidance.

Effective November 18, 2014, the Company adopted new guidance on when, if ever, the cost of acquiring an entity should be used to establish a new accounting basis (“pushdown”) in the acquired entity’s separate financial statements. The guidance provides an acquired entity and its subsidiaries with an irrevocable option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. If a reporting entity elects to apply pushdown accounting, its stand-alone financial statements would reflect the acquirer’s new basis in the acquired entity’s assets and liabilities. The election to apply pushdown accounting should be determined by an acquired entity for each individual change-in-control event in which an acquirer obtains control of the acquired entity; however, an entity that does not elect to apply pushdown accounting in the period of a change-in-control can later elect to retrospectively apply pushdown accounting to the most recent change-in-control transaction as a change in accounting principle. The new guidance did not have a material impact on the consolidated financial statements upon adoption.

Effective January 1, 2014, the Company adopted new guidance regarding reporting of discontinued operations and disclosures of disposals of components of an entity. The guidance increases the threshold for a disposal to qualify as a discontinued operation, expands the disclosures for discontinued operations and requires new disclosures for certain disposals that do not meet the definition of a discontinued operation. Disposals must now represent a strategic shift that has or will have a major effect on the entity’s operations and financial results to qualify as discontinued operations. As discussed in Note 4, the Company sold its wholly-owned subsidiary, MetLife Assurance Limited (“MAL”). As a result of the adoption of this new guidance, the results of operations of MAL and the loss on sale have been included in income from continuing operations.

33

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Future Adoption of New Accounting Pronouncements

In February 2017, the FASB issued new guidance on derecognition of nonfinancial assets ASU 2017- 05,Other Income-Gains and Losses from the Derecognition of Nonfinancial Assets(Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those years. Early adoption is permitted for interim or annual reporting periods beginning after December 15, 2016. The guidance may be applied retrospectively for all periods presented or retrospectively with a cumulative-effect adjustment at the date of adoption. The new guidance clarifies the scope and accounting of a financial asset that meets the definition of an “in-substance nonfinancial asset” and defines the term, “in-substance nonfinancial asset.” The ASU also adds guidance for partial sales of nonfinancial assets. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In January 2017, the FASB issued new guidance on business combinations (ASU 2017- 01,Business Combinations (Topic 805): Clarifying the Definition of a Business).The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a prospective basis. Early adoption is permitted as specified in the guidance. The new guidance clarifies the definition of a business and requires that an entity apply certain criteria in order to determine when a set of assets and activities qualifies as a business. The adoption of this standard will result in fewer acquisitions qualifying as businesses and, accordingly, acquisition costs for those acquisitions that do not qualify as businesses will be capitalized rather than expensed. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In November 2016, the FASB issued new guidance on restricted cash (ASU 2016-18,Statement of Cash Flows (Topic 230): a consensus of the FASB Emerging Issues Task Force). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a retrospective basis. Early adoption is permitted. The new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, the new guidance requires that amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The new guidance does not provide a definition of restricted cash or restricted cash equivalents. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In October 2016, the FASB issued new guidance on consolidation evaluation for entities under common control (ASU 2016-17,Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control).The new guidance is effective for fiscal years beginning after December 15, 2016 and interim periods within those fiscal years, and should be applied on a retrospective basis. Early adoption is permitted. The new guidance does not change the characteristics of a primary beneficiary under current GAAP. It changes how a reporting entity evaluates whether it is the primary beneficiary of a VIE by changing how a reporting entity that is a single decisionmaker of a VIE handles indirect interests in the entity held through related parties that are under common control with the reporting entity. The adoption of this new guidance will not have a material impact on the Company’s consolidated financial statements.

In October 2016, the FASB issued new guidance on tax accounting for intra-entity transfers of assets (ASU 2016-16,Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a modified retrospective basis. Early adoption is permitted in the first interim or annual reporting period. Current guidance prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. The new guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Also, the guidance eliminates the exception for an intra-entity transfer of an asset other than inventory. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In August 2016, the FASB issued new guidance on cash flow statement presentation (ASU 2016-15,Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied retrospectively to all periods presented. Early adoption is permitted in any interim or annual period. This ASU addresses diversity in how certain cash receipts and cash payments are presented and classified on the statement of cash flows. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

34

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

In June 2016, the FASB issued new guidance on measurement of credit losses on financial instruments (ASU 2016-13,Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments). The new guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This ASU replaces the incurred loss impairment methodology with one that reflects expected credit losses. The measurement of expected credit losses should be based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance requires that an OTTI on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses. The guidance also requires enhanced disclosures. The Company has assessed the asset classes impacted by the new guidance and is currently assessing the accounting and reporting system changes that will be required to comply with the new guidance. The Company believes that the most significant impact upon adoption will be to its mortgage loan investments. The Company is continuing to evaluate the overall impact of the new guidance on its consolidated financial statements.

In January 2016, the FASB issued new guidance (ASU 2016-01,Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities)on the recognition and measurement of financial instruments. The new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted for the instrument-specific credit risk provision. The new guidance changes the current accounting guidance related to (i) the classification and measurement of certain equity investments, (ii) the presentation of changes in the fair value of financial liabilities measured under the FVO that are due to instrument-specific credit risk, and (iii) certain disclosures associated with the fair value of financial instruments. Additionally, there will no longer be a requirement to assess equity securities for impairment since such securities will be measured at fair value through net income. The Company has assessed the population of financial instruments that are subject to the new guidance and has determined that the most significant impact will be the requirement to report changes in fair value in net income each reporting period for all equity securities currently classified as AFS and to a lesser extent, other limited partnership interests and real estate joint ventures that are currently accounted for under the cost method. The population of these investments accounted for under the cost method is not material. The Company is continuing to evaluate the overall impact of this guidance on its consolidated financial statements.

In May 2014, the FASB issued a comprehensive new revenue recognition standard (ASU 2014‑09,Revenue from Contracts with Customers (Topic 606)), effective for fiscal years beginning after December 15, 2017 and interim periods within those years. The guidance may be applied retrospectively for all periods presented or retrospectively with a cumulative-effect adjustment at the date of adoption. The new guidance will supersede nearly all existing revenue recognition guidance under U.S. GAAP; however, it will not impact the accounting for insurance and investment contracts within the scope of Financial Services insurance (Topic 944), leases, financial instruments and guarantees. For those contracts that are impacted, the guidance will require an entity to recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled, in exchange for those goods or services. Given the scope of the new revenue recognition guidance, the Company does not expect the adoption to have a material impact on its consolidated revenues or statements of operations, with the Company’s implementation efforts primarily focused on other revenues on the consolidated statements of operations.

Other

Effective January 3, 2017, the Chicago Mercantile Exchange (“CME”) amended its rulebook, resulting in the characterization of variation margin transfers as settlement payments, as opposed to adjustments to collateral. These amendments will impact the accounting treatment of the Company’s centrally cleared derivatives, for which the CME serves as the central clearing party. The application of the amended rulebook is expected to reduce the gross derivative assets and liabilities, as well as the related collateral, recorded on the consolidated balance sheet for trades cleared through the CME. The Company is currently evaluating the impact of these amendments on its consolidated financial statements. This change is not expected to impact the tax treatment of such derivatives, although the IRS is being asked to issue definitive guidance.

2. Segment Information

In anticipation of the planned Separation, in the third quarter of 2016, the Company reorganized its businesses intothreesegments: Annuities, Life and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other. Also, in the fourth quarter of 2016, the Company moved the universal life policies with secondary guarantees (“ULSG”) business

35

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

2. Segment Information (continued)

from the Life segment to the Run-off segment. These and certain other presentation changes were applied retrospectively and did not have an impact on total consolidated net income (loss) or operating earnings in the prior periods.

Annuities

The Annuities segment offers a variety of variable, fixed, index-linked and income annuities designed to address contractholders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.

Life

The Life segment offers insurance products and services, including term, whole, universal and variable life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis.

Run-off

The Run-off segment consists of products no longer actively sold and which are separately managed, including structured settlements, certain company-owned life insurance policies, bank-owned life insurance policies, funding agreements and ULSG.

Corporate & Other

Corporate & Other contains the excess capital not allocated to the segments and interest expense related to the majority of the Company’s outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. Additionally, Corporate & Other includes assumed reinsurance of certain variable annuity products from a former affiliated operating joint venture in Japan. Under this in-force reinsurance agreement, the Company reinsured living and death benefit guarantees issued in connection with variable annuity products. Also, Corporate & Other includes a reinsurance agreement to assume certain blocks of indemnity reinsurance from an affiliate. These reinsurance agreements were recaptured effective November 1, 2014. Corporate & Other also includes the elimination of intersegment amounts and a portion of MetLife’s U.S. insurance business sold direct to consumers.

Financial Measures and Segment Accounting Policies

Operating earnings is used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is also the Company’s GAAP measure of segment performance and is reported below. Operating earnings should not be viewed as a substitute for net income (loss). The Company believes the presentation of operating earnings as the Company measures it for management purposes enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings allows analysis of the Company’s performance and facilitates comparisons to industry results.

Operating earnings is defined as operating revenues less operating expenses, both net of income tax.

The following are excluded from total revenues in calculating operating revenues:

• Net investment gains (losses);

• Net derivative gains (losses) except: (i) earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment and (ii) earned income on derivatives and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment;

• Amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees (“GMIB Fees”);

• Certain amounts related to securitization entities that are VIEs consolidated under GAAP;and

• Results of discontinued operations and other businesses that have been or will be sold or exited by the Company (“Divested Businesses”).

36

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

2. Segment Information (continued)

The following are excluded from total expenses in calculating operating expenses:

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets, benefits and hedging costs related to GMIBs (“GMIB Costs”) and market value adjustments associated with surrenders or terminations of contracts;

• Amounts related to: (i) net investment gains (losses) and net derivative gains (losses) and (ii) GMIB Fees and GMIB Costs included in amortization of deferred policy acquisition costs and value of business acquired;

• Recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance;

• Results of discontinued operations and Divested Businesses;

• Amounts related to securitization entities that are VIEs consolidated under GAAP;

• Goodwill impairment; and

• Costs related to: (i) implementation of new insurance regulatory requirements and (ii) acquisition and integration costs.

The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from the Company’s effective tax rate.

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the years ended December 31, 2016, 2015 and 2014 and at December 31, 2016 and 2015. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for operating earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below.

The internal capital model is a MetLife developed risk capital model that reflects management’s judgment and view of required capital to represent the measurement of the risk profile of the business, to meet the Company’s long term promises to clients, to service long-term obligations and to support the credit ratings of the Company. It accounts for the unique and specific nature of the risks inherent in the Company’s business. Management is responsible for the ongoing production and enhancement of the internal capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards. As such, the internal capital allocation methodology in the future may differ from MetLife’s historical model.

The Company allocates equity to the segments based on the internal capital model, coupled with considerations of local capital requirements, and aligns with emerging standards and consistent risk principles.

Segment net investment income is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company’s consolidated net investment income or net income (loss).

Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee time incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.

37

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

2. Segment Information (continued)

	Operating Results
Year Ended December 31, 2016	Annuities		Life			Run-off			Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,494	$	6		$	(249	)	$	23		$	1,274
Provision for income tax expense (benefit)	441		—			(90		)	(10		)	341
Operating earnings	$	1,053	$	6		$	(159	)	$	33		933
Adjustments for:
Net investment gains (losses)												(67		)
Net derivative gains (losses)												(5,770		)
Other adjustments to net income												98
Provision for income tax (expense) benefit												2,031
Net income (loss)												$	(2,775	)
Inter-segment revenues	$	716	$	(722	)	$	135		$	20
Interest revenue	$	1,446	$	351		$	1,411		$	197
Interest expense	$	—	$	—		$	60		$	67

At December 31, 2016	Annuities		Life		Run-off		Corporate & Other		Total
	(In millions)
Total assets	$	146,224	$	12,296	$	40,575	$	12,330	$	211,425
Separate account assets	$	100,209	$	1,671	$	3,466	$	—	$	105,346
Separate account liabilities	$	100,209	$	1,671	$	3,466	$	—	$	105,346

38

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

2. Segment Information (continued)

	Operating Results
Year Ended December 31, 2015	Annuities		Life			Run-off		Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,339	$	(56	)	$	713	$	(77	)	$	1,919
Provision for income tax expense (benefit)	329		(21		)	247		(43		)	512
Operating earnings	$	1,010	$	(35	)	$	466	$	(34	)	1,407
Adjustments for:
Net investment gains (losses)											5
Net derivative gains (losses)											(497		)
Other adjustments to net income											(262		)
Provision for income tax (expense) benefit											265
Net income (loss)											$	918
Inter-segment revenues	$	595	$	(695	)	$	118	$	215
Interest revenue	$	1,266	$	313		$	1,551	$	97
Interest expense	$	—	$	—		$	60	$	69

At December 31, 2015	Annuities		Life		Run-off		Corporate & Other		Total
	(In millions)
Total assets	$	142,646	$	13,242	$	44,176	$	15,552	$	215,616
Separate account assets	$	101,714	$	1,580	$	3,233	$	—	$	106,527
Separate account liabilities	$	101,714	$	1,580	$	3,233	$	—	$	106,527

	Operating Results
Year Ended December 31, 2014	Annuities		Life			Run-off		Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,182	$	(7	)	$	824	$	(16	)	$	1,983
Provision for income tax expense (benefit)	281		(4		)	283		(21		)	539
Operating earnings	$	901	$	(3	)	$	541	$	5		1,444
Adjustments for:
Net investment gains (losses)											(489		)
Net derivative gains (losses)											294
Other adjustments to net income											(720		)
Provision for income tax (expense) benefit											278
Net income (loss)											$	807
Inter-segment revenues	$	849	$	(575	)	$	23	$	36
Interest revenue	$	1,119	$	359		$	1,518	$	66
Interest expense	$	—	$	5		$	60	$	68

39

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

2. Segment Information (continued)

Reconciliation of Company operating revenues to total revenues:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Annuities	$	4,423		$	4,665		$	4,790
Life	1,036			881			897
Run-off	2,313			2,366			2,319
Total segment	7,772			7,912			8,006
Corporate & Other	338			398			314
Net investment gains (losses)	(67		)	5			(489		)
Net derivative gains (losses)	(5,770		)	(497		)	294
Other adjustments	(13		)	54			245
Total	$	2,260		$	7,872		$	8,370

The following table presents total premiums, universal life and investment-type product policy fees and other revenues by major product groups of the Company’s segments, as well as Corporate & Other:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Annuity products	$	3,411	$	3,701	$	4,110
Life insurance products	1,552		1,529		1,466
Other products	23		133		5
Total	$	4,986	$	5,363	$	5,581

Substantially all of the Company’s consolidated premiums, universal life and investment-type product policy fees and other revenues originated in the U.S.

Revenues derived from any customer did not exceed 10% of consolidated premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2016, 2015 and 2014.

3. Organizational Changes

Contribution Transactions

On April 28, 2017, in connection with the Separation, MetLife, Inc. contributed MetLife Reinsurance Company of Delaware, MetLife Reinsurance Company of South Carolina (“MRSC”), MetLife Reinsurance Company of Vermont II, all affiliated reinsurance companies, and Brighthouse NY to Brighthouse Life Insurance Company. The affiliated reinsurance companies were then merged into BRCD, and certain reserve financing arrangements were restructured, resulting in a net return of capital to MetLife of $2.7 billion. The return of capital included $3.4 billion in cash, offset by a non-cash capital contribution of $703 million primarily comprised of the $643 million tax impact of a basis adjustment for BRCD in connection with the Contribution Transactions. The affiliated reinsurance companies reinsured risks, including level premium term life and ULSG assumed from the Company and other entities and operations of Brighthouse.

The Contribution Transactions were between entities under common control and have been accounted for in a manner similar to the pooling-of-interests method, which requires that the acquired entities be combined at their historical cost. The Company’s consolidated financial statements and related footnotes are presented as if the transaction occurred at the beginning of the earliest date presented and the prior periods have been retrospectively adjusted.

The effect of the Contribution Transactions on net income (loss) was an increase of $162 million, $79 million and $512 million for the years ended December 31, 2016, 2015 and 2014, respectively.

40

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

3. Organization Changes (continued)

The effect of the Contribution Transactions on OCI was an increase (decrease) of ($120) million, ($230) million and $206 million for years ended December 31, 2016, 2015 and 2014, respectively.

Simultaneously with the Contribution Transactions, the following additional transactions occurred:

• The existing reserve financing arrangements of the affiliated reinsurance companies with unaffiliated financial institutions were terminated and replaced with a single financing arrangement supported by a pool of highly rated third-party reinsurers. See Note 18.

• Invested assets held in trust totaling $3.4 billion were liquidated, of which $2.8 billion provided funding for MetLife, Inc.’s repayment of the associated collateral financing arrangement, and the remainder was remitted to MetLife, Inc. See Note 18.

• Loans outstanding to MetLife, Inc. totaling $1.1 billion were repaid in an exchange transaction that resulted in the satisfaction of $1.1 billion of surplus notes due to MetLife. See Note 18.

Mergers

In November 2014, MetLife Insurance Company of Connecticut, a wholly-owned subsidiary of MetLife, Inc., re-domesticated from Connecticut to Delaware, changed its name to MetLife Insurance Company USA and merged with its subsidiary, MLI-USA, and its affiliate, MLIIC, each a U.S. insurance company that issued variable annuity products in addition to other products, and Exeter, a former offshore, captive reinsurance subsidiary of MetLife, Inc. and affiliate of MetLife Insurance Company of Connecticut that mainly reinsured guarantees associated with variable annuity products (the “Mergers”). The surviving entity of the Mergers was MetLife USA. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. Prior to the Mergers, 40,000,000 authorized shares of common stock, of which 30,000,000 shares were issued and outstanding, were converted to 4,000 authorized shares of common stock, of which 3,000 shares were issued and outstanding.

Prior to the Mergers, effective January 1, 2014, following receipt of New York State Department of Financial Services approval, MetLife Insurance Company of Connecticut withdrew its license to issue insurance policies and annuity contracts in New York. Also effective January 1, 2014, MetLife Insurance Company of Connecticut reinsured with MLIC, an affiliate, all existing New York insurance policies and annuity contracts that include a separate account feature and deposited investments with an estimated fair market value of $6.3 billion into a custodial account to secure MetLife Insurance Company of Connecticut’s remaining New York policyholder liabilities not covered by such reinsurance. Also prior to the Mergers, certain risks ceded to Exeter were recaptured. See Notes 8, 9 and 13 for information regarding additional transactions in connection with the Mergers.

The Mergers represent a transaction among entities under common control and have been accounted for in a manner similar to the pooling-of-interests method, which requires that the merged entities be combined at their historical cost. The Company’s consolidated financial statements and related footnotes are presented as if the transaction occurred at the beginning of the earliest date presented and the prior periods have been retrospectively adjusted.

4. Disposition

In May 2014, the Company completed the sale of its wholly-owned subsidiary, MAL, for $702 million (£418 million) in net cash consideration. As a result of the sale, a loss of $608 million ($436 million, net of income tax), was recorded for the year ended December 31, 2014, which includes a reduction to goodwill of $112 million ($94 million, net of income tax). The loss is reflected within net investment gains (losses) on the consolidated statements of operations and comprehensive income (loss). Compared to the expected loss at the time of the sales agreement, the actual loss on the sale was increased by net income from MAL of $77 million for the year ended December 31, 2014. MAL’s results of operations are included in continuing operations. They were historically included in the Run-off segment.

41

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

5. Insurance

Insurance Liabilities

Insurance liabilities, including affiliated insurance liabilities on reinsurance assumed and ceded, are comprised of future policy benefits, policyholder account balances and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:

	December 31,
	2016		2015
	(In millions)
Annuities	$	32,793	$	28,673
Life	6,932		7,309
Run-off	24,887		26,885
Corporate & Other	7,431		7,168
Total	$	72,043	$	70,035

See Note 7 for discussion of affiliated reinsurance liabilities included in the table above.

Future policy benefits are measured as follows:

Product Type:	Measurement Assumptions:
Participating life	Aggregate of (i) net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate of 4%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends.
Nonparticipating life	Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities range from 3% to 8%.
Individual and group traditional fixed annuities after annuitization	Present value of expected future payments. Interest rate assumptions used in establishing such liabilities range from 3% to 8%.
Non-medical health insurance	The net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rate assumptions used in establishing such liabilities range from 4% to 7%.
Disabled lives	Present value of benefits method and experience assumptions as to claim terminations, expenses and interest. Interest rate assumptions used in establishing such liabilities range from 3% to 7%.

Participating business represented 4% and 3% of the Company’s life insurance in-force at December 31, 2016 and 2015, respectively. Participating policies represented 42%, 39% and 35% of gross traditional life insurance premiums for the years ended December 31, 2016, 2015 and 2014, respectively.

Policyholder account balances are equal to: (i) policy account values, which consist of an accumulation of gross premium payments; (ii) credited interest, ranging from less than 1% to 8%, less expenses, mortality charges and withdrawals; and (iii) fair value adjustments relating to business combinations.

42

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

5. Insurance (continued)

Guarantees

The Company issues variable annuity products with guaranteed minimum benefits. GMABs, the non-life contingent portion of GMWBs and the portion of certain GMIBs that do not require annuitization are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 9. Guarantees accounted for as insurance liabilities include:

Guarantee:			Measurement Assumptions:
GMDBs	•	A return of purchase payment upon death even if the account value is reduced to zero.	•	Present value of expected death benefits in excess of the projected account balance recognizing the excess ratably over the accumulation period based on the present value of total expected assessments.
	•	An enhanced death benefit may be available for an additional fee.	•	Assumptions are consistent with those used for amortizing DAC, and are thus subject to the same variability and risk.
			•	Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index.
			•	Benefit assumptions are based on the average benefits payable over a range of scenarios.
GMIBs	•	After a specified period of time determined at the time of issuance of the variable annuity contract, a minimum accumulation of purchase payments, even if the account value is reduced to zero, that can be annuitized to receive a monthly income stream that is not less than a specified amount.	•	Present value of expected income benefits in excess of the projected account balance at any future date of annuitization and recognizing the excess ratably over the accumulation period based on present value of total expected assessments.
	•	Certain contracts also provide for a guaranteed lump sum return of purchase premium in lieu of the annuitization benefit.	•	Assumptions are consistent with those used for estimating GMDB liabilities.
			•	Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder.
GMWBs	•	A return of purchase payment via partial withdrawals, even if the account value is reduced to zero, provided that cumulative withdrawals in a contract year do not exceed a certain limit.	•	Expected value of the life contingent payments and expected assessments using assumptions consistent with those used for estimating the GMDB liabilities.
	•	Certain contracts include guaranteed withdrawals that are life contingent.

43

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

5. Insurance (continued)

Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity and universal and variable life contracts was as follows:

	Annuity Contracts						Universal and Variable Life Contracts
	GMDBs			GMIBs			Secondary Guarantees		Total
	(In millions)
Direct
Balance at January 1, 2014	$	409		$	1,231		$	1,784	$	3,424
Incurred guaranteed benefits (1)	233			304			590		1,127
Paid guaranteed benefits	(23		)	—			—		(23		)
Balance at December 31, 2014	619			1,535			2,374		4,528
Incurred guaranteed benefits	248			337			413		998
Paid guaranteed benefits	(36		)	—			—		(36		)
Balance at December 31, 2015	831			1,872			2,787		5,490
Incurred guaranteed benefits	335			334			753		1,422
Paid guaranteed benefits	(60		)	—			—		(60		)
Balance at December 31, 2016	$	1,106		$	2,206		$	3,540	$	6,852
Net Ceded/(Assumed)
Balance at January 1, 2014	$	(200	)	$	(130	)	$	683	$	353
Incurred guaranteed benefits (1)	177			104			163		444
Paid guaranteed benefits	2			—			—		2
Balance at December 31, 2014	(21		)	(26		)	846		799
Incurred guaranteed benefits	20			(2		)	161		179
Paid guaranteed benefits	(33		)	—			—		(33		)
Balance at December 31, 2015	(34		)	(28		)	1,007		945
Incurred guaranteed benefits	44			9			98		151
Paid guaranteed benefits	(55		)	—			—		(55		)
Balance at December 31, 2016	$	(45	)	$	(19	)	$	1,105	$	1,041
Net
Balance at January 1, 2014	$	609		$	1,361		$	1,101	$	3,071
Incurred guaranteed benefits (1)	56			200			427		683
Paid guaranteed benefits	(25		)	—			—		(25		)
Balance at December 31, 2014	640			1,561			1,528		3,729
Incurred guaranteed benefits	228			339			252		819
Paid guaranteed benefits	(3		)	—			—		(3		)
Balance at December 31, 2015	865			1,900			1,780		4,545
Incurred guaranteed benefits	291			325			655		1,271
Paid guaranteed benefits	(5		)	—			—		(5		)
Balance at December 31, 2016	$	1,151		$	2,225		$	2,435	$	5,811

______________

(1) See Note 7.

44

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

5. Insurance (continued)

Information regarding the Company’s guarantee exposure was as follows at:

	December 31,
	2016						2015
	In the Event of Death			At Annuitization			In the Event of Death			At Annuitization
	(Dollars in millions)
Annuity Contracts (1), (2)
Variable Annuity Guarantees
Total account value (3)	$	106,590		$	61,340		$	108,625		$	62,645
Separate account value	$	101,991		$	60,016		$	103,685		$	61,311
Net amount at risk	$	6,763	(4)	$	3,116	(5)	$	8,296	(4)	$	2,241	(5)
Average attained age of contractholders	67 years			67 years			66 years			66 years

	December 31,
	2016		2015
	Secondary Guarantees
	(Dollars in millions)
Universal and Variable Life Contracts
Total account value (3)	$	7,176	$	6,919
Net amount at risk (6)	$	90,973	$	90,940
Average attained age of policyholders	60 years		59 years

______________

(1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the NARs presented reflect the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 7 for a discussion of GMxBs which have been reinsured.

(3) Includes the contractholder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved.

(6) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.

45

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

5. Insurance (continued)

Account balances of contracts with guarantees were invested in separate account asset classes as follows at: 

	December 31,
	2016		2015
	(In millions)
Fund Groupings:
Balanced	$	52,170	$	52,837
Equity	41,152		42,723
Bond	6,086		5,119
Money Market	703		820
Total	$	100,111	$	101,499

Obligations Under Funding Agreements

The Company issues fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. During the years ended December 31, 2016, 2015 and 2014, the Company issued $1.4 billion, $13.0 billion and $12.2 billion, respectively, and repaid $3.4 billion, $14.4 billion and $13.9 billion, respectively, of such funding agreements. As of December 31, 2016 and 2015, liabilities for funding agreements outstanding, which are included in policyholder account balances, were $127 million and $2.2 billion, respectively.

The Company is a member of the Federal Home Loan Bank (“FHLB”) of Pittsburgh and holds common stock in certain regional banks in the FHLB system (“FHLBanks”). Holdings of common stock of FHLBanks, included in equity securities, were as follows as of:

	December 31,
	2016		2015
	(In millions)
FHLB of Pittsburgh	$	44	$	85
FHLB of Boston	$	27	$	36
FHLB of Des Moines	$	4	$	4

The Company has also entered into funding agreements with FHLBanks. The liability for such funding agreements is included in policyholder account balances. Information related to such funding agreements was as follows as of:

	Liability				Collateral
	December 31,
	2016		2015		2016			2015
	(In millions)
FHLB of Pittsburgh (1)	$	500	$	1,570	$	3,765	(2)	$	1,789	(2)
FHLB of Boston (1)	$	50	$	250	$	144	(2)	$	311	(2)
FHLB of Des Moines (1)	$	95	$	95	$	266	(2)	$	147	(2)

______________

(1) Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities (“RMBS”), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank’s recovery on the collateral is limited to the amount of the Company’s liability to such FHLBank.

46

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

5. Insurance (continued)

(2) Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value.

Liabilities for Unpaid Claims and Claim Expenses

Information regarding the liabilities for unpaid claims and claim expense was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at December 31 of prior period	$	1,693		$	1,483		$	1,325
Less: Reinsurance recoverables	1,545			1,400			1,235
Net balance at December 31 of prior period	148			83			90
Cumulative adjustment (1)	68			—			—
Net balance at January 1,	216			83			90
Incurred related to:
Current year	651			105			3
Prior years (2)	(20		)	—			2
Total incurred	631			105			5
Paid related to:
Current year	(626		)	(30		)	—
Prior years	(63		)	(10		)	(12		)
Total paid	(689		)	(40		)	(12		)
Net balance at December 31,	158			148			83
Add: Reinsurance recoverables	1,811			1,545			1,400
Balance at December 31,	$	1,969		$	1,693		$	1,483

______________

(1) Reflects the accumulated adjustment, net of reinsurance, upon implementation of the new guidance related to short-duration contracts. Prior periods have not been restated. See Note 1.

(2) During 2016, 2015 and 2014, claims and claims adjustment expenses associated with prior years changed due to differences between the actual benefits paid and the expected benefits owed during those periods.

Separate Accounts

Separate account assets and liabilities include two categories of account types: pass-through separate accounts totaling $105.3 billion and $106.3 billion at December 31, 2016 and 2015, respectively, for which the policyholder assumes all investment risk, and separate accounts for which the Company contractually guarantees either a minimum return or account value to the policyholder which totaled $33 million and $189 million at December 31, 2016 and 2015, respectively. The latter category consisted of bank owned life insurance contracts. The average interest rate credited on these contracts was 2.63% and 2.56% at December 31, 2016 and 2015, respectively.

For each of the years ended December 31, 2016, 2015 and 2014, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts.

6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles

See Note 1 for a description of capitalized acquisition costs.

47

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (continued)

Nonparticipating and Non-Dividend-Paying Traditional Contracts

The Company amortizes DAC and VOBA related to these contracts (primarily term insurance) over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes.

Participating, Dividend-Paying Traditional Contracts

The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales, are reasonably likely to significantly impact the rate of DAC amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC balances.

Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts

The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, benefit elections and withdrawals, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and benefit elections and withdrawals are reasonably likely to significantly impact the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances.

48

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (continued)

Factors Impacting Amortization

Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company’s long-term expectation produce higher account balances, which increases the Company’s future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company’s long-term expectation. The Company’s practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.

The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency, benefit elections and withdrawals and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will generally decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease.

Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.

Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized.

49

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (continued)

Information regarding DAC and VOBA was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DAC
Balance at January 1,	$	5,066		$	5,097		$	5,712
Capitalizations	330			399			376
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	1,371			163			(184		)
Other expenses	(1,076		)	(690		)	(745		)
Total amortization	295			(527		)	(929		)
Unrealized investment gains (losses)	(24		)	97			(64		)
Other	—			—			2
Balance at December 31,	5,667			5,066			5,097
VOBA
Balance at January 1,	711			763			932
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	2			(19		)	(1		)
Other expenses	(72		)	(127		)	(139		)
Total amortization	(70		)	(146		)	(140		)
Unrealized investment gains (losses)	31			94			(29		)
Balance at December 31,	672			711			763
Total DAC and VOBA
Balance at December 31,	$	6,339		$	5,777		$	5,860

Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:

	December 31,
	2016		2015
	(In millions)
Annuities	$	4,820	$	3,724
Life	787		969
Run-off	584		974
Corporate & Other	148		110
Total	$	6,339	$	5,777

50

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (continued)

Information regarding other intangibles was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DSI
Balance at January 1,	$	515		$	566		$	669
Capitalization	3			3			5
Amortization	(83		)	(72		)	(80		)
Unrealized investment gains (losses)	(3		)	18			(28		)
Balance at December 31,	$	432		$	515		$	566
VODA and VOCRA
Balance at January 1,	$	136		$	155		$	173
Amortization	(16		)	(19		)	(18		)
Balance at December 31,	$	120		$	136		$	155
Accumulated amortization	$	140		$	124		$	105

The estimated future amortization expense to be reported in other expenses for the next five years is as follows:

	VOBA		VODA and VOCRA
	(In millions)
2017	$	110	$	15
2018	$	94	$	14
2019	$	80	$	13
2020	$	60	$	12
2021	$	52	$	10

7. Reinsurance

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by affiliated and unaffiliated companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 8.

Annuities and Life

For annuities, the Company reinsures portions of the living and death benefit guarantees issued in connection with certain variable annuities to unaffiliated reinsurers. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders, and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The value of embedded derivatives on the ceded risk is determined using a methodology consistent with the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. The Company also assumes 100% of the living and death benefit guarantees issued in connection with certain variable annuities issued by New England Life Insurance Company (“NELICO”).

51

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

7. Reinsurance (continued)

For its life products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. The Company currently reinsures 90% of the mortality risk in excess of $2 million for most products. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. On a case by case basis, the Company may retain up to $20 million per life and reinsure 100% of amounts in excess of the amount the Company retains. The Company also reinsures 90% of the risk associated with participating whole life policies to an affiliate and assumes certain term life policies and universal life policies with secondary death benefit guarantees issued by an affiliate. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time.

Corporate & Other

The Company reinsures, through 100% quota share reinsurance agreements certain run-off long-term care and workers’ compensation business written by the Company.

Catastrophe Coverage

The Company has exposure to catastrophes which could contribute to significant fluctuations in the Company’s results of operations. The Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks.

Reinsurance Recoverables

The Company reinsures its business through a diversified group of well-capitalized reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers. The Company monitors ratings and evaluates the financial strength of its reinsurers by analyzing their financial statements. In addition, the reinsurance recoverable balance due from each reinsurer is evaluated as part of the overall monitoring process. Recoverability of reinsurance recoverable balances is evaluated based on these analyses. The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at both December 31, 2016 and 2015, were not significant.

The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts and funds withheld accounts. The Company had $2.6 billion and $2.5 billion of unsecured unaffiliated reinsurance recoverable balances at December 31, 2016 and 2015, respectively.

At December 31, 2016, the Company had $9.1 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $7.8 billion, or 86%, were with the Company’s five largest unaffiliated ceded reinsurers, including $1.5 billion of net unaffiliated ceded reinsurance recoverables which were unsecured. At December 31, 2015, the Company had $8.6 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $7.4 billion, or 86%, were with the Company’s five largest unaffiliated ceded reinsurers, including $1.5 billion of net unaffiliated ceded reinsurance recoverables which were unsecured.

52

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

7. Reinsurance (continued)

The amounts on the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Premiums
Direct premiums	$	2,226		$	2,404		$	2,359
Reinsurance assumed	81			296			95
Reinsurance ceded	(1,127		)	(1,063		)	(1,003		)
Net premiums	$	1,180		$	1,637		$	1,451
Universal life and investment-type product policy fees
Direct universal life and investment-type product policy fees	$	3,582		$	3,722		$	3,729
Reinsurance assumed	126			139			383
Reinsurance ceded	(611		)	(568		)	(502		)
Net universal life and investment-type product policy fees	$	3,097		$	3,293		$	3,610
Other revenues
Direct other revenues	$	271		$	271		$	270
Reinsurance assumed	89			2			30
Reinsurance ceded	349			160			220
Net other revenues	$	709		$	433		$	520
Policyholder benefits and claims
Direct policyholder benefits and claims	$	6,101		$	4,944		$	4,924
Reinsurance assumed	127			302			254
Reinsurance ceded	(2,490		)	(2,159		)	(1,980		)
Net policyholder benefits and claims	$	3,738		$	3,087		$	3,198
Interest credited to policyholder account balances
Direct interest credited to policyholder account balances	$	1,067		$	1,156		$	1,180
Reinsurance assumed	75			78			76
Reinsurance ceded	(11		)	(10		)	(11		)
Net interest credited to policyholder account balances	$	1,131		$	1,224		$	1,245
Amortization of deferred policy acquisition costs and value of business acquired
Direct amortization of deferred policy acquisition costs and value of business acquired	$	(182	)	$	727		$	1,018
Reinsurance assumed	148			8			99
Reinsurance ceded	(191		)	(62		)	(48		)
Net amortization of deferred policy acquisition costs and value of business acquired	$	(225	)	$	673		$	1,069
Other expenses
Direct other expenses	$	1,700		$	1,723		$	1,797
Reinsurance assumed	36			47			3
Reinsurance ceded	(36		)	(47		)	(43		)
Net other expenses	$	1,700		$	1,723		$	1,757

53

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

7. Reinsurance (continued)

The amounts on the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at:

	December 31,
	2016									2015
	Direct		Assumed		Ceded			Total Balance Sheet		Direct		Assumed		Ceded			Total Balance Sheet
	(In millions)
Assets
Premiums, reinsurance and other receivables	$	1,161	$	23	$	12,669		$	13,853	$	765	$	161	$	17,178		$	18,104
Deferred policy acquisition costs and value of business acquired	6,638		71		(370		)	6,339		6,013		218		(454		)	5,777
Total assets	$	7,799	$	94	$	12,299		$	20,192	$	6,778	$	379	$	16,724		$	23,881
Liabilities
Future policy benefits	$	32,520	$	232	$	—		$	32,752	$	29,214	$	1,294	$	—		$	30,508
Policyholder account balances	35,838		741		—			36,579		36,013		712		—			36,725
Other policy-related balances	1,035		1,677		—			2,712		999		1,804		(1		)	2,802
Other liabilities	4,525		13		907			5,445		2,620		87		1,218			3,925
Total liabilities	$	73,918	$	2,663	$	907		$	77,488	$	68,846	$	3,897	$	1,217		$	73,960

Effective December 1, 2016, the Company terminated two agreements with an unaffiliated reinsurer which covered 90% of the liabilities on certain participating whole life insurance policies issued between April 1, 2000 and December 31, 2001 by MLIC. This termination resulted in a decrease in other invested assets of $713 million, a decrease in deferred policy acquisition costs and value of business acquired of $95 million, a decrease in future policy benefits of $654 million, and a decrease in other liabilities of $43 million. The Company recognized a loss of approximately $72 million, net of income tax, as a result of this transaction.

Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance were $1.5 billion and $6.6 billion at December 31, 2016 and 2015, respectively. The deposit liabilities on reinsurance was $1 million at both December 31, 2016 and 2015.

Related Party Reinsurance Transactions

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by certain affiliates companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

The Company has reinsurance agreements with its affiliate NELICO and certain MetLife, Inc. subsidiaries, including MLIC, General American Life Insurance Company, MetLife Europe d.a.c., MetLife Reinsurance Company of Vermont, Delaware American Life Insurance Company and American Life Insurance Company, all of which are related parties.

54

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

7. Reinsurance (continued)

Information regarding the significant effects of affiliated reinsurance included on the consolidated statements of operations was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Premiums
Reinsurance assumed	$	35		$	227		$	56
Reinsurance ceded	(766		)	(687		)	(652		)
Net premiums	$	(731	)	$	(460	)	$	(596	)
Universal life and investment-type product policy fees
Reinsurance assumed	$	126		$	139		$	276
Reinsurance ceded	(60		)	(58		)	(47		)
Net universal life and investment-type product policy fees	$	66		$	81		$	229
Other revenues
Reinsurance assumed	$	59		$	2		$	30
Reinsurance ceded	348			160			220
Net other revenues	$	407		$	162		$	250
Policyholder benefits and claims
Reinsurance assumed	$	90		$	252		$	220
Reinsurance ceded	(737		)	(656		)	(622		)
Net policyholder benefits and claims	$	(647	)	$	(404	)	$	(402	)
Interest credited to policyholder account balances
Reinsurance assumed	$	75		$	78		$	76
Reinsurance ceded	(11		)	(10		)	(11		)
Net interest credited to policyholder account balances	$	64		$	68		$	65
Amortization of deferred policy acquisition costs and value of business acquired
Reinsurance assumed	$	49		$	24		$	90
Reinsurance ceded	(175		)	(59		)	(42		)
Net amortization of deferred policy acquisition costs and value of business acquired	$	(126	)	$	(35	)	$	48
Other expenses
Reinsurance assumed	$	19		$	41		$	(2	)
Reinsurance ceded	(21		)	(31		)	(23		)
Net other expenses	$	(2	)	$	10		$	(25	)

55

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

7. Reinsurance (continued)

Information regarding the significant effects of affiliated reinsurance included on the consolidated balance sheets was as follows at:

	December 31,
	2016					2015
	Assumed		Ceded			Assumed		Ceded
	(In millions)
Assets
Premiums, reinsurance and other receivables	$	23	$	3,382		$	128	$	8,452
Deferred policy acquisition costs and value of business acquired	71		(356		)	120		(439		)
Total assets	$	94	$	3,026		$	248	$	8,013
Liabilities
Future policy benefits	$	211	$	—		$	630	$	—
Policyholder account balances	741		—			712		—
Other policy-related balances	1,677		—			1,785		(1		)
Other liabilities	11		578			28		876
Total liabilities	$	2,640	$	578		$	3,155	$	875

The Company assumes risks from affiliates related to guaranteed minimum benefit guarantees written directly by the affiliates. These assumed reinsurance agreements contain embedded derivatives and changes in their estimated fair value are also included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within policyholder account balances and were $741 million and $712 million at December 31, 2016 and 2015, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($21) million, ($47) million and ($453) million for the years ended December 31, 2016, 2015 and 2014, respectively.

The Company ceded risks to an affiliate related to guaranteed minimum benefit guarantees written directly by the Company. This ceded reinsurance agreement contains embedded derivatives and changes in their estimated fair value are also included within net derivative gains (losses). The embedded derivatives associated with this cession is included within premiums, reinsurance and other receivables and were $171 million and $126 million at December 31, 2016and2015, respectively. Net derivative gains (losses) associated with the embedded derivatives were $46 million, $54 million, and $42 million for the years ended December 31, 2016, 2015 and 2014, respectively.

In April 2016, the Company recaptured risks related to certain single premium deferred annuity contracts previously reinsured to MLIC. As a result of this recapture, the significant effects to the Company were an increase in investments and cash and cash equivalents of $4.3 billion and an increase in DAC of $87 million, offset by a decrease in premiums, reinsurance and other receivables of $4.0 billion. The Company recognized a gain of $246 million, net of income tax, as a result of this recapture.

The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. The Company had $2.6 billion and $7.5 billion of unsecured affiliated reinsurance recoverable balances at December 31, 2016 and 2015, respectively.

Affiliated reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on affiliated reinsurance were $1.4 billion and $6.4 billion at December 31, 2016 and 2015, respectively. There were no deposit liabilities on affiliated reinsurance at both December 31, 2016 and 2015.

56

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments

See Note 10 for information about the fair value hierarchy for investments and the related valuation methodologies.

Investment Risks and Uncertainties

Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of VIEs. The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented on the consolidated financial statements.

The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available.

The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, ABS and certain structured investment transactions) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned.

Fixed Maturity and Equity Securities AFS

Fixed Maturity and Equity Securities AFS by Sector

The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, commercial mortgage-backed securities (“CMBS”) and ABS (collectively, “Structured Securities”).

	December 31, 2016											December 31, 2015
	Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value		Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses							Gains		Temporary Losses		OTTI Losses
										(In millions)
Fixed maturity securities:
U.S. corporate	$	20,663	$	1,287	$	285	$	—		$	21,665	$	19,930	$	1,077	$	532	$	—		$	20,475
U.S. government and agency	11,872		1,281		237		—			12,916		13,145		1,362		66		—			14,441
RMBS	7,876		203		139		—			7,940		9,803		219		127		22			9,873
Foreign corporate	6,071		220		168		—			6,123		5,536		165		217		1			5,483
State and political subdivision	3,520		376		38		—			3,858		3,184		387		24		1			3,546
CMBS (1)	3,687		40		32		(1		)	3,696		3,286		28		34		(1		)	3,281
ABS	2,600		11		13		—			2,598		4,303		19		59		—			4,263
Foreign government	1,000		114		11		—			1,103		665		105		11		—			759
Total fixed maturity securities	$	57,289	$	3,532	$	923	$	(1	)	$	59,899	$	59,852	$	3,362	$	1,070	$	23		$	62,121
Equity securities:
Non-redeemable preferred stock	$	180	$	6	$	9	$	—		$	177	$	265	$	15	$	9	$	—		$	272
Common stock	100		23		—		—			123		167		23		5		—			185
Total equity securities	$	280	$	29	$	9	$	—		$	300	$	432	$	38	$	14	$	—		$	457

______________

(1) The noncredit loss component of OTTI losses for CMBS was in an unrealized gain position of $1 million at both December 31, 2016and 2015, due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”

57

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

The Company held non-income producing fixed maturity securities with an estimated fair value of $5 million and $11 million with unrealized gains (losses) of less than $1 million and $1 million at December 31, 2016 and 2015, respectively.

Methodology for Amortization of Premium and Accretion of Discount on Structured Securities

Amortization of premium and accretion of discount on Structured Securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for Structured Securities are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive Structured Securities and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other Structured Securities, the effective yield is recalculated on a retrospective basis.

Maturities of Fixed Maturity Securities

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2016:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In millions)
Amortized cost	$	1,824	$	9,020	$	9,814	$	22,468	$	14,163	$	57,289
Estimated fair value	$	1,829	$	9,408	$	9,931	$	24,497	$	14,234	$	59,899

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

58

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector

The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	December 31, 2016								December 31, 2015
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in millions)
Fixed maturity securities:
U.S. corporate	$	4,632	$	187	$	699	$	98	$	6,365	$	383	$	832	$	149
U.S. government and agency	4,396		237		—		—		4,256		66		—		—
RMBS	3,457		107		818		32		5,172		105		520		44
Foreign corporate	1,443		64		573		104		1,896		107		680		111
State and political subdivision	887		35		29		3		624		22		43		3
CMBS	1,553		26		171		5		1,864		30		97		3
ABS	450		5		461		8		2,651		42		547		17
Foreign government	242		10		6		1		133		10		6		1
Total fixed maturity securities	$	17,060	$	671	$	2,757	$	251	$	22,961	$	765	$	2,725	$	328
Equity securities:
Non-redeemable preferred stock	$	57	$	2	$	40	$	7	$	24	$	1	$	40	$	8
Common stock	—		—		—		—		7		5		1		—
Total equity securities	$	57	$	2	$	40	$	7	$	31	$	6	$	41	$	8
Total number of securities in an unrealized loss position	1,711				475				2,224				452

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

Evaluation and Measurement Methodologies

Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.

59

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows: 

• The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment.

• When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management’s best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security’s position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies.

• Additional considerations are made when assessing the unique features that apply to certain Structured Securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security.

• When determining the amount of the credit loss for U.S. and foreign corporate securities, state and political subdivision securities and foreign government securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities.

With respect to securities that have attributes of debt and equity (“perpetual hybrid securities”), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security’s cost and its estimated fair value with a corresponding charge to earnings.

The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value.

In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows.

Current Period Evaluation

Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at December 31, 2016. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods.

Gross unrealized losses on fixed maturity securities decreased $171 million during the year ended December 31, 2016 to $922 million. The decrease in gross unrealized losses for the year ended December 31, 2016, was primarily attributable to narrowing credit spreads, partially offset by an increase in interest rates and, to a lesser extent, the impact of weakening foreign currencies on non-functional currency denominated fixed maturity securities.

60

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

At December 31,2016,$57 millionof the total$922 millionof gross unrealized losses were from15fixed maturity securities with an unrealized loss position of20%or more of amortized cost for six months or greater.

The change in gross unrealized losses on equity securities was not significant during the year ended December 31, 2016.

Investment Grade Fixed Maturity Securities

Of the $57 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $53 million, or 93%, were related to gross unrealized losses on six investment grade fixed maturity securities. Unrealized losses on investment grade fixed maturity securities are principally related to widening credit spreads since purchase and, with respect to fixed-rate fixed maturity securities, rising interest rates since purchase.

Below Investment Grade Fixed Maturity Securities

Of the $57 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $4 million, or 7%, were related to gross unrealized losses on nine below investment grade fixed maturity securities. Unrealized losses on below investment grade fixed maturity securities are principally related to U.S. and foreign corporate securities (primarily industrial securities) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over lower oil prices in the energy sector. Management evaluates U.S. and foreign corporate securities based on factors such as expected cash flows and the financial condition and near-term and long-term prospects of the issuers.

Mortgage Loans

Mortgage Loans by Portfolio Segment

Mortgage loans are summarized as follows at:

	December 31,
	2016					2015
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in millions)
Mortgage loans
Commercial	$	6,497		69.9	%	$	5,452		73.7	%
Agricultural	1,830			19.7		1,481			20.0
Residential	867			9.3		335			4.5
Subtotal	9,194			98.9		7,268			98.2
Valuation allowances	(40		)	(0.4	)	(36		)	(0.5	)
Subtotal mortgage loans, net	9,154			98.5		7,232			97.7
Commercial mortgage loans held by CSEs — FVO	136			1.5		172			2.3
Total mortgage loans, net	$	9,290		100.0	%	$	7,404		100.0	%

The Company purchases unaffiliated mortgage loans under a master participation agreement, from an affiliate, simultaneously with the affiliate’s origination or acquisition of mortgage loans. The aggregate amount of unaffiliated mortgage loan participation interests purchased by the Company from an affiliate during the years ended December 31, 2016, 2015 and 2014 were $2.4 billion, $2.0 billion and $370 million, respectively. In connection with the mortgage loan participations, the affiliate collected mortgage loan principal and interest payments on the Company’s behalf and the affiliate remitted such payments to the Company in the amount of $1.6 billion, $1.0 billion and $1.0 billion during the years ended December 31, 2016, 2015 and 2014, respectively.

Purchases of mortgage loans from third parties were $619 million and $346 million for the years ended December 31, 2016 and 2015, respectively, and were primarily comprised of residential mortgage loans.

See “— Variable Interest Entities” for discussion of CSEs.

61

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

See “— Related Party Investment Transactions” for discussion of related party mortgage loans.

Information on commercial, agricultural and residential mortgage loans is presented in the tables below. Information on commercial mortgage loans held by CSEs - FVO is presented in Note 10. The Company elects the FVO for certain commercial mortgage loans and related long-term debt that are managed on a total return basis.

Mortgage Loans, Valuation Allowance and Impaired Loans by Portfolio Segment

Mortgage loans by portfolio segment, by method of evaluation of credit loss, impaired mortgage loans including those modified in a troubled debt restructuring, and the related valuation allowances, were as follows at and for the years ended:

	Evaluated Individually for Credit Losses										Evaluated Collectively for Credit Losses				Impaired Loans
	Impaired Loans with a Valuation  Allowance						Impaired Loans without a Valuation Allowance
	Unpaid Principal Balance		Recorded Investment		Valuation Allowances		Unpaid Principal Balance		Recorded Investment		Recorded Investment		Valuation Allowances		Carrying Value		Average Recorded Investment
	(In millions)
December 31, 2016
Commercial	$	—	$	—	$	—	$	—	$	—	$	6,497	$	32	$	—	$	—
Agricultural	4		3		—		—		—		1,827		5		3		3
Residential	—		—		—		1		1		866		3		1		—
Total	$	4	$	3	$	—	$	1	$	1	$	9,190	$	40	$	4	$	3
December 31, 2015
Commercial	$	—	$	—	$	—	$	—	$	—	$	5,452	$	28	$	—	$	—
Agricultural	4		3		—		—		—		1,478		5		3		3
Residential	—		—		—		—		—		335		3		—		—
Total	$	4	$	3	$	—	$	—	$	—	$	7,265	$	36	$	3	$	3

The average recorded investment for impaired commercial, agricultural and residential mortgage loans was $43 million, $3 million and $0, respectively, for the year ended December 31, 2014.

Valuation Allowance Rollforward by Portfolio Segment

The changes in the valuation allowance, by portfolio segment, were as follows:

	Commercial			Agricultural		Residential		Total
	(In millions)
Balance at January 1, 2014	$	31		$	4	$	—	$	35
Provision (release)	(10		)	—		—		(10		)
Balance at December 31, 2014	21			4		—		25
Provision (release)	7			1		3		11
Balance at December 31, 2015	28			5		3		36
Provision (release)	4			—		—		4
Balance at December 31, 2016	$	32		$	5	$	3	$	40

62

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Valuation Allowance Methodology

Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for all three portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for all loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

Commercial and Agricultural Mortgage Loan Portfolio Segments

The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans.

All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio.

For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property’s net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio and the values utilized in calculating the ratio are updated annually on a rolling basis, with a portion of the portfolio updated each quarter. In addition, the loan-to-value ratio is routinely updated for all but the lowest risk loans as part of the Company’s ongoing review of its commercial mortgage loan portfolio.

For agricultural mortgage loans, the Company’s primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated.

63

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Residential Mortgage Loan Portfolio Segment

The Company’s residential mortgage loan portfolio is comprised primarily of closed end, amortizing residential mortgage loans. For evaluations of residential mortgage loans, the key inputs of expected frequency and expected loss reflect current market conditions, with expected frequency adjusted, when appropriate, for differences from market conditions and historical experience. In contrast to the commercial and agricultural mortgage loan portfolios, residential mortgage loans are smaller-balance homogeneous loans that are collectively evaluated for impairment. Non-specific valuation allowances are established using the evaluation framework described above for pools of loans with similar risk characteristics from inputs that are unique to the residential segment of the loan portfolio. Loan specific valuation allowances are only established on residential mortgage loans when they have been restructured and are established using the methodology described above for all loan portfolio segments.

For residential mortgage loans, the Company’s primary credit quality indicator is whether the loan is performing or nonperforming. The Company generally defines nonperforming residential mortgage loans as those that are 60 or more days past due and/or in nonaccrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.

Credit Quality of Commercial Mortgage Loans

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment										Estimated Fair Value		% of Total
	Debt Service Coverage Ratios						Total		% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x
	(Dollars in millions)
December 31, 2016
Loan-to-value ratios
Less than 65%	$	5,718	$	230	$	167	$	6,115	94.1	%	$	6,197	94.3	%
65% to 75%	291		—		19		310		4.8		303		4.6
76% to 80%	34		—		—		34		0.5		33		0.5
Greater than 80%	24		14		—		38		0.6		37		0.6
Total	$	6,067	$	244	$	186	$	6,497	100.0	%	$	6,570	100.0	%
December 31, 2015
Loan-to-value ratios
Less than 65%	$	4,771	$	153	$	105	$	5,029	92.2	%	$	5,250	92.7	%
65% to 75%	330		—		10		340		6.2		332		5.9
76% to 80%	—		—		—		—		—		—		—
Greater than 80%	44		25		14		83		1.6		80		1.4
Total	$	5,145	$	178	$	129	$	5,452	100.0	%	$	5,662	100.0	%

64

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Credit Quality of Agricultural Mortgage Loans

The credit quality of agricultural mortgage loans was as follows at:

	December 31,
	2016				2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Loan-to-value ratios
Less than 65%	$	1,789	97.8	%	$	1,386	93.6	%
65% to 75%	41		2.2		95		6.4
Total	$	1,830	100.0	%	$	1,481	100.0	%

The estimated fair value of agricultural mortgage loans was $1.9 billion and $1.5 billion at December 31, 2016 and 2015, respectively.

Credit Quality of Residential Mortgage Loans

The credit quality of residential mortgage loans was as follows at:

	December 31,
	2016				2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Performance indicators:
Performing	$	856	98.7	%	$	331	98.8	%
Nonperforming	11		1.3		4		1.2
Total	$	867	100.0	%	$	335	100.0	%

The estimated fair value of residential mortgage loans was $867 million and $345 million at December 31, 2016 and 2015, respectively.

Past Due and Nonaccrual Mortgage Loans

The Company has a high quality, well performing, mortgage loan portfolio, with over99%of all mortgage loans classified as performing as of bothDecember 31, 2016and2015. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. The Company hadnocommercial or agricultural mortgage loans past due andnocommercial or agricultural mortgage loans in nonaccrual status at eitherDecember 31, 2016, or2015. The recorded investment of residential mortgage loans past due and in nonaccrual status was$11 millionand$4 millionatDecember 31, 2016and2015, respectively.

Mortgage Loans Modified in a Troubled Debt Restructuring

The Company may grant concessions related to borrowers experiencing financial difficulties, which are classified as troubled debt restructurings. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concessions granted are considered in determining any impairment or changes in the specific valuation allowance. During the year ended December 31, 2016, the Company did not have a significant amount of mortgage loans modified in a troubled debt restructuring. There were no mortgage loans modified in a troubled debt restructuring during the year ended December 31, 2015.

65

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Other Invested Assets

Other invested assets is comprised primarily of freestanding derivatives with positive estimated fair values (see Note 9), operating joint venture, tax credit and renewable energy partnerships, leveraged leases and funds withheld.

Tax Credit Partnerships

The carrying value of tax credit partnerships was $41 million and $42 million at December 31, 2016 and 2015, respectively. Net investment income (loss) from tax credit partnerships were ($1) million for both years ended December 31, 2016 and 2015. Net investment income (loss) was $3 million for the year ended December 31, 2014.

Leveraged Leases

Investment in leveraged leases consisted of the following at:

	December 31,
	2016			2015
	(In millions)
Rental receivables, net	$	87		$	90
Estimated residual values	14			14
Subtotal	101			104
Unearned income	(32		)	(33		)
Investment in leveraged leases, net of non-recourse debt	$	69		$	71

Rental receivables are generally due in periodic installments. The payment periods for leveraged leases range from one to 16 years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. The Company generally defines nonperforming rental receivables as those that are 90 days or more past due. At December 31, 2016 and 2015, all rental receivables were performing.

The deferred income tax liability related to leveraged leases was $74 million and $76 million at December 31, 2016 and 2015, respectively.

Cash Equivalents

The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $4.7 billion and $1.2 billion at December 31, 2016 and 2015, respectively.

Net Unrealized Investment Gains (Losses)

Unrealized investment gains (losses) on fixed maturity and equity securities AFS and the effect on DAC, VOBA, DSI and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in accumulated other comprehensive income (loss) (“AOCI”).

66

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Fixed maturity securities	$	2,600		$	2,283		$	4,729
Fixed maturity securities with noncredit OTTI losses included in AOCI	1			(23		)	(38		)
Total fixed maturity securities	2,601			2,260			4,691
Equity securities	32			54			69
Derivatives	397			370			281
Short-term investments	(42		)	—			—
Other	59			79			10
Subtotal	3,047			2,763			5,051
Amounts allocated from:
Future policy benefits	(922		)	(126		)	(613		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)	(1		)	(2		)
DAC, VOBA and DSI	(193		)	(198		)	(406		)
Subtotal	(1,117		)	(325		)	(1,021		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	—			9			14
Deferred income tax benefit (expense)	(653		)	(827		)	(1,416		)
Net unrealized investment gains (losses)	$	1,277		$	1,620		$	2,628

The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:

	Years Ended December 31,
	2016			2015
	(In millions)
Balance at January 1,	$	(23	)	$	(38	)
Noncredit OTTI losses and subsequent changes recognized	3			8
Securities sold with previous noncredit OTTI loss	18			19
Subsequent changes in estimated fair value	3			(12		)
Balance at December 31,	$	1		$	(23	)

67

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

The changes in net unrealized investment gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at January 1,	$	1,620		$	2,628		$	930
Fixed maturity securities on which noncredit OTTI losses have been recognized	24			15			15
Unrealized investment gains (losses) during the year	260			(2,303		)	3,234
Unrealized investment gains (losses) relating to:
Future policy benefits	(796		)	487			(613		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(1		)	1			(2		)
DAC, VOBA and DSI	5			208			(119		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(9		)	(5		)	(4		)
Deferred income tax benefit (expense)	174			589			(813		)
Balance at December 31,	$	1,277		$	1,620		$	2,628
Change in net unrealized investment gains (losses)	$	(343	)	$	(1,008	)	$	1,698

Concentrations of Credit Risk

There were no investments in any counterparty that were greater than 10% of the Company’s stockholder’s equity, other than the U.S. government and its agencies, at both December 31, 2016 and 2015.

Securities Lending

Elements of the securities lending program are presented below at:

	December 31,
	2016		2015
	(In millions)
Securities on loan: (1)
Amortized cost	$	5,895	$	8,047
Estimated fair value	$	6,555	$	8,830
Cash collateral on deposit from counterparties (2)	$	6,642	$	8,981
Security collateral on deposit from counterparties (3)	$	27	$	23
Reinvestment portfolio — estimated fair value	$	6,571	$	8,938

______________

(1) Included within fixed maturity securities and short-term investments.

(2) Included within payables for collateral under securities loaned and other transactions.

(3) Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the consolidated financial statements.

68

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	December 31, 2016								December 31, 2015
	Remaining Tenor of Securities Lending Agreements								Remaining Tenor of Securities Lending Agreements
	Open (1)		1 Month or Less		1 to 6 Months		Total		Open (1)		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
U.S. government and agency	$	2,129	$	1,906	$	1,743	$	5,778	$	2,631	$	3,140	$	1,338	$	7,109
U.S. corporate	—		480		—		480		9		302		—		311
Agency RMBS	—		—		274		274		—		939		579		1,518
Foreign corporate	—		58		—		58		—		—		—		—
Foreign government	—		52		—		52		1		42		—		43
Total	$	2,129	$	2,496	$	2,017	$	6,642	$	2,641	$	4,423	$	1,917	$	8,981

_____________

(1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral.

If the Company is required to return significant amounts of cash collateral on short notice and is forced to sell securities to meet the return obligation, it may have difficulty selling such collateral that is invested in securities in a timely manner, be forced to sell securities in a volatile or illiquid market for less than what otherwise would have been realized under normal market conditions, or both. The estimated fair value of the securities on loan related to the cash collateral on open at December 31, 2016 was $2.1 billion, all of which were U.S. government and agency securities which, if put back to the Company, could be immediately sold to satisfy the cash requirement.

The reinvestment portfolio acquired with the cash collateral consisted principally of fixed maturity securities (including agency RMBS, ABS, non-agency RMBS, U.S. corporate securities and U.S. government and agency) with 48% invested in agency RMBS, short-term investments, U.S. government and agency, cash equivalents or held in cash at December 31, 2016. If the securities on loan or the reinvestment portfolio become less liquid, the Company has the liquidity resources of most of its general account available to meet any potential cash demands when securities on loan are put back to the Company.

Invested Assets on Deposit, Held in Trust and Pledged as Collateral

Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes at:

	December 31,
	2016		2015
	(In millions)
Invested assets on deposit (regulatory deposits)	$	7,644	$	7,247
Invested assets held in trust (reinsurance agreements) (1)	9,054		8,083
Invested assets pledged as collateral (2)	3,548		2,801
Total invested assets on deposit, held in trust, and pledged as collateral	$	20,246	$	18,131

______________

(1) The Company has held in trust certain investments in connection with certain reinsurance transactions.

(2) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 5) and derivative transactions (see Note 9).

See “— Securities Lending” for information regarding securities on loan.

69

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Purchased Credit Impaired Investments

Investments acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments are classified as purchased credit impaired (“PCI”) investments. For each investment, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI.

The Company’s PCI fixed maturity securities were as follows at:

	December 31,
	2016		2015
	(In millions)
Outstanding principal and interest balance (1)	$	1,458	$	1,219
Carrying value (2)	$	1,113	$	907

______________

(1) Represents the contractually required payments, which is the sum of contractual principal, whether or not currently due, and accrued interest.

(2) Estimated fair value plus accrued interest.

The following table presents information about PCI fixed maturity securities acquired during the periods indicated:

	Years Ended December 31,
	2016		2015
	(In millions)
Contractually required payments (including interest)	$	558	$	797
Cash flows expected to be collected (1)	$	483	$	709
Fair value of investments acquired	$	341	$	520

______________

(1) Represents undiscounted principal and interest cash flow expectations, at the date of acquisition.

The following table presents activity for the accretable yield on PCI fixed maturity securities for:

	Years Ended December 31,
	2016			2015
	(In millions)
Accretable yield, January 1,	$	400		$	244
Investments purchased	142			189
Accretion recognized in earnings	(66		)	(47		)
Disposals	(8		)	(8		)
Reclassification (to) from nonaccretable difference	(49		)	22
Accretable yield, December 31,	$	419		$	400

70

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Collectively Significant Equity Method Investments

The Company holds investments in real estate joint ventures, real estate funds and other limited partnership interests consisting of leveraged buy-out funds, hedge funds, private equity funds, joint ventures and other funds. The portion of these investments accounted for under the equity method had a carrying value of $1.9 billion at December 31, 2016. The Company’s maximum exposure to loss related to these equity method investments is limited to the carrying value of these investments plus unfunded commitments of $1.1 billion at December 31, 2016. Except for certain real estate joint ventures, the Company’s investments in real estate funds and other limited partnership interests are generally of a passive nature in that the Company does not participate in the management of the entities.

As described in Note 1, the Company generally records its share of earnings in its equity method investments using a three-month lag methodology and within net investment income. Aggregate net investment income from these equity method investments exceeded 10% of the Company’s consolidated pre-tax income (loss) for the two of the most recent annual periods: 2015 and 2014. This aggregated summarized financial data does not represent the Company’s proportionate share of the assets, liabilities, or earnings of such entities.

The aggregated summarized financial data presented below reflects the latest available financial information and is as of, and for, the years ended December 31, 2016, 2015 and 2014. Aggregate total assets of these entities totaled $285.1 billion and $294.3 billion at December 31, 2016 and 2015, respectively. Aggregate total liabilities of these entities totaled $26.3 billion and $46.3 billion at December 31, 2016 and 2015, respectively. Aggregate net income (loss) of these entities totaled $21.3 billion, $13.7 billion and $25.1 billion for the years ended December 31, 2016, 2015 and 2014, respectively. Aggregate net income (loss) from the underlying entities in which the Company invests is primarily comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses).

Variable Interest Entities

The Company has invested in certain entities (including CSEs) that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity.

Consolidated VIEs

Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company’s obligation to the VIEs is limited to the amount of its committed investment.

The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2016 and 2015.

	December 31,
	2016		2015
	(In millions)
MRSC (collateral financing arrangement ) (1)	$	3,422	$	3,374
CSEs: (2)
Assets:
Mortgage loans (commercial mortgage loans)	136		172
Accrued investment income	1		1
Total assets	$	137	$	173
Liabilities:
Long-term debt	$	23	$	48
Other liabilities	1		1
Total liabilities	$	24	$	49

______________

71

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

(1) See Note 3 for additional information on MRSC collateral financing arrangement.

(2) The Company consolidates entities that are structured as CMBS. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $95 million and $105 million at estimated fair value at December 31, 2016 and 2015, respectively.

Unconsolidated VIEs

The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:

	December 31,
	2016				2015
	Carrying Amount		Maximum Exposure to Loss (1)		Carrying Amount		Maximum Exposure to Loss (1)
	(In millions)
Fixed maturity securities AFS:
Structured Securities (2)	$	12,809	$	12,809	$	16,454	$	16,454
U.S. and foreign corporate	536		536		625		625
Other limited partnership interests	1,491		2,287		1,367		1,646
Real estate joint ventures	17		22		35		38
Other investments (3)	60		66		58		62
Total	$	14,913	$	15,720	$	18,539	$	18,825

______________

(1) The maximum exposure to loss relating to fixed maturity and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties. There were no income tax credits and less than $1 million at December 31, 2016 and 2015, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.

(2) For these variable interests, the Company’s involvement is limited to that of a passive investor in mortgage-backed or asset-backed securities issued by trusts that do not have substantial equity.

(3) Other investments is comprised of other invested assets and non-redeemable preferred stock.

As described in Note 16, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during the years ended December 31, 2016, 2015 and 2014.

72

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Net Investment Income

The components of net investment income were as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Investment income:
Fixed maturity securities	$	2,567	$	2,398	$	2,269
Equity securities	19		19		17
Mortgage loans	393		367		344
Policy loans	54		54		59
Real estate and real estate joint ventures	32		108		80
Other limited partnership interests	163		134		266
Cash, cash equivalents and short-term investments	20		9		5
Operating joint venture	11		11		2
Other	14		11		4
Subtotal	3,273		3,111		3,046
Less: Investment expenses	173		126		111
Subtotal, net	3,100		2,985		2,935
FVO CSEs — interest income — commercial mortgage loans	11		16		49
Net investment income	$	3,111	$	3,001	$	2,984

See “— Variable Interest Entities” for discussion of CSEs.

See “— Related Party Investment Transactions” for discussion of affiliated net investment income and investment expenses.

73

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Net Investment Gains (Losses)

Components of Net Investment Gains (Losses)

The components of net investment gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Total gains (losses) on fixed maturity securities:
Total OTTI losses recognized — by sector and industry:
U.S. and foreign corporate securities — by industry:
Industrial	$	(16	)	$	(3	)	$	—
Consumer	—			(8		)	(2		)
Utility	—			(6		)	—
Transportation	—			—			(2		)
Total U.S. and foreign corporate securities	(16		)	(17		)	(4		)
RMBS	(6		)	(14		)	(10		)
OTTI losses on fixed maturity securities recognized in earnings	(22		)	(31		)	(14		)
Fixed maturity securities — net gains (losses) on sales and disposals	(28		)	(60		)	10
Total gains (losses) on fixed maturity securities	(50		)	(91		)	(4		)
Total gains (losses) on equity securities:
Total OTTI losses recognized — by sector:
Common stock	(1		)	(3		)	(7		)
Non-redeemable preferred stock	(1		)	—			(8		)
OTTI losses on equity securities recognized in earnings	(2		)	(3		)	(15		)
Equity securities — net gains (losses) on sales and disposals	10			18			14
Total gains (losses) on equity securities	8			15			(1		)
Mortgage loans	5			(11		)	18
Real estate and real estate joint ventures	(34		)	98			(4		)
Other limited partnership interests	(7		)	(1		)	(9		)
Other	11			(2		)	43
Subtotal	(67		)	8			43
FVO CSEs:
Commercial mortgage loans	(2		)	(7		)	(13		)
Long-term debt — related to commercial mortgage loans	1			4			19
Non-investment portfolio gains (losses) (1)	1			—			(538		)
Subtotal	—			(3		)	(532		)
Total net investment gains (losses)	$	(67	)	$	5		$	(489	)

______________

(1) Non-investment portfolio gains (losses) for the year ended December 31, 2014 includes a loss of $608 million related to the disposition of MAL as more fully described in Note 4.

See “— Variable Interest Entities” for discussion of CSEs.

See “— Related Party Investment Transactions” for discussion of affiliated net investment gains (losses) related to transfers of invested assets to affiliates.

Gains (losses) from foreign currency transactions included within net investment gains (losses) were $8 million, ($5) million and $66 million for the years ended December 31, 2016, 2015 and 2014, respectively.

74

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

Sales or Disposals and Impairments of Fixed Maturity and Equity Securities

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) were as shown in the table below.

	Years Ended December 31,
	2016			2015			2014			2016			2015			2014
	Fixed Maturity Securities									Equity Securities
	(In millions)
Proceeds	$	39,210		$	32,085		$	16,943		$	48		$	80		$	57
Gross investment gains	$	253		$	184		$	95		$	10		$	26		$	15
Gross investment losses	(281		)	(244		)	(85		)	—			(8		)	(1		)
OTTI losses	(22		)	(31		)	(14		)	(2		)	(3		)	(15		)
Net investment gains (losses)	$	(50	)	$	(91	)	$	(4	)	$	8		$	15		$	(1	)

Credit Loss Rollforward

The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI:

	Years Ended December 31,
	2016			2015
	(In millions)
Balance at January 1,	$	66		$	67
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	—			6
Additional impairments — credit loss OTTI on securities previously impaired	5			11
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(42		)	(16		)
Increase in cash flows — accretion of previous credit loss OTTI	(1		)	(2		)
Balance at December 31,	$	28		$	66

Related Party Investment Transactions

The Company transfers invested assets, primarily consisting of fixed maturity securities, to and from affiliates. Invested assets transferred to and from affiliates were as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Estimated fair value of invested assets transferred to affiliates	$	1,495	$	185	$	1,441
Amortized cost of invested assets transferred to affiliates	$	1,400	$	169	$	1,362
Net investment gains (losses) recognized on transfers	$	27	$	16	$	79
Change in additional paid-in-capital recognized on transfers	$	68	$	—	$	—
Estimated fair value of invested assets transferred from affiliates	$	5,582	$	928	$	132

In April 2016 and in November 2016, the Company received a transfer of investments and cash and cash equivalents totaling $5.2 billion for the recapture of risks related to certain single premium deferred annuity contracts previously reinsured to MLIC, an affiliate, which are included in the table above. See Note 7 for additional information related to these transfers.

75

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

8. Investments (continued)

In July 2014, prior to the Mergers, the Company sold affiliated loans to other affiliates, which were included in other invested assets and in the table above, at an estimated fair value totaling $520 million and a $45 million gain was recognized in net investment gains (losses). Net investment income from these affiliated loans was $13 million for the year ended December 31, 2014.

The Company had affiliated loans outstanding to wholly-owned real estate subsidiaries of MLIC, which were included in mortgage loans, with a carrying value of $242 million at December 31, 2014. In August 2015 and November 2014, one affiliated loan with a carrying value of $132 million and two affiliated loans with a total carrying value of $120 million were repaid in cash prior to maturity. The remaining loan with a carrying value of $110 million was repaid in cash upon maturity in December 31, 2015. These affiliated loans were secured by interests in the real estate subsidiaries, which owned operating real estate with an estimated fair value in excess of the affiliated loans. Net investment income from these affiliated loans was $8 million and $34 million for the years ended December 31, 2015 and 2014, respectively. In addition, mortgage loan prepayment income earned from the three repayments prior to maturity described above was $31 million and $16 million for the years ended December 31, 2015 and 2014, respectively.

The Company had loans outstanding to affiliates, which were included in other invested assets, totaling $1.1 billion and $1.2 billion as of December 31, 2016 and 2015, respectively. Two loans totaling $1.1 billion as of both December 31, 2016 and 2015, were outstanding to MetLife, Inc., which bear interest at fixed rates of 4.21% and 5.10%, payable semiannually, and are due on September 30, 2032 and December 31, 2033, respectively. See also Note 12 for the related surplus notes payable totaling$1.1 billion. In addition, the Company had affiliated loans outstanding to an investment subsidiary of MLIC totaling $50 million as of December 31, 2015 with interest rates ranging from 1.55% to 2.39% and scheduled maturity dates from October 31, 2021 to June 30, 2022. In March 2016, the loans outstanding to an investment subsidiary of MLIC were repaid in cash prior to maturity. Net investment income from these affiliated loans was $51 million and $52 million for the years ended December 31, 2016 and 2015.

The Company receives investment administrative services from an affiliate. The related investment administrative service charges were $98 million, $79 million, and $70 million for the years ended December 31, 2016, 2015 and 2014, respectively.

See “— Mortgage Loans — Mortgage Loans by Portfolio Segment” for discussion of mortgage loan participation agreements with an affiliate.

9. Derivatives

Accounting for Derivatives

See Note 1 for a description of the Company’s accounting policies for derivatives and Note 10 for information about the fair value hierarchy for derivatives.

Derivative Strategies

The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps to synthetically replicate investment risks and returns which are not readily available in the cash markets.

Interest Rate Derivatives

The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, caps, floors, swaptions, futures and forwards.

76

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and nonqualifying hedging relationships.

Interest rate total return swaps are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the London Interbank Offered Rate (“LIBOR”), calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. Interest rate total return swaps are used by the Company to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). The Company utilizes interest rate total return swaps in nonqualifying hedging relationships.

The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in nonqualifying hedging relationships.

In exchange-traded interest rate (Treasury and swap) futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance, and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded interest rate futures in nonqualifying hedging relationships.

Swaptions are used by the Company to hedge interest rate risk associated with the Company’s long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. The Company utilizes swaptions in nonqualifying hedging relationships. Swaptions are included in interest rate options.

The Company enters into interest rate forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. The Company utilizes interest rate forwards in cash flow hedging relationships.

Foreign Currency Exchange Rate Derivatives

The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in cash flow and nonqualifying hedging relationships.

To a lesser extent, the Company uses foreign currency forwards in nonqualifying hedging relationships.

77

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

Credit Derivatives

The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional amount in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, involuntary restructuring or governmental intervention. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. (“ISDA”) deems that a credit event has occurred. The Company utilizes credit default swaps in nonqualifying hedging relationships.

The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. government and agency securities or other fixed maturity securities. These credit default swaps are not designated as hedging instruments.

Equity Derivatives

The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, equity variance swaps, exchange-traded equity futures and equity total return swaps.

Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in nonqualifying hedging relationships.

Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in nonqualifying hedging relationships.

In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in nonqualifying hedging relationships.

In an equity total return swapare swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the LIBOR, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses equity total return swaps to hedge its equity market guarantees in certain of its insurance products. Equity total return swaps can be used as hedges or to synthetically create investments. The Company utilizes equity total return swaps in nonqualifying hedging relationships.

78

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

Primary Risks Managed by Derivatives

The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:

	Primary Underlying Risk Exposure	December 31,
		2016						2015
				Estimated Fair Value						Estimated Fair Value
		Gross Notional Amount		Assets		Liabilities		Gross Notional Amount		Assets		Liabilities
		(In millions)
Derivatives Designated as Hedging Instruments
Fair value hedges:
Interest rate swaps	Interest rate	$	310	$	41	$	—	$	420	$	38	$	1
Cash flow hedges:
Interest rate swaps	Interest rate	45		7		—		230		60		—
Interest rate forwards	Interest rate	—		—		—		35		8		—
Foreign currency swaps	Foreign currency exchange rate	1,420		186		10		969		129		3
Subtotal		1,465		193		10		1,234		197		3
Total qualifying hedges		1,775		234		10		1,654		235		4
Derivatives Not Designated or Not Qualifying as Hedging Instruments
Interest rate swaps	Interest rate	28,175		1,928		1,688		23,086		1,802		638
Interest rate floors	Interest rate	2,100		5		2		7,036		33		24
Interest rate caps	Interest rate	12,042		25		—		13,792		38		—
Interest rate futures	Interest rate	1,288		9		—		630		2		—
Interest rate options	Interest rate	15,520		136		—		18,620		472		5
Interest rate total return swaps	Interest rate	3,876		—		611		48		2		—
Foreign currency swaps	Foreign currency exchange rate	1,250		153		4		673		77		—
Foreign currency forwards	Foreign currency exchange rate	158		9		—		185		4		1
Credit default swaps — purchased	Credit	34		—		—		21		—		—
Credit default swaps — written	Credit	1,891		28		—		2,093		13		1
Equity futures	Equity market	8,037		38		—		3,669		37		—
Equity index options	Equity market	37,501		897		934		44,035		1,032		626
Equity variance swaps	Equity market	14,894		140		517		14,866		120		434
Equity total return swaps	Equity market	2,855		1		117		2,814		31		49
Total non-designated or nonqualifying derivatives		129,621		3,369		3,873		131,568		3,663		1,778
Total		$	131,396	$	3,603	$	3,883	$	133,222	$	3,898	$	1,782

Based on gross notional amounts, a substantial portion of the Company’s derivatives was not designated or did not qualify as part of a hedging relationship at both December 31, 2016 and 2015. The Company’s use of derivatives includes (i) derivatives that serve as macro hedges of the Company’s exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to synthetically create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these nonqualified derivatives, changes in market factors can lead to the recognition of fair value changes on the statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged.

79

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

Net Derivative Gains (Losses)

The components of net derivative gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Freestanding derivatives and hedging gains (losses) (1)	$	(4,029	)	$	(153	)	$	870
Embedded derivatives gains (losses)	(1,741		)	(344		)	(576		)
Total net derivative gains (losses)	$	(5,770	)	$	(497	)	$	294

______________

(1) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships, which are not presented elsewhere in this note.

The following table presents earned income on derivatives:

	Years Ended December 31,
	2016		2015			2014
	(In millions)
Qualifying hedges:
Net investment income	$	19	$	11		$	4
Interest credited to policyholder account balances	—		(2		)	(1		)
Nonqualifying hedges:
Net derivative gains (losses)	460		361			273
Policyholder benefits and claims	16		14			32
Total	$	495	$	384		$	308

80

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

Nonqualifying Derivatives and Derivatives for Purposes Other Than Hedging

The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments:

	Net Derivative Gains (Losses)			Net Investment Income (1)			Policyholder Benefits and Claims (2)
	(In millions)
Year Ended December 31, 2016
Interest rate derivatives	$	(2,873	)	$	—		$	(4	)
Foreign currency exchange rate derivatives	76			—			—
Credit derivatives — purchased	—			—			—
Credit derivatives — written	10			—			—
Equity derivatives	(1,724		)	(6		)	(320		)
Total	$	(4,511	)	$	(6	)	$	(324	)
Year Ended December 31, 2015
Interest rate derivatives	$	(67	)	$	—		$	5
Foreign currency exchange rate derivatives	44			—			—
Credit derivatives — purchased	—			—			—
Credit derivatives — written	(14		)	—			—
Equity derivatives	(476		)	(4		)	(25		)
Total	$	(513	)	$	(4	)	$	(20	)
Year Ended December 31, 2014
Interest rate derivatives	$	1,174		$	—		$	43
Foreign currency exchange rate derivatives	6			—			—
Credit derivatives — purchased	(22		)	—			—
Credit derivatives — written	18			—			—
Equity derivatives	(591		)	(8		)	(279		)
Total	$	585		$	(8	)	$	(236	)

______________

(1) Changes in estimated fair value related to economic hedges of equity method investments in joint ventures.

(2) Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.

Fair Value Hedges

The Company designates and accounts for interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities as fair value hedges when they have met the requirements of fair value hedging.

81

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):

Derivatives in Fair Value Hedging Relationships	Hedged Items in Fair Value Hedging Relationships	Net Derivative Gains (Losses) Recognized for Derivatives		Net Derivative Gains (Losses) Recognized for Hedged Items			Ineffectiveness Recognized in Net Derivative Gains (Losses)
		(In millions)
Year Ended December 31, 2016
Interest rate swaps:	Fixed maturity securities	$	1	$	(1	)	$	—
	Policyholder liabilities (1)	—		—			—
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	1	$	(1	)	$	—
Year Ended December 31, 2015
Interest rate swaps:	Fixed maturity securities	$	1	$	1		$	2
	Policyholder liabilities (1)	2		(2		)	—
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	3	$	(1	)	$	2
Year Ended December 31, 2014
Interest rate swaps:	Fixed maturity securities	$	1	$	(1	)	$	—
	Policyholder liabilities (1)	32		(31		)	1
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	33	$	(32	)	$	1

______________

(1) Fixed rate liabilities reported in policyholder account balances or future policy benefits.

(2) Fixed rate or floating rate liabilities.

All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

Cash Flow Hedges

The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; and (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments.

In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. Because certain of the forecasted transactions also were not probable of occurring within two months of the anticipated date, the Company reclassified amounts from AOCI into net derivative gains (losses). These amounts were $1 million and $3 million for the years ended December 31, 2016 and 2015, respectively. These amounts were not significant for the year ended December 31, 2014.

At December 31, 2016 and 2015, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed three years and four years, respectively.

At December 31, 2016 and 2015, the balance in AOCI associated with cash flow hedges was $397 million and $370 million, respectively.

82

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of stockholder’s equity:

Derivatives in Cash Flow Hedging Relationships	Amount of Gains (Losses) Deferred in AOCI on Derivatives		Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)					Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives
	(Effective Portion)		(Effective Portion)					(Ineffective Portion)
			Net Derivative Gains (Losses)			Net Investment Income		Net Derivative Gains (Losses)
	(In millions)
Year Ended December 31, 2016
Interest rate swaps	$	24	$	33		$	3	$	—
Interest rate forwards	4		2			2		—
Foreign currency swaps	42		3			—		—
Credit forwards	—		—			—		—
Total	$	70	$	38		$	5	$	—
Year Ended December 31, 2015
Interest rate swaps	$	15	$	1		$	1	$	1
Interest rate forwards	1		2			2		—
Foreign currency swaps	79		—			—		—
Credit forwards	—		—			—		—
Total	$	95	$	3		$	3	$	1
Year Ended December 31, 2014
Interest rate swaps	$	131	$	1		$	1	$	—
Interest rate forwards	55		1			1		—
Foreign currency swaps	57		(6		)	—		—
Credit forwards	—		—			—		—
Total	$	243	$	(4	)	$	2	$	—

All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

At December 31, 2016, the Company expects to reclassify $40 million of deferred net gains (losses) on derivatives in AOCI to earnings within the next 12 months.

Credit Derivatives

In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the nonqualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company’s maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $1.9 billion and $2.1 billion at December 31, 2016 and 2015, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current estimated fair value of the credit default swaps. At December 31, 2016 and 2015, the Company would have received $28 million and $12 million, respectively, to terminate all of these contracts.

83

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:

	December 31,
	2016					2015
Rating Agency Designation of Referenced Credit Obligations (1)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)
	(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (3)	$	1	$	45	2.2	$	1	$	207	1.5
Credit default swaps referencing indices	8		433		3.7	1		219		4.0
Subtotal	9		478		3.6	2		426		2.8
Baa
Single name credit default swaps (3)	1		180		1.6	2		409		1.6
Credit default swaps referencing indices	18		1,213		4.8	8		1,222		4.8
Subtotal	19		1,393		4.4	10		1,631		4.0
Ba
Single name credit default swaps (3)	—		20		2.7	—		—		—
Credit default swaps referencing indices	—		—		—	—		—		—
Subtotal	—		20		2.7	—		—		—
B
Single name credit default swaps (3)	—		—		—	—		—		—
Credit default swaps referencing indices	—		—		—	—		36		5.0
Subtotal	—		—		—	—		36		5.0
Total	$	28	$	1,891	4.2	$	12	$	2,093	3.8

______________

(1) The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.

(2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.

(3) Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or state and political subdivisions.

Credit Risk on Freestanding Derivatives

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

84

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

The Company’s OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives.

See Note 10 for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	December 31,
	2016						2015
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	3,394		$	2,929		$	3,875		$	1,725
OTC-cleared (1)	267			905			78			78
Exchange-traded	46			—			39			—
Total gross estimated fair value of derivatives (1)	3,707			3,834			3,992			1,803
Amounts offset on the consolidated balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the consolidated balance sheets (1)	3,707			3,834			3,992			1,803
Gross amounts not offset on the consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(2,231		)	(2,231		)	(1,577		)	(1,577		)
OTC-cleared	(165		)	(165		)	(70		)	(70		)
Exchange-traded	—			—			—			—
Cash collateral: (3), (4)
OTC-bilateral	(634		)	—			(1,608		)	—
OTC-cleared	(91		)	(740		)	(8		)	(8		)
Exchange-traded	—			—			—			—
Securities collateral: (5)
OTC-bilateral	(429		)	(698		)	(553		)	(148		)
OTC-cleared	—			—			—			—
Exchange-traded	—			—			—			—
Net amount after application of master netting agreements and collateral	$	157		$	—		$	176		$	—

______________

(1) At December 31, 2016 and 2015, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $104 million and $94 million, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($49) million and $21 million, respectively.

85

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.

(4) The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2016 and 2015, the Company received excess cash collateral of $3 million and $1 million, respectively, and provided excess cash collateral of $25 million and $62 million, respectively, which is not included in the table above due to the foregoing limitation.

(5) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at December 31, 2016none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2016 and 2015, the Company received excess securities collateral with an estimated fair value of $135 million and $0, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At December 31, 2016 and 2015, the Company provided excess securities collateral with an estimated fair value of $108 million and $36 million, respectively, for its OTC-bilateral derivatives, $630 million and $34 million, respectively, for its OTC-cleared derivatives, and $453 million and $156 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.

The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the collateral amount owed by that counterparty reaches a minimum transfer amount. A small number of these arrangements also include credit-contingent provisions that include a threshold above which collateral must be posted. Such agreements provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the credit ratings of Brighthouse Life Insurance Company, and/or the counterparty. In addition, substantially all of the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’s and S&P. If a party’s credit or financial strength ratings, as applicable, were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.

86

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The Company’s collateral agreements require both parties to be fully collateralized, as such, Brighthouse Life Insurance Company would not be required to post additional collateral as a result of a downgrade in financial strength rating. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.

	December 31,
	2016		2015
	(In millions)
Estimated fair value of derivatives in a net liability position (1)	$	698	$	148
Estimated Fair Value of Collateral Provided
Fixed maturity securities	$	777	$	179
Cash	$	—	$	—
Fair Value of Incremental Collateral Provided Upon
One-notch downgrade in financial strength rating	$	—	$	—
Downgrade in financial strength rating to a level that triggers full overnight collateralization or termination of the derivative position	$	—	$	—

______________

(1) After taking into consideration the existence of netting agreements.

Embedded Derivatives

The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; affiliated ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs; affiliated assumed reinsurance of guaranteed minimum benefits related to GMWBs and certain GMIBs; funds withheld on assumed and ceded reinsurance; fixed annuities with equity indexed returns; and certain debt and equity securities.

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

		December 31,
	Balance Sheet Location	2016			2015
		(In millions)
Embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	409		$	363
Funds withheld on assumed reinsurance	Other invested assets	—			35
Options embedded in debt or equity securities	Investments	(49		)	(62		)
Embedded derivatives within asset host contracts		$	360		$	336
Embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances	$	2,237		$	122
Assumed guaranteed minimum benefits	Policyholder account balances	741			712
Funds withheld on ceded reinsurance	Other liabilities	—			—
Fixed annuities with equity indexed returns	Policyholder account balances	192			6
Embedded derivatives within liability host contracts		$	3,170		$	840

87

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

9. Derivatives (continued)

The following table presents changes in estimated fair value related to embedded derivatives:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Net derivative gains (losses) (1), (2)	$	(1,741	)	$	(344	)	$	(576	)
Policyholder benefits and claims	$	(4	)	$	21		$	87

______________

(1) The valuation of direct and assumed guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were $244 million, $26 million and $69 million for the years ended December 31, 2016, 2015 and 2014, respectively.

(2) See Note 7 for discussion of affiliated net derivative gains (losses).

Related Party Freestanding Derivative Transactions

In November 2014, as part of the settlement of related party reinsurance transactions, the Company transferred derivatives to affiliates. The estimated fair value of freestanding derivative assets and liabilities transferred was $1.8 billion and $1.2 billion, respectively.

10. Fair Value

When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows:

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities.

Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company’s ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities.

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

88

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below at:

	December 31, 2016
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	20,221	$	1,444	$	21,665
U.S. government and agency	6,110		6,806		—		12,916
RMBS	—		6,627		1,313		7,940
Foreign corporate	—		5,257		866		6,123
State and political subdivision	—		3,841		17		3,858
CMBS	—		3,529		167		3,696
ABS	—		2,383		215		2,598
Foreign government	—		1,103		—		1,103
Total fixed maturity securities	6,110		49,767		4,022		59,899
Equity securities	39		124		137		300
Short-term investments	702		568		2		1,272
Commercial mortgage loans held by CSEs — FVO	—		136		—		136
Derivative assets: (1)
Interest rate	9		2,142		—		2,151
Foreign currency exchange rate	—		348		—		348
Credit	—		20		8		28
Equity market	37		860		179		1,076
Total derivative assets	46		3,370		187		3,603
Embedded derivatives within asset host contracts (2)	—		—		409		409
Separate account assets (3)	720		104,616		10		105,346
Total assets	$	7,617	$	158,581	$	4,767	$	170,965
Liabilities
Derivative liabilities: (1)
Interest rate	$	—	$	1,690	$	611	$	2,301
Foreign currency exchange rate	—		14		—		14
Equity market	—		1,038		530		1,568
Total derivative liabilities	—		2,742		1,141		3,883
Embedded derivatives within liability host contracts (2)	—		—		3,170		3,170
Long-term debt of CSEs — FVO	—		23		—		23
Total liabilities	$	—	$	2,765	$	4,311	$	7,076

89

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

	December 31, 2015
	Fair Value Hierarchy						Total Estimated Fair Value
	Level 1		Level 2		Level 3
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	18,787	$	1,688	$	20,475
U.S. government and agency	8,150		6,291		—		14,441
RMBS	—		8,522		1,351		9,873
Foreign corporate	—		4,761		722		5,483
State and political subdivision	—		3,533		13		3,546
CMBS	—		3,066		215		3,281
ABS	—		3,833		430		4,263
Foreign government	—		732		27		759
Total fixed maturity securities	8,150		49,525		4,446		62,121
Equity securities	44		316		97		457
Short-term investments (4)	74		1,666		47		1,787
Commercial mortgage loans held by CSEs — FVO	—		172		—		172
Derivative assets: (1)
Interest rate	2		2,445		8		2,455
Foreign currency exchange rate	—		210		—		210
Credit	—		12		1		13
Equity market	37		968		215		1,220
Total derivative assets	39		3,635		224		3,898
Embedded derivatives within asset host contracts (2)	—		—		398		398
Separate account assets (3)	624		105,757		146		106,527
Total assets	$	8,931	$	161,071	$	5,358	$	175,360
Liabilities
Derivative liabilities: (1)
Interest rate	$	—	$	668	$	—	$	668
Foreign currency exchange rate	—		4		—		4
Credit	—		1		—		1
Equity market	—		653		456		1,109
Total derivative liabilities	—		1,326		456		1,782
Embedded derivatives within liability host contracts (2)	—		—		840		840
Long-term debt of CSEs — FVO	—		48		—		48
Total liabilities	$	—	$	1,374	$	1,296	$	2,670

______________

(1) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the roll-forward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.

(2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances and other liabilities on the consolidated balance sheets. At December 31, 2016 and 2015, debt and equity securities also included embedded derivatives of ($49) million and ($62) million, respectively.

90

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

(3) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.

(4) Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.

The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy.

Investments

Valuation Controls and Procedures

On behalf of the Company and MetLife, Inc.’s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third-party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of Brighthouse Life Insurance Company’s Board of Directors regarding compliance with fair value accounting standards.

The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management’s knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as “consensus pricing,” represent a reasonable estimate of fair value by considering such pricing relative to the Company’s knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent less than 1% of the total estimated fair value of fixed maturity securities and 5% of the total estimated fair value of Level 3 fixed maturity securities at December 31, 2016.

The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management’s best estimate is used.

Securities, Short-term Investments and Long-term Debt of CSEs — FVO

When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company’s securities holdings and valuation of these securities does not involve management’s judgment.

91

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management’s judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances.

The estimated fair value of long-term debt of CSEs — FVO is determined on a basis consistent with the methodologies described herein for securities.

The valuation of most instruments listed below is determined using independent pricing sources, matrix pricing, discounted cash flow methodologies or other similar techniques that use either observable market inputs or unobservable inputs.

Instrument		Level 2 Observable Inputs		Level 3 Unobservable Inputs
Fixed Maturity Securities
U.S. corporate and Foreign corporate securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	illiquidity premium
	•	benchmark yields; spreads off benchmark yields; new issuances; issuer rating		•	delta spread adjustments to reflect specific credit-related issues
	•	trades of identical or comparable securities; duration		•	credit spreads
	•	Privately-placed securities are valued using the additional key inputs:		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
		•	market yield curve; call provisions
		•	observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer	•	independent non-binding broker quotations
		•	delta spread adjustments to reflect specific credit-related issues
U.S. government and agency, State and political subdivision and Foreign government securities
	Valuation Techniques: Principally the market approach.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	independent non-binding broker quotations
	•	benchmark U.S. Treasury yield or other yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	the spread off the U.S. Treasury yield curve for the identical security
	•	issuer ratings and issuer spreads; broker-dealer quotes		•	credit spreads
	•	comparable securities that are actively traded
Structured Securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market and income approaches.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	credit spreads
	•	spreads for actively traded securities; spreads off benchmark yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	expected prepayment speeds and volumes
	•	current and forecasted loss severity; ratings; geographic region		•	independent non-binding broker quotations
	•	weighted average coupon and weighted average maturity
	•	average delinquency rates; debt-service coverage ratios
	•	issuance-specific information, including, but not limited to:
		•	collateral type; structure of the security; vintage of the loans
		•	payment terms of the underlying assets
		•	payment priority within the tranche; deal performance

92

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Instrument	Level 2 Observable Inputs		Level 3 Unobservable Inputs
Equity Securities
	Valuation Techniques: Principally the market approach.		Valuation Techniques: Principally the market and income approaches.
	Key Input:		Key Inputs:
	•	quoted prices in markets that are not considered active	•	credit ratings; issuance structures
			•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
			•	independent non-binding broker quotations
Short-term investments
	•	Short-term investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and observable inputs used in their valuation are also similar to those described above.	•	Short-term investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and unobservable inputs used in their valuation are also similar to those described above.
Commercial mortgage loans held by CSEs — FVO
	Valuation Techniques: Principally the market approach.		•	N/A
	Key Input:
	•	quoted securitization market price of the obligations of the CSEs determined principally by independent pricing services using observable inputs
Separate Account Assets (1)
Mutual funds without readily determinable fair values as prices are not published publicly
	Key Input:		•	N/A
	•	quoted prices or reported net asset value (“NAV”) provided by the fund managers
Other limited partnership interests
	•	N/A	Valuation Techniques: Valued giving consideration to the underlying holdings of the partnerships and by applying a premium or discount, if appropriate.
			Key Inputs:
			•	liquidity; bid/ask spreads; performance record of the fund manager
			•	other relevant variables that may impact the exit value of the particular partnership interest

______________

(1) Estimated fair value equals carrying value, based on the value of the underlying assets, including: mutual fund interests, fixed maturity securities, equity securities, derivatives, other limited partnership interests, short-term investments and cash and cash equivalents. Fixed maturity securities, equity securities, derivatives, short-term investments and cash and cash equivalents are similar in nature to the instruments described under “— Securities, Short-term Investments and Long-term Debt of CSEs — FVO” and “— Derivatives — Freestanding Derivatives.”

Derivatives

The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in “— Investments — Valuation Controls and Procedures.”

The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

93

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income.

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

Freestanding Derivatives

Level 2 Valuation Techniques and Key Inputs:

This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3.

Level 3 Valuation Techniques and Key Inputs:

These valuation methodologies generally use the same inputs as described in the corresponding sections for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data.

Freestanding derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. Key inputs are as follows:

Instrument		Interest Rate		Foreign Currency Exchange Rate		Credit		Equity Market
Inputs common to Level 2 and Level 3 by instrument type	•	swap yield curves	•	swap yield curves	•	swap yield curves	•	swap yield curves
	•	basis curves	•	basis curves	•	credit curves	•	spot equity index levels
	•	interest rate volatility (1)	•	currency spot rates	•	recovery rates	•	dividend yield curves
			•	cross currency basis curves			•	equity volatility (1)
Level 3	•	swap yield curves (2)	•	N/A	•	swap yield curves (2)	•	dividend yield curves (2)
	•	basis curves (2)			•	credit curves (2)	•	equity volatility (1), (2)
	•	repurchase rates			•	credit spreads	•	correlation between model inputs (1)
					•	repurchase rates
					•	independent non-binding broker quotations

______________

(1) Option-based only.

(2) Extrapolation beyond the observable limits of the curve(s).

94

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Embedded Derivatives

Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees, equity or bond indexed crediting rates within certain annuity contracts, and those related to funds withheld on ceded reinsurance agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

The Company’s actuarial department calculates the fair value of these embedded derivatives, which are estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries as compared to MetLife, Inc.

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.

The Company assumed from an affiliated insurance company the risk associated with certain GMIBs. These embedded derivatives are included in policyholder account balances on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on these assumed risks is determined using a methodology consistent with that described previously for the guarantees directly written by the Company.

The Company ceded to an affiliate the risk associated with certain of the GMIBs, GMABs and GMWBs described above that are also accounted for as embedded derivatives. In addition to ceding risks associated with guarantees that are accounted for as embedded derivatives, the Company also cedes, to an affiliated company, certain directly written GMIBs that are accounted for as insurance (i.e., not as embedded derivatives), but where the reinsurance agreement contains an embedded derivative. These embedded derivatives are included within premiums, reinsurance and other receivables on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.

95

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in “— Investments — Securities, Short-term Investments and Long-term Debt of CSEs — FVO.” The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities on the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.

The Company issues certain annuity contracts which allow the policyholder to participate in returns from equity indices. These equity indexed features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

The estimated fair value of the embedded equity indexed derivatives, based on the present value of future equity returns to the policyholder using actuarial and present value assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business and uses standard capital market techniques, such as Black-Scholes, to calculate the value of the portion of the embedded derivative for which the terms are set. The portion of the embedded derivative covering the period beyond where terms are set is calculated as the present value of amounts expected to be spent to provide equity indexed returns in those periods. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk.

Embedded Derivatives Within Asset and Liability Host Contracts

Level 3 Valuation Techniques and Key Inputs:

Direct and assumed guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curves, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curves and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin.

Reinsurance ceded on certain guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in “— Direct and assumed guaranteed minimum benefits” and also include counterparty credit spreads.

Transfers between Levels

Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period.

Transfers between Levels 1 and 2:

For assets and liabilities measured at estimated fair value and still held at December 31, 2016 and 2015, transfers between Levels 1 and 2 were not significant.

96

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Transfers into or out of Level 3:

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					December 31, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)					(65)	-	240	49	Decrease
			•	Offered quotes (5)	18	-	138	104	96	-	100	98	Increase
	•	Market pricing	•	Quoted prices (5)	13	-	700	99	13	-	780	282	Increase
	•	Consensus pricing	•	Offered quotes (5)	37	-	109	85	68	-	100	86	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	38	-	111	91	29	-	292	93	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	94	-	106	100	97	-	103	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	100	99	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	—	-	—		317	-	317		Increase (8)
			•	Repurchase rates (9)	(44)	-	18						Decrease (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	98		—	-	—		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	14%	-	32%		17%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.09%		0%	-	0.09%		Decrease (14)
				Ages 41 - 60	0.04%	-	0.65%		0.04%	-	0.65%		Decrease (14)
				Ages 61 - 115	0.26%	-	100%		0.26%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		3%	-	100%		Decrease (15)
				Durations 21 - 116	2%	-	100%		3%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0.25%	-	10%		0.25%	-	10%		(17)
			•	Long-term equity volatilities	17.40%	-	25%		17.40%	-	25%		Increase (18)
			•	Nonperformance risk spread	0.04%	-	0.57%		0.04%	-	0.52%		Decrease (19)

______________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

97

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) As of December 31, 2016 and 2015, independent non-binding broker quotations were used in the determination of 3% and less than 1% of the total net derivative estimated fair value, respectively.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contractholders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

98

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets and embedded derivatives within funds withheld related to certain ceded and assumed reinsurance, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in “— Nonrecurring Fair Value Measurements.”

99

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			State and Political Subdivision			Foreign Government			Equity Securities			Short-term Investments			Net Derivatives (2)			Net Embedded Derivatives (3)			Separate Account Assets (4)
	(In millions)
Balance, January 1, 2015	$	2,403		$	1,212		$	—		$	—		$	100		$	71		$	(196	)	$	354		$	158
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	16			21			—			—			11			—			(74		)	(303		)	(6		)
Total realized/unrealized gains (losses) included in AOCI	(120		)	(14		)	—			(2		)	(10		)	—			2			—			—
Purchases (7)	406			1,342			13			29			—			47			22			—			3
Sales (7)	(191		)	(364		)	—			—			(16		)	—			—			—			(5		)
Issuances (7)	—			—			—			—			—			—			—			—			—
Settlements (7)	—			—			—			—			—			—			14			(493		)	—
Transfers into Level 3 (8)	202			31			—			—			19			—			—			—			—
Transfers out of Level 3 (8)	(306		)	(232		)	—			—			(7		)	(71		)	—			—			(4		)
Balance, December 31, 2015	$	2,410		$	1,996		$	13		$	27		$	97		$	47		$	(232	)	$	(442	)	$	146
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	(11		)	30			—			—			—			—			(703		)	(1,760		)	—
Total realized/unrealized gains (losses) included in AOCI	(24		)	21			—			—			(11		)	—			4			—			—
Purchases (7)	584			600			—			—			—			3			10			—			2
Sales (7)	(443		)	(598		)	—			—			(26		)	(1		)	—			—			(134		)
Issuances (7)	—			—			—			—			—			—			—			—			—
Settlements (7)	—			—			—			—			—			—			(33		)	(559		)	—
Transfers into Level 3 (8)	119			12			9			—			131			—			—			—			—
Transfers out of Level 3 (8)	(325		)	(366		)	(5		)	(27		)	(54		)	(47		)	—			—			(4		)
Balance, December 31, 2016	$	2,310		$	1,695		$	17		$	—		$	137		$	2		$	(954	)	$	(2,761	)	$	10
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2014 (9)	$	2		$	6		$	—		$	—		$	(1	)	$	—		$	(7	)	$	(565	)	$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2015(9)	$	11		$	21		$	—		$	—		$	—		$	—		$	(64	)	$	(310	)	$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2016 (9)	$	2		$	28		$	—		$	—		$	—		$	—		$	(687	)	$	(1,772	)	$	—
Gains (Losses) Data for the year ended December 31, 2014
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	$	3		$	10		$	—		$	—		$	(2	)	$	—		$	(4	)	$	(468	)	$	(1	)
Total realized/unrealized gains (losses) included in AOCI	$	72		$	13		$	—		$	—		$	7		$	—		$	57		$	107		$	—

____________

(1) Comprised of U.S. and foreign corporate securities.

100

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

(2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses).

(5) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and embedded derivatives are reported in net derivatives gains (losses).

(6) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.

(7) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(8) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(9) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and embedded derivatives are reported in net derivative gains (losses).

Fair Value Option

The following table presents information for certain assets and liabilities of CSEs, which are accounted for under the FVO. These assets and liabilities were initially measured at fair value. 

	December 31,
	2016		2015
	(In millions)
Assets (1)
Unpaid principal balance	$	88	$	121
Difference between estimated fair value and unpaid principal balance	48		51
Carrying value at estimated fair value	$	136	$	172
Liabilities (1)
Contractual principal balance	$	22	$	46
Difference between estimated fair value and contractual principal balance	1		2
Carrying value at estimated fair value	$	23	$	48

______________

(1) These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.

101

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Nonrecurring Fair Value Measurements

The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).

	At December 31,						Years Ended December 31,
	2016		2015		2014		2016			2015			2014
	Carrying Value After Measurement						Gains (Losses)
	(In millions)
Mortgage loans (1)	$	3	$	3	$	3	$	—		$	—		$	—
Other limited partnership interests (2)	$	3	$	2	$	38	$	(2	)	$	(1	)	$	(6	)
Other assets (3)	$	—	$	—	$	—	$	(11	)	$	—		$	—
Goodwill (4)	$	—	$	—	$	—	$	(381	)	$	—		$	(33	)

______________ 

(1) Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.

(2) For these cost method investments, estimated fair value is determined from information provided on the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both December 31, 2016 and 2015 were not significant.

(3) During the year ended December 31, 2016, the Company recognized an impairment of computer software in connection with the sale to Massachusetts Mutual Life Insurance Company (“MassMutual”) of MetLife, Inc.’s U.S. retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MetLife’s affiliated broker-dealer, MetLife Securities, Inc. (“MSI”), a wholly-owned subsidiary of MetLife, Inc. See Note 17.

(4) As discussed in Note 11, for the year ended December 31, 2016, the Company recorded an impairment of goodwill associated with the Run-off reporting unit.

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the “— Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

102

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	December 31, 2016
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	9,154	$	—	$	—	$	9,298	$	9,298
Policy loans	$	1,093	$	—	$	746	$	431	$	1,177
Real estate joint ventures	$	12	$	—	$	—	$	44	$	44
Other limited partnership interests	$	44	$	—	$	—	$	42	$	42
Loans to affiliates	$	1,100	$	—	$	1,090	$	—	$	1,090
Premiums, reinsurance and other receivables	$	2,363	$	—	$	834	$	1,981	$	2,815
Liabilities
Policyholder account balances	$	16,043	$	—	$	—	$	17,259	$	17,259
Long-term debt	$	1,881	$	—	$	2,117	$	—	$	2,117
Other liabilities	$	256	$	—	$	90	$	166	$	256
Separate account liabilities	$	1,110	$	—	$	1,110	$	—	$	1,110

	December 31, 2015
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	7,232	$	—	$	—	$	7,535	$	7,535
Policy loans	$	1,266	$	—	$	917	$	430	$	1,347
Real estate joint ventures	$	23	$	—	$	—	$	65	$	65
Other limited partnership interests	$	52	$	—	$	—	$	57	$	57
Loans to affiliates	$	1,150	$	—	$	1,178	$	—	$	1,178
Premiums, reinsurance and other receivables	$	6,639	$	—	$	83	$	7,511	$	7,594
Liabilities
Policyholder account balances	$	20,260	$	—	$	—	$	21,726	$	21,726
Long-term debt	$	1,888	$	—	$	2,320	$	—	$	2,320
Other liabilities	$	255	$	—	$	81	$	174	$	255
Separate account liabilities	$	1,275	$	—	$	1,275	$	—	$	1,275

The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows:

103

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Mortgage Loans

The estimated fair value of mortgage loans is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans.

Policy Loans

Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk, as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates.

Real Estate Joint Ventures and Other Limited Partnership Interests

The estimated fair values of these cost method investments are generally based on the Company’s share of the NAV as provided on the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.

Loans to Affiliates

The estimated fair value of loans to affiliates is principally determined using market standard valuation methodologies. Valuations of instruments are based primarily on discounted cash flow methodologies that use standard market observable inputs including market yield curve, duration, observable prices and spreads for similar publicly traded or privately traded issues.

Premiums, Reinsurance and Other Receivables

Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled.

Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty.

The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value.

Policyholder Account Balances

These policyholder account balances include investment contracts which primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability.

Long-term Debt

The estimated fair value of long-term debt is principally determined using market standard valuation methodologies. Valuations of instruments are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, observable prices and spreads for similar publicly traded or privately traded issues.

104

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

10. Fair Value (continued)

Other Liabilities

Other liabilities consist primarily of interest payable, amounts due for securities purchased but not yet settled and funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values.

Separate Account Liabilities

Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts.

Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance and certain contracts that provide for benefit funding.

Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section “— Recurring Fair Value Measurements,” the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets.

11. Goodwill

The Company tests goodwill for impairment during the third quarter of each year at the reporting unit level based upon best available data as of June 30 of that year. A reporting unit is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level.

In anticipation of the planned Separation, in the third quarter of 2016, the Company reorganized its businesses into three segments: Annuities; Life; and Run-off. As a result, the Company reallocated goodwill. In connection with the reorganization and the 2016 annual goodwill impairment test, the Company performed Step 1 of the goodwill impairment process, which requires a comparison of the estimated fair value of a reporting unit to its carrying value. To determine the estimated fair value for the Run-off reporting unit, an actuarial based approach, embedded value, was utilized to estimate the net worth of the reporting unit and the value of existing business. This actuarial based approach requires judgments and assumptions about the projected cash flows, the level of internal capital required to support the mix of business, the account value of in-force business, projections of renewal business and margins on such business, interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for this reporting unit.

Based on a quantitative analysis performed for the Run-off reporting unit, the Company concluded that the carrying value exceeded the estimated fair value, indicating a potential for goodwill impairment. Accordingly, the Company performed Step 2 of the goodwill impairment process for the reporting unit, which compares the implied estimated fair value of the reporting unit’s goodwill with its carrying value. This analysis indicated that the goodwill associated with this reporting unit was not recoverable. As a result, the Company recorded a non-cash charge of $381 million ($305 million, net of income tax) for the impairment of the entire goodwill balance, which is reported in goodwill impairment on the consolidated statements of operations for the year ended December 31, 2016.

105

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

11. Goodwill (continued)

Information regarding goodwill by segment was as follows:

	Annuities			Life			Run-off			Total
	(In millions)
Balance at January 1, 2014
Goodwill	$	427		$	66		$	493		$	986
Accumulated impairment	(394		)	(66		)	—			(460		)
Total goodwill, net	33			—			493			526
Dispositions (1)	—			—			(112		)	(112		)
Impairments	(33		)	—			—			(33		)
Balance at December 31, 2014
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	—			(493		)
Total goodwill, net	—			—			381			381
Balance at December 31, 2015
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	—			(493		)
Total goodwill, net	—			—			381			381
Impairments	—			—			(381		)	(381		)
Balance at December 31, 2016
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	(381		)	(874		)
Total goodwill, net	$	—		$	—		$	—		$	—

______________

(1) In connection with the sale of MAL, goodwill in the Run-off reporting unit was reduced by $112 million during the year ended December 31, 2014. See Note 4. This goodwill was allocated to MAL based on the relative fair values of MAL and the remaining portion of the Run-off reporting unit.

106

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

12. Debt

Long-term debt outstanding was as follows:

	Interest Rate	Maturity	December 31,
			2016		2015
			(In millions)
Surplus note — affiliated with MetLife, Inc. (1), (2)	8.60%	2038	$	744	$	750
Surplus note — affiliated with MetLife, Inc. (3)	5.13%	2032	750		750
Surplus note — affiliated with MetLife, Inc. (3)	6.00%	2033	350		350
Long-term debt — unaffiliated (4)	7.03%	2030	37		38
Total long-term debt (5)			$	1,881	$	1,888

______________  

(1) Payments of interest and principal on the affiliated surplus note, which is subordinate to all other obligations, may be made only with the prior approval of the Delaware Commissioner of Insurance (the “Delaware Commissioner”). See Note 18 for information regarding subsequent forgiveness of this surplus note.

(2) Includes $6 million of debt issuance costs at December 31, 2016. Debt issuance costs were reported in other assets at December 31, 2015.

(3) Interest is paid semi-annually. See Note 18 for information regarding subsequent settlement of these surplus notes.

(4) Principal and interest is paid quarterly.

(5) Excludes $23 million and $48 million of long-term debt relating to CSEs at December 31, 2016 and 2015, respectively. See Note 8.

In December 2014, Brighthouse Insurance repaid in cash at maturity its $75 million6.80% affiliated note.

The aggregate maturities of long-term debt at December 31, 2016 were $1 million in 2017, $2 million in each of 2018, 2019, 2020 and 2021 and $1.9 billion thereafter.

Interest expense related to the Company’s indebtedness is included in other expenses and was $128 million, $128 million and $133 million for the years ended December 31, 2016, 2015 and 2014, respectively.

Letters of Credit

The Company had access to unsecured revolving credit facilities from various banks, either directly with the bank or indirectly through letters of credit available to MetLife, Inc. for the benefit of the Company and certain other affiliates of MetLife, Inc. These facilities were used for collateral for certain of the Company’s affiliated reinsurance liabilities. Total fees associated with letters of credit was $55 million, $61 million and $73 million for the years ended December 31, 2016, 2015 and 2014, respectively, and was included in other expenses. At December 31, 2016, the Company had $3.3 billion in letters of credit outstanding and the remaining availability was $5.2 billion.

107

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

12. Debt (continued)

Account Party/Borrower(s)	Expiration	Maximum Capacity		Letters of Credit Used by the Company		Letters of Credit Used by Affiliates		Drawdowns by Affiliates		Unused Commitments
		(In millions)
MetLife, Inc. and MetLife Funding, Inc.	May 2019 (1)	$	4,000	$	90	$	640	$	—	$	3,270
MetLife, Inc.	June 2018 (1)	425		170		255		—		—
MRSC and MetLife, Inc.	June 2037 (2)	3,500		—		—		2,797		703
MRV Cell and MetLife, Inc.	September 2038 (2)	4,250		3,000		—		—		1,250
Total		$	12,175	$	3,260	$	895	$	2,797	$	5,223

______________

(1) The letters of credit used by the Company under these facilities were cancelled in connection with a new financing arrangement described in Note 18.

(2) See Note 18 for information regarding subsequent termination of these facilities, as well as information regarding a new financing arrangement.

13. Equity

See Note 3 for a discussion of the Mergers.

Common Stock

In August 2014, MetLife Insurance Company of Connecticut, the predecessor to MetLife USA, redeemed for $1.4 billion and retired 4,595,317 shares of its common stock owned by MetLife Investors Group, LLC, an affiliate.

Capital Contributions

During the years ended December 31, 2016, 2015 and 2014, Brighthouse Life Insurance Company received cash capital contributions of $1.6 billion, $21 million and $476 million, respectively and non-cash capital contributions of $69 million, $181 million and $457 million, respectively.

In December 2015 and 2014, the Company accrued in premiums, reinsurance and other receivables and stockholder’s equity, $120 million and $385 million, respectively, in capital contributions from MetLife, Inc. The receivables were settled for cash in 2016 and 2015, respectively.

Statutory Equity and Income

The state of domicile of Brighthouse Life Insurance Company imposes risk-based capital (“RBC”) requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). Regulatory compliance is determined by a ratio of a company’s total adjusted capital, calculated in the manner prescribed by the NAIC (“TAC”) to its authorized control level RBC, calculated in the manner prescribed by the NAIC (“ACL RBC”), based on the statutory-based filed financial statements. Companies below specific trigger levels or ratios are classified by their respective levels, each of which requires specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC (“CAL RBC”). The CAL RBC ratio for Brighthouse Life Insurance Company was in excess of 400% for all periods presented.

Brighthouse Life Insurance Company prepares statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the Delaware Department of Insurance. The NAIC has adopted the Codification of Statutory Accounting Principles (“Statutory Codification”). Statutory Codification is intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. Modifications by the state insurance department may impact the effect of Statutory Codification on the statutory capital and surplus of Brighthouse Life Insurance Company.

Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt, reporting of reinsurance agreements and valuing securities on a different basis.

108

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

13. Equity (continued)

In addition, certain assets are not admitted under statutory accounting principles and are charged directly to surplus. The most significant assets not admitted by Brighthouse Life Insurance Company are net deferred income tax assets resulting from temporary differences between statutory accounting principles basis and tax basis not expected to reverse and become recoverable within three years.

The tables below present amounts from Brighthouse Life Insurance Company, which are derived from the statutory-basis financial statements as filed with the Delaware Department of Insurance.

Statutory net income (loss) was as follows:

		Years Ended December 31,
Company	State of Domicile	2016			2015			2014
		(In millions)
Brighthouse Life Insurance Company	Delaware	$	1,186		$	(1,022	)	$	1,543
Brighthouse Life Insurance Company of NY	New York	$	(87	)	$	17		$	11

Statutory capital and surplus was as follows at:

	December 31,
Company	2016		2015
	(In millions)
Brighthouse Life Insurance Company	$	4,374	$	5,942
Brighthouse Life Insurance Company of NY	$	196	$	321

Dividend Restrictions

The table below sets forth the dividends permitted to be paid by the Company’s without insurance regulatory approval and dividends paid:

	2017		2016		2015
Company	Permitted Without Approval (1)		Paid (2)		Paid (2)
	(In millions)
Brighthouse Life Insurance Company	$	473	$	261	$	500
Brighthouse Life Insurance Company of NY	$	—	$	—	$	—

______________ 

(1) Reflects dividend amounts that may be paid during 2017 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2017, some or all of such dividends may require regulatory approval.

(2) Reflects all amounts paid, including those requiring regulatory approval.

109

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

13. Equity (continued)

Under the Delaware Insurance Code, Brighthouse Life Insurance Company is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net statutory gain from operations for the immediately preceding calendar year (excluding realized capital gains). Brighthouse Life Insurance Company will be permitted to pay a stockholder dividend in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Delaware Commissioner and the Delaware Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as “unassigned funds (surplus)”) as of the immediately preceding calendar year requires insurance regulatory approval. Under the Delaware Insurance Code, the Delaware Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.

Effective for dividends paid during 2016 and going forward, the New York Insurance Law was amended permitting Brighthouse NY, without prior insurance regulatory clearance, to pay stockholder dividends to its parent in any calendar year based on either of two standards. Under one standard, Brighthouse NY is permitted, without prior insurance regulatory clearance, to pay dividends out of earned surplus (defined as positive “unassigned funds (surplus)”), excluding 85% of the change in net unrealized capital gains or losses (less capital gains tax), for the immediately preceding calendar year, in an amount up to the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year, or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains), not to exceed 30% of surplus to policyholders as of the end of the immediately preceding calendar year. In addition, under this standard, Brighthouse NY may not, without prior insurance regulatory clearance, pay any dividends in any calendar year immediately following a calendar year for which its net gain from operations, excluding realized capital gains, was negative. Under the second standard, if dividends are paid out of other than earned surplus, Brighthouse NY may, without prior insurance regulatory clearance, pay an amount up to the lesser of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year, or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). In addition, Brighthouse NY will be permitted to pay a dividend to its parent in excess of the amounts allowed under both standards only if it files notice of its intention to declare such a dividend and the amount thereof with the New York Superintendent of Financial Services (the “Superintendent”) and the Superintendent either approves the distribution of the dividend or does not approve the dividend within 30 days of its filing. Under New York Insurance Law, the Superintendent has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.

Under BRCD’s plan of operations, no dividend or distribution may be made by BRCD without the prior approval of the Delaware Commissioner. Further, under the Delaware Insurance Code, no dividend or distribution may be made by BRCD that would (i) jeopardize the fulfillment of the obligations of BRCD pursuant to its special purpose financing transactions or insurance risk transfer contracts or threaten the solvency or liquidity of BRCD, (ii) violate the terms of its special purpose financing transactions, or (iii) decrease the capital and surplus of BRCD below $250,000.

110

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

13. Equity (continued)

Accumulated Other Comprehensive Income (Loss)

Information regarding changes on the balances of each component of AOCI was as follows:

	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Total
	(In millions)
Balance at January 1, 2014	$	906		$	24		$	40		$	970
OCI before reclassifications	2,601			243			(56		)	2,788
Deferred income tax benefit (expense)	(815		)	(85		)	4			(896		)
AOCI before reclassifications, net of income tax	2,692			182			(12		)	2,862
Amounts reclassified from AOCI	(11		)	2			—			(9		)
Deferred income tax benefit (expense)	4			(1		)	—			3
Amounts reclassified from AOCI, net of income tax	(7		)	1			—			(6		)
Sale of subsidiary (2)	(320		)	—			6			(314		)
Deferred income tax benefit (expense)	80			—			—			80
Sale of subsidiary, net of income tax	(240		)	—			6			(234		)
Balance at December 31, 2014	2,445			183			(6		)	2,622
OCI before reclassifications	(1,759		)	95			(29		)	(1,693		)
Deferred income tax benefit (expense)	643			(33		)	9			619
AOCI before reclassifications, net of income tax	1,329			245			(26		)	1,548
Amounts reclassified from AOCI	78			(6		)	—			72
Deferred income tax benefit (expense)	(28		)	2			—			(26		)
Amounts reclassified from AOCI, net of income tax	50			(4		)	—			46
Balance at December 31, 2015	1,379			241			(26		)	1,594
OCI before reclassifications	(565		)	70			(3		)	(498		)
Deferred income tax benefit (expense)	185			(25		)	—			160
AOCI before reclassifications, net of income tax	999			286			(29		)	1,256
Amounts reclassified from AOCI	30			(43		)	—			(13		)
Deferred income tax benefit (expense)	(10		)	15			—			5
Amounts reclassified from AOCI, net of income tax	20			(28		)	—			(8		)
Balance at December 31, 2016	$	1,019		$	258		$	(29	)	$	1,248

__________________

(1) See Note 8 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI.

(2) See Note 4.

111

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

13. Equity (continued)

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI									Consolidated Statements of Operations and Comprehensive Income (Loss) Locations
	Years Ended December 31,
	2016			2015			2014
	(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains(losses)	$	(39	)	$	(81	)	$	(6	)	Net investment gains (losses)
Net unrealized investment gains (losses)	3			13			13			Net investment income
Net unrealized investment gains (losses)	6			(10		)	4			Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	(30		)	(78		)	11
Income tax (expense) benefit	10			28			(4		)
Net unrealized investment gains (losses), net of income tax	$	(20	)	$	(50	)	$	7
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate swaps	$	33		$	1		$	1		Net derivative gains (losses)
Interest rate swaps	3			1			1			Net investment income
Interest rate forwards	2			2			1			Net derivative gains (losses)
Interest rate forwards	2			2			1			Net investment income
Foreign currency swaps	3			—			(6		)	Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax	43			6			(2		)
Income tax (expense) benefit	(15		)	(2		)	1
Gains (losses) on cash flow hedges, net of income tax	$	28		$	4		$	(1	)
Total reclassifications, net of income tax	$	8		$	(46	)	$	6

14. Other Expenses

Information on other expenses was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Compensation	$	356		$	487		$	360
Commissions	641			722			634
Volume-related costs	279			231			263
Affiliated expenses on ceded and assumed reinsurance	22			17			39
Capitalization of DAC	(330		)	(399		)	(376		)
Interest expense on debt	130			137			170
Premium taxes, licenses and fees	59			71			56
Professional services	85			22			60
Rent and related expenses	46			54			43
Other	412			381			508
Total other expenses	$	1,700		$	1,723		$	1,757

112

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

14. Other Expenses (continued)

Capitalization of DAC

See Note 6 for additional information on the capitalization of DAC.

Interest Expense on Debt

Interest expense on debt includes interest expense on debt (see Note 12) and interest expense related to CSEs (see Note 8).

Affiliated Expenses

Commissions and capitalization of DAC include the impact of affiliated reinsurance transactions. See Notes 7, 12 and 17 for a discussion of affiliated expenses included in the table above.

15. Income Tax

The provision for income tax was as follows:

	Years Ended December 31,
	2016			2015		2014
	(In millions)
Current:
Federal	$	(374	)	$	35	$	(592	)
Foreign	4			—		6
Subtotal	(370		)	35		(586		)
Deferred:
Federal	(1,320		)	212		847
Foreign	—			—		—
Subtotal	(1,320		)	212		847
Provision for income tax expense (benefit)	$	(1,690	)	$	247	$	261

The Company’s income (loss) before income tax expense (benefit) from domestic and foreign operations were as follows:

	Years Ended December 31,
	2016			2015		2014
	(In millions)
Income (loss):
Domestic	$	(4,477	)	$	1,152	$	604
Foreign	12			13		464
Total	$	(4,465	)	$	1,165	$	1,068

113

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

15. Income Tax (continued)

The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Tax provision at U.S. statutory rate	$	(1,563	)	$	408		$	374
Tax effect of:
Dividend received deduction	(110		)	(132		)	(119		)
Prior year tax	24			(5		)	(20		)
Tax credits	(22		)	(16		)	(14		)
Foreign tax rate differential	2			(5		)	4
Goodwill impairment	(20		)	—			12
Sale of subsidiary	(6		)	—			24
Other, net	5			(3		)	—
Provision for income tax expense (benefit)	$	(1,690	)	$	247		$	261

Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at:

	December 31,
	2016			2015
	(In millions)
Deferred income tax assets:
Investments, including derivatives	$	357		$	—
Tax credit carryforwards	184			172
Other	55			39
Total deferred income tax assets	596			211
Deferred income tax liabilities:
Policyholder liabilities and receivables	536			1,419
Investments, including derivatives	—			125
Intangibles	293			394
Net unrealized investment gains	653			818
DAC	1,565			1,390
Total deferred income tax liabilities	3,047			4,146
Net deferred income tax asset (liability)	$	(2,451	)	$	(3,935	)

114

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

15. Income Tax (continued)

The following table sets forth the general business credits, foreign tax credits, and other credit carryforwards for tax purposes as of December 31, 2016.

	Tax Credit Carryforwards
	General Business Credits		Foreign Tax Credits		Other
	(In millions)
Expiration
2017-2021	$	—	$	—	$	—
2022-2026	—		35		—
2027-2031	—		—		—
2032-2036	7		—		—
Indefinite	—		—		145
	$	7	$	35	$	145

The Company currently participates in a tax sharing agreement with MetLife, Inc., as described in Note 1. Pursuant to this tax sharing agreement, the amounts due from affiliates included $775 million and $259 million for the years ended December 31, 2016 and 2015 respectively.

The Company also files income tax returns with the U.S. federal government and various state and local jurisdictions, as well as foreign jurisdictions. The Company is under continuous examination by the IRS and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction and subsidiary. The Company is no longer subject to U.S. federal, state or local income tax examinations for years prior to 2007.

Management believes it has established adequate tax liabilities for all open years and any future resolve is not expected to have a material impact on the Company’s financial statements.

A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at January 1,	$	43		$	39		$	27
Additions for tax positions of prior years	1			5			15
Reductions for tax positions of prior years	(9		)	—			(5		)
Additions for tax positions of current year	5			3			2
Settlements with tax authorities	(2		)	(4		)	—
Balance at December 31,	$	38		$	43		$	39
Unrecognized tax benefits that, if recognized would impact the effective rate	$	38		$	33		$	29

The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included within other expenses, while penalties are included in income tax expense.

115

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

15. Income Tax (continued)

Interest was as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Interest recognized on the consolidated statements of operations	$	1	$	—	$	—
			December 31,
			2016		2015
			(In millions)
Interest included in other liabilities on the consolidated balance sheets			$	1	$	2

The Company had no penalties for each of the years ended December 31, 2016, 2015 and 2014.

The U.S. Treasury Department and the IRS have indicated that they intend to address through regulations the methodology to be followed in determining the dividends received deduction (“DRD”), related to variable life insurance and annuity contracts. The DRD reduces the amount of dividend income subject to tax and is a significant component of the difference between the actual tax expense and expected amount determined using the federal statutory tax rate of 35%. Any regulations that the IRS ultimately proposes for issuance in this area will be subject to public notice and comment, at which time insurance companies and other interested parties will have the opportunity to raise legal and practical questions about the content, scope and application of such regulations. As a result, the ultimate timing and substance of any such regulations are unknown at this time. For the years ended December 31, 2016, 2015 and 2014, the Company recognized an income tax benefit of $88 million, $143 million and $141 million, respectively, related to the separate account DRD. The 2016 benefit included an expense of $22 million related to a true-up of the 2015 tax return. The 2015 and 2014 benefit included a benefit of $13 million and $22 million related to a true-up of the 2014 and 2013 tax returns, respectively.

16. Contingencies, Commitments and Guarantees

Contingencies

Litigation

The Company is a defendant in a number of litigation matters. In some of the matters, large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.

Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.

The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be reasonably estimated at December 31, 2016.

116

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

16. Contingencies, Commitments and Guarantees (continued)

Matters as to Which an Estimate Can Be Made

For some loss contingency matters, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of December 31, 2016, the aggregate range of reasonably possible losses in excess of amounts accrued for these matters was not material for the Company.

Matters as to Which an Estimate Cannot Be Made

For other matters, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.

Unclaimed Property Litigation

On November 14, 2012, the West Virginia Treasurer filed an action against MetLife Investors USA Insurance Company in West Virginia state court (West Virginia ex rel. John D. Perdue v. MetLife Investors USA Insurance Company, Circuit Court of Putnam County, Civil Action No. 12-C-363) alleging that MetLife Investors USA Insurance Company violated the West Virginia Uniform Unclaimed Property Act (the “Act”), seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On December 28, 2012, the Treasurer filed a substantially identical suit against MetLife Insurance Company of Connecticut (West Virginia ex rel. John D. Perdue v. MetLife Insurance Company of Connecticut, Circuit Court of Putnam County, Civil Action No. 12-C-430). On January 31, 2017, the parties entered into a settlement agreement resolving these actions.

Other Litigation

Thrivent Financial for Lutherans v. MetLife Insurance Company USA, (E.D. Wis., filed September 12, 2016)

Plaintiff filed a complaint against MetLife USA contending that its use of the Brighthouse Financial trademark and logo will infringe on its trademarks. Alleging violations of federal and state law, plaintiff sought preliminary and permanent injunctions, compensatory damages, and other relief. On December 23, 2016, plaintiff filed an amended complaint adding Brighthouse Financial, Inc. as an additional defendant. The parties have resolved this matter, and the action was voluntarily dismissed on February 15, 2017.

Sales Practices Claims

Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made on its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters.

Summary

Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for on the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

117

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

16. Contingencies, Commitments and Guarantees (continued)

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods.

Insolvency Assessments

Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets.

Assets and liabilities held for insolvency assessments were as follows:

	December 31,
	2016		2015
	(In millions)
Other Assets:
Premium tax offset for future discounted and undiscounted assessments	$	13	$	13
Premium tax offsets currently available for paid assessments	8		14
Total	$	21	$	27
Other Liabilities:
Insolvency assessments	$	17	$	18

Commitments

Mortgage Loan Commitments

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $335 million and $128 million at December 31, 2016 and 2015, respectively.

Commitments to Fund Partnership Investments and Private Corporate Bond Investments

The Company commits to fund partnership investments and to lend funds under private corporate bond investments. The amounts of these unfunded commitments were $1.3 billion and $1.0 billion at December 31, 2016 and 2015, respectively.

Other Commitments

The Company has entered into collateral arrangements with affiliates, which require the transfer of collateral in connection with secured demand notes. At both December 31, 2016 and 2015, the Company had agreed to fund up to $20 million of cash upon the request by these affiliates and had transferred collateral consisting of various securities with a fair market value of $25 million to custody accounts to secure the demand notes. Each of these affiliates is permitted by contract to sell or re-pledge this collateral.

118

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

16. Contingencies, Commitments and Guarantees (continued)

Guarantees

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from $6 million to $222 million, with a cumulative maximum of $228 million, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company’s recorded liabilities were $2 million at both December 31, 2016 and 2015, for indemnities, guarantees and commitments.

17. Related Party Transactions

The Company has various existing relationships with MetLife for services necessary to conduct its activities.

Non-Broker-Dealer Transactions

The following table summarizes income and expense from transactions with MetLife (excluding broker-dealer transactions) for the years indicated:

	Years Ended December 31,								Years Ended December 31,
	2016			2015		2014			2016		2015		2014
	Income								Expense
	(In millions)
MetLife	$	(45	)	$	36	$	(68	)	$	370	$	855	$	974

The following table summarizes assets and liabilities from transactions with MetLife (excluding broker-dealer transactions) at:

	At December 31,				At December 31,
	2016		2015		2016		2015
	Assets				Liabilities
	(In millions)
MetLife	$	4,288	$	9,720	$	5,125	$	5,933

119

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

17. Related Party Transactions (continued)

The material arrangements between the Company and MetLife are as follows:

Reinsurance Agreements

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by certain affiliates. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

The Company has reinsurance agreements with its affiliate NELICO and certain of MetLife, Inc subsidiaries, all of which are related parties. See Note 7 for further discussion of the affiliated reinsurance agreements.

Financing Arrangements

The Company has financing arrangements with MetLife that are used to support reinsurance obligations arising under affiliated reinsurance agreements. The Company recognized interest expense for affiliated debt of $125 million, $125 million and $130 million, for the years ended December 31, 2016, 2015 and 2014, respectively. See Note 12 for further discussion of the related party financing arrangements.

Investment Transactions

The Company has extended loans to certain subsidiaries of MetLife, Inc. Additionally, in the ordinary course of business, the Company transfers invested assets, primarily consisting of fixed maturity securities, to and from MetLife affiliates. See Note 8 for further discussion of the related party investment transactions.

Shared Services and Overhead Allocations

MetLife provides the Company certain services, which include, but are not limited to, executive oversight, treasury, finance, legal, human resources, tax planning, internal audit, financial reporting, information technology, distribution services and investor relations. The Company is charged for these services based on direct and indirect costs. When specific identification is not practicable, an allocation methodology is used, primarily based on sales, in-force liabilities, or headcount. For certain agreements, charges are based on various performance measures or activity-based costing, such as sales, new policies/contracts issued, reserves, and in-force policy counts. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Management believes that the methods used to allocate expenses under these arrangements are reasonable. Expenses incurred with MetLife related to these arrangements, recorded in other operating expenses, were $847 million, $1.1 billion and $1.1 billion for the years ended December 31, 2016, 2015 and 2014, respectively.

Sales Distribution Services

In July 2016, MetLife, Inc. completed the sale to MassMutual of MetLife’s retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MSI. MassMutual assumed all of the liabilities related to such assets and that arise or occur after the closing of the sale.

Broker-Dealer Transactions

The Company accrues related party revenues and expenses arising from transactions with MetLife’s broker-dealers whereby the MetLife broker-dealers sell the Company’s variable annuity and life products. The affiliated revenue for the Company is fee income from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. The affiliated expense for the Company is commissions collected on the sale of variable products by the Company and passed through to the broker-dealer.

The following table summarizes income and expense from transactions with related broker-dealers for the years indicated:

	Years Ended December 31,						Years Ended December 31,
	2016		2015		2014		2016		2015		2014
	Fee Income						Commission Expense
	(In millions)
MetLife broker-dealers	$	202	$	218	$	212	$	638	$	643	$	602

120

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

17. Related Party Transactions (continued)

The following table summarizes assets and liabilities from transactions with affiliated broker-dealers as follows:

	At December 31,				At December 31,
	2016		2015		2016		2015
	Fee Income Receivables				Secured Demand Notes
	(In millions)
MetLife broker-dealers	$	19	$	19	$	20	$	20

18. Subsequent Events

Reinsurance Transactions

Effective May 2017, the Company and Brighthouse NY recaptured from MLIC risks related to multiple life products ceded under yearly renewable term and coinsurance agreements. This recapture resulted in an increase in cash and cash equivalents of $214 million and a decrease in premiums, reinsurance and other receivables of $189 million. The Company recognized a gain of $17 million, net of income tax, as a result of reinsurance termination.

Effective January 2017, the Company executed a novation and assignment agreement whereby it replaced MLIC as the reinsurer of certain variable annuities, including guaranteed minimum benefits, issued by NELICO. This novation and assignment resulted in an increase in cash and cash equivalents of $184 million, an increase in future policy benefits of $34 million, an increase in policyholder account balances of $219 million and a decrease in other liabilities of $68 million. The Company recognized no gain or loss as a result of this transaction.

EffectiveJanuary 2017, MLIC recaptured risks related to certain variable annuities, including guaranteed minimum benefits, issued by Brighthouse NY. This recapture resulted in a decrease in cash and cash equivalents of $150 million, an increase in future policy benefits of $45 million, an increase in policyholder account balances of $168 million and a decrease in other liabilities of $359 million. The Company recognized no gain or loss as a result of this transaction.

Effective January 2017, MLIC recaptured risks related to guaranteed minimum benefit guarantees on certain variable annuities being reinsured by Brighthouse Life Insurance Company. This recapture resulted in a decrease in investments and cash and cash equivalents of $568 million, a decrease in future policy benefits of $106 million, and a decrease in policyholder account balances of $460 million. In June 2017, there was an adjustment to the recapture amounts of this transaction, which resulted in an increase in premiums, reinsurance and other receivables of $140 million. The Company recognized a gain of $89 million, net of income tax, as a result of this transaction.

Committed Facilities and Reinsurance Financing Arrangement

On April 28, 2017, MetLife, Inc. and MetLife Reinsurance of Vermont terminated the $4.3 billion committed facility, and MetLife, Inc. and MRSC terminated the $3.5 billion committed facility.

On April 28, 2017, BRCD entered into a new financing arrangement with a pool of highly rated third party reinsurers and a total capacity of $10.0 billion. This financing arrangement consists of credit-linked notes that each have a term of 20 years. At September 14, 2017, there were no drawdowns on such notes and there was $8.1 billion of funding available under this arrangement.

121

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Consolidated Financial Statements — (continued)

18. Subsequent Events (continued)

Surplus Notes - Affiliated

On June 16, 2017, MetLife, Inc. forgave Brighthouse Life Insurance Company’s obligation to pay the principal under the $750 million aggregate principal amount, 8.595% surplus notes. The forgiveness of the surplus notes was treated as a capital transaction and recorded as an increase to additional paid-in-capital.

On April 28, 2017, the surplus note obligations with MetLife, Inc. totaling $1.1 billion, which were due on September 30, 2032 and December 31, 2033 and bore interest at 5.13% and 6.00%, respectively, were satisfied in a noncash exchange for $1.1 billion of loans outstanding from MetLife, Inc.

Capital Transactions

On September 8, 2017, Brighthouse Life Insurance Company received a capital contribution of $100 million in cash from Brighthouse Holdings, LLC.

On August 10, 2017, Brighthouse Life Insurance Company received a capital contribution of $400 million in cash from Brighthouse Holdings, LLC.

On June 30, 2017, Brighthouse Life Insurance Company received a capital contribution of $600 million in cash from Brighthouse Holdings, LLC.

On April 28, 2017, the Contribution Transactions discussed in Note 3 included a net cash return of capital of $2.7 billion.

122

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Schedule I

Consolidated Summary of Investments —

Other Than Investments in Related Parties

December 31, 2016

(In millions)

Types of Investments	Cost or Amortized Cost (1)		Estimated Fair Value		Amount at Which Shown on Balance Sheet
Fixed maturity securities:
Bonds:
U.S. government and agency securities	$	11,872	$	12,916	$	12,916
State and political subdivision securities	3,520		3,858		3,858
Public utilities	2,067		2,268		2,268
Foreign government securities	1,000		1,103		1,103
All other corporate bonds	24,419		25,181		25,181
Total bonds	42,878		45,326		45,326
Mortgage-backed and asset-backed securities	14,163		14,234		14,234
Redeemable preferred stock	248		339		339
Total fixed maturity securities	57,289		59,899		59,899
Equity securities:
Common stock:
Industrial, miscellaneous and all other	98		116		116
Public utilities	—		2		2
Banks, trust and insurance companies	2		5		5
Non-redeemable preferred stock	180		177		177
Total equity securities	280		300		300
Mortgage loans	9,290				9,290
Policy loans	1,093				1,093
Real estate and real estate joint ventures	215				215
Other limited partnership interests	1,639				1,639
Short-term investments	1,272				1,272
Other invested assets	5,029				5,029
Total investments	$	76,107			$	78,737

______________

(1) Cost or amortized cost for fixed maturity securities and mortgage loans represents original cost reduced by repayments, valuation allowances and impairments from other-than-temporary declines in estimated fair value that are charged to earnings and adjusted for amortization of premiums or accretion of discounts; for equity securities, cost represents original cost reduced by impairments from other-than-temporary declines in estimated fair value; for real estate, cost represents original cost reduced by impairments and adjusted for valuation allowances and depreciation; for real estate joint ventures and other limited partnership interests, cost represents original cost reduced for impairments or original cost adjusted for equity in earnings and distributions.

123

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information

(Parent Company Only)

December 31, 2016 and 2015

(In millions, except share and per share data)

	2016				2015
Condensed Balance Sheets
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $49,356 and $50,206, respectively)	$	51,880			$	52,514
Equity securities available-for-sale, at estimated fair value (cost: $280 and $384, respectively)	300				409
Mortgage loans (net of valuation allowances of $38 and $35, respectively)	8,746				7,088
Policy loans	1,093				1,266
Real estate and real estate joint ventures	200				575
Other limited partnership interests	1,632				1,836
Short-term investments, principally at estimated fair value	926				1,730
Investment in subsidiaries	7,338				7,326
Other invested assets, at estimated fair value	3,712				4,746
Total investments	75,827				77,490
Cash and cash equivalents	1,881				1,379
Accrued investment income	591				506
Premium, reinsurance and other receivable	10,397			—	9,239
Receivable from subsidiaries	9,703				13,011
Deferred policy acquisition costs and value of business acquired	5,274				4,809
Current income tax recoverable	454				—
Deferred income tax receivable	1,016				—
Goodwill	—				381
Other assets, principally at estimated fair value	667				838
Separate account assets	100,588				101,735
Total assets	$	206,398			$	209,388
Liabilities and Stockholder’s Equity
Liabilities
Future policy benefits	$	31,684			$	29,894
Policyholder account balances	35,588				35,661
Other policy-related balances	3,384				3,549
Payables for collateral under securities loaned and other transactions	7,362				10,619
Long-term debt	744				750
Current income tax payable	—				20
Deferred income tax liability	—				807
Other liabilities	10,183				7,717
Separate account liabilities	100,588				101,735
Total liabilities	189,533				190,752
Stockholder’s Equity
Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding	75				75
Additional paid-in capital	18,461				16,850
Retained earnings (deficit)	(2,919		)		117
Accumulated other comprehensive income (loss)	1,248				1,594
Total stockholder’s equity	16,865				18,636
Total liabilities and stockholder’s equity	$	206,398			$	209,388

See accompanying notes to the condensed financial information.

124

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information — (continued)

(Parent Company Only)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Condensed Statements of Operations
Revenues
Premiums	$	921		$	1,433		$	1,126
Universal life and investment-type product policy fees	2,696			2,940			3,193
Equity in earnings of subsidiaries	157			144			(102		)
Net investment income	2,680			2,550			2,530
Other revenues	760			504			524
Net investment gains (losses)	(2		)	20			(52		)
Net derivative gains (losses)	(5,878		)	(424		)	(261		)
Total revenues	1,334			7,167			6,958
Expenses
Policyholder benefits and claims	2,984			2,696			2,621
Interest credited to policyholder account balances	957			1,037			1,062
Goodwill impairment	381			—			33
Amortization of deferred policy acquisition costs and value of business acquired	(172		)	595			384
Other expenses	1,733			1,710			1,707
Total expenses	5,883			6,038			5,807
Income (loss) before provision for income tax	(4,549		)	1,129			1,151
Provision for income tax expense (benefit)	(1,774		)	211			344
Net income (loss)	$	(2,775	)	$	918		$	807
Comprehensive income (loss)	$	(3,121	)	$	(110	)	$	2,459

See accompanying notes to the condensed financial information.

125

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information — (continued)

(Parent Company Only)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Condensed Statements of Cash Flows
Net cash provided by operating activities	$	3,256		$	4,196		$	4,547
Cash flows from investing activities
Sales, maturities, and repayments of:
Fixed maturity securities	39,104			35,728			20,197
Equity securities	175			308			98
Mortgage loans	1,484			958			1,049
Real estate and real estate joint ventures	441			368			27
Other limited partnership interests	413			422			254
Purchases of:
Fixed maturity securities	(34,906		)	(39,298		)	(24,524		)
Equity securities	(58		)	(273		)	(41		)
Mortgage loans	(2,803		)	(2,515		)	(343		)
Real estate and real estate joint ventures	(75		)	(105		)	(204		)
Other limited partnership interests	(203		)	(233		)	(345		)
Cash received in connection with freestanding derivatives	707			223			366
Cash paid in connection with freestanding derivatives	(2,764		)	(868		)	(1,784		)
Cash received under repurchase agreements	—			199			—
Cash paid under repurchase agreements	—			(199		)	—
Cash received under reverse repurchase agreements	—			199			—
Cash paid under reverse repurchase agreements	—			(199		)	—
Sales of loans to affiliates	—			—			520
Returns of capital from subsidiaries	32			169			818
Capital contributions to subsidiaries	(1		)	(2		)	(2		)
Net change in policy loans	109			(72		)	52
Net change in short-term investments	876			(495		)	3,645
Net change in other invested assets	5			(59		)	(151		)
Net cash provided by (used in) investing activities	2,536			(5,744		)	(368		)
Cash flows from financing activities
Policyholder account balances:
Deposits	9,672			19,970			18,602
Withdrawals	(12,001		)	(20,797		)	(21,584		)
Net change in payables for collateral under securities loaned and other transactions	(3,257		)	3,118			680
Long-term debt issued	—			175			—
Long-term debt repaid	—			(148		)	(75		)
Financing element on certain derivative instruments and other derivative related transactions, net	(1,011		)	(97		)	(414		)
Redemption of common stock	—			—			(906		)
Common stock redemption premium	—			—			(484		)
Dividends on common stock	(261		)	(500		)	(155		)
Capital contributions	1,568			11			231
Net cash provided by (used in) financing activities	(5,290		)	1,732			(4,105		)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	—			(2		)	(45		)
Change in cash and cash equivalents	502			182			29
Cash and cash equivalents, beginning of year	1,379			1,197			1,168
Cash and cash equivalents, end of year	$	1,881		$	1,379		$	1,197

126

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information — (continued)

(Parent Company Only)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016		2015			2014
Supplemental disclosures of cash flow information
Net cash paid (received) for:
Interest	$	64	$	65		$	70
Income tax	$	428	$	(267	)	$	(231	)
Non-cash transactions:
Capital contributions	$	43	$	141		$	703
Transfer of fixed maturity securities from affiliates	$	3,565	$	—		$	—
Transfer of mortgage loans from affiliates	$	395	$	—		$	—
Transfer of short-term investments from affiliates	$	94	$	—		$	—
Transfer of fixed maturity securities to affiliates	$	346	$	—		$	804
Transfer of mortgage loans to affiliates	$	—	$	—		$	94
Transfer of policyholder account balances to affiliates	$	—	$	—		$	528
Reduction of other invested assets in connection with reinsurance transactions	$	676	$	—		$	863

127

Brighthouse Life Insurance Company

Schedule II

Notes to the Condensed Financial Information

(Parent Company Only)

1. Basis of Presentation

The condensed financial information of Brighthouse Life Insurance Company (the “Parent Company”) should be read in conjunction with the consolidated financial statements of Brighthouse Life Insurance Company and its subsidiaries and the notes thereto (the “Consolidated Financial Statements”). These condensed unconsolidated financial statements reflect the results of operations, financial position and cash flows for the Parent Company. Investments in subsidiaries are accounted for using the equity method of accounting.

The preparation of these condensed unconsolidated financial statements in conformity with GAAP requires management to adopt accounting policies and make certain estimates and assumptions. The most important of these estimates and assumptions relate to the fair value measurements, the accounting for goodwill and identifiable intangible assets and the provision for potential losses that may arise from litigation and regulatory proceedings and tax audits, which may affect the amounts reported in the condensed unconsolidated financial statements and accompanying notes. Actual results could differ from these estimates.

128

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Schedule III

Consolidated Supplementary Insurance Information

December 31, 2016, 2015 and 2014

(In millions)

Segment	DAC and VOBA		Future Policy Benefits and Other Policy-Related Balances		Policyholder Account Balances		Unearned Premiums (1), (2)		Unearned Revenue (1)
2016
Annuities	$	4,820	$	7,560	$	25,233	$	—	$	86
Life	787		4,094		2,838		13		53
Run-off	584		16,381		8,506		—		79
Corporate & Other	148		7,429		2		6		—
Total	$	6,339	$	35,464	$	36,579	$	19	$	218
2015
Annuities	$	3,724	$	6,659	$	22,014	$	—	$	96
Life	969		4,618		2,691		13		52
Run-off	974		14,867		12,018		—		60
Corporate & Other	110		7,166		2		5		—
Total	$	5,777	$	33,310	$	36,725	$	18	$	208
2014
Annuities	$	3,829	$	5,431	$	21,246	$	—	$	101
Life	942		4,124		2,673		10		48
Run-off	1,026		15,201		12,665		—		75
Corporate & Other	63		6,771		1		5		—
Total	$	5,860	$	31,527	$	36,585	$	15	$	224

______________

(1) Amounts are included within the future policy benefits and other policy-related balances column.

(2) Includes premiums received in advance.

129

Brighthouse Life Insurance Company

(A Wholly-Owned Subsidiary of MetLife, Inc.)

Schedule III

Consolidated Supplementary Insurance Information — (continued)

December 31, 2016, 2015 and 2014

(In millions)

Segment	Premiums and Universal Life and Investment-Type Product Policy Fees		Net Investment Income (1)		Policyholder Benefits and Claims and Interest Credited to Policyholder   Account Balances		Amortization of DAC and VOBA			Other Operating Expenses
2016
Annuities	$	2,714	$	1,324	$	2,340	$	(908	)	$	903
Life	546		330		541		261			242
Run-off	878		1,311		1,901		399			275
Corporate & Other	139		146		87		23			280
Total	$	4,277	$	3,111	$	4,869	$	(225	)	$	1,700
2015
Annuities	$	3,282	$	1,141	$	2,285	$	432		$	938
Life	555		295		507		150			259
Run-off	793		1,461		1,301		67			285
Corporate & Other	300		104		218		24			241
Total	$	4,930	$	3,001	$	4,311	$	673		$	1,723
2014
Annuities	$	3,511	$	1,056	$	2,641	$	759		$	976
Life	545		345		469		173			282
Run-off	757		1,492		1,251		115			236
Corporate & Other	248		91		82		22			263
Total	$	5,061	$	2,984	$	4,443	$	1,069		$	1,757

______________

(1) See Note 2 of the Notes to the Consolidated Financial Statements for information on certain segment reporting changes which were retrospectively applied.

130

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Schedule IV

Consolidated Reinsurance

December 31, 2016, 2015 and 2014

(Dollars in millions)

	Gross Amount		Ceded		Assumed		Net Amount		% Amount Assumed to Net
2016
Life insurance in-force	$	610,206	$	450,000	$	7,006	$	167,212	4.2	%
Insurance premium
Life insurance (1)	$	1,850	$	909	$	67	$	1,008	6.6	%
Accident & health insurance	376		218		14		172		8.1	%
Total insurance premium	$	2,226	$	1,127	$	81	$	1,180	6.9	%
2015
Life insurance in-force	$	591,105	$	466,406	$	94,863	$	219,562	43.2	%
Insurance premium
Life insurance (1)	$	2,172	$	824	$	84	$	1,432	5.9	%
Accident & health insurance	232		239		212		205		103.4	%
Total insurance premium	$	2,404	$	1,063	$	296	$	1,637	18.1	%
2014
Life insurance in-force	$	544,635	$	450,615	$	55,381	$	149,401	37.1	%
Insurance premium
Life insurance (1)	$	2,064	$	689	$	65	$	1,440	4.5	%
Accident & health insurance	295		314		30		11		272.7	%
Total insurance premium	$	2,359	$	1,003	$	95	$	1,451	6.5	%

______________

(1) Includes annuities with life contingencies.

For the year ended December 31, 2016, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $266.3 billion and $7.0 billion, respectively, and life insurance premiums of $766 million and $35 million, respectively. For the year ended December 31, 2015, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $278.4 billion and $86.4 billion, respectively, and life insurance premiums of $687 million and $227 million, respectively. For the year ended December 31, 2014, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $279.7 billion and $52.9 billion, respectively, and life insurance premiums of $652 million and $56 million, respectively.

131

XML

Document and Entity Information	12 Months Ended
	Dec. 31, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	BRIGHTHOUSE LIFE INSURANCE Co
Entity Central Index Key	0000733076
Document Type	8-K
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Entity Current Reporting Status	Yes

XML

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $57,289 and $59,852, respectively, includes $0 and $3,194, respectively, relating to variable interest entities)	$ 59,899	$ 62,121
Equity securities available-for-sale, at estimated fair value (cost: $280 and $432, respectively, includes $0 and $48, respectively, relating to variable interest entities)	300	457
Mortgage loans (net of valuation allowances of $40 and $36, respectively; includes $136 and $172, respectively, at estimated fair value, relating to variable interest entities)	9,290	7,404
Policy loans	1,093	1,266
Real Estate Investments, Net	215	628
Other limited partnership interests	1,639	1,846
Short-term investments, principally at estimated fair value (includes $344 and $35, respectively, relating to variable interest entities)	1,272	1,796
Other invested assets, principally at estimated fair value (includes $0 and $50, respectively, relating to variable interest entities)	5,029	6,129
Total investments	78,737	81,647
Cash and cash equivalents, principally at estimated fair value (includes $3,078 and $47, respectively, relating to variable interest entities)	5,057	1,507
Accrued investment income (includes $1 and $1, respectively, relating to variable interest entities)	668	585
Premiums, reinsurance and other receivables	13,853	18,104
Deferred policy acquisition costs and value of business acquired	6,339	5,777
Current income tax recoverable	736	226
Goodwill	0	381
Other assets, principally at estimated fair value	689	862
Separate account assets	105,346	106,527
Total assets	211,425	215,616
Liabilities
Future policy benefits	32,752	30,508
Policyholder account balances	36,579	36,725
Other policy-related balances	2,712	2,802
Payables for collateral under securities loaned and other transactions	7,371	10,622
Long-term debt (includes $23 and $48, respectively, at estimated fair value, relating to variable interest entities)	1,904	1,936
Deferred income tax liability	2,451	3,935
Other liabilities (includes $1 and $1, respectively, relating to variable interest entities)	5,445	3,925
Separate account liabilities	105,346	106,527
Total liabilities	194,560	196,980
Contingencies, Commitments and Guarantees (Note 16)
Stockholder’s Equity
Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding	75	75
Additional paid-in capital	18,461	16,850
Retained earnings (deficit)	(2,919)	117
Accumulated other comprehensive income (loss)	1,248	1,594
Total stockholder’s equity	16,865	18,636
Total liabilities and stockholder’s equity	$ 211,425	$ 215,616

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Assets
Amortized cost of fixed maturity securities available-for-sale	$ 57,289	$ 59,852
Fixed maturity securities relating to variable interest entities	59,899	62,121
Cost of equity securities available-for-sale	280	432
Equity securities available-for-sale, at estimated fair value (cost: $280 and $432, respectively, includes $0 and $48, respectively, relating to variable interest entities)	300	457
Mortgage loans valuation allowances	40	36
Mortgage Loans on Real Estate	9,290	7,404
Real estate held-for-sale	0	5
Short-term investments, principally at estimated fair value (includes $344 and $35, respectively, relating to variable interest entities)	1,272	1,796
Other Investments	5,029	6,129
Cash and Cash Equivalents, at Carrying Value	5,057	1,507
Accrued investment income relating to variable interest entities	668	585
Liabilities
Long-term debt, at estimated fair value, relating to variable interest entities	1,904	1,936
Other liabilities relating to variable interest entities	$ 5,445	$ 3,925
Stockholder’s Equity
Common stock, par value	$ 25,000	$ 25,000
Common stock, shares authorized	4,000	4,000
Common stock, shares issued	3,000	3,000
Common stock, shares outstanding	3,000	3,000
Variable interest entities
Assets
Fixed maturity securities relating to variable interest entities	$ 0	$ 3,194
Equity securities available-for-sale, at estimated fair value (cost: $280 and $432, respectively, includes $0 and $48, respectively, relating to variable interest entities)	0	48
Mortgage Loans on Real Estate	136	172
Short-term investments, principally at estimated fair value (includes $344 and $35, respectively, relating to variable interest entities)	344	35
Other Investments	0	50
Cash and Cash Equivalents, at Carrying Value	3,078	47
Accrued investment income relating to variable interest entities	1	1
Liabilities
Long-term debt, at estimated fair value, relating to variable interest entities	23	48
Other liabilities relating to variable interest entities	$ 1	$ 1

XML

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues
Premiums	$ 1,180	$ 1,637	$ 1,451
Universal life and investment-type product policy fees	3,097	3,293	3,610
Net investment income	3,111	3,001	2,984
Other revenues	709	433	520
Net investment gains (losses):
Other-than-temporary impairments on fixed maturity securities	(19)	(23)	(6)
Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss)	(3)	(8)	(8)
Other net investment gains (losses)	(45)	36	(475)
Total net investment gains (losses)	(67)	5	(489)
Net derivative gains (losses)	(5,770)	(497)	294
Total revenues	2,260	7,872	8,370
Expenses
Policyholder benefits and claims	3,738	3,087	3,198
Interest credited to policyholder account balances	1,131	1,224	1,245
Goodwill impairment	381	0	33
Amortization of DAC and VOBA Charged to Other Expenses	(225)	673	1,069
Other expenses	1,700	1,723	1,757
Total expenses	6,725	6,707	7,302
Income (loss) before provision for income tax	(4,465)	1,165	1,068
Provision for income tax expense (benefit)	(1,690)	247	261
Net income (loss)	$ (2,775)	$ 918	$ 807

XML

Consolidated Statements Of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (2,775)	$ 918	$ 807
Other comprehensive income (loss):
Unrealized investment gains (losses), net of related offsets	(535)	(1,681)	2,270
Unrealized gains (losses) on derivatives	27	89	245
Foreign currency translation adjustments	(3)	(29)	(50)
Other comprehensive income (loss), before income tax	(511)	(1,621)	2,465
Income tax (expense) benefit related to items of other comprehensive income (loss)	165	593	(813)
Other comprehensive income (loss), net of income tax	(346)	(1,028)	1,652
Comprehensive income (loss)	$ (3,121)	$ (110)	$ 2,459

XML

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2013	$ 17,287	$ 86	$ 16,700	$ (469)	$ 970
Redemption of common stock	(1,390)	(11)	(895)	(484)
Capital contributions from MetLife, Inc.	933		933
Dividends paid to MetLife, Inc.	(155)			(155)
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital	(40)		(40)
Net income (loss)	807			807
Other comprehensive income (loss), net of income tax	1,652				1,652
Ending Balance at Dec. 31, 2014	19,094	75	16,698	(301)	2,622
Capital contributions from MetLife, Inc.	202		202
Dividends paid to MetLife, Inc.	(500)			(500)
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital	(50)		(50)
Net income (loss)	918			918
Other comprehensive income (loss), net of income tax	(1,028)				(1,028)
Ending Balance at Dec. 31, 2015	18,636	75	16,850	117	1,594
Capital contributions from MetLife, Inc.	1,637		1,637
Dividends paid to MetLife, Inc.	(261)			(261)
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital	(26)		(26)
Net income (loss)	(2,775)			(2,775)
Other comprehensive income (loss), net of income tax	(346)				(346)
Ending Balance at Dec. 31, 2016	$ 16,865	$ 75	$ 18,461	$ (2,919)	$ 1,248

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities
Net income (loss)	$ (2,775)	$ 918	$ 807
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization expenses	56	25	31
Amortization of premiums and accretion of discounts associated with investments, net	(231)	(233)	(173)
(Gains) losses on investments and from sales of businesses, net	66	(5)	489
(Gains) losses on derivatives, net	6,998	1,321	1,255
(Income) loss from equity method investments, net of dividends or distributions	26	110	(17)
Interest credited to policyholder account balances	1,131	1,224	1,245
Universal life and investment-type product policy fees	(3,097)	(3,293)	(3,610)
Goodwill impairment	381	0	33
Change in accrued investment income	(35)	10	107
Change in premiums, reinsurance and other receivables	45	(403)	(879)
Change in deferred policy acquisition costs and value of business acquired, net	(555)	273	690
Change in income tax	(1,830)	724	762
Change in other assets	2,152	2,231	2,376
Change in future policy benefits and other policy-related balances	2,404	2,283	1,103
Change in other liabilities	(590)	(206)	1,562
Other, net	(15)	13	(20)
Net cash provided by (used in) operating activities	4,131	4,992	5,761
Cash flows from investing activities
Sales, maturities and repayments of fixed maturity securities	45,460	38,341	22,990
Sales, maturities and repayments of equity securities	224	308	98
Sales, maturities and repayments of mortgage loans	1,560	1,083	2,456
Sales, maturities and repayments of real estate and real estate joint ventures	446	512	28
Sales, maturities and repayments of other limited partnership interests	417	425	255
Purchases of fixed maturity securities	(39,097)	(43,502)	(28,056)
Purchases of equity securities	(58)	(273)	(89)
Purchases of mortgage loans	(2,847)	(2,560)	(353)
Purchases of real estate and real estate joint ventures	(75)	(109)	(209)
Purchases of other limited partnership interests	(203)	(233)	(345)
Cash received in connection with freestanding derivatives	707	224	788
Cash paid in connection with freestanding derivatives	(2,764)	(869)	(1,991)
Cash received under repurchase agreements	0	199	0
Cash paid under repurchase agreements	0	(199)	0
Cash received under reverse repurchase agreements	0	199	0
Cash paid under reverse repurchase agreements	0	(199)	0
Sale of business, net of cash and cash equivalents disposed of $0, $0 and $251, respectively	0	0	451
Sales of loans to affiliates	0	26	520
Receipts on loans to affiliates	50	0	0
Net change in policy loans	109	(72)	52
Net change in short-term investments	596	(343)	3,491
Net change in other invested assets	7	(55)	(598)
Net cash provided by (used in) investing activities	4,532	(7,097)	(512)
Cash flows from financing activities
Policyholder account balances: Deposits	10,040	20,269	18,947
Policyholder account balances: Withdrawals	(12,292)	(21,078)	(21,853)
Net change in payables for collateral under securities loaned and other transactions	(3,251)	3,121	704
Long-term debt issued	0	175	0
Long-term debt repaid	(26)	(235)	(1,379)
Financing element on certain derivative instruments and other derivative related transactions, net	(1,011)	(97)	(414)
Redemption of common stock	0	0	(906)
Common stock redemption premium	0	0	(484)
Dividends paid to MetLife, Inc.	(261)	(500)	(155)
Capital contributions from MetLife, Inc.	1,688	406	476
Net cash provided by (used in) financing activities	(5,113)	2,061	(5,064)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	0	(2)	(45)
Change in cash and cash equivalents	3,550	(46)	140
Cash and cash equivalents, beginning of year	1,507	1,553	1,413
Cash and cash equivalents, end of year	5,057	1,507	1,553
Supplemental disclosures of cash flow information
Interest	130	137	171
Income tax	150	(463)	(471)
Non-cash transactions:
Returns of capital	26	50	40
Capital contributions	69	181	457
Transfer of fixed maturity securities from affiliates	4,030	0	0
Transfer of mortgage loans from affiliates	662	0	0
Transfer of short-term investments from affiliates	94	0	0
Transfer of fixed maturity securities to affiliates	346	0	804
Transfer of mortgage loans to affiliates	0	0	94
Reduction of other invested assets in connection with reinsurance transactions	676	0	863
Transfer of policyholder account balances to affiliate	$ 0	$ 0	$ 528

XML

Consolidated Statements of Cash Flows Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Cash Flows [Abstract]
Cash disposed from sale of business	$ 0	$ 0	$ 251

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business, Basis of Presentation and Summary of Significant Accounting Policies

1. Business, Basis of Presentation and Summary of Significant Accounting Policies

Business

“Brighthouse Insurance” and the “Company” refer to Brighthouse Life Insurance Company (formerly, MetLife Insurance Company USA, “MetLife USA”), a Delaware corporation originally incorporated in Connecticut in 1863, and its subsidiaries. Brighthouse Life Insurance Company is a wholly-owned subsidiary of Brighthouse Holdings, LLC, which until July 28, 2017 was a direct wholly-owned subsidiary of MetLife, Inc. (MetLife, Inc., together with its subsidiaries and affiliates, “MetLife”). The Company offers a range of individual annuities and individual life insurance products.

On January 12, 2016, MetLife, Inc. announced its plan to pursue the separation of a substantial portion of its former U.S. retail business (the “Separation”). Additionally, on July 21, 2016, MetLife, Inc. announced that the separated business would be rebranded as “Brighthouse Financial.” Effective March 6, 2017, and in connection with the Separation, the Company changed its name from MetLife Insurance Company USA to Brighthouse Life Insurance Company.

On October 5, 2016, Brighthouse Financial, Inc. (together with its subsidiaries and affiliates, “Brighthouse”), which until the completion of the Separation on August 4, 2017, was a wholly-owned subsidiary of MetLife, Inc., filed a registration statement on Form 10 (as amended, the “Form 10”) with the U.S. Securities and Exchange Commission (“SEC”) that was declared effective by the SEC on July 6, 2017. The Form 10 disclosed MetLife, Inc.’s plans to undertake several actions, including an internal reorganization involving its U.S. retail business (the “Restructuring”) and include Brighthouse Insurance and certain affiliates in the planned separated business and distribute at least80.1%of the shares of Brighthouse Financial, Inc’s common stock on a pro rata basis to the holders of MetLife, Inc. common stock. In connection with the Restructuring, effective April 2017, following receipt of applicable regulatory approvals, MetLife, Inc. contributed certain affiliated reinsurance companies and Brighthouse Life Insurance Company of NY (“Brighthouse NY”) to Brighthouse Insurance (the “Contribution Transactions”). The affiliated reinsurance companies were then merged into Brighthouse Reinsurance Company of Delaware (“BRCD”), a licensed reinsurance subsidiary of Brighthouse Life Insurance Company. SeeNote 3for further information on this change, which was applied retrospectively. On July 28, 2017, MetLife, Inc. contributed Brighthouse Holdings, LLC to Brighthouse Financial, Inc., resulting in Brighthouse Life Insurance Company becoming an indirect wholly-owned subsidiary of Brighthouse Financial, Inc.On August 4, 2017, MetLife, Inc. completed the Separation through a distribution of 96,776,670 of the 119,773,106 shares of the common stock of Brighthouse Financial, Inc., representing 80.8% of MetLife Inc.’s interest in Brighthouse Financial, Inc., to holders of MetLife, Inc. common stock.

In anticipation of the Separation, in the third quarter of 2016, the Company reorganized its businesses intothreesegments: Annuities, Life and Run-off. SeeNote 2for further information on the reorganization of the Company’s segments in the third quarter of 2016, which was applied retrospectively.

In November 2014, MetLife Insurance Company of Connecticut re-domesticated from Connecticut to Delaware, changed its name to MetLife Insurance Company USA and merged with its subsidiary, MetLife Investors USA Insurance Company (“MLI-USA”), and its affiliates, MetLife Investors Insurance Company (“MLIIC”) and Exeter Reassurance Company, Ltd. (“Exeter”). See Note 3 for further information on the merger transactions and the prior periods’ adjustments.

Basis of Presentation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.

Consolidation

The accompanying consolidated financial statements include the accounts of Brighthouse Life Insurance Company and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.

Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.

Discontinued Operations

The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. Effective January 1, 2014, the Company adopted new guidance regarding reporting of discontinued operations for disposals or classifications as held-for-sale that have not been previously reported on the consolidated financial statements. A disposal of a component is reported in discontinued operations if the disposal represents a strategic shift that has or will have a major effect on the Company’s operations and financial results. See “— Adoption of New Accounting Pronouncements.”

Separate Accounts

Separate accounts are established in conformity with insurance laws. Generally, the assets of the separate accounts cannot be used to settle the liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if:

• such separate accounts are legally recognized;

• assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities;

• investments are directed by the contractholder; and

• all investment performance, net of contract fees and assessments, is passed through to the contractholder.

The Company reports separate account assets at their fair value, which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line on the statements of operations. Separate accounts credited with a contractual investment return are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses and the accounting for these investments is consistent with the methodologies described herein for similar financial instruments held within the general account.

The Company’s revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees on the statements of operations.

Reclassifications

Certain amounts in the prior years’ consolidated financial statements and related footnotes thereto have been reclassified to conform with the current year presentation as discussed throughout the Notes to the Consolidated Financial Statements.

Summary of Significant Accounting Policies

The following are the Company’s significant accounting policies with references to notes providing additional information on such policies and critical accounting estimates relating to such policies.

Accounting Policy	Note
Insurance	5
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles	6
Reinsurance	7
Investments	8
Derivatives	9
Fair Value	10
Income Tax	15
Litigation Contingencies	16

Insurance

Future Policy Benefit Liabilities and Policyholder Account Balances

The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid, reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions that are in accordance with GAAP and applicable actuarial standards. The principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, policy renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. These assumptions are established at the time the policy is issued and locked in and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality, morbidity and interest rates are locked in upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation. To assess whether or not a premium deficiency exists, the Company groups insurance contracts based on the manner acquired, serviced, and the measurement of profitability. In applying the profitability criteria, groupings are limited by segment.

Liabilities for universal and variable life secondary guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the contract period based on total expected assessments. The assumptions used in estimating the secondary guarantee liabilities are consistent with those used for amortizing deferred policy acquisition costs (“DAC”), and are therefore subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of the appropriate underlying equity indices, such as the Standard & Poor’s Global Ratings (“S&P”) 500 Index. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios.

The Company regularly reviews its assumptions supporting its estimates of actuarial liabilities for future policy benefits. For universal life and annuity product guarantees, assumptions are updated periodically, whereas for traditional life products, such as term life and non-participating whole life insurance, assumptions are established and locked in at inception but reviewed periodically to determine whether a premium deficiency exists that would trigger an unlocking of assumptions. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur.

Policyholder account balances relate to contracts or contract features where the Company has no significant insurance risk.

See “— Variable Annuity Guarantees” for additional information on the Company’s variable annuity guarantee features that are accounted for as insurance liabilities and recorded in future policy benefits, as well as the guarantee features that are accounted for at fair value as embedded derivatives and recorded in policyholder account balances.

Other Policy-Related Balances

Other policy-related balances primarily include assumed affiliated reinsurance payables, affiliated deferred experience refunds, policy and contract claims and unearned revenue liabilities.

The assumed affiliated reinsurance payable relates primarily to reinsurance for certain universal life business assumed from an affiliate, net of other reinsurance. 

The affiliated deferred experience refunds relate to the repayment of acquisition costs under an affiliated reinsurance agreement and represent part of the net cost of reinsurance for the business reinsured. The deferred experience refund is being amortized consistent with the DAC methodology on the underlying contracts.

The liability for policy and contract claims generally relates to incurred but not reported death, disability and long-term care claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company’s estimated ultimate cost of settling all claims. The Company derives estimates for the development of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made.

The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product’s estimated gross profits, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees.

Recognition of Insurance Revenues and Deposits

Premiums related to traditional life and annuity contracts with life contingencies are recognized as revenues when due from policyholders. When premiums are due over a significantly shorter period than the period over which policyholder benefits are incurred, any excess profit is deferred and recognized into earnings in proportion to insurance in-force or, for annuities, the amount of expected future policy benefit payments.

Premiums related to non-medical health and disability contracts are recognized on a pro rata basis over the applicable contract term.

Deposits related to universal life-type and investment-type products are credited to policyholder account balances. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which policyholder benefits and expenses are incurred. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related policyholder account balances.

Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance.

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles

The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include:

• incremental direct costs of contract acquisition, such as commissions;

• the portion of an employee’s total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed;

• other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and

• the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits.

All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred.

Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections.

DAC and VOBA are amortized as follows:

Products:		In proportion to the following over estimated lives of the contracts:
•	Nonparticipating and non-dividend-paying traditional contracts (primarily term insurance)		Actual and expected future gross premiums.
•	Participating, dividend-paying traditional contracts		Actual and expected future gross margins.
•	Fixed and variable universal life contracts		Actual and expected future gross profits.
•	Fixed and variable deferred annuity contracts

See Note 6 for additional information on DAC and VOBA amortization.

The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated on the financial statements for reporting purposes.

The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a specified percentage of the customer’s deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements (“DSI”) to determine the recoverability of the asset.

Value of distribution agreements acquired (“VODA”) is reported in other assets and represents the present value of expected future profits associated with the expected future business derived from the distribution agreements acquired as part of a business combination. Value of customer relationships acquired (“VOCRA”) is also reported in other assets and represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business. The VODA and VOCRA associated with past business combinations are amortized over useful lives ranging from 10 to 40 years and such amortization is included in other expenses. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews VODA and VOCRA to determine whether the asset is impaired.

Reinsurance

For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims.

For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC when there is a gain at inception on the ceding entity and to other liabilities when there is a loss at inception. The net cost of reinsurance is recognized as a component of other expenses when there is a gain at inception and as policyholder benefits and claims when there is a loss and is subsequently amortized on a basis consistent with the methodology used for amortizing DAC related to the underlying reinsured contracts. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums and ceded (assumed) premiums, reinsurance and other receivables (future policy benefits) are established.

Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance.

The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. The Company withholds the funds rather than transferring the underlying investments and, as a result, records funds withheld liability within other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio.

Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to guaranteed minimum income benefits (“GMIBs”), a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in net derivative gains (losses).

If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. Certain assumed non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”), guaranteed minimum accumulation benefits (“GMABs”) and GMIBs are also accounted for as embedded derivatives with changes in estimated fair value reported in net derivative gains (losses).

Variable Annuity Guarantees

The Company issues directly and assumes from an affiliate through reinsurance certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. In some cases, the benefit base may be increased by additional deposits, bonus amounts, accruals or optional market value step-ups.

Certain of the Company’s variable annuity guarantee features are accounted for as insurance liabilities and recorded in future policy benefits while others are accounted for at fair value as embedded derivatives and recorded in policyholder account balances. Generally speaking, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. Alternatively, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize, that is, the policyholder can receive the guarantee on a net basis. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Further, changes in assumptions, principally involving behavior, can result in a change of expected future cash outflows of a guarantee between portions accounted for as insurance liabilities and portions accounted for as embedded derivatives.

Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits (“GMDBs”), the life contingent portion of the GMWBs and the portion of the GMIBs that require annuitization, as well as the life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value.

These insurance liabilities are accrued over the accumulation phase of the contract in proportion to actual and future expected policy assessments based on the level of guaranteed minimum benefits generated using multiple scenarios of separate account returns. The scenarios are based on best estimate assumptions consistent with those used to amortize DAC. When current estimates of future benefits exceed those previously projected or when current estimates of future assessments are lower than those previously projected, liabilities will increase, resulting in a current period charge to net income. The opposite result occurs when the current estimates of future benefits are lower than those previously projected or when current estimates of future assessments exceed those previously projected. At each reporting period, we update the actual amount of business remaining in-force, which impacts expected future assessments and the projection of estimated future benefits resulting in a current period charge or increase to earnings.SeeNote 5for additional details of guarantees accounted for as insurance liabilities.

Guarantees accounted for as embedded derivatives in policyholder account balances include the non-life contingent portion of GMWBs,GMABs,and for GMIBs the non-life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value, as well as the Guaranteed Principal Option.

The estimated fair values of guarantees accounted for as embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees. At policy inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees. In valuing the embedded derivative, the percentage of fees included in the fair value measurement is locked-in at inception.

The projections of future benefits and future fees require capital market and actuarial assumptions including expectations concerning policyholder behavior. A risk neutral valuation methodology is used to project the cash flows from the guarantees under multiple capital market scenarios to determine an economic liability. The reported estimated fair value is then determined by taking the present value of these risk-free generated cash flows using a discount rate that incorporates a spread over the risk-free rate to reflect our nonperformance risk and adding a risk margin. For more information on the determination of estimated fair value,seeNote 10Fair Value.

Investments

Net Investment Income and Net Investment Gains (Losses)

Income from investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein.

Fixed Maturity and Equity Securities

The Company’s fixed maturity and equity securities are classified as available-for-sale (“AFS”) and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) (“OCI”), net of policy-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis.

Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for mortgage-backed and asset-backed securities (“ABS”) considers the estimated timing and amount of prepayments of the underlying loans. See Note 8 “Investments — Fixed Maturity and Equity Securities AFS — Methodology for Amortization of Premium and Accretion of Discount on Structured Securities”. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Dividends on equity securities are recognized when declared.

The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 8 “— Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities.”

For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment (“OTTI”) is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in OCI.

With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security’s cost and its estimated fair value.

Mortgage Loans

The Company disaggregates its mortgage loan investments into three portfolio segments: commercial, agricultural and residential. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 8.

Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts.

Also included in mortgage loans are commercial mortgage loans held by consolidated securitization entities (“CSEs”) for which the fair value option (“FVO”) was elected, which are stated at estimated fair value. Changes in estimated fair value are recognized in net investment gains (losses) for commercial mortgage loans held by CSEs.

Policy Loans

Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy.

Real Estate

Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Rental income is recognized on a straight-line basis over the term of the respective leases. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable and exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, which is generally computed using the present value of expected future cash flows discounted at a rate commensurate with the underlying risks.

Real estate for which the Company commits to a plan to sell within one year and actively markets in its current condition for a reasonable price in comparison to its estimated fair value is classified as held-for-sale. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated.

Real Estate Joint Ventures and Other Limited Partnership Interests

The Company uses the equity method of accounting for investments (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, while the cost method is used when the Company has virtually no influence over the investee’s operations. The Company generally recognizes its share of the equity method investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period; while distributions on cost method investments are recognized as earned or received.

The Company routinely evaluates such investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value (“NAV”). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired.

Short-term Investments

Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. Short-term investments also include investments in affiliated money market pools.

Other Invested Assets

Other invested assets consist principally of the following:

• Freestanding derivatives with positive estimated fair values which are described in “— Derivatives” below.

• Tax credit and renewable energy partnerships which derive a significant source of investment return in the form of income tax credits or other tax incentives. Where tax credits are guaranteed by a creditworthy third party, the investment is accounted for under the effective yield method. Otherwise, the investment is accounted for under the equity method.

• Leveraged leases which are recorded net of non-recourse debt. Income is recognized by applying the leveraged lease’s estimated rate of return to the net investment in the lease. The Company regularly reviews residual values for impairment.

• Investments in an operating joint venture that engages in insurance underwriting activities which are accounted for under the equity method.

• Funds withheld which represent a receivable for amounts contractually withheld by ceding companies in accordance with reinsurance agreements. The Company recognizes interest on funds withheld at rates defined by the terms of the agreement which may be contractually specified or directly related to the underlying investments.

Securities Lending Program

Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with securities lending transactions may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the Company’s financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary throughout the duration of the loan. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income.

Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:

Statement of Operations Presentation:	Derivative:
Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
Net investment income	•	Economic hedges of equity method investments in joint ventures

Hedge Accounting

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:

• Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in estimated fair value of the hedged item attributable to the designated risk being hedged.

• Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).

The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported on the statement of operations within interest income or interest expense to match the location of the hedged item.

In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:

• the combined instrument is not accounted for in its entirety at estimated fair value with changes in estimated fair value recorded in earnings;

• the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and

• a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.

See “Variable Annuity Guarantees” for additional information on the accounting policy for embedded derivatives bifurcated from variable annuity host contracts.

Such embedded derivatives are carried on the balance sheet at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses), except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation.

Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition.

Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities.

Income Tax

Brighthouse Life Insurance Company and its includable subsidiaries join with MetLife, Inc. and its includable subsidiaries in filing a consolidated U.S. life and non-life federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended. Current taxes (and the benefits of tax attributes such as losses) are allocated to Brighthouse Life Insurance Company and its subsidiaries under the consolidated tax return regulations and a tax sharing agreement. Under the consolidated tax return regulations, MetLife, Inc. has elected the “percentage method” (and 100% under such method) of reimbursing companies for tax attributes e.g. net operating losses. As a result, 100% of tax attributes are reimbursed by MetLife, Inc. to the extent that consolidated federal income tax of the consolidated federal tax return group is reduced in a year by tax attributes. On an annual basis, each of the profitable subsidiaries pays to MetLife, Inc. the federal income tax which it would have paid based upon that year’s taxable income. If Brighthouse Life Insurance Company or its includable subsidiaries has current or prior deductions and credits (including but not limited to losses) which reduce the consolidated tax liability of the consolidated federal tax return group, the deductions and credits are characterized as realized (or realizable) by Brighthouse Life Insurance Company and its includable subsidiaries when those tax attributes are realized (or realizable) by the consolidated federal tax return group, even if Brighthouse Life Insurance Company or its includable subsidiaries would not have realized the attributes on a stand-alone basis under a “wait and see” method.

The Company’s accounting for income taxes represents management’s best estimate of various events and transactions.

Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse.

The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established against deferred tax assets when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination the Company considers many factors, including:

• the nature, frequency, and amount of cumulative financial reporting income and losses in recent years;

• the jurisdiction in which the deferred tax asset was generated;

• the length of time that carryforward can be utilized in the various taxing jurisdiction;

• future taxable income exclusive of reversing temporary differences and carryforwards;

• future reversals of existing taxable temporary differences;

• taxable income in prior carryback years; and

• tax planning strategies.

The Company may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, the effect of changes in tax laws, tax regulations, or interpretations of such laws or regulations, is recognized in net income tax expense (benefit) in the period of change.

The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded on the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made.

The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax expense.

Litigation Contingencies

The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company’s financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected on the Company’s financial statements.

Other Accounting Policies

Cash and Cash Equivalents

The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value.

Property, Equipment, Leasehold Improvements and Computer Software

Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, as appropriate. Estimated lives generally range from five to 10 years for leasehold improvements, and from three to seven years for all other property and equipment. The net book value of the property, equipment and leasehold improvements was insignificant at both December 31, 2016 and 2015.

Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $248 million and $266 million at December 31, 2016 and 2015, respectively. Accumulated amortization of capitalized software was $142 million and $110 million at December 31, 2016 and 2015, respectively. Related amortization expense was $39 million, less than $1 million and $3 million for the years ended December 31, 2016, 2015 and 2014, respectively.

Other Revenues

Other revenues primarily include, in addition to items described elsewhere herein, fee income on financial reinsurance agreements and broker-dealer fees.

Employee Benefit Plans

Through December 31, 2016, Metropolitan Life Insurance Company (“MLIC”) provided and the Company contributed to defined benefit pension and postemployment plans for its employees and retirees. MLIC also provides and the Company contributes to a postretirement medical and life insurance benefit plan for certain retired employees. The Company accounts for these plans as multiemployer benefit plans and as a result the assets, obligations and other comprehensive gains and losses of these benefit plans are not included on the consolidated balance sheet. Within its consolidated statement of operations, the Company has included expense associated with its participants in these plans. These plans also include participants from other affiliates of MLIC. The Company’s participation in these plans ceased December 31, 2016.

Defined Contribution Plans

Through December 31, 2016, MLIC provides and the Company contributes to a defined contribution plan sponsored by MLIC for substantially all employees under which a portion of employee contributions are matched. The Company’s participation in this plan ceased on December 31, 2016.

Foreign Currency

Assets, liabilities and operations of a foreign affiliate (owned in 2014) are recorded based on functional currency. The determination of the functional currency is made based on the appropriate economic and management indicators. The local currencies of foreign operations are the functional currencies. Assets and liabilities of this foreign affiliate are translated from the functional currency to U.S. dollars at the exchange rates in effect at each year-end and revenues and expenses are translated at the average exchange rates during the year. The resulting translation adjustments are charged or credited directly to OCI, net of applicable taxes. Gains and losses from foreign currency transactions, including the effect of re-measurement of monetary assets and liabilities to the appropriate functional currency, are reported as part of net investment gains (losses) in the period in which they occur.

Goodwill

Goodwill represents the future economic benefits arising from net assets acquired in a business combination that are not individually identified and recognized. Goodwill is calculated as the excess of cost over the estimated fair value of such net assets acquired, is not amortized, and is tested for impairment based on a fair value approach at least annually or more frequently if events or circumstances indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event.

The impairment test is performed at the reporting unit level, which is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income.

On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company’s reporting units to assess whether any goodwill impairment exists.

Adoption of New Accounting Pronouncements

Effective January 1, 2016, the Company adopted guidance relating to short-duration contracts. Upon adopting the new guidance, the Company updated the disclosure for the rollforward of the liability of the unpaid policy and contract claims to include incurred and paid long-duration life claims that are settled within one year. The Company’s liability for unpaid policy and contract claims includes incurred but not reported claims, as well as claims which have been reported but not yet settled. The net incurred and paid claims within the Company’s tabular rollforward are principally comprised of death benefits on long-duration life contracts. The adoption did not have an impact on the consolidated financial statements and given the Company’s minimal extent of short-duration insurance contracts did not require any other expanded disclosures.

Effective January 1, 2016, the Company retrospectively adopted new guidance relating to the consolidation of certain entities. The objective of the new standard is to improve targeted areas of the consolidation guidance and to reduce the number of consolidation models. The new consolidation standard provides guidance on how a reporting entity (i) evaluates whether the entity should consolidate limited partnerships and similar entities, (ii) assesses whether the fees paid to a decisionmaker or service provider are variable interests in a VIE, and (iii) assesses the variable interests in a VIE held by related parties of the reporting entity. The new guidance also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. The adoption of the new guidance did not impact which entities are consolidated by the Company. The consolidated VIE assets and liabilities and unconsolidated VIE carrying amounts and maximum exposure to loss as of December 31, 2016, disclosed in Note 8, reflect the application of the new guidance.

Effective November 18, 2014, the Company adopted new guidance on when, if ever, the cost of acquiring an entity should be used to establish a new accounting basis (“pushdown”) in the acquired entity’s separate financial statements. The guidance provides an acquired entity and its subsidiaries with an irrevocable option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. If a reporting entity elects to apply pushdown accounting, its stand-alone financial statements would reflect the acquirer’s new basis in the acquired entity’s assets and liabilities. The election to apply pushdown accounting should be determined by an acquired entity for each individual change-in-control event in which an acquirer obtains control of the acquired entity; however, an entity that does not elect to apply pushdown accounting in the period of a change-in-control can later elect to retrospectively apply pushdown accounting to the most recent change-in-control transaction as a change in accounting principle. The new guidance did not have a material impact on the consolidated financial statements upon adoption.

Effective January 1, 2014, the Company adopted new guidance regarding reporting of discontinued operations and disclosures of disposals of components of an entity. The guidance increases the threshold for a disposal to qualify as a discontinued operation, expands the disclosures for discontinued operations and requires new disclosures for certain disposals that do not meet the definition of a discontinued operation. Disposals must now represent a strategic shift that has or will have a major effect on the entity’s operations and financial results to qualify as discontinued operations. As discussed in Note 4, the Company sold its wholly-owned subsidiary, MetLife Assurance Limited (“MAL”). As a result of the adoption of this new guidance, the results of operations of MAL and the loss on sale have been included in income from continuing operations.

Future Adoption of New Accounting Pronouncements

In February 2017, the FASB issued new guidance on derecognition of nonfinancial assets ASU 2017- 05,Other Income-Gains and Losses from the Derecognition of Nonfinancial Assets(Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those years. Early adoption is permitted for interim or annual reporting periods beginning after December 15, 2016. The guidance may be applied retrospectively for all periods presented or retrospectively with a cumulative-effect adjustment at the date of adoption. The new guidance clarifies the scope and accounting of a financial asset that meets the definition of an “in-substance nonfinancial asset” and defines the term, “in-substance nonfinancial asset.” The ASU also adds guidance for partial sales of nonfinancial assets. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In January 2017, the FASB issued new guidance on business combinations (ASU 2017- 01,Business Combinations (Topic 805): Clarifying the Definition of a Business).The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a prospective basis. Early adoption is permitted as specified in the guidance. The new guidance clarifies the definition of a business and requires that an entity apply certain criteria in order to determine when a set of assets and activities qualifies as a business. The adoption of this standard will result in fewer acquisitions qualifying as businesses and, accordingly, acquisition costs for those acquisitions that do not qualify as businesses will be capitalized rather than expensed. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In November 2016, the FASB issued new guidance on restricted cash (ASU 2016-18,Statement of Cash Flows (Topic 230): a consensus of the FASB Emerging Issues Task Force). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a retrospective basis. Early adoption is permitted. The new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, the new guidance requires that amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The new guidance does not provide a definition of restricted cash or restricted cash equivalents. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In October 2016, the FASB issued new guidance on consolidation evaluation for entities under common control (ASU 2016-17,Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control).The new guidance is effective for fiscal years beginning after December 15, 2016 and interim periods within those fiscal years, and should be applied on a retrospective basis. Early adoption is permitted. The new guidance does not change the characteristics of a primary beneficiary under current GAAP. It changes how a reporting entity evaluates whether it is the primary beneficiary of a VIE by changing how a reporting entity that is a single decisionmaker of a VIE handles indirect interests in the entity held through related parties that are under common control with the reporting entity. The adoption of this new guidance will not have a material impact on the Company’s consolidated financial statements.

In October 2016, the FASB issued new guidance on tax accounting for intra-entity transfers of assets (ASU 2016-16,Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a modified retrospective basis. Early adoption is permitted in the first interim or annual reporting period. Current guidance prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. The new guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Also, the guidance eliminates the exception for an intra-entity transfer of an asset other than inventory. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In August 2016, the FASB issued new guidance on cash flow statement presentation (ASU 2016-15,Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied retrospectively to all periods presented. Early adoption is permitted in any interim or annual period. This ASU addresses diversity in how certain cash receipts and cash payments are presented and classified on the statement of cash flows. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In June 2016, the FASB issued new guidance on measurement of credit losses on financial instruments (ASU 2016-13,Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments). The new guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This ASU replaces the incurred loss impairment methodology with one that reflects expected credit losses. The measurement of expected credit losses should be based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance requires that an OTTI on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses. The guidance also requires enhanced disclosures. The Company has assessed the asset classes impacted by the new guidance and is currently assessing the accounting and reporting system changes that will be required to comply with the new guidance. The Company believes that the most significant impact upon adoption will be to its mortgage loan investments. The Company is continuing to evaluate the overall impact of the new guidance on its consolidated financial statements.

In January 2016, the FASB issued new guidance (ASU 2016-01,Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities)on the recognition and measurement of financial instruments. The new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted for the instrument-specific credit risk provision. The new guidance changes the current accounting guidance related to (i) the classification and measurement of certain equity investments, (ii) the presentation of changes in the fair value of financial liabilities measured under the FVO that are due to instrument-specific credit risk, and (iii) certain disclosures associated with the fair value of financial instruments. Additionally, there will no longer be a requirement to assess equity securities for impairment since such securities will be measured at fair value through net income. The Company has assessed the population of financial instruments that are subject to the new guidance and has determined that the most significant impact will be the requirement to report changes in fair value in net income each reporting period for all equity securities currently classified as AFS and to a lesser extent, other limited partnership interests and real estate joint ventures that are currently accounted for under the cost method. The population of these investments accounted for under the cost method is not material. The Company is continuing to evaluate the overall impact of this guidance on its consolidated financial statements.

In May 2014, the FASB issued a comprehensive new revenue recognition standard (ASU 2014‑09,Revenue from Contracts with Customers (Topic 606)), effective for fiscal years beginning after December 15, 2017 and interim periods within those years. The guidance may be applied retrospectively for all periods presented or retrospectively with a cumulative-effect adjustment at the date of adoption. The new guidance will supersede nearly all existing revenue recognition guidance under U.S. GAAP; however, it will not impact the accounting for insurance and investment contracts within the scope of Financial Services insurance (Topic 944), leases, financial instruments and guarantees. For those contracts that are impacted, the guidance will require an entity to recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled, in exchange for those goods or services. Given the scope of the new revenue recognition guidance, the Company does not expect the adoption to have a material impact on its consolidated revenues or statements of operations, with the Company’s implementation efforts primarily focused on other revenues on the consolidated statements of operations.

Other

Effective January 3, 2017, the Chicago Mercantile Exchange (“CME”) amended its rulebook, resulting in the characterization of variation margin transfers as settlement payments, as opposed to adjustments to collateral. These amendments will impact the accounting treatment of the Company’s centrally cleared derivatives, for which the CME serves as the central clearing party. The application of the amended rulebook is expected to reduce the gross derivative assets and liabilities, as well as the related collateral, recorded on the consolidated balance sheet for trades cleared through the CME. The Company is currently evaluating the impact of these amendments on its consolidated financial statements. This change is not expected to impact the tax treatment of such derivatives, although the IRS is being asked to issue definitive guidance.

XML

Segment Information

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Segment Information

2. Segment Information

In anticipation of the planned Separation, in the third quarter of 2016, the Company reorganized its businesses intothreesegments: Annuities, Life and Run-off. In addition, the Company reports certain of its results of operations in Corporate & Other. Also, in the fourth quarter of 2016, the Company moved the universal life policies with secondary guarantees (“ULSG”) business from the Life segment to the Run-off segment. These and certain other presentation changes were applied retrospectively and did not have an impact on total consolidated net income (loss) or operating earnings in the prior periods.

Annuities

The Annuities segment offers a variety of variable, fixed, index-linked and income annuities designed to address contractholders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.

Life

The Life segment offers insurance products and services, including term, whole, universal and variable life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis.

Run-off

The Run-off segment consists of products no longer actively sold and which are separately managed, including structured settlements, certain company-owned life insurance policies, bank-owned life insurance policies, funding agreements and ULSG.

Corporate & Other

Corporate & Other contains the excess capital not allocated to the segments and interest expense related to the majority of the Company’s outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. Additionally, Corporate & Other includes assumed reinsurance of certain variable annuity products from a former affiliated operating joint venture in Japan. Under this in-force reinsurance agreement, the Company reinsured living and death benefit guarantees issued in connection with variable annuity products. Also, Corporate & Other includes a reinsurance agreement to assume certain blocks of indemnity reinsurance from an affiliate. These reinsurance agreements were recaptured effective November 1, 2014. Corporate & Other also includes the elimination of intersegment amounts and a portion of MetLife’s U.S. insurance business sold direct to consumers.

Financial Measures and Segment Accounting Policies

Operating earnings is used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is also the Company’s GAAP measure of segment performance and is reported below. Operating earnings should not be viewed as a substitute for net income (loss). The Company believes the presentation of operating earnings as the Company measures it for management purposes enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings allows analysis of the Company’s performance and facilitates comparisons to industry results.

Operating earnings is defined as operating revenues less operating expenses, both net of income tax.

The following are excluded from total revenues in calculating operating revenues:

• Net investment gains (losses);

• Net derivative gains (losses) except: (i) earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment and (ii) earned income on derivatives and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment;

• Amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees (“GMIB Fees”);

• Certain amounts related to securitization entities that are VIEs consolidated under GAAP;and

• Results of discontinued operations and other businesses that have been or will be sold or exited by the Company (“Divested Businesses”).

The following are excluded from total expenses in calculating operating expenses:

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets, benefits and hedging costs related to GMIBs (“GMIB Costs”) and market value adjustments associated with surrenders or terminations of contracts;

• Amounts related to: (i) net investment gains (losses) and net derivative gains (losses) and (ii) GMIB Fees and GMIB Costs included in amortization of deferred policy acquisition costs and value of business acquired;

• Recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance;

• Results of discontinued operations and Divested Businesses;

• Amounts related to securitization entities that are VIEs consolidated under GAAP;

• Goodwill impairment; and

• Costs related to: (i) implementation of new insurance regulatory requirements and (ii) acquisition and integration costs.

The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from the Company’s effective tax rate.

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the years ended December 31, 2016, 2015 and 2014 and at December 31, 2016 and 2015. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for operating earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below.

The internal capital model is a MetLife developed risk capital model that reflects management’s judgment and view of required capital to represent the measurement of the risk profile of the business, to meet the Company’s long term promises to clients, to service long-term obligations and to support the credit ratings of the Company. It accounts for the unique and specific nature of the risks inherent in the Company’s business. Management is responsible for the ongoing production and enhancement of the internal capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards. As such, the internal capital allocation methodology in the future may differ from MetLife’s historical model.

The Company allocates equity to the segments based on the internal capital model, coupled with considerations of local capital requirements, and aligns with emerging standards and consistent risk principles.

Segment net investment income is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company’s consolidated net investment income or net income (loss).

Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee time incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.

	Operating Results
Year Ended December 31, 2016	Annuities		Life			Run-off			Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,494	$	6		$	(249	)	$	23		$	1,274
Provision for income tax expense (benefit)	441		—			(90		)	(10		)	341
Operating earnings	$	1,053	$	6		$	(159	)	$	33		933
Adjustments for:
Net investment gains (losses)												(67		)
Net derivative gains (losses)												(5,770		)
Other adjustments to net income												98
Provision for income tax (expense) benefit												2,031
Net income (loss)												$	(2,775	)
Inter-segment revenues	$	716	$	(722	)	$	135		$	20
Interest revenue	$	1,446	$	351		$	1,411		$	197
Interest expense	$	—	$	—		$	60		$	67

At December 31, 2016	Annuities		Life		Run-off		Corporate & Other		Total
	(In millions)
Total assets	$	146,224	$	12,296	$	40,575	$	12,330	$	211,425
Separate account assets	$	100,209	$	1,671	$	3,466	$	—	$	105,346
Separate account liabilities	$	100,209	$	1,671	$	3,466	$	—	$	105,346

	Operating Results
Year Ended December 31, 2015	Annuities		Life			Run-off		Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,339	$	(56	)	$	713	$	(77	)	$	1,919
Provision for income tax expense (benefit)	329		(21		)	247		(43		)	512
Operating earnings	$	1,010	$	(35	)	$	466	$	(34	)	1,407
Adjustments for:
Net investment gains (losses)											5
Net derivative gains (losses)											(497		)
Other adjustments to net income											(262		)
Provision for income tax (expense) benefit											265
Net income (loss)											$	918
Inter-segment revenues	$	595	$	(695	)	$	118	$	215
Interest revenue	$	1,266	$	313		$	1,551	$	97
Interest expense	$	—	$	—		$	60	$	69

At December 31, 2015	Annuities		Life		Run-off		Corporate & Other		Total
	(In millions)
Total assets	$	142,646	$	13,242	$	44,176	$	15,552	$	215,616
Separate account assets	$	101,714	$	1,580	$	3,233	$	—	$	106,527
Separate account liabilities	$	101,714	$	1,580	$	3,233	$	—	$	106,527

	Operating Results
Year Ended December 31, 2014	Annuities		Life			Run-off		Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,182	$	(7	)	$	824	$	(16	)	$	1,983
Provision for income tax expense (benefit)	281		(4		)	283		(21		)	539
Operating earnings	$	901	$	(3	)	$	541	$	5		1,444
Adjustments for:
Net investment gains (losses)											(489		)
Net derivative gains (losses)											294
Other adjustments to net income											(720		)
Provision for income tax (expense) benefit											278
Net income (loss)											$	807
Inter-segment revenues	$	849	$	(575	)	$	23	$	36
Interest revenue	$	1,119	$	359		$	1,518	$	66
Interest expense	$	—	$	5		$	60	$	68

Reconciliation of Company operating revenues to total revenues:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Annuities	$	4,423		$	4,665		$	4,790
Life	1,036			881			897
Run-off	2,313			2,366			2,319
Total segment	7,772			7,912			8,006
Corporate & Other	338			398			314
Net investment gains (losses)	(67		)	5			(489		)
Net derivative gains (losses)	(5,770		)	(497		)	294
Other adjustments	(13		)	54			245
Total	$	2,260		$	7,872		$	8,370

The following table presents total premiums, universal life and investment-type product policy fees and other revenues by major product groups of the Company’s segments, as well as Corporate & Other:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Annuity products	$	3,411	$	3,701	$	4,110
Life insurance products	1,552		1,529		1,466
Other products	23		133		5
Total	$	4,986	$	5,363	$	5,581

Substantially all of the Company’s consolidated premiums, universal life and investment-type product policy fees and other revenues originated in the U.S.

Revenues derived from any customer did not exceed 10% of consolidated premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2016, 2015 and 2014.

XML

Organizational Changes

12 Months Ended

Dec. 31, 2016

Contribution Transactions [Abstract]

Accounting Changes [Text Block]

Contribution Transactions

On April 28, 2017, in connection with the Separation, MetLife, Inc. contributed MetLife Reinsurance Company of Delaware, MetLife Reinsurance Company of South Carolina (“MRSC”), MetLife Reinsurance Company of Vermont II, all affiliated reinsurance companies, and Brighthouse NY to Brighthouse Life Insurance Company. The affiliated reinsurance companies were then merged into BRCD, and certain reserve financing arrangements were restructured, resulting in a net return of capital to MetLife of $2.7 billion. The return of capital included $3.4 billion in cash, offset by a non-cash capital contribution of $703 million primarily comprised of the $643 million tax impact of a basis adjustment for BRCD in connection with the Contribution Transactions. The affiliated reinsurance companies reinsured risks, including level premium term life and ULSG assumed from the Company and other entities and operations of Brighthouse.

The Contribution Transactions were between entities under common control and have been accounted for in a manner similar to the pooling-of-interests method, which requires that the acquired entities be combined at their historical cost. The Company’s consolidated financial statements and related footnotes are presented as if the transaction occurred at the beginning of the earliest date presented and the prior periods have been retrospectively adjusted.

The effect of the Contribution Transactions on net income (loss) was an increase of $162 million, $79 million and $512 million for the years ended December 31, 2016, 2015 and 2014, respectively.

The effect of the Contribution Transactions on OCI was an increase (decrease) of ($120) million, ($230) million and $206 million for years ended December 31, 2016, 2015 and 2014, respectively.

Simultaneously with the Contribution Transactions, the following additional transactions occurred:

• The existing reserve financing arrangements of the affiliated reinsurance companies with unaffiliated financial institutions were terminated and replaced with a single financing arrangement supported by a pool of highly rated third-party reinsurers. See Note 18.

• Invested assets held in trust totaling $3.4 billion were liquidated, of which $2.8 billion provided funding for MetLife, Inc.’s repayment of the associated collateral financing arrangement, and the remainder was remitted to MetLife, Inc. See Note 18.

• Loans outstanding to MetLife, Inc. totaling $1.1 billion were repaid in an exchange transaction that resulted in the satisfaction of $1.1 billion of surplus notes due to MetLife. See Note 18.

XML

Mergers

12 Months Ended

Dec. 31, 2016

Business Combinations [Abstract]

Mergers

3. Organizational Changes

Mergers

In November 2014, MetLife Insurance Company of Connecticut, a wholly-owned subsidiary of MetLife, Inc., re-domesticated from Connecticut to Delaware, changed its name to MetLife Insurance Company USA and merged with its subsidiary, MLI-USA, and its affiliate, MLIIC, each a U.S. insurance company that issued variable annuity products in addition to other products, and Exeter, a former offshore, captive reinsurance subsidiary of MetLife, Inc. and affiliate of MetLife Insurance Company of Connecticut that mainly reinsured guarantees associated with variable annuity products (the “Mergers”). The surviving entity of the Mergers was MetLife USA. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. Prior to the Mergers, 40,000,000 authorized shares of common stock, of which 30,000,000 shares were issued and outstanding, were converted to 4,000 authorized shares of common stock, of which 3,000 shares were issued and outstanding.

Prior to the Mergers, effective January 1, 2014, following receipt of New York State Department of Financial Services approval, MetLife Insurance Company of Connecticut withdrew its license to issue insurance policies and annuity contracts in New York. Also effective January 1, 2014, MetLife Insurance Company of Connecticut reinsured with MLIC, an affiliate, all existing New York insurance policies and annuity contracts that include a separate account feature and deposited investments with an estimated fair market value of $6.3 billion into a custodial account to secure MetLife Insurance Company of Connecticut’s remaining New York policyholder liabilities not covered by such reinsurance. Also prior to the Mergers, certain risks ceded to Exeter were recaptured. See Notes 8, 9 and 13 for information regarding additional transactions in connection with the Mergers.

The Mergers represent a transaction among entities under common control and have been accounted for in a manner similar to the pooling-of-interests method, which requires that the merged entities be combined at their historical cost. The Company’s consolidated financial statements and related footnotes are presented as if the transaction occurred at the beginning of the earliest date presented and the prior periods have been retrospectively adjusted.

XML

Dispositions

12 Months Ended

Dec. 31, 2016

Discontinued Operations and Disposal Groups [Abstract]

Dispositions

4. Disposition

In May 2014, the Company completed the sale of its wholly-owned subsidiary, MAL, for $702 million (£418 million) in net cash consideration. As a result of the sale, a loss of $608 million ($436 million, net of income tax), was recorded for the year ended December 31, 2014, which includes a reduction to goodwill of $112 million ($94 million, net of income tax). The loss is reflected within net investment gains (losses) on the consolidated statements of operations and comprehensive income (loss). Compared to the expected loss at the time of the sales agreement, the actual loss on the sale was increased by net income from MAL of $77 million for the year ended December 31, 2014. MAL’s results of operations are included in continuing operations. They were historically included in the Run-off segment.

XML

Insurance

12 Months Ended

Dec. 31, 2016

Insurance [Abstract]

Insurance

5. Insurance

Insurance Liabilities

Insurance liabilities, including affiliated insurance liabilities on reinsurance assumed and ceded, are comprised of future policy benefits, policyholder account balances and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:

	December 31,
	2016		2015
	(In millions)
Annuities	$	32,793	$	28,673
Life	6,932		7,309
Run-off	24,887		26,885
Corporate & Other	7,431		7,168
Total	$	72,043	$	70,035

See Note 7 for discussion of affiliated reinsurance liabilities included in the table above.

Future policy benefits are measured as follows:

Product Type:	Measurement Assumptions:
Participating life	Aggregate of (i) net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate of 4%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends.
Nonparticipating life	Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities range from 3% to 8%.
Individual and group traditional fixed annuities after annuitization	Present value of expected future payments. Interest rate assumptions used in establishing such liabilities range from 3% to 8%.
Non-medical health insurance	The net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rate assumptions used in establishing such liabilities range from 4% to 7%.
Disabled lives	Present value of benefits method and experience assumptions as to claim terminations, expenses and interest. Interest rate assumptions used in establishing such liabilities range from 3% to 7%.

Participating business represented 4% and 3% of the Company’s life insurance in-force at December 31, 2016 and 2015, respectively. Participating policies represented 42%, 39% and 35% of gross traditional life insurance premiums for the years ended December 31, 2016, 2015 and 2014, respectively.

Policyholder account balances are equal to: (i) policy account values, which consist of an accumulation of gross premium payments; (ii) credited interest, ranging from less than 1% to 8%, less expenses, mortality charges and withdrawals; and (iii) fair value adjustments relating to business combinations.

Guarantees

The Company issues variable annuity products with guaranteed minimum benefits. GMABs, the non-life contingent portion of GMWBs and the portion of certain GMIBs that do not require annuitization are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 9. Guarantees accounted for as insurance liabilities include:

Guarantee:			Measurement Assumptions:
GMDBs	•	A return of purchase payment upon death even if the account value is reduced to zero.	•	Present value of expected death benefits in excess of the projected account balance recognizing the excess ratably over the accumulation period based on the present value of total expected assessments.
	•	An enhanced death benefit may be available for an additional fee.	•	Assumptions are consistent with those used for amortizing DAC, and are thus subject to the same variability and risk.
			•	Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index.
			•	Benefit assumptions are based on the average benefits payable over a range of scenarios.
GMIBs	•	After a specified period of time determined at the time of issuance of the variable annuity contract, a minimum accumulation of purchase payments, even if the account value is reduced to zero, that can be annuitized to receive a monthly income stream that is not less than a specified amount.	•	Present value of expected income benefits in excess of the projected account balance at any future date of annuitization and recognizing the excess ratably over the accumulation period based on present value of total expected assessments.
	•	Certain contracts also provide for a guaranteed lump sum return of purchase premium in lieu of the annuitization benefit.	•	Assumptions are consistent with those used for estimating GMDB liabilities.
			•	Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder.
GMWBs	•	A return of purchase payment via partial withdrawals, even if the account value is reduced to zero, provided that cumulative withdrawals in a contract year do not exceed a certain limit.	•	Expected value of the life contingent payments and expected assessments using assumptions consistent with those used for estimating the GMDB liabilities.
	•	Certain contracts include guaranteed withdrawals that are life contingent.

Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity and universal and variable life contracts was as follows:

	Annuity Contracts						Universal and Variable Life Contracts
	GMDBs			GMIBs			Secondary Guarantees		Total
	(In millions)
Direct
Balance at January 1, 2014	$	409		$	1,231		$	1,784	$	3,424
Incurred guaranteed benefits (1)	233			304			590		1,127
Paid guaranteed benefits	(23		)	—			—		(23		)
Balance at December 31, 2014	619			1,535			2,374		4,528
Incurred guaranteed benefits	248			337			413		998
Paid guaranteed benefits	(36		)	—			—		(36		)
Balance at December 31, 2015	831			1,872			2,787		5,490
Incurred guaranteed benefits	335			334			753		1,422
Paid guaranteed benefits	(60		)	—			—		(60		)
Balance at December 31, 2016	$	1,106		$	2,206		$	3,540	$	6,852
Net Ceded/(Assumed)
Balance at January 1, 2014	$	(200	)	$	(130	)	$	683	$	353
Incurred guaranteed benefits (1)	177			104			163		444
Paid guaranteed benefits	2			—			—		2
Balance at December 31, 2014	(21		)	(26		)	846		799
Incurred guaranteed benefits	20			(2		)	161		179
Paid guaranteed benefits	(33		)	—			—		(33		)
Balance at December 31, 2015	(34		)	(28		)	1,007		945
Incurred guaranteed benefits	44			9			98		151
Paid guaranteed benefits	(55		)	—			—		(55		)
Balance at December 31, 2016	$	(45	)	$	(19	)	$	1,105	$	1,041
Net
Balance at January 1, 2014	$	609		$	1,361		$	1,101	$	3,071
Incurred guaranteed benefits (1)	56			200			427		683
Paid guaranteed benefits	(25		)	—			—		(25		)
Balance at December 31, 2014	640			1,561			1,528		3,729
Incurred guaranteed benefits	228			339			252		819
Paid guaranteed benefits	(3		)	—			—		(3		)
Balance at December 31, 2015	865			1,900			1,780		4,545
Incurred guaranteed benefits	291			325			655		1,271
Paid guaranteed benefits	(5		)	—			—		(5		)
Balance at December 31, 2016	$	1,151		$	2,225		$	2,435	$	5,811

______________

(1) See Note 7.

Information regarding the Company’s guarantee exposure was as follows at:

	December 31,
	2016						2015
	In the Event of Death			At Annuitization			In the Event of Death			At Annuitization
	(Dollars in millions)
Annuity Contracts (1), (2)
Variable Annuity Guarantees
Total account value (3)	$	106,590		$	61,340		$	108,625		$	62,645
Separate account value	$	101,991		$	60,016		$	103,685		$	61,311
Net amount at risk	$	6,763	(4)	$	3,116	(5)	$	8,296	(4)	$	2,241	(5)
Average attained age of contractholders	67 years			67 years			66 years			66 years

	December 31,
	2016		2015
	Secondary Guarantees
	(Dollars in millions)
Universal and Variable Life Contracts
Total account value (3)	$	7,176	$	6,919
Net amount at risk (6)	$	90,973	$	90,940
Average attained age of policyholders	60 years		59 years

______________

(1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the NARs presented reflect the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 7 for a discussion of GMxBs which have been reinsured.

(3) Includes the contractholder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved.

(6) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.

Account balances of contracts with guarantees were invested in separate account asset classes as follows at: 

	December 31,
	2016		2015
	(In millions)
Fund Groupings:
Balanced	$	52,170	$	52,837
Equity	41,152		42,723
Bond	6,086		5,119
Money Market	703		820
Total	$	100,111	$	101,499

Obligations Under Funding Agreements

The Company issues fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. During the years ended December 31, 2016, 2015 and 2014, the Company issued $1.4 billion, $13.0 billion and $12.2 billion, respectively, and repaid $3.4 billion, $14.4 billion and $13.9 billion, respectively, of such funding agreements. As of December 31, 2016 and 2015, liabilities for funding agreements outstanding, which are included in policyholder account balances, were $127 million and $2.2 billion, respectively.

The Company is a member of the Federal Home Loan Bank (“FHLB”) of Pittsburgh and holds common stock in certain regional banks in the FHLB system (“FHLBanks”). Holdings of common stock of FHLBanks, included in equity securities, were as follows as of:

	December 31,
	2016		2015
	(In millions)
FHLB of Pittsburgh	$	44	$	85
FHLB of Boston	$	27	$	36
FHLB of Des Moines	$	4	$	4

The Company has also entered into funding agreements with FHLBanks. The liability for such funding agreements is included in policyholder account balances. Information related to such funding agreements was as follows as of:

	Liability				Collateral
	December 31,
	2016		2015		2016			2015
	(In millions)
FHLB of Pittsburgh (1)	$	500	$	1,570	$	3,765	(2)	$	1,789	(2)
FHLB of Boston (1)	$	50	$	250	$	144	(2)	$	311	(2)
FHLB of Des Moines (1)	$	95	$	95	$	266	(2)	$	147	(2)

______________

(1) Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities (“RMBS”), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank’s recovery on the collateral is limited to the amount of the Company’s liability to such FHLBank.

(2) Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value.

Liabilities for Unpaid Claims and Claim Expenses

Information regarding the liabilities for unpaid claims and claim expense was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at December 31 of prior period	$	1,693		$	1,483		$	1,325
Less: Reinsurance recoverables	1,545			1,400			1,235
Net balance at December 31 of prior period	148			83			90
Cumulative adjustment (1)	68			—			—
Net balance at January 1,	216			83			90
Incurred related to:
Current year	651			105			3
Prior years (2)	(20		)	—			2
Total incurred	631			105			5
Paid related to:
Current year	(626		)	(30		)	—
Prior years	(63		)	(10		)	(12		)
Total paid	(689		)	(40		)	(12		)
Net balance at December 31,	158			148			83
Add: Reinsurance recoverables	1,811			1,545			1,400
Balance at December 31,	$	1,969		$	1,693		$	1,483

______________

(1) Reflects the accumulated adjustment, net of reinsurance, upon implementation of the new guidance related to short-duration contracts. Prior periods have not been restated. See Note 1.

(2) During 2016, 2015 and 2014, claims and claims adjustment expenses associated with prior years changed due to differences between the actual benefits paid and the expected benefits owed during those periods.

Separate Accounts

Separate account assets and liabilities include two categories of account types: pass-through separate accounts totaling $105.3 billion and $106.3 billion at December 31, 2016 and 2015, respectively, for which the policyholder assumes all investment risk, and separate accounts for which the Company contractually guarantees either a minimum return or account value to the policyholder which totaled $33 million and $189 million at December 31, 2016 and 2015, respectively. The latter category consisted of bank owned life insurance contracts. The average interest rate credited on these contracts was 2.63% and 2.56% at December 31, 2016 and 2015, respectively.

For each of the years ended December 31, 2016, 2015 and 2014, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts.

XML

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles

12 Months Ended

Dec. 31, 2016

Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles

6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles

See Note 1 for a description of capitalized acquisition costs.

Nonparticipating and Non-Dividend-Paying Traditional Contracts

The Company amortizes DAC and VOBA related to these contracts (primarily term insurance) over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes.

Participating, Dividend-Paying Traditional Contracts

The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales, are reasonably likely to significantly impact the rate of DAC amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC balances.

Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts

The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, benefit elections and withdrawals, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and benefit elections and withdrawals are reasonably likely to significantly impact the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances.

Factors Impacting Amortization

Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company’s long-term expectation produce higher account balances, which increases the Company’s future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company’s long-term expectation. The Company’s practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.

The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency, benefit elections and withdrawals and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will generally decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease.

Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.

Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized.

Information regarding DAC and VOBA was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DAC
Balance at January 1,	$	5,066		$	5,097		$	5,712
Capitalizations	330			399			376
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	1,371			163			(184		)
Other expenses	(1,076		)	(690		)	(745		)
Total amortization	295			(527		)	(929		)
Unrealized investment gains (losses)	(24		)	97			(64		)
Other	—			—			2
Balance at December 31,	5,667			5,066			5,097
VOBA
Balance at January 1,	711			763			932
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	2			(19		)	(1		)
Other expenses	(72		)	(127		)	(139		)
Total amortization	(70		)	(146		)	(140		)
Unrealized investment gains (losses)	31			94			(29		)
Balance at December 31,	672			711			763
Total DAC and VOBA
Balance at December 31,	$	6,339		$	5,777		$	5,860

Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:

	December 31,
	2016		2015
	(In millions)
Annuities	$	4,820	$	3,724
Life	787		969
Run-off	584		974
Corporate & Other	148		110
Total	$	6,339	$	5,777

Information regarding other intangibles was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DSI
Balance at January 1,	$	515		$	566		$	669
Capitalization	3			3			5
Amortization	(83		)	(72		)	(80		)
Unrealized investment gains (losses)	(3		)	18			(28		)
Balance at December 31,	$	432		$	515		$	566
VODA and VOCRA
Balance at January 1,	$	136		$	155		$	173
Amortization	(16		)	(19		)	(18		)
Balance at December 31,	$	120		$	136		$	155
Accumulated amortization	$	140		$	124		$	105

The estimated future amortization expense to be reported in other expenses for the next five years is as follows:

	VOBA		VODA and VOCRA
	(In millions)
2017	$	110	$	15
2018	$	94	$	14
2019	$	80	$	13
2020	$	60	$	12
2021	$	52	$	10

XML

Reinsurance

12 Months Ended

Dec. 31, 2016

Reinsurance Disclosures [Abstract]

Reinsurance

7. Reinsurance

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by affiliated and unaffiliated companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 8.

Annuities and Life

For annuities, the Company reinsures portions of the living and death benefit guarantees issued in connection with certain variable annuities to unaffiliated reinsurers. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders, and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The value of embedded derivatives on the ceded risk is determined using a methodology consistent with the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. The Company also assumes 100% of the living and death benefit guarantees issued in connection with certain variable annuities issued by New England Life Insurance Company (“NELICO”).

For its life products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. The Company currently reinsures 90% of the mortality risk in excess of $2 million for most products. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. On a case by case basis, the Company may retain up to $20 million per life and reinsure 100% of amounts in excess of the amount the Company retains. The Company also reinsures 90% of the risk associated with participating whole life policies to an affiliate and assumes certain term life policies and universal life policies with secondary death benefit guarantees issued by an affiliate. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time.

Corporate & Other

The Company reinsures, through 100% quota share reinsurance agreements certain run-off long-term care and workers’ compensation business written by the Company.

Catastrophe Coverage

The Company has exposure to catastrophes which could contribute to significant fluctuations in the Company’s results of operations. The Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks.

Reinsurance Recoverables

The Company reinsures its business through a diversified group of well-capitalized reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers. The Company monitors ratings and evaluates the financial strength of its reinsurers by analyzing their financial statements. In addition, the reinsurance recoverable balance due from each reinsurer is evaluated as part of the overall monitoring process. Recoverability of reinsurance recoverable balances is evaluated based on these analyses. The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at both December 31, 2016 and 2015, were not significant.

The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts and funds withheld accounts. The Company had $2.6 billion and $2.5 billion of unsecured unaffiliated reinsurance recoverable balances at December 31, 2016 and 2015, respectively.

At December 31, 2016, the Company had $9.1 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $7.8 billion, or 86%, were with the Company’s five largest unaffiliated ceded reinsurers, including $1.5 billion of net unaffiliated ceded reinsurance recoverables which were unsecured. At December 31, 2015, the Company had $8.6 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $7.4 billion, or 86%, were with the Company’s five largest unaffiliated ceded reinsurers, including $1.5 billion of net unaffiliated ceded reinsurance recoverables which were unsecured.

The amounts on the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Premiums
Direct premiums	$	2,226		$	2,404		$	2,359
Reinsurance assumed	81			296			95
Reinsurance ceded	(1,127		)	(1,063		)	(1,003		)
Net premiums	$	1,180		$	1,637		$	1,451
Universal life and investment-type product policy fees
Direct universal life and investment-type product policy fees	$	3,582		$	3,722		$	3,729
Reinsurance assumed	126			139			383
Reinsurance ceded	(611		)	(568		)	(502		)
Net universal life and investment-type product policy fees	$	3,097		$	3,293		$	3,610
Other revenues
Direct other revenues	$	271		$	271		$	270
Reinsurance assumed	89			2			30
Reinsurance ceded	349			160			220
Net other revenues	$	709		$	433		$	520
Policyholder benefits and claims
Direct policyholder benefits and claims	$	6,101		$	4,944		$	4,924
Reinsurance assumed	127			302			254
Reinsurance ceded	(2,490		)	(2,159		)	(1,980		)
Net policyholder benefits and claims	$	3,738		$	3,087		$	3,198
Interest credited to policyholder account balances
Direct interest credited to policyholder account balances	$	1,067		$	1,156		$	1,180
Reinsurance assumed	75			78			76
Reinsurance ceded	(11		)	(10		)	(11		)
Net interest credited to policyholder account balances	$	1,131		$	1,224		$	1,245
Amortization of deferred policy acquisition costs and value of business acquired
Direct amortization of deferred policy acquisition costs and value of business acquired	$	(182	)	$	727		$	1,018
Reinsurance assumed	148			8			99
Reinsurance ceded	(191		)	(62		)	(48		)
Net amortization of deferred policy acquisition costs and value of business acquired	$	(225	)	$	673		$	1,069
Other expenses
Direct other expenses	$	1,700		$	1,723		$	1,797
Reinsurance assumed	36			47			3
Reinsurance ceded	(36		)	(47		)	(43		)
Net other expenses	$	1,700		$	1,723		$	1,757

The amounts on the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at:

	December 31,
	2016									2015
	Direct		Assumed		Ceded			Total Balance Sheet		Direct		Assumed		Ceded			Total Balance Sheet
	(In millions)
Assets
Premiums, reinsurance and other receivables	$	1,161	$	23	$	12,669		$	13,853	$	765	$	161	$	17,178		$	18,104
Deferred policy acquisition costs and value of business acquired	6,638		71		(370		)	6,339		6,013		218		(454		)	5,777
Total assets	$	7,799	$	94	$	12,299		$	20,192	$	6,778	$	379	$	16,724		$	23,881
Liabilities
Future policy benefits	$	32,520	$	232	$	—		$	32,752	$	29,214	$	1,294	$	—		$	30,508
Policyholder account balances	35,838		741		—			36,579		36,013		712		—			36,725
Other policy-related balances	1,035		1,677		—			2,712		999		1,804		(1		)	2,802
Other liabilities	4,525		13		907			5,445		2,620		87		1,218			3,925
Total liabilities	$	73,918	$	2,663	$	907		$	77,488	$	68,846	$	3,897	$	1,217		$	73,960

Effective December 1, 2016, the Company terminated two agreements with an unaffiliated reinsurer which covered 90% of the liabilities on certain participating whole life insurance policies issued between April 1, 2000 and December 31, 2001 by MLIC. This termination resulted in a decrease in other invested assets of $713 million, a decrease in deferred policy acquisition costs and value of business acquired of $95 million, a decrease in future policy benefits of $654 million, and a decrease in other liabilities of $43 million. The Company recognized a loss of approximately $72 million, net of income tax, as a result of this transaction.

Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance were $1.5 billion and $6.6 billion at December 31, 2016 and 2015, respectively. The deposit liabilities on reinsurance was $1 million at both December 31, 2016 and 2015.

Related Party Reinsurance Transactions

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by certain affiliates companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

The Company has reinsurance agreements with its affiliate NELICO and certain MetLife, Inc. subsidiaries, including MLIC, General American Life Insurance Company, MetLife Europe d.a.c., MetLife Reinsurance Company of Vermont, Delaware American Life Insurance Company and American Life Insurance Company, all of which are related parties.

Information regarding the significant effects of affiliated reinsurance included on the consolidated statements of operations was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Premiums
Reinsurance assumed	$	35		$	227		$	56
Reinsurance ceded	(766		)	(687		)	(652		)
Net premiums	$	(731	)	$	(460	)	$	(596	)
Universal life and investment-type product policy fees
Reinsurance assumed	$	126		$	139		$	276
Reinsurance ceded	(60		)	(58		)	(47		)
Net universal life and investment-type product policy fees	$	66		$	81		$	229
Other revenues
Reinsurance assumed	$	59		$	2		$	30
Reinsurance ceded	348			160			220
Net other revenues	$	407		$	162		$	250
Policyholder benefits and claims
Reinsurance assumed	$	90		$	252		$	220
Reinsurance ceded	(737		)	(656		)	(622		)
Net policyholder benefits and claims	$	(647	)	$	(404	)	$	(402	)
Interest credited to policyholder account balances
Reinsurance assumed	$	75		$	78		$	76
Reinsurance ceded	(11		)	(10		)	(11		)
Net interest credited to policyholder account balances	$	64		$	68		$	65
Amortization of deferred policy acquisition costs and value of business acquired
Reinsurance assumed	$	49		$	24		$	90
Reinsurance ceded	(175		)	(59		)	(42		)
Net amortization of deferred policy acquisition costs and value of business acquired	$	(126	)	$	(35	)	$	48
Other expenses
Reinsurance assumed	$	19		$	41		$	(2	)
Reinsurance ceded	(21		)	(31		)	(23		)
Net other expenses	$	(2	)	$	10		$	(25	)

Information regarding the significant effects of affiliated reinsurance included on the consolidated balance sheets was as follows at:

	December 31,
	2016					2015
	Assumed		Ceded			Assumed		Ceded
	(In millions)
Assets
Premiums, reinsurance and other receivables	$	23	$	3,382		$	128	$	8,452
Deferred policy acquisition costs and value of business acquired	71		(356		)	120		(439		)
Total assets	$	94	$	3,026		$	248	$	8,013
Liabilities
Future policy benefits	$	211	$	—		$	630	$	—
Policyholder account balances	741		—			712		—
Other policy-related balances	1,677		—			1,785		(1		)
Other liabilities	11		578			28		876
Total liabilities	$	2,640	$	578		$	3,155	$	875

The Company assumes risks from affiliates related to guaranteed minimum benefit guarantees written directly by the affiliates. These assumed reinsurance agreements contain embedded derivatives and changes in their estimated fair value are also included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within policyholder account balances and were $741 million and $712 million at December 31, 2016 and 2015, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($21) million, ($47) million and ($453) million for the years ended December 31, 2016, 2015 and 2014, respectively.

The Company ceded risks to an affiliate related to guaranteed minimum benefit guarantees written directly by the Company. This ceded reinsurance agreement contains embedded derivatives and changes in their estimated fair value are also included within net derivative gains (losses). The embedded derivatives associated with this cession is included within premiums, reinsurance and other receivables and were $171 million and $126 million at December 31, 2016and2015, respectively. Net derivative gains (losses) associated with the embedded derivatives were $46 million, $54 million, and $42 million for the years ended December 31, 2016, 2015 and 2014, respectively.

In April 2016, the Company recaptured risks related to certain single premium deferred annuity contracts previously reinsured to MLIC. As a result of this recapture, the significant effects to the Company were an increase in investments and cash and cash equivalents of $4.3 billion and an increase in DAC of $87 million, offset by a decrease in premiums, reinsurance and other receivables of $4.0 billion. The Company recognized a gain of $246 million, net of income tax, as a result of this recapture.

The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. The Company had $2.6 billion and $7.5 billion of unsecured affiliated reinsurance recoverable balances at December 31, 2016 and 2015, respectively.

Affiliated reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on affiliated reinsurance were $1.4 billion and $6.4 billion at December 31, 2016 and 2015, respectively. There were no deposit liabilities on affiliated reinsurance at both December 31, 2016 and 2015.

XML

Investments

12 Months Ended

Dec. 31, 2016

Investments, Debt and Equity Securities [Abstract]

Investments

8. Investments

See Note 10 for information about the fair value hierarchy for investments and the related valuation methodologies.

Investment Risks and Uncertainties

Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of VIEs. The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented on the consolidated financial statements.

The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available.

The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, ABS and certain structured investment transactions) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned.

Fixed Maturity and Equity Securities AFS

Fixed Maturity and Equity Securities AFS by Sector

The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, commercial mortgage-backed securities (“CMBS”) and ABS (collectively, “Structured Securities”).

	December 31, 2016											December 31, 2015
	Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value		Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses							Gains		Temporary Losses		OTTI Losses
										(In millions)
Fixed maturity securities:
U.S. corporate	$	20,663	$	1,287	$	285	$	—		$	21,665	$	19,930	$	1,077	$	532	$	—		$	20,475
U.S. government and agency	11,872		1,281		237		—			12,916		13,145		1,362		66		—			14,441
RMBS	7,876		203		139		—			7,940		9,803		219		127		22			9,873
Foreign corporate	6,071		220		168		—			6,123		5,536		165		217		1			5,483
State and political subdivision	3,520		376		38		—			3,858		3,184		387		24		1			3,546
CMBS (1)	3,687		40		32		(1		)	3,696		3,286		28		34		(1		)	3,281
ABS	2,600		11		13		—			2,598		4,303		19		59		—			4,263
Foreign government	1,000		114		11		—			1,103		665		105		11		—			759
Total fixed maturity securities	$	57,289	$	3,532	$	923	$	(1	)	$	59,899	$	59,852	$	3,362	$	1,070	$	23		$	62,121
Equity securities:
Non-redeemable preferred stock	$	180	$	6	$	9	$	—		$	177	$	265	$	15	$	9	$	—		$	272
Common stock	100		23		—		—			123		167		23		5		—			185
Total equity securities	$	280	$	29	$	9	$	—		$	300	$	432	$	38	$	14	$	—		$	457

______________

(1) The noncredit loss component of OTTI losses for CMBS was in an unrealized gain position of $1 million at both December 31, 2016and 2015, due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”

The Company held non-income producing fixed maturity securities with an estimated fair value of $5 million and $11 million with unrealized gains (losses) of less than $1 million and $1 million at December 31, 2016 and 2015, respectively.

Methodology for Amortization of Premium and Accretion of Discount on Structured Securities

Amortization of premium and accretion of discount on Structured Securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for Structured Securities are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive Structured Securities and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other Structured Securities, the effective yield is recalculated on a retrospective basis.

Maturities of Fixed Maturity Securities

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2016:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In millions)
Amortized cost	$	1,824	$	9,020	$	9,814	$	22,468	$	14,163	$	57,289
Estimated fair value	$	1,829	$	9,408	$	9,931	$	24,497	$	14,234	$	59,899

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector

The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	December 31, 2016								December 31, 2015
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in millions)
Fixed maturity securities:
U.S. corporate	$	4,632	$	187	$	699	$	98	$	6,365	$	383	$	832	$	149
U.S. government and agency	4,396		237		—		—		4,256		66		—		—
RMBS	3,457		107		818		32		5,172		105		520		44
Foreign corporate	1,443		64		573		104		1,896		107		680		111
State and political subdivision	887		35		29		3		624		22		43		3
CMBS	1,553		26		171		5		1,864		30		97		3
ABS	450		5		461		8		2,651		42		547		17
Foreign government	242		10		6		1		133		10		6		1
Total fixed maturity securities	$	17,060	$	671	$	2,757	$	251	$	22,961	$	765	$	2,725	$	328
Equity securities:
Non-redeemable preferred stock	$	57	$	2	$	40	$	7	$	24	$	1	$	40	$	8
Common stock	—		—		—		—		7		5		1		—
Total equity securities	$	57	$	2	$	40	$	7	$	31	$	6	$	41	$	8
Total number of securities in an unrealized loss position	1,711				475				2,224				452

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

Evaluation and Measurement Methodologies

Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.

The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows: 

• The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment.

• When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management’s best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security’s position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies.

• Additional considerations are made when assessing the unique features that apply to certain Structured Securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security.

• When determining the amount of the credit loss for U.S. and foreign corporate securities, state and political subdivision securities and foreign government securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities.

With respect to securities that have attributes of debt and equity (“perpetual hybrid securities”), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security’s cost and its estimated fair value with a corresponding charge to earnings.

The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value.

In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows.

Current Period Evaluation

Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at December 31, 2016. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods.

Gross unrealized losses on fixed maturity securities decreased $171 million during the year ended December 31, 2016 to $922 million. The decrease in gross unrealized losses for the year ended December 31, 2016, was primarily attributable to narrowing credit spreads, partially offset by an increase in interest rates and, to a lesser extent, the impact of weakening foreign currencies on non-functional currency denominated fixed maturity securities.

At December 31,2016,$57 millionof the total$922 millionof gross unrealized losses were from15fixed maturity securities with an unrealized loss position of20%or more of amortized cost for six months or greater.

The change in gross unrealized losses on equity securities was not significant during the year ended December 31, 2016.

Investment Grade Fixed Maturity Securities

Of the $57 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $53 million, or 93%, were related to gross unrealized losses on six investment grade fixed maturity securities. Unrealized losses on investment grade fixed maturity securities are principally related to widening credit spreads since purchase and, with respect to fixed-rate fixed maturity securities, rising interest rates since purchase.

Below Investment Grade Fixed Maturity Securities

Of the $57 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $4 million, or 7%, were related to gross unrealized losses on nine below investment grade fixed maturity securities. Unrealized losses on below investment grade fixed maturity securities are principally related to U.S. and foreign corporate securities (primarily industrial securities) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over lower oil prices in the energy sector. Management evaluates U.S. and foreign corporate securities based on factors such as expected cash flows and the financial condition and near-term and long-term prospects of the issuers.

Mortgage Loans

Mortgage Loans by Portfolio Segment

Mortgage loans are summarized as follows at:

	December 31,
	2016					2015
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in millions)
Mortgage loans
Commercial	$	6,497		69.9	%	$	5,452		73.7	%
Agricultural	1,830			19.7		1,481			20.0
Residential	867			9.3		335			4.5
Subtotal	9,194			98.9		7,268			98.2
Valuation allowances	(40		)	(0.4	)	(36		)	(0.5	)
Subtotal mortgage loans, net	9,154			98.5		7,232			97.7
Commercial mortgage loans held by CSEs — FVO	136			1.5		172			2.3
Total mortgage loans, net	$	9,290		100.0	%	$	7,404		100.0	%

The Company purchases unaffiliated mortgage loans under a master participation agreement, from an affiliate, simultaneously with the affiliate’s origination or acquisition of mortgage loans. The aggregate amount of unaffiliated mortgage loan participation interests purchased by the Company from an affiliate during the years ended December 31, 2016, 2015 and 2014 were $2.4 billion, $2.0 billion and $370 million, respectively. In connection with the mortgage loan participations, the affiliate collected mortgage loan principal and interest payments on the Company’s behalf and the affiliate remitted such payments to the Company in the amount of $1.6 billion, $1.0 billion and $1.0 billion during the years ended December 31, 2016, 2015 and 2014, respectively.

Purchases of mortgage loans from third parties were $619 million and $346 million for the years ended December 31, 2016 and 2015, respectively, and were primarily comprised of residential mortgage loans.

See “— Variable Interest Entities” for discussion of CSEs.

See “— Related Party Investment Transactions” for discussion of related party mortgage loans.

Information on commercial, agricultural and residential mortgage loans is presented in the tables below. Information on commercial mortgage loans held by CSEs - FVO is presented in Note 10. The Company elects the FVO for certain commercial mortgage loans and related long-term debt that are managed on a total return basis.

Mortgage Loans, Valuation Allowance and Impaired Loans by Portfolio Segment

Mortgage loans by portfolio segment, by method of evaluation of credit loss, impaired mortgage loans including those modified in a troubled debt restructuring, and the related valuation allowances, were as follows at and for the years ended:

	Evaluated Individually for Credit Losses										Evaluated Collectively for Credit Losses				Impaired Loans
	Impaired Loans with a Valuation  Allowance						Impaired Loans without a Valuation Allowance
	Unpaid Principal Balance		Recorded Investment		Valuation Allowances		Unpaid Principal Balance		Recorded Investment		Recorded Investment		Valuation Allowances		Carrying Value		Average Recorded Investment
	(In millions)
December 31, 2016
Commercial	$	—	$	—	$	—	$	—	$	—	$	6,497	$	32	$	—	$	—
Agricultural	4		3		—		—		—		1,827		5		3		3
Residential	—		—		—		1		1		866		3		1		—
Total	$	4	$	3	$	—	$	1	$	1	$	9,190	$	40	$	4	$	3
December 31, 2015
Commercial	$	—	$	—	$	—	$	—	$	—	$	5,452	$	28	$	—	$	—
Agricultural	4		3		—		—		—		1,478		5		3		3
Residential	—		—		—		—		—		335		3		—		—
Total	$	4	$	3	$	—	$	—	$	—	$	7,265	$	36	$	3	$	3

The average recorded investment for impaired commercial, agricultural and residential mortgage loans was $43 million, $3 million and $0, respectively, for the year ended December 31, 2014.

Valuation Allowance Rollforward by Portfolio Segment

The changes in the valuation allowance, by portfolio segment, were as follows:

	Commercial			Agricultural		Residential		Total
	(In millions)
Balance at January 1, 2014	$	31		$	4	$	—	$	35
Provision (release)	(10		)	—		—		(10		)
Balance at December 31, 2014	21			4		—		25
Provision (release)	7			1		3		11
Balance at December 31, 2015	28			5		3		36
Provision (release)	4			—		—		4
Balance at December 31, 2016	$	32		$	5	$	3	$	40

Valuation Allowance Methodology

Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for all three portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for all loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

Commercial and Agricultural Mortgage Loan Portfolio Segments

The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans.

All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio.

For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property’s net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio and the values utilized in calculating the ratio are updated annually on a rolling basis, with a portion of the portfolio updated each quarter. In addition, the loan-to-value ratio is routinely updated for all but the lowest risk loans as part of the Company’s ongoing review of its commercial mortgage loan portfolio.

For agricultural mortgage loans, the Company’s primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated.

Residential Mortgage Loan Portfolio Segment

The Company’s residential mortgage loan portfolio is comprised primarily of closed end, amortizing residential mortgage loans. For evaluations of residential mortgage loans, the key inputs of expected frequency and expected loss reflect current market conditions, with expected frequency adjusted, when appropriate, for differences from market conditions and historical experience. In contrast to the commercial and agricultural mortgage loan portfolios, residential mortgage loans are smaller-balance homogeneous loans that are collectively evaluated for impairment. Non-specific valuation allowances are established using the evaluation framework described above for pools of loans with similar risk characteristics from inputs that are unique to the residential segment of the loan portfolio. Loan specific valuation allowances are only established on residential mortgage loans when they have been restructured and are established using the methodology described above for all loan portfolio segments.

For residential mortgage loans, the Company’s primary credit quality indicator is whether the loan is performing or nonperforming. The Company generally defines nonperforming residential mortgage loans as those that are 60 or more days past due and/or in nonaccrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.

Credit Quality of Commercial Mortgage Loans

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment										Estimated Fair Value		% of Total
	Debt Service Coverage Ratios						Total		% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x
	(Dollars in millions)
December 31, 2016
Loan-to-value ratios
Less than 65%	$	5,718	$	230	$	167	$	6,115	94.1	%	$	6,197	94.3	%
65% to 75%	291		—		19		310		4.8		303		4.6
76% to 80%	34		—		—		34		0.5		33		0.5
Greater than 80%	24		14		—		38		0.6		37		0.6
Total	$	6,067	$	244	$	186	$	6,497	100.0	%	$	6,570	100.0	%
December 31, 2015
Loan-to-value ratios
Less than 65%	$	4,771	$	153	$	105	$	5,029	92.2	%	$	5,250	92.7	%
65% to 75%	330		—		10		340		6.2		332		5.9
76% to 80%	—		—		—		—		—		—		—
Greater than 80%	44		25		14		83		1.6		80		1.4
Total	$	5,145	$	178	$	129	$	5,452	100.0	%	$	5,662	100.0	%

Credit Quality of Agricultural Mortgage Loans

The credit quality of agricultural mortgage loans was as follows at:

	December 31,
	2016				2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Loan-to-value ratios
Less than 65%	$	1,789	97.8	%	$	1,386	93.6	%
65% to 75%	41		2.2		95		6.4
Total	$	1,830	100.0	%	$	1,481	100.0	%

The estimated fair value of agricultural mortgage loans was $1.9 billion and $1.5 billion at December 31, 2016 and 2015, respectively.

Credit Quality of Residential Mortgage Loans

The credit quality of residential mortgage loans was as follows at:

	December 31,
	2016				2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Performance indicators:
Performing	$	856	98.7	%	$	331	98.8	%
Nonperforming	11		1.3		4		1.2
Total	$	867	100.0	%	$	335	100.0	%

The estimated fair value of residential mortgage loans was $867 million and $345 million at December 31, 2016 and 2015, respectively.

Past Due and Nonaccrual Mortgage Loans

The Company has a high quality, well performing, mortgage loan portfolio, with over99%of all mortgage loans classified as performing as of bothDecember 31, 2016and2015.The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days.The Company hadnocommercial or agricultural mortgage loans past due andnocommercial or agricultural mortgage loans in nonaccrual status at eitherDecember 31, 2016, or2015. The recorded investment of residential mortgage loans past due and in nonaccrual status was$11 millionand$4 millionatDecember 31, 2016and2015, respectively.

Mortgage Loans Modified in a Troubled Debt Restructuring

The Company may grant concessions related to borrowers experiencing financial difficulties, which are classified as troubled debt restructurings. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concessions granted are considered in determining any impairment or changes in the specific valuation allowance. During the year ended December 31, 2016, the Company did not have a significant amount of mortgage loans modified in a troubled debt restructuring. There were no mortgage loans modified in a troubled debt restructuring during the year ended December 31, 2015.

Other Invested Assets

Other invested assets is comprised primarily of freestanding derivatives with positive estimated fair values (see Note 9), operating joint venture, tax credit and renewable energy partnerships, leveraged leases and funds withheld.

Tax Credit Partnerships

The carrying value of tax credit partnerships was $41 million and $42 million at December 31, 2016 and 2015, respectively. Net investment income (loss) from tax credit partnerships were ($1) million for both years ended December 31, 2016 and 2015. Net investment income (loss) was $3 million for the year ended December 31, 2014.

Leveraged Leases

Investment in leveraged leases consisted of the following at:

	December 31,
	2016			2015
	(In millions)
Rental receivables, net	$	87		$	90
Estimated residual values	14			14
Subtotal	101			104
Unearned income	(32		)	(33		)
Investment in leveraged leases, net of non-recourse debt	$	69		$	71

Rental receivables are generally due in periodic installments. The payment periods for leveraged leases range from one to 16 years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. The Company generally defines nonperforming rental receivables as those that are 90 days or more past due. At December 31, 2016 and 2015, all rental receivables were performing.

The deferred income tax liability related to leveraged leases was $74 million and $76 million at December 31, 2016 and 2015, respectively.

Cash Equivalents

The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $4.7 billion and $1.2 billion at December 31, 2016 and 2015, respectively.

Net Unrealized Investment Gains (Losses)

Unrealized investment gains (losses) on fixed maturity and equity securities AFS and the effect on DAC, VOBA, DSI and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in accumulated other comprehensive income (loss) (“AOCI”).

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Fixed maturity securities	$	2,600		$	2,283		$	4,729
Fixed maturity securities with noncredit OTTI losses included in AOCI	1			(23		)	(38		)
Total fixed maturity securities	2,601			2,260			4,691
Equity securities	32			54			69
Derivatives	397			370			281
Short-term investments	(42		)	—			—
Other	59			79			10
Subtotal	3,047			2,763			5,051
Amounts allocated from:
Future policy benefits	(922		)	(126		)	(613		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)	(1		)	(2		)
DAC, VOBA and DSI	(193		)	(198		)	(406		)
Subtotal	(1,117		)	(325		)	(1,021		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	—			9			14
Deferred income tax benefit (expense)	(653		)	(827		)	(1,416		)
Net unrealized investment gains (losses)	$	1,277		$	1,620		$	2,628

The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:

	Years Ended December 31,
	2016			2015
	(In millions)
Balance at January 1,	$	(23	)	$	(38	)
Noncredit OTTI losses and subsequent changes recognized	3			8
Securities sold with previous noncredit OTTI loss	18			19
Subsequent changes in estimated fair value	3			(12		)
Balance at December 31,	$	1		$	(23	)

The changes in net unrealized investment gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at January 1,	$	1,620		$	2,628		$	930
Fixed maturity securities on which noncredit OTTI losses have been recognized	24			15			15
Unrealized investment gains (losses) during the year	260			(2,303		)	3,234
Unrealized investment gains (losses) relating to:
Future policy benefits	(796		)	487			(613		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(1		)	1			(2		)
DAC, VOBA and DSI	5			208			(119		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(9		)	(5		)	(4		)
Deferred income tax benefit (expense)	174			589			(813		)
Balance at December 31,	$	1,277		$	1,620		$	2,628
Change in net unrealized investment gains (losses)	$	(343	)	$	(1,008	)	$	1,698

Concentrations of Credit Risk

There were no investments in any counterparty that were greater than 10% of the Company’s stockholder’s equity, other than the U.S. government and its agencies, at both December 31, 2016 and 2015.

Securities Lending

Elements of the securities lending program are presented below at:

	December 31,
	2016		2015
	(In millions)
Securities on loan: (1)
Amortized cost	$	5,895	$	8,047
Estimated fair value	$	6,555	$	8,830
Cash collateral on deposit from counterparties (2)	$	6,642	$	8,981
Security collateral on deposit from counterparties (3)	$	27	$	23
Reinvestment portfolio — estimated fair value	$	6,571	$	8,938

______________

(1) Included within fixed maturity securities and short-term investments.

(2) Included within payables for collateral under securities loaned and other transactions.

(3) Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the consolidated financial statements.

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	December 31, 2016								December 31, 2015
	Remaining Tenor of Securities Lending Agreements								Remaining Tenor of Securities Lending Agreements
	Open (1)		1 Month or Less		1 to 6 Months		Total		Open (1)		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
U.S. government and agency	$	2,129	$	1,906	$	1,743	$	5,778	$	2,631	$	3,140	$	1,338	$	7,109
U.S. corporate	—		480		—		480		9		302		—		311
Agency RMBS	—		—		274		274		—		939		579		1,518
Foreign corporate	—		58		—		58		—		—		—		—
Foreign government	—		52		—		52		1		42		—		43
Total	$	2,129	$	2,496	$	2,017	$	6,642	$	2,641	$	4,423	$	1,917	$	8,981

_____________

(1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral.

If the Company is required to return significant amounts of cash collateral on short notice and is forced to sell securities to meet the return obligation, it may have difficulty selling such collateral that is invested in securities in a timely manner, be forced to sell securities in a volatile or illiquid market for less than what otherwise would have been realized under normal market conditions, or both. The estimated fair value of the securities on loan related to the cash collateral on open at December 31, 2016 was $2.1 billion, all of which were U.S. government and agency securities which, if put back to the Company, could be immediately sold to satisfy the cash requirement.

The reinvestment portfolio acquired with the cash collateral consisted principally of fixed maturity securities (including agency RMBS, ABS, non-agency RMBS, U.S. corporate securities and U.S. government and agency) with 48% invested in agency RMBS, short-term investments, U.S. government and agency, cash equivalents or held in cash at December 31, 2016. If the securities on loan or the reinvestment portfolio become less liquid, the Company has the liquidity resources of most of its general account available to meet any potential cash demands when securities on loan are put back to the Company.

Invested Assets on Deposit, Held in Trust and Pledged as Collateral

Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes at:

	December 31,
	2016		2015
	(In millions)
Invested assets on deposit (regulatory deposits)	$	7,644	$	7,247
Invested assets held in trust (reinsurance agreements) (1)	9,054		8,083
Invested assets pledged as collateral (2)	3,548		2,801
Total invested assets on deposit, held in trust, and pledged as collateral	$	20,246	$	18,131

______________

(1) The Company has held in trust certain investments in connection with certain reinsurance transactions.

(2) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 5) and derivative transactions (see Note 9).

See “— Securities Lending” for information regarding securities on loan.

Purchased Credit Impaired Investments

Investments acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments are classified as purchased credit impaired (“PCI”) investments. For each investment, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI.

The Company’s PCI fixed maturity securities were as follows at:

	December 31,
	2016		2015
	(In millions)
Outstanding principal and interest balance (1)	$	1,458	$	1,219
Carrying value (2)	$	1,113	$	907

______________

(1) Represents the contractually required payments, which is the sum of contractual principal, whether or not currently due, and accrued interest.

(2) Estimated fair value plus accrued interest.

The following table presents information about PCI fixed maturity securities acquired during the periods indicated:

	Years Ended December 31,
	2016		2015
	(In millions)
Contractually required payments (including interest)	$	558	$	797
Cash flows expected to be collected (1)	$	483	$	709
Fair value of investments acquired	$	341	$	520

______________

(1) Represents undiscounted principal and interest cash flow expectations, at the date of acquisition.

The following table presents activity for the accretable yield on PCI fixed maturity securities for:

	Years Ended December 31,
	2016			2015
	(In millions)
Accretable yield, January 1,	$	400		$	244
Investments purchased	142			189
Accretion recognized in earnings	(66		)	(47		)
Disposals	(8		)	(8		)
Reclassification (to) from nonaccretable difference	(49		)	22
Accretable yield, December 31,	$	419		$	400

Collectively Significant Equity Method Investments

The Company holds investments in real estate joint ventures, real estate funds and other limited partnership interests consisting of leveraged buy-out funds, hedge funds, private equity funds, joint ventures and other funds. The portion of these investments accounted for under the equity method had a carrying value of $1.9 billion at December 31, 2016. The Company’s maximum exposure to loss related to these equity method investments is limited to the carrying value of these investments plus unfunded commitments of $1.1 billion at December 31, 2016. Except for certain real estate joint ventures, the Company’s investments in real estate funds and other limited partnership interests are generally of a passive nature in that the Company does not participate in the management of the entities.

As described in Note 1, the Company generally records its share of earnings in its equity method investments using a three-month lag methodology and within net investment income. Aggregate net investment income from these equity method investments exceeded 10% of the Company’s consolidated pre-tax income (loss) for the two of the most recent annual periods: 2015 and 2014. This aggregated summarized financial data does not represent the Company’s proportionate share of the assets, liabilities, or earnings of such entities.

The aggregated summarized financial data presented below reflects the latest available financial information and is as of, and for, the years ended December 31, 2016, 2015 and 2014. Aggregate total assets of these entities totaled $285.1 billion and $294.3 billion at December 31, 2016 and 2015, respectively. Aggregate total liabilities of these entities totaled $26.3 billion and $46.3 billion at December 31, 2016 and 2015, respectively. Aggregate net income (loss) of these entities totaled $21.3 billion, $13.7 billion and $25.1 billion for the years ended December 31, 2016, 2015 and 2014, respectively. Aggregate net income (loss) from the underlying entities in which the Company invests is primarily comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses).

Variable Interest Entities

The Company has invested in certain entities (including CSEs) that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity.

Consolidated VIEs

Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company’s obligation to the VIEs is limited to the amount of its committed investment.

The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2016 and 2015.

	December 31,
	2016		2015
	(In millions)
MRSC (collateral financing arrangement ) (1)	$	3,422	$	3,374
CSEs: (2)
Assets:
Mortgage loans (commercial mortgage loans)	136		172
Accrued investment income	1		1
Total assets	$	137	$	173
Liabilities:
Long-term debt	$	23	$	48
Other liabilities	1		1
Total liabilities	$	24	$	49

______________

(1) See Note 3 for additional information on MRSC collateral financing arrangement.

(2) The Company consolidates entities that are structured as CMBS. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $95 million and $105 million at estimated fair value at December 31, 2016 and 2015, respectively.

Unconsolidated VIEs

The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:

	December 31,
	2016				2015
	Carrying Amount		Maximum Exposure to Loss (1)		Carrying Amount		Maximum Exposure to Loss (1)
	(In millions)
Fixed maturity securities AFS:
Structured Securities (2)	$	12,809	$	12,809	$	16,454	$	16,454
U.S. and foreign corporate	536		536		625		625
Other limited partnership interests	1,491		2,287		1,367		1,646
Real estate joint ventures	17		22		35		38
Other investments (3)	60		66		58		62
Total	$	14,913	$	15,720	$	18,539	$	18,825

______________

(1) The maximum exposure to loss relating to fixed maturity and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties. There were no income tax credits and less than $1 million at December 31, 2016 and 2015, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.

(2) For these variable interests, the Company’s involvement is limited to that of a passive investor in mortgage-backed or asset-backed securities issued by trusts that do not have substantial equity.

(3) Other investments is comprised of other invested assets and non-redeemable preferred stock.

As described in Note 16, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during the years ended December 31, 2016, 2015 and 2014.

Net Investment Income

The components of net investment income were as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Investment income:
Fixed maturity securities	$	2,567	$	2,398	$	2,269
Equity securities	19		19		17
Mortgage loans	393		367		344
Policy loans	54		54		59
Real estate and real estate joint ventures	32		108		80
Other limited partnership interests	163		134		266
Cash, cash equivalents and short-term investments	20		9		5
Operating joint venture	11		11		2
Other	14		11		4
Subtotal	3,273		3,111		3,046
Less: Investment expenses	173		126		111
Subtotal, net	3,100		2,985		2,935
FVO CSEs — interest income — commercial mortgage loans	11		16		49
Net investment income	$	3,111	$	3,001	$	2,984

See “— Variable Interest Entities” for discussion of CSEs.

See “— Related Party Investment Transactions” for discussion of affiliated net investment income and investment expenses.

Net Investment Gains (Losses)

Components of Net Investment Gains (Losses)

The components of net investment gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Total gains (losses) on fixed maturity securities:
Total OTTI losses recognized — by sector and industry:
U.S. and foreign corporate securities — by industry:
Industrial	$	(16	)	$	(3	)	$	—
Consumer	—			(8		)	(2		)
Utility	—			(6		)	—
Transportation	—			—			(2		)
Total U.S. and foreign corporate securities	(16		)	(17		)	(4		)
RMBS	(6		)	(14		)	(10		)
OTTI losses on fixed maturity securities recognized in earnings	(22		)	(31		)	(14		)
Fixed maturity securities — net gains (losses) on sales and disposals	(28		)	(60		)	10
Total gains (losses) on fixed maturity securities	(50		)	(91		)	(4		)
Total gains (losses) on equity securities:
Total OTTI losses recognized — by sector:
Common stock	(1		)	(3		)	(7		)
Non-redeemable preferred stock	(1		)	—			(8		)
OTTI losses on equity securities recognized in earnings	(2		)	(3		)	(15		)
Equity securities — net gains (losses) on sales and disposals	10			18			14
Total gains (losses) on equity securities	8			15			(1		)
Mortgage loans	5			(11		)	18
Real estate and real estate joint ventures	(34		)	98			(4		)
Other limited partnership interests	(7		)	(1		)	(9		)
Other	11			(2		)	43
Subtotal	(67		)	8			43
FVO CSEs:
Commercial mortgage loans	(2		)	(7		)	(13		)
Long-term debt — related to commercial mortgage loans	1			4			19
Non-investment portfolio gains (losses) (1)	1			—			(538		)
Subtotal	—			(3		)	(532		)
Total net investment gains (losses)	$	(67	)	$	5		$	(489	)

______________

(1) Non-investment portfolio gains (losses) for the year ended December 31, 2014 includes a loss of $608 million related to the disposition of MAL as more fully described in Note 4.

See “— Variable Interest Entities” for discussion of CSEs.

See “— Related Party Investment Transactions” for discussion of affiliated net investment gains (losses) related to transfers of invested assets to affiliates.

Gains (losses) from foreign currency transactions included within net investment gains (losses) were $8 million, ($5) million and $66 million for the years ended December 31, 2016, 2015 and 2014, respectively.

Sales or Disposals and Impairments of Fixed Maturity and Equity Securities

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) were as shown in the table below.

	Years Ended December 31,
	2016			2015			2014			2016			2015			2014
	Fixed Maturity Securities									Equity Securities
	(In millions)
Proceeds	$	39,210		$	32,085		$	16,943		$	48		$	80		$	57
Gross investment gains	$	253		$	184		$	95		$	10		$	26		$	15
Gross investment losses	(281		)	(244		)	(85		)	—			(8		)	(1		)
OTTI losses	(22		)	(31		)	(14		)	(2		)	(3		)	(15		)
Net investment gains (losses)	$	(50	)	$	(91	)	$	(4	)	$	8		$	15		$	(1	)

Credit Loss Rollforward

The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI:

	Years Ended December 31,
	2016			2015
	(In millions)
Balance at January 1,	$	66		$	67
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	—			6
Additional impairments — credit loss OTTI on securities previously impaired	5			11
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(42		)	(16		)
Increase in cash flows — accretion of previous credit loss OTTI	(1		)	(2		)
Balance at December 31,	$	28		$	66

Related Party Investment Transactions

The Company transfers invested assets, primarily consisting of fixed maturity securities, to and from affiliates. Invested assets transferred to and from affiliates were as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Estimated fair value of invested assets transferred to affiliates	$	1,495	$	185	$	1,441
Amortized cost of invested assets transferred to affiliates	$	1,400	$	169	$	1,362
Net investment gains (losses) recognized on transfers	$	27	$	16	$	79
Change in additional paid-in-capital recognized on transfers	$	68	$	—	$	—
Estimated fair value of invested assets transferred from affiliates	$	5,582	$	928	$	132

In April 2016 and in November 2016, the Company received a transfer of investments and cash and cash equivalents totaling $5.2 billion for the recapture of risks related to certain single premium deferred annuity contracts previously reinsured to MLIC, an affiliate, which are included in the table above. See Note 7 for additional information related to these transfers.

In July 2014, prior to the Mergers, the Company sold affiliated loans to other affiliates, which were included in other invested assets and in the table above, at an estimated fair value totaling $520 million and a $45 million gain was recognized in net investment gains (losses). Net investment income from these affiliated loans was $13 million for the year ended December 31, 2014.

The Company had affiliated loans outstanding to wholly-owned real estate subsidiaries of MLIC, which were included in mortgage loans, with a carrying value of $242 million at December 31, 2014. In August 2015 and November 2014, one affiliated loan with a carrying value of $132 million and two affiliated loans with a total carrying value of $120 million were repaid in cash prior to maturity. The remaining loan with a carrying value of $110 million was repaid in cash upon maturity in December 31, 2015. These affiliated loans were secured by interests in the real estate subsidiaries, which owned operating real estate with an estimated fair value in excess of the affiliated loans. Net investment income from these affiliated loans was $8 million and $34 million for the years ended December 31, 2015 and 2014, respectively. In addition, mortgage loan prepayment income earned from the three repayments prior to maturity described above was $31 million and $16 million for the years ended December 31, 2015 and 2014, respectively.

The Company had loans outstanding to affiliates, which were included in other invested assets, totaling $1.1 billion and $1.2 billion as of December 31, 2016 and 2015, respectively. Two loans totaling $1.1 billion as of both December 31, 2016 and 2015, were outstanding to MetLife, Inc., which bear interest at fixed rates of 4.21% and 5.10%, payable semiannually, and are due on September 30, 2032 and December 31, 2033, respectively. See also Note 12 for the related surplus notes payable totaling$1.1 billion. In addition, the Company had affiliated loans outstanding to an investment subsidiary of MLIC totaling $50 million as of December 31, 2015 with interest rates ranging from 1.55% to 2.39% and scheduled maturity dates from October 31, 2021 to June 30, 2022. In March 2016, the loans outstanding to an investment subsidiary of MLIC were repaid in cash prior to maturity. Net investment income from these affiliated loans was $51 million and $52 million for the years ended December 31, 2016 and 2015.

The Company receives investment administrative services from an affiliate. The related investment administrative service charges were $98 million, $79 million, and $70 million for the years ended December 31, 2016, 2015 and 2014, respectively.

See “— Mortgage Loans — Mortgage Loans by Portfolio Segment” for discussion of mortgage loan participation agreements with an affiliate.

XML

Derivatives

12 Months Ended

Dec. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

9. Derivatives

Accounting for Derivatives

See Note 1 for a description of the Company’s accounting policies for derivatives and Note 10 for information about the fair value hierarchy for derivatives.

Derivative Strategies

The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps to synthetically replicate investment risks and returns which are not readily available in the cash markets.

Interest Rate Derivatives

The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, caps, floors, swaptions, futures and forwards.

Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and nonqualifying hedging relationships.

Interest rate total return swaps are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the London Interbank Offered Rate (“LIBOR”), calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. Interest rate total return swaps are used by the Company to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). The Company utilizes interest rate total return swaps in nonqualifying hedging relationships.

The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in nonqualifying hedging relationships.

In exchange-traded interest rate (Treasury and swap) futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance, and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded interest rate futures in nonqualifying hedging relationships.

Swaptions are used by the Company to hedge interest rate risk associated with the Company’s long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. The Company utilizes swaptions in nonqualifying hedging relationships. Swaptions are included in interest rate options.

The Company enters into interest rate forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. The Company utilizes interest rate forwards in cash flow hedging relationships.

Foreign Currency Exchange Rate Derivatives

The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in cash flow and nonqualifying hedging relationships.

To a lesser extent, the Company uses foreign currency forwards in nonqualifying hedging relationships.

Credit Derivatives

The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional amount in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, involuntary restructuring or governmental intervention. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. (“ISDA”) deems that a credit event has occurred. The Company utilizes credit default swaps in nonqualifying hedging relationships.

The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. government and agency securities or other fixed maturity securities. These credit default swaps are not designated as hedging instruments.

Equity Derivatives

The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, equity variance swaps, exchange-traded equity futures and equity total return swaps.

Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in nonqualifying hedging relationships.

Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in nonqualifying hedging relationships.

In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in nonqualifying hedging relationships.

In an equity total return swapare swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the LIBOR, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses equity total return swaps to hedge its equity market guarantees in certain of its insurance products. Equity total return swaps can be used as hedges or to synthetically create investments. The Company utilizes equity total return swaps in nonqualifying hedging relationships.

Primary Risks Managed by Derivatives

The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:

	Primary Underlying Risk Exposure	December 31,
		2016						2015
				Estimated Fair Value						Estimated Fair Value
		Gross Notional Amount		Assets		Liabilities		Gross Notional Amount		Assets		Liabilities
		(In millions)
Derivatives Designated as Hedging Instruments
Fair value hedges:
Interest rate swaps	Interest rate	$	310	$	41	$	—	$	420	$	38	$	1
Cash flow hedges:
Interest rate swaps	Interest rate	45		7		—		230		60		—
Interest rate forwards	Interest rate	—		—		—		35		8		—
Foreign currency swaps	Foreign currency exchange rate	1,420		186		10		969		129		3
Subtotal		1,465		193		10		1,234		197		3
Total qualifying hedges		1,775		234		10		1,654		235		4
Derivatives Not Designated or Not Qualifying as Hedging Instruments
Interest rate swaps	Interest rate	28,175		1,928		1,688		23,086		1,802		638
Interest rate floors	Interest rate	2,100		5		2		7,036		33		24
Interest rate caps	Interest rate	12,042		25		—		13,792		38		—
Interest rate futures	Interest rate	1,288		9		—		630		2		—
Interest rate options	Interest rate	15,520		136		—		18,620		472		5
Interest rate total return swaps	Interest rate	3,876		—		611		48		2		—
Foreign currency swaps	Foreign currency exchange rate	1,250		153		4		673		77		—
Foreign currency forwards	Foreign currency exchange rate	158		9		—		185		4		1
Credit default swaps — purchased	Credit	34		—		—		21		—		—
Credit default swaps — written	Credit	1,891		28		—		2,093		13		1
Equity futures	Equity market	8,037		38		—		3,669		37		—
Equity index options	Equity market	37,501		897		934		44,035		1,032		626
Equity variance swaps	Equity market	14,894		140		517		14,866		120		434
Equity total return swaps	Equity market	2,855		1		117		2,814		31		49
Total non-designated or nonqualifying derivatives		129,621		3,369		3,873		131,568		3,663		1,778
Total		$	131,396	$	3,603	$	3,883	$	133,222	$	3,898	$	1,782

Based on gross notional amounts, a substantial portion of the Company’s derivatives was not designated or did not qualify as part of a hedging relationship at both December 31, 2016 and 2015. The Company’s use of derivatives includes (i) derivatives that serve as macro hedges of the Company’s exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to synthetically create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these nonqualified derivatives, changes in market factors can lead to the recognition of fair value changes on the statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged.

Net Derivative Gains (Losses)

The components of net derivative gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Freestanding derivatives and hedging gains (losses) (1)	$	(4,029	)	$	(153	)	$	870
Embedded derivatives gains (losses)	(1,741		)	(344		)	(576		)
Total net derivative gains (losses)	$	(5,770	)	$	(497	)	$	294

______________

(1) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships, which are not presented elsewhere in this note.

The following table presents earned income on derivatives:

	Years Ended December 31,
	2016		2015			2014
	(In millions)
Qualifying hedges:
Net investment income	$	19	$	11		$	4
Interest credited to policyholder account balances	—		(2		)	(1		)
Nonqualifying hedges:
Net derivative gains (losses)	460		361			273
Policyholder benefits and claims	16		14			32
Total	$	495	$	384		$	308

Nonqualifying Derivatives and Derivatives for Purposes Other Than Hedging

The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments:

	Net Derivative Gains (Losses)			Net Investment Income (1)			Policyholder Benefits and Claims (2)
	(In millions)
Year Ended December 31, 2016
Interest rate derivatives	$	(2,873	)	$	—		$	(4	)
Foreign currency exchange rate derivatives	76			—			—
Credit derivatives — purchased	—			—			—
Credit derivatives — written	10			—			—
Equity derivatives	(1,724		)	(6		)	(320		)
Total	$	(4,511	)	$	(6	)	$	(324	)
Year Ended December 31, 2015
Interest rate derivatives	$	(67	)	$	—		$	5
Foreign currency exchange rate derivatives	44			—			—
Credit derivatives — purchased	—			—			—
Credit derivatives — written	(14		)	—			—
Equity derivatives	(476		)	(4		)	(25		)
Total	$	(513	)	$	(4	)	$	(20	)
Year Ended December 31, 2014
Interest rate derivatives	$	1,174		$	—		$	43
Foreign currency exchange rate derivatives	6			—			—
Credit derivatives — purchased	(22		)	—			—
Credit derivatives — written	18			—			—
Equity derivatives	(591		)	(8		)	(279		)
Total	$	585		$	(8	)	$	(236	)

______________

(1) Changes in estimated fair value related to economic hedges of equity method investments in joint ventures.

(2) Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.

Fair Value Hedges

The Company designates and accounts for interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities as fair value hedges when they have met the requirements of fair value hedging.

The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):

Derivatives in Fair Value Hedging Relationships	Hedged Items in Fair Value Hedging Relationships	Net Derivative Gains (Losses) Recognized for Derivatives		Net Derivative Gains (Losses) Recognized for Hedged Items			Ineffectiveness Recognized in Net Derivative Gains (Losses)
		(In millions)
Year Ended December 31, 2016
Interest rate swaps:	Fixed maturity securities	$	1	$	(1	)	$	—
	Policyholder liabilities (1)	—		—			—
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	1	$	(1	)	$	—
Year Ended December 31, 2015
Interest rate swaps:	Fixed maturity securities	$	1	$	1		$	2
	Policyholder liabilities (1)	2		(2		)	—
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	3	$	(1	)	$	2
Year Ended December 31, 2014
Interest rate swaps:	Fixed maturity securities	$	1	$	(1	)	$	—
	Policyholder liabilities (1)	32		(31		)	1
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	33	$	(32	)	$	1

______________

(1) Fixed rate liabilities reported in policyholder account balances or future policy benefits.

(2) Fixed rate or floating rate liabilities.

All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

Cash Flow Hedges

The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; and (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments.

In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. Because certain of the forecasted transactions also were not probable of occurring within two months of the anticipated date, the Company reclassified amounts from AOCI into net derivative gains (losses). These amounts were $1 million and $3 million for the years ended December 31, 2016 and 2015, respectively. These amounts were not significant for the year ended December 31, 2014.

At December 31, 2016 and 2015, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed three years and four years, respectively.

At December 31, 2016 and 2015, the balance in AOCI associated with cash flow hedges was $397 million and $370 million, respectively.

The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of stockholder’s equity:

Derivatives in Cash Flow Hedging Relationships	Amount of Gains (Losses) Deferred in AOCI on Derivatives		Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)					Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives
	(Effective Portion)		(Effective Portion)					(Ineffective Portion)
			Net Derivative Gains (Losses)			Net Investment Income		Net Derivative Gains (Losses)
	(In millions)
Year Ended December 31, 2016
Interest rate swaps	$	24	$	33		$	3	$	—
Interest rate forwards	4		2			2		—
Foreign currency swaps	42		3			—		—
Credit forwards	—		—			—		—
Total	$	70	$	38		$	5	$	—
Year Ended December 31, 2015
Interest rate swaps	$	15	$	1		$	1	$	1
Interest rate forwards	1		2			2		—
Foreign currency swaps	79		—			—		—
Credit forwards	—		—			—		—
Total	$	95	$	3		$	3	$	1
Year Ended December 31, 2014
Interest rate swaps	$	131	$	1		$	1	$	—
Interest rate forwards	55		1			1		—
Foreign currency swaps	57		(6		)	—		—
Credit forwards	—		—			—		—
Total	$	243	$	(4	)	$	2	$	—

All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

At December 31, 2016, the Company expects to reclassify $40 million of deferred net gains (losses) on derivatives in AOCI to earnings within the next 12 months.

Credit Derivatives

In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the nonqualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company’s maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $1.9 billion and $2.1 billion at December 31, 2016 and 2015, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current estimated fair value of the credit default swaps. At December 31, 2016 and 2015, the Company would have received $28 million and $12 million, respectively, to terminate all of these contracts.

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:

	December 31,
	2016					2015
Rating Agency Designation of Referenced Credit Obligations (1)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)
	(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (3)	$	1	$	45	2.2	$	1	$	207	1.5
Credit default swaps referencing indices	8		433		3.7	1		219		4.0
Subtotal	9		478		3.6	2		426		2.8
Baa
Single name credit default swaps (3)	1		180		1.6	2		409		1.6
Credit default swaps referencing indices	18		1,213		4.8	8		1,222		4.8
Subtotal	19		1,393		4.4	10		1,631		4.0
Ba
Single name credit default swaps (3)	—		20		2.7	—		—		—
Credit default swaps referencing indices	—		—		—	—		—		—
Subtotal	—		20		2.7	—		—		—
B
Single name credit default swaps (3)	—		—		—	—		—		—
Credit default swaps referencing indices	—		—		—	—		36		5.0
Subtotal	—		—		—	—		36		5.0
Total	$	28	$	1,891	4.2	$	12	$	2,093	3.8

______________

(1) The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.

(2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.

(3) Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or state and political subdivisions.

Credit Risk on Freestanding Derivatives

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

The Company’s OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives.

See Note 10 for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	December 31,
	2016						2015
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	3,394		$	2,929		$	3,875		$	1,725
OTC-cleared (1)	267			905			78			78
Exchange-traded	46			—			39			—
Total gross estimated fair value of derivatives (1)	3,707			3,834			3,992			1,803
Amounts offset on the consolidated balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the consolidated balance sheets (1)	3,707			3,834			3,992			1,803
Gross amounts not offset on the consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(2,231		)	(2,231		)	(1,577		)	(1,577		)
OTC-cleared	(165		)	(165		)	(70		)	(70		)
Exchange-traded	—			—			—			—
Cash collateral: (3), (4)
OTC-bilateral	(634		)	—			(1,608		)	—
OTC-cleared	(91		)	(740		)	(8		)	(8		)
Exchange-traded	—			—			—			—
Securities collateral: (5)
OTC-bilateral	(429		)	(698		)	(553		)	(148		)
OTC-cleared	—			—			—			—
Exchange-traded	—			—			—			—
Net amount after application of master netting agreements and collateral	$	157		$	—		$	176		$	—

______________

(1) At December 31, 2016 and 2015, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $104 million and $94 million, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($49) million and $21 million, respectively.

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.

(4) The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2016 and 2015, the Company received excess cash collateral of $3 million and $1 million, respectively, and provided excess cash collateral of $25 million and $62 million, respectively, which is not included in the table above due to the foregoing limitation.

(5) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at December 31, 2016none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2016 and 2015, the Company received excess securities collateral with an estimated fair value of $135 million and $0, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At December 31, 2016 and 2015, the Company provided excess securities collateral with an estimated fair value of $108 million and $36 million, respectively, for its OTC-bilateral derivatives, $630 million and $34 million, respectively, for its OTC-cleared derivatives, and $453 million and $156 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.

The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the collateral amount owed by that counterparty reaches a minimum transfer amount. A small number of these arrangements also include credit-contingent provisions that include a threshold above which collateral must be posted. Such agreements provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the credit ratings of Brighthouse Life Insurance Company, and/or the counterparty. In addition, substantially all of the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’s and S&P. If a party’s credit or financial strength ratings, as applicable, were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.

The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The Company’s collateral agreements require both parties to be fully collateralized, as such, Brighthouse Life Insurance Company would not be required to post additional collateral as a result of a downgrade in financial strength rating. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.

	December 31,
	2016		2015
	(In millions)
Estimated fair value of derivatives in a net liability position (1)	$	698	$	148
Estimated Fair Value of Collateral Provided
Fixed maturity securities	$	777	$	179
Cash	$	—	$	—
Fair Value of Incremental Collateral Provided Upon
One-notch downgrade in financial strength rating	$	—	$	—
Downgrade in financial strength rating to a level that triggers full overnight collateralization or termination of the derivative position	$	—	$	—

______________

(1) After taking into consideration the existence of netting agreements.

Embedded Derivatives

The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; affiliated ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs; affiliated assumed reinsurance of guaranteed minimum benefits related to GMWBs and certain GMIBs; funds withheld on assumed and ceded reinsurance; fixed annuities with equity indexed returns; and certain debt and equity securities.

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

		December 31,
	Balance Sheet Location	2016			2015
		(In millions)
Embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	409		$	363
Funds withheld on assumed reinsurance	Other invested assets	—			35
Options embedded in debt or equity securities	Investments	(49		)	(62		)
Embedded derivatives within asset host contracts		$	360		$	336
Embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances	$	2,237		$	122
Assumed guaranteed minimum benefits	Policyholder account balances	741			712
Funds withheld on ceded reinsurance	Other liabilities	—			—
Fixed annuities with equity indexed returns	Policyholder account balances	192			6
Embedded derivatives within liability host contracts		$	3,170		$	840

The following table presents changes in estimated fair value related to embedded derivatives:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Net derivative gains (losses) (1), (2)	$	(1,741	)	$	(344	)	$	(576	)
Policyholder benefits and claims	$	(4	)	$	21		$	87

______________

(1) The valuation of direct and assumed guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were $244 million, $26 million and $69 million for the years ended December 31, 2016, 2015 and 2014, respectively.

(2) See Note 7 for discussion of affiliated net derivative gains (losses).

Related Party Freestanding Derivative Transactions

In November 2014, as part of the settlement of related party reinsurance transactions, the Company transferred derivatives to affiliates. The estimated fair value of freestanding derivative assets and liabilities transferred was $1.8 billion and $1.2 billion, respectively.

XML

Fair Value

12 Months Ended

Dec. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value

10. Fair Value

When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows:

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities.

Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company’s ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities.

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below at:

	December 31, 2016
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	20,221	$	1,444	$	21,665
U.S. government and agency	6,110		6,806		—		12,916
RMBS	—		6,627		1,313		7,940
Foreign corporate	—		5,257		866		6,123
State and political subdivision	—		3,841		17		3,858
CMBS	—		3,529		167		3,696
ABS	—		2,383		215		2,598
Foreign government	—		1,103		—		1,103
Total fixed maturity securities	6,110		49,767		4,022		59,899
Equity securities	39		124		137		300
Short-term investments	702		568		2		1,272
Commercial mortgage loans held by CSEs — FVO	—		136		—		136
Derivative assets: (1)
Interest rate	9		2,142		—		2,151
Foreign currency exchange rate	—		348		—		348
Credit	—		20		8		28
Equity market	37		860		179		1,076
Total derivative assets	46		3,370		187		3,603
Embedded derivatives within asset host contracts (2)	—		—		409		409
Separate account assets (3)	720		104,616		10		105,346
Total assets	$	7,617	$	158,581	$	4,767	$	170,965
Liabilities
Derivative liabilities: (1)
Interest rate	$	—	$	1,690	$	611	$	2,301
Foreign currency exchange rate	—		14		—		14
Equity market	—		1,038		530		1,568
Total derivative liabilities	—		2,742		1,141		3,883
Embedded derivatives within liability host contracts (2)	—		—		3,170		3,170
Long-term debt of CSEs — FVO	—		23		—		23
Total liabilities	$	—	$	2,765	$	4,311	$	7,076

	December 31, 2015
	Fair Value Hierarchy						Total Estimated Fair Value
	Level 1		Level 2		Level 3
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	18,787	$	1,688	$	20,475
U.S. government and agency	8,150		6,291		—		14,441
RMBS	—		8,522		1,351		9,873
Foreign corporate	—		4,761		722		5,483
State and political subdivision	—		3,533		13		3,546
CMBS	—		3,066		215		3,281
ABS	—		3,833		430		4,263
Foreign government	—		732		27		759
Total fixed maturity securities	8,150		49,525		4,446		62,121
Equity securities	44		316		97		457
Short-term investments (4)	74		1,666		47		1,787
Commercial mortgage loans held by CSEs — FVO	—		172		—		172
Derivative assets: (1)
Interest rate	2		2,445		8		2,455
Foreign currency exchange rate	—		210		—		210
Credit	—		12		1		13
Equity market	37		968		215		1,220
Total derivative assets	39		3,635		224		3,898
Embedded derivatives within asset host contracts (2)	—		—		398		398
Separate account assets (3)	624		105,757		146		106,527
Total assets	$	8,931	$	161,071	$	5,358	$	175,360
Liabilities
Derivative liabilities: (1)
Interest rate	$	—	$	668	$	—	$	668
Foreign currency exchange rate	—		4		—		4
Credit	—		1		—		1
Equity market	—		653		456		1,109
Total derivative liabilities	—		1,326		456		1,782
Embedded derivatives within liability host contracts (2)	—		—		840		840
Long-term debt of CSEs — FVO	—		48		—		48
Total liabilities	$	—	$	1,374	$	1,296	$	2,670

______________

(1) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the roll-forward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.

(2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances and other liabilities on the consolidated balance sheets. At December 31, 2016 and 2015, debt and equity securities also included embedded derivatives of ($49) million and ($62) million, respectively.

(3) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.

(4) Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.

The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy.

Investments

Valuation Controls and Procedures

On behalf of the Company and MetLife, Inc.’s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third-party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of Brighthouse Life Insurance Company’s Board of Directors regarding compliance with fair value accounting standards.

The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management’s knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as “consensus pricing,” represent a reasonable estimate of fair value by considering such pricing relative to the Company’s knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent less than 1% of the total estimated fair value of fixed maturity securities and 5% of the total estimated fair value of Level 3 fixed maturity securities at December 31, 2016.

The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management’s best estimate is used.

Securities, Short-term Investments and Long-term Debt of CSEs — FVO

When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company’s securities holdings and valuation of these securities does not involve management’s judgment.

When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management’s judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances.

The estimated fair value of long-term debt of CSEs — FVO is determined on a basis consistent with the methodologies described herein for securities.

The valuation of most instruments listed below is determined using independent pricing sources, matrix pricing, discounted cash flow methodologies or other similar techniques that use either observable market inputs or unobservable inputs.

Instrument		Level 2 Observable Inputs		Level 3 Unobservable Inputs
Fixed Maturity Securities
U.S. corporate and Foreign corporate securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	illiquidity premium
	•	benchmark yields; spreads off benchmark yields; new issuances; issuer rating		•	delta spread adjustments to reflect specific credit-related issues
	•	trades of identical or comparable securities; duration		•	credit spreads
	•	Privately-placed securities are valued using the additional key inputs:		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
		•	market yield curve; call provisions
		•	observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer	•	independent non-binding broker quotations
		•	delta spread adjustments to reflect specific credit-related issues
U.S. government and agency, State and political subdivision and Foreign government securities
	Valuation Techniques: Principally the market approach.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	independent non-binding broker quotations
	•	benchmark U.S. Treasury yield or other yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	the spread off the U.S. Treasury yield curve for the identical security
	•	issuer ratings and issuer spreads; broker-dealer quotes		•	credit spreads
	•	comparable securities that are actively traded
Structured Securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market and income approaches.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	credit spreads
	•	spreads for actively traded securities; spreads off benchmark yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	expected prepayment speeds and volumes
	•	current and forecasted loss severity; ratings; geographic region		•	independent non-binding broker quotations
	•	weighted average coupon and weighted average maturity
	•	average delinquency rates; debt-service coverage ratios
	•	issuance-specific information, including, but not limited to:
		•	collateral type; structure of the security; vintage of the loans
		•	payment terms of the underlying assets
		•	payment priority within the tranche; deal performance

Instrument	Level 2 Observable Inputs		Level 3 Unobservable Inputs
Equity Securities
	Valuation Techniques: Principally the market approach.		Valuation Techniques: Principally the market and income approaches.
	Key Input:		Key Inputs:
	•	quoted prices in markets that are not considered active	•	credit ratings; issuance structures
			•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
			•	independent non-binding broker quotations
Short-term investments
	•	Short-term investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and observable inputs used in their valuation are also similar to those described above.	•	Short-term investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and unobservable inputs used in their valuation are also similar to those described above.
Commercial mortgage loans held by CSEs — FVO
	Valuation Techniques: Principally the market approach.		•	N/A
	Key Input:
	•	quoted securitization market price of the obligations of the CSEs determined principally by independent pricing services using observable inputs
Separate Account Assets (1)
Mutual funds without readily determinable fair values as prices are not published publicly
	Key Input:		•	N/A
	•	quoted prices or reported net asset value (“NAV”) provided by the fund managers
Other limited partnership interests
	•	N/A	Valuation Techniques: Valued giving consideration to the underlying holdings of the partnerships and by applying a premium or discount, if appropriate.
			Key Inputs:
			•	liquidity; bid/ask spreads; performance record of the fund manager
			•	other relevant variables that may impact the exit value of the particular partnership interest

______________

(1) Estimated fair value equals carrying value, based on the value of the underlying assets, including: mutual fund interests, fixed maturity securities, equity securities, derivatives, other limited partnership interests, short-term investments and cash and cash equivalents. Fixed maturity securities, equity securities, derivatives, short-term investments and cash and cash equivalents are similar in nature to the instruments described under “— Securities, Short-term Investments and Long-term Debt of CSEs — FVO” and “— Derivatives — Freestanding Derivatives.”

Derivatives

The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in “— Investments — Valuation Controls and Procedures.”

The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income.

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

Freestanding Derivatives

Level 2 Valuation Techniques and Key Inputs:

This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3.

Level 3 Valuation Techniques and Key Inputs:

These valuation methodologies generally use the same inputs as described in the corresponding sections for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data.

Freestanding derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. Key inputs are as follows:

Instrument		Interest Rate		Foreign Currency Exchange Rate		Credit		Equity Market
Inputs common to Level 2 and Level 3 by instrument type	•	swap yield curves	•	swap yield curves	•	swap yield curves	•	swap yield curves
	•	basis curves	•	basis curves	•	credit curves	•	spot equity index levels
	•	interest rate volatility (1)	•	currency spot rates	•	recovery rates	•	dividend yield curves
			•	cross currency basis curves			•	equity volatility (1)
Level 3	•	swap yield curves (2)	•	N/A	•	swap yield curves (2)	•	dividend yield curves (2)
	•	basis curves (2)			•	credit curves (2)	•	equity volatility (1), (2)
	•	repurchase rates			•	credit spreads	•	correlation between model inputs (1)
					•	repurchase rates
					•	independent non-binding broker quotations

______________

(1) Option-based only.

(2) Extrapolation beyond the observable limits of the curve(s).

Embedded Derivatives

Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees, equity or bond indexed crediting rates within certain annuity contracts, and those related to funds withheld on ceded reinsurance agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

The Company’s actuarial department calculates the fair value of these embedded derivatives, which are estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries as compared to MetLife, Inc.

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.

The Company assumed from an affiliated insurance company the risk associated with certain GMIBs. These embedded derivatives are included in policyholder account balances on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on these assumed risks is determined using a methodology consistent with that described previously for the guarantees directly written by the Company.

The Company ceded to an affiliate the risk associated with certain of the GMIBs, GMABs and GMWBs described above that are also accounted for as embedded derivatives. In addition to ceding risks associated with guarantees that are accounted for as embedded derivatives, the Company also cedes, to an affiliated company, certain directly written GMIBs that are accounted for as insurance (i.e., not as embedded derivatives), but where the reinsurance agreement contains an embedded derivative. These embedded derivatives are included within premiums, reinsurance and other receivables on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.

The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in “— Investments — Securities, Short-term Investments and Long-term Debt of CSEs — FVO.” The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities on the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.

The Company issues certain annuity contracts which allow the policyholder to participate in returns from equity indices. These equity indexed features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

The estimated fair value of the embedded equity indexed derivatives, based on the present value of future equity returns to the policyholder using actuarial and present value assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business and uses standard capital market techniques, such as Black-Scholes, to calculate the value of the portion of the embedded derivative for which the terms are set. The portion of the embedded derivative covering the period beyond where terms are set is calculated as the present value of amounts expected to be spent to provide equity indexed returns in those periods. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk.

Embedded Derivatives Within Asset and Liability Host Contracts

Level 3 Valuation Techniques and Key Inputs:

Direct and assumed guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curves, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curves and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin.

Reinsurance ceded on certain guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in “— Direct and assumed guaranteed minimum benefits” and also include counterparty credit spreads.

Transfers between Levels

Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period.

Transfers between Levels 1 and 2:

For assets and liabilities measured at estimated fair value and still held at December 31, 2016 and 2015, transfers between Levels 1 and 2 were not significant.

Transfers into or out of Level 3:

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					December 31, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)					(65)	-	240	49	Decrease
			•	Offered quotes (5)	18	-	138	104	96	-	100	98	Increase
	•	Market pricing	•	Quoted prices (5)	13	-	700	99	13	-	780	282	Increase
	•	Consensus pricing	•	Offered quotes (5)	37	-	109	85	68	-	100	86	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	38	-	111	91	29	-	292	93	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	94	-	106	100	97	-	103	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	100	99	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	—	-	—		317	-	317		Increase (8)
			•	Repurchase rates (9)	(44)	-	18						Decrease (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	98		—	-	—		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	14%	-	32%		17%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.09%		0%	-	0.09%		Decrease (14)
				Ages 41 - 60	0.04%	-	0.65%		0.04%	-	0.65%		Decrease (14)
				Ages 61 - 115	0.26%	-	100%		0.26%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		3%	-	100%		Decrease (15)
				Durations 21 - 116	2%	-	100%		3%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0.25%	-	10%		0.25%	-	10%		(17)
			•	Long-term equity volatilities	17.40%	-	25%		17.40%	-	25%		Increase (18)
			•	Nonperformance risk spread	0.04%	-	0.57%		0.04%	-	0.52%		Decrease (19)

______________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) As of December 31, 2016 and 2015, independent non-binding broker quotations were used in the determination of 3% and less than 1% of the total net derivative estimated fair value, respectively.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contractholders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets and embedded derivatives within funds withheld related to certain ceded and assumed reinsurance, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in “— Nonrecurring Fair Value Measurements.”

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			State and Political Subdivision			Foreign Government			Equity Securities			Short-term Investments			Net Derivatives (2)			Net Embedded Derivatives (3)			Separate Account Assets (4)
	(In millions)
Balance, January 1, 2015	$	2,403		$	1,212		$	—		$	—		$	100		$	71		$	(196	)	$	354		$	158
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	16			21			—			—			11			—			(74		)	(303		)	(6		)
Total realized/unrealized gains (losses) included in AOCI	(120		)	(14		)	—			(2		)	(10		)	—			2			—			—
Purchases (7)	406			1,342			13			29			—			47			22			—			3
Sales (7)	(191		)	(364		)	—			—			(16		)	—			—			—			(5		)
Issuances (7)	—			—			—			—			—			—			—			—			—
Settlements (7)	—			—			—			—			—			—			14			(493		)	—
Transfers into Level 3 (8)	202			31			—			—			19			—			—			—			—
Transfers out of Level 3 (8)	(306		)	(232		)	—			—			(7		)	(71		)	—			—			(4		)
Balance, December 31, 2015	$	2,410		$	1,996		$	13		$	27		$	97		$	47		$	(232	)	$	(442	)	$	146
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	(11		)	30			—			—			—			—			(703		)	(1,760		)	—
Total realized/unrealized gains (losses) included in AOCI	(24		)	21			—			—			(11		)	—			4			—			—
Purchases (7)	584			600			—			—			—			3			10			—			2
Sales (7)	(443		)	(598		)	—			—			(26		)	(1		)	—			—			(134		)
Issuances (7)	—			—			—			—			—			—			—			—			—
Settlements (7)	—			—			—			—			—			—			(33		)	(559		)	—
Transfers into Level 3 (8)	119			12			9			—			131			—			—			—			—
Transfers out of Level 3 (8)	(325		)	(366		)	(5		)	(27		)	(54		)	(47		)	—			—			(4		)
Balance, December 31, 2016	$	2,310		$	1,695		$	17		$	—		$	137		$	2		$	(954	)	$	(2,761	)	$	10
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2014 (9)	$	2		$	6		$	—		$	—		$	(1	)	$	—		$	(7	)	$	(565	)	$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2015(9)	$	11		$	21		$	—		$	—		$	—		$	—		$	(64	)	$	(310	)	$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2016 (9)	$	2		$	28		$	—		$	—		$	—		$	—		$	(687	)	$	(1,772	)	$	—
Gains (Losses) Data for the year ended December 31, 2014
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	$	3		$	10		$	—		$	—		$	(2	)	$	—		$	(4	)	$	(468	)	$	(1	)
Total realized/unrealized gains (losses) included in AOCI	$	72		$	13		$	—		$	—		$	7		$	—		$	57		$	107		$	—

____________

(1) Comprised of U.S. and foreign corporate securities.

(2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses).

(5) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and embedded derivatives are reported in net derivatives gains (losses).

(6) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.

(7) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(8) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(9) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and embedded derivatives are reported in net derivative gains (losses).

Fair Value Option

The following table presents information for certain assets and liabilities of CSEs, which are accounted for under the FVO. These assets and liabilities were initially measured at fair value. 

	December 31,
	2016		2015
	(In millions)
Assets (1)
Unpaid principal balance	$	88	$	121
Difference between estimated fair value and unpaid principal balance	48		51
Carrying value at estimated fair value	$	136	$	172
Liabilities (1)
Contractual principal balance	$	22	$	46
Difference between estimated fair value and contractual principal balance	1		2
Carrying value at estimated fair value	$	23	$	48

______________

(1) These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.

Nonrecurring Fair Value Measurements

The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).

	At December 31,						Years Ended December 31,
	2016		2015		2014		2016			2015			2014
	Carrying Value After Measurement						Gains (Losses)
	(In millions)
Mortgage loans (1)	$	3	$	3	$	3	$	—		$	—		$	—
Other limited partnership interests (2)	$	3	$	2	$	38	$	(2	)	$	(1	)	$	(6	)
Other assets (3)	$	—	$	—	$	—	$	(11	)	$	—		$	—
Goodwill (4)	$	—	$	—	$	—	$	(381	)	$	—		$	(33	)

______________ 

(1) Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.

(2) For these cost method investments, estimated fair value is determined from information provided on the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both December 31, 2016 and 2015 were not significant.

(3) During the year ended December 31, 2016, the Company recognized an impairment of computer software in connection with the sale to Massachusetts Mutual Life Insurance Company (“MassMutual”) of MetLife, Inc.’s U.S. retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MetLife’s affiliated broker-dealer, MetLife Securities, Inc. (“MSI”), a wholly-owned subsidiary of MetLife, Inc. See Note 17.

(4) As discussed in Note 11, for the year ended December 31, 2016, the Company recorded an impairment of goodwill associated with the Run-off reporting unit.

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the “— Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	December 31, 2016
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	9,154	$	—	$	—	$	9,298	$	9,298
Policy loans	$	1,093	$	—	$	746	$	431	$	1,177
Real estate joint ventures	$	12	$	—	$	—	$	44	$	44
Other limited partnership interests	$	44	$	—	$	—	$	42	$	42
Loans to affiliates	$	1,100	$	—	$	1,090	$	—	$	1,090
Premiums, reinsurance and other receivables	$	2,363	$	—	$	834	$	1,981	$	2,815
Liabilities
Policyholder account balances	$	16,043	$	—	$	—	$	17,259	$	17,259
Long-term debt	$	1,881	$	—	$	2,117	$	—	$	2,117
Other liabilities	$	256	$	—	$	90	$	166	$	256
Separate account liabilities	$	1,110	$	—	$	1,110	$	—	$	1,110

	December 31, 2015
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	7,232	$	—	$	—	$	7,535	$	7,535
Policy loans	$	1,266	$	—	$	917	$	430	$	1,347
Real estate joint ventures	$	23	$	—	$	—	$	65	$	65
Other limited partnership interests	$	52	$	—	$	—	$	57	$	57
Loans to affiliates	$	1,150	$	—	$	1,178	$	—	$	1,178
Premiums, reinsurance and other receivables	$	6,639	$	—	$	83	$	7,511	$	7,594
Liabilities
Policyholder account balances	$	20,260	$	—	$	—	$	21,726	$	21,726
Long-term debt	$	1,888	$	—	$	2,320	$	—	$	2,320
Other liabilities	$	255	$	—	$	81	$	174	$	255
Separate account liabilities	$	1,275	$	—	$	1,275	$	—	$	1,275

The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows:

Mortgage Loans

The estimated fair value of mortgage loans is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans.

Policy Loans

Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk, as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates.

Real Estate Joint Ventures and Other Limited Partnership Interests

The estimated fair values of these cost method investments are generally based on the Company’s share of the NAV as provided on the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.

Loans to Affiliates

The estimated fair value of loans to affiliates is principally determined using market standard valuation methodologies. Valuations of instruments are based primarily on discounted cash flow methodologies that use standard market observable inputs including market yield curve, duration, observable prices and spreads for similar publicly traded or privately traded issues.

Premiums, Reinsurance and Other Receivables

Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled.

Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty.

The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value.

Policyholder Account Balances

These policyholder account balances include investment contracts which primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability.

Long-term Debt

The estimated fair value of long-term debt is principally determined using market standard valuation methodologies. Valuations of instruments are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, observable prices and spreads for similar publicly traded or privately traded issues.

Other Liabilities

Other liabilities consist primarily of interest payable, amounts due for securities purchased but not yet settled and funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values.

Separate Account Liabilities

Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts.

Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance and certain contracts that provide for benefit funding.

Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section “— Recurring Fair Value Measurements,” the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets.

XML

Goodwill

12 Months Ended

Dec. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

11. Goodwill

The Company tests goodwill for impairment during the third quarter of each year at the reporting unit level based upon best available data as of June 30 of that year. A reporting unit is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level.

In anticipation of the planned Separation, in the third quarter of 2016, the Company reorganized its businesses into three segments: Annuities; Life; and Run-off. As a result, the Company reallocated goodwill. In connection with the reorganization and the 2016 annual goodwill impairment test, the Company performed Step 1 of the goodwill impairment process, which requires a comparison of the estimated fair value of a reporting unit to its carrying value. To determine the estimated fair value for the Run-off reporting unit, an actuarial based approach, embedded value, was utilized to estimate the net worth of the reporting unit and the value of existing business. This actuarial based approach requires judgments and assumptions about the projected cash flows, the level of internal capital required to support the mix of business, the account value of in-force business, projections of renewal business and margins on such business, interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for this reporting unit.

Based on a quantitative analysis performed for the Run-off reporting unit, the Company concluded that the carrying value exceeded the estimated fair value, indicating a potential for goodwill impairment. Accordingly, the Company performed Step 2 of the goodwill impairment process for the reporting unit, which compares the implied estimated fair value of the reporting unit’s goodwill with its carrying value. This analysis indicated that the goodwill associated with this reporting unit was not recoverable. As a result, the Company recorded a non-cash charge of $381 million ($305 million, net of income tax) for the impairment of the entire goodwill balance, which is reported in goodwill impairment on the consolidated statements of operations for the year ended December 31, 2016.

Information regarding goodwill by segment was as follows:

	Annuities			Life			Run-off			Total
	(In millions)
Balance at January 1, 2014
Goodwill	$	427		$	66		$	493		$	986
Accumulated impairment	(394		)	(66		)	—			(460		)
Total goodwill, net	33			—			493			526
Dispositions (1)	—			—			(112		)	(112		)
Impairments	(33		)	—			—			(33		)
Balance at December 31, 2014
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	—			(493		)
Total goodwill, net	—			—			381			381
Balance at December 31, 2015
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	—			(493		)
Total goodwill, net	—			—			381			381
Impairments	—			—			(381		)	(381		)
Balance at December 31, 2016
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	(381		)	(874		)
Total goodwill, net	$	—		$	—		$	—		$	—

______________

(1) In connection with the sale of MAL, goodwill in the Run-off reporting unit was reduced by $112 million during the year ended December 31, 2014. See Note 4. This goodwill was allocated to MAL based on the relative fair values of MAL and the remaining portion of the Run-off reporting unit.

XML

Debt

12 Months Ended

Dec. 31, 2016

Debt Disclosure [Abstract]

Debt

12. Debt

Long-term debt outstanding was as follows:

	Interest Rate	Maturity	December 31,
			2016		2015
			(In millions)
Surplus note — affiliated with MetLife, Inc. (1), (2)	8.60%	2038	$	744	$	750
Surplus note — affiliated with MetLife, Inc. (3)	5.13%	2032	750		750
Surplus note — affiliated with MetLife, Inc. (3)	6.00%	2033	350		350
Long-term debt — unaffiliated (4)	7.03%	2030	37		38
Total long-term debt (5)			$	1,881	$	1,888

______________  

(1) Payments of interest and principal on the affiliated surplus note, which is subordinate to all other obligations, may be made only with the prior approval of the Delaware Commissioner of Insurance (the “Delaware Commissioner”). See Note 18 for information regarding subsequent forgiveness of this surplus note.

(2) Includes $6 million of debt issuance costs at December 31, 2016. Debt issuance costs were reported in other assets at December 31, 2015.

(3) Interest is paid semi-annually. See Note 18 for information regarding subsequent settlement of these surplus notes.

(4) Principal and interest is paid quarterly.

(5) Excludes $23 million and $48 million of long-term debt relating to CSEs at December 31, 2016 and 2015, respectively. See Note 8.

In December 2014, Brighthouse Insurance repaid in cash at maturity its $75 million6.80% affiliated note.

The aggregate maturities of long-term debt at December 31, 2016 were $1 million in 2017, $2 million in each of 2018, 2019, 2020 and 2021 and $1.9 billion thereafter.

Interest expense related to the Company’s indebtedness is included in other expenses and was $128 million, $128 million and $133 million for the years ended December 31, 2016, 2015 and 2014, respectively.

Letters of Credit

The Company had access to unsecured revolving credit facilities from various banks, either directly with the bank or indirectly through letters of credit available to MetLife, Inc. for the benefit of the Company and certain other affiliates of MetLife, Inc. These facilities were used for collateral for certain of the Company’s affiliated reinsurance liabilities. Total fees associated with letters of credit was $55 million, $61 million and $73 million for the years ended December 31, 2016, 2015 and 2014, respectively, and was included in other expenses. At December 31, 2016, the Company had $3.3 billion in letters of credit outstanding and the remaining availability was $5.2 billion.

Account Party/Borrower(s)	Expiration	Maximum Capacity		Letters of Credit Used by the Company		Letters of Credit Used by Affiliates		Drawdowns by Affiliates		Unused Commitments
		(In millions)
MetLife, Inc. and MetLife Funding, Inc.	May 2019 (1)	$	4,000	$	90	$	640	$	—	$	3,270
MetLife, Inc.	June 2018 (1)	425		170		255		—		—
MRSC and MetLife, Inc.	June 2037 (2)	3,500		—		—		2,797		703
MRV Cell and MetLife, Inc.	September 2038 (2)	4,250		3,000		—		—		1,250
Total		$	12,175	$	3,260	$	895	$	2,797	$	5,223

______________

(1) The letters of credit used by the Company under these facilities were cancelled in connection with a new financing arrangement described in Note 18.

(2) See Note 18 for information regarding subsequent termination of these facilities, as well as information regarding a new financing arrangement.

XML

Equity

12 Months Ended

Dec. 31, 2016

Equity [Abstract]

Equity

13. Equity

See Note 3 for a discussion of the Mergers.

Common Stock

In August 2014, MetLife Insurance Company of Connecticut, the predecessor to MetLife USA, redeemed for $1.4 billion and retired 4,595,317 shares of its common stock owned by MetLife Investors Group, LLC, an affiliate.

Capital Contributions

During the years ended December 31, 2016, 2015 and 2014, Brighthouse Life Insurance Company received cash capital contributions of $1.6 billion, $21 million and $476 million, respectively and non-cash capital contributions of $69 million, $181 million and $457 million, respectively.

In December 2015 and 2014, the Company accrued in premiums, reinsurance and other receivables and stockholder’s equity, $120 million and $385 million, respectively, in capital contributions from MetLife, Inc. The receivables were settled for cash in 2016 and 2015, respectively.

Statutory Equity and Income

The state of domicile of Brighthouse Life Insurance Company imposes risk-based capital (“RBC”) requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). Regulatory compliance is determined by a ratio of a company’s total adjusted capital, calculated in the manner prescribed by the NAIC (“TAC”) to its authorized control level RBC, calculated in the manner prescribed by the NAIC (“ACL RBC”), based on the statutory-based filed financial statements. Companies below specific trigger levels or ratios are classified by their respective levels, each of which requires specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC (“CAL RBC”). The CAL RBC ratio for Brighthouse Life Insurance Company was in excess of 400% for all periods presented.

Brighthouse Life Insurance Company prepares statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the Delaware Department of Insurance. The NAIC has adopted the Codification of Statutory Accounting Principles (“Statutory Codification”). Statutory Codification is intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. Modifications by the state insurance department may impact the effect of Statutory Codification on the statutory capital and surplus of Brighthouse Life Insurance Company.

Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt, reporting of reinsurance agreements and valuing securities on a different basis.

In addition, certain assets are not admitted under statutory accounting principles and are charged directly to surplus. The most significant assets not admitted by Brighthouse Life Insurance Company are net deferred income tax assets resulting from temporary differences between statutory accounting principles basis and tax basis not expected to reverse and become recoverable within three years.

The tables below present amounts from Brighthouse Life Insurance Company, which are derived from the statutory-basis financial statements as filed with the Delaware Department of Insurance.

Statutory net income (loss) was as follows:

		Years Ended December 31,
Company	State of Domicile	2016			2015			2014
		(In millions)
Brighthouse Life Insurance Company	Delaware	$	1,186		$	(1,022	)	$	1,543
Brighthouse Life Insurance Company of NY	New York	$	(87	)	$	17		$	11

Statutory capital and surplus was as follows at:

	December 31,
Company	2016		2015
	(In millions)
Brighthouse Life Insurance Company	$	4,374	$	5,942
Brighthouse Life Insurance Company of NY	$	196	$	321

Dividend Restrictions

The table below sets forth the dividends permitted to be paid by the Company’s without insurance regulatory approval and dividends paid:

	2017		2016		2015
Company	Permitted Without Approval (1)		Paid (2)		Paid (2)
	(In millions)
Brighthouse Life Insurance Company	$	473	$	261	$	500
Brighthouse Life Insurance Company of NY	$	—	$	—	$	—

______________ 

(1) Reflects dividend amounts that may be paid during 2017 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2017, some or all of such dividends may require regulatory approval.

(2) Reflects all amounts paid, including those requiring regulatory approval.

Under the Delaware Insurance Code, Brighthouse Life Insurance Company is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net statutory gain from operations for the immediately preceding calendar year (excluding realized capital gains). Brighthouse Life Insurance Company will be permitted to pay a stockholder dividend in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Delaware Commissioner and the Delaware Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as “unassigned funds (surplus)”) as of the immediately preceding calendar year requires insurance regulatory approval. Under the Delaware Insurance Code, the Delaware Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.

Effective for dividends paid during 2016 and going forward, the New York Insurance Law was amended permitting Brighthouse NY, without prior insurance regulatory clearance, to pay stockholder dividends to its parent in any calendar year based on either of two standards. Under one standard, Brighthouse NY is permitted, without prior insurance regulatory clearance, to pay dividends out of earned surplus (defined as positive “unassigned funds (surplus)”), excluding 85% of the change in net unrealized capital gains or losses (less capital gains tax), for the immediately preceding calendar year, in an amount up to the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year, or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains), not to exceed 30% of surplus to policyholders as of the end of the immediately preceding calendar year. In addition, under this standard, Brighthouse NY may not, without prior insurance regulatory clearance, pay any dividends in any calendar year immediately following a calendar year for which its net gain from operations, excluding realized capital gains, was negative. Under the second standard, if dividends are paid out of other than earned surplus, Brighthouse NY may, without prior insurance regulatory clearance, pay an amount up to the lesser of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year, or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). In addition, Brighthouse NY will be permitted to pay a dividend to its parent in excess of the amounts allowed under both standards only if it files notice of its intention to declare such a dividend and the amount thereof with the New York Superintendent of Financial Services (the “Superintendent”) and the Superintendent either approves the distribution of the dividend or does not approve the dividend within 30 days of its filing. Under New York Insurance Law, the Superintendent has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.

Under BRCD’s plan of operations, no dividend or distribution may be made by BRCD without the prior approval of the Delaware Commissioner. Further, under the Delaware Insurance Code, no dividend or distribution may be made by BRCD that would (i) jeopardize the fulfillment of the obligations of BRCD pursuant to its special purpose financing transactions or insurance risk transfer contracts or threaten the solvency or liquidity of BRCD, (ii) violate the terms of its special purpose financing transactions, or (iii) decrease the capital and surplus of BRCD below $250,000.

Accumulated Other Comprehensive Income (Loss)

Information regarding changes on the balances of each component of AOCI was as follows:

	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Total
	(In millions)
Balance at January 1, 2014	$	906		$	24		$	40		$	970
OCI before reclassifications	2,601			243			(56		)	2,788
Deferred income tax benefit (expense)	(815		)	(85		)	4			(896		)
AOCI before reclassifications, net of income tax	2,692			182			(12		)	2,862
Amounts reclassified from AOCI	(11		)	2			—			(9		)
Deferred income tax benefit (expense)	4			(1		)	—			3
Amounts reclassified from AOCI, net of income tax	(7		)	1			—			(6		)
Sale of subsidiary (2)	(320		)	—			6			(314		)
Deferred income tax benefit (expense)	80			—			—			80
Sale of subsidiary, net of income tax	(240		)	—			6			(234		)
Balance at December 31, 2014	2,445			183			(6		)	2,622
OCI before reclassifications	(1,759		)	95			(29		)	(1,693		)
Deferred income tax benefit (expense)	643			(33		)	9			619
AOCI before reclassifications, net of income tax	1,329			245			(26		)	1,548
Amounts reclassified from AOCI	78			(6		)	—			72
Deferred income tax benefit (expense)	(28		)	2			—			(26		)
Amounts reclassified from AOCI, net of income tax	50			(4		)	—			46
Balance at December 31, 2015	1,379			241			(26		)	1,594
OCI before reclassifications	(565		)	70			(3		)	(498		)
Deferred income tax benefit (expense)	185			(25		)	—			160
AOCI before reclassifications, net of income tax	999			286			(29		)	1,256
Amounts reclassified from AOCI	30			(43		)	—			(13		)
Deferred income tax benefit (expense)	(10		)	15			—			5
Amounts reclassified from AOCI, net of income tax	20			(28		)	—			(8		)
Balance at December 31, 2016	$	1,019		$	258		$	(29	)	$	1,248

__________________

(1) See Note 8 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI.

(2) See Note 4.

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI									Consolidated Statements of Operations and Comprehensive Income (Loss) Locations
	Years Ended December 31,
	2016			2015			2014
	(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains(losses)	$	(39	)	$	(81	)	$	(6	)	Net investment gains (losses)
Net unrealized investment gains (losses)	3			13			13			Net investment income
Net unrealized investment gains (losses)	6			(10		)	4			Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	(30		)	(78		)	11
Income tax (expense) benefit	10			28			(4		)
Net unrealized investment gains (losses), net of income tax	$	(20	)	$	(50	)	$	7
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate swaps	$	33		$	1		$	1		Net derivative gains (losses)
Interest rate swaps	3			1			1			Net investment income
Interest rate forwards	2			2			1			Net derivative gains (losses)
Interest rate forwards	2			2			1			Net investment income
Foreign currency swaps	3			—			(6		)	Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax	43			6			(2		)
Income tax (expense) benefit	(15		)	(2		)	1
Gains (losses) on cash flow hedges, net of income tax	$	28		$	4		$	(1	)
Total reclassifications, net of income tax	$	8		$	(46	)	$	6

XML

Other Expenses

12 Months Ended

Dec. 31, 2016

Other Income and Expenses [Abstract]

Other Expenses

14. Other Expenses

Information on other expenses was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Compensation	$	356		$	487		$	360
Commissions	641			722			634
Volume-related costs	279			231			263
Affiliated expenses on ceded and assumed reinsurance	22			17			39
Capitalization of DAC	(330		)	(399		)	(376		)
Interest expense on debt	130			137			170
Premium taxes, licenses and fees	59			71			56
Professional services	85			22			60
Rent and related expenses	46			54			43
Other	412			381			508
Total other expenses	$	1,700		$	1,723		$	1,757

Capitalization of DAC

See Note 6 for additional information on the capitalization of DAC.

Interest Expense on Debt

Interest expense on debt includes interest expense on debt (see Note 12) and interest expense related to CSEs (see Note 8).

Affiliated Expenses

Commissions and capitalization of DAC include the impact of affiliated reinsurance transactions. See Notes 7, 12 and 17 for a discussion of affiliated expenses included in the table above.

XML

Income Tax

12 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Abstract]

Income Tax

15. Income Tax

The provision for income tax was as follows:

	Years Ended December 31,
	2016			2015		2014
	(In millions)
Current:
Federal	$	(374	)	$	35	$	(592	)
Foreign	4			—		6
Subtotal	(370		)	35		(586		)
Deferred:
Federal	(1,320		)	212		847
Foreign	—			—		—
Subtotal	(1,320		)	212		847
Provision for income tax expense (benefit)	$	(1,690	)	$	247	$	261

The Company’s income (loss) before income tax expense (benefit) from domestic and foreign operations were as follows:

	Years Ended December 31,
	2016			2015		2014
	(In millions)
Income (loss):
Domestic	$	(4,477	)	$	1,152	$	604
Foreign	12			13		464
Total	$	(4,465	)	$	1,165	$	1,068

The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Tax provision at U.S. statutory rate	$	(1,563	)	$	408		$	374
Tax effect of:
Dividend received deduction	(110		)	(132		)	(119		)
Prior year tax	24			(5		)	(20		)
Tax credits	(22		)	(16		)	(14		)
Foreign tax rate differential	2			(5		)	4
Goodwill impairment	(20		)	—			12
Sale of subsidiary	(6		)	—			24
Other, net	5			(3		)	—
Provision for income tax expense (benefit)	$	(1,690	)	$	247		$	261

Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at:

	December 31,
	2016			2015
	(In millions)
Deferred income tax assets:
Investments, including derivatives	$	357		$	—
Tax credit carryforwards	184			172
Other	55			39
Total deferred income tax assets	596			211
Deferred income tax liabilities:
Policyholder liabilities and receivables	536			1,419
Investments, including derivatives	—			125
Intangibles	293			394
Net unrealized investment gains	653			818
DAC	1,565			1,390
Total deferred income tax liabilities	3,047			4,146
Net deferred income tax asset (liability)	$	(2,451	)	$	(3,935	)

The following table sets forth the general business credits, foreign tax credits, and other credit carryforwards for tax purposes as of December 31, 2016.

	Tax Credit Carryforwards
	General Business Credits		Foreign Tax Credits		Other
	(In millions)
Expiration
2017-2021	$	—	$	—	$	—
2022-2026	—		35		—
2027-2031	—		—		—
2032-2036	7		—		—
Indefinite	—		—		145
	$	7	$	35	$	145

The Company currently participates in a tax sharing agreement with MetLife, Inc., as described in Note 1. Pursuant to this tax sharing agreement, the amounts due from affiliates included $775 million and $259 million for the years ended December 31, 2016 and 2015 respectively.

The Company also files income tax returns with the U.S. federal government and various state and local jurisdictions, as well as foreign jurisdictions. The Company is under continuous examination by the IRS and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction and subsidiary. The Company is no longer subject to U.S. federal, state or local income tax examinations for years prior to 2007.

Management believes it has established adequate tax liabilities for all open years and any future resolve is not expected to have a material impact on the Company’s financial statements.

A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at January 1,	$	43		$	39		$	27
Additions for tax positions of prior years	1			5			15
Reductions for tax positions of prior years	(9		)	—			(5		)
Additions for tax positions of current year	5			3			2
Settlements with tax authorities	(2		)	(4		)	—
Balance at December 31,	$	38		$	43		$	39
Unrecognized tax benefits that, if recognized would impact the effective rate	$	38		$	33		$	29

The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included within other expenses, while penalties are included in income tax expense.

Interest was as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Interest recognized on the consolidated statements of operations	$	1	$	—	$	—
			December 31,
			2016		2015
			(In millions)
Interest included in other liabilities on the consolidated balance sheets			$	1	$	2

The Company had no penalties for each of the years ended December 31, 2016, 2015 and 2014.

The U.S. Treasury Department and the IRS have indicated that they intend to address through regulations the methodology to be followed in determining the dividends received deduction (“DRD”), related to variable life insurance and annuity contracts. The DRD reduces the amount of dividend income subject to tax and is a significant component of the difference between the actual tax expense and expected amount determined using the federal statutory tax rate of 35%. Any regulations that the IRS ultimately proposes for issuance in this area will be subject to public notice and comment, at which time insurance companies and other interested parties will have the opportunity to raise legal and practical questions about the content, scope and application of such regulations. As a result, the ultimate timing and substance of any such regulations are unknown at this time. For the years ended December 31, 2016, 2015 and 2014, the Company recognized an income tax benefit of $88 million, $143 million and $141 million, respectively, related to the separate account DRD. The 2016 benefit included an expense of $22 million related to a true-up of the 2015 tax return. The 2015 and 2014 benefit included a benefit of $13 million and $22 million related to a true-up of the 2014 and 2013 tax returns, respectively.

XML

Contingencies, Commitments and Guarantees

12 Months Ended

Dec. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Contingencies, Commitments and Guarantees

16. Contingencies, Commitments and Guarantees

Contingencies

Litigation

The Company is a defendant in a number of litigation matters. In some of the matters, large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.

Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.

The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be reasonably estimated at December 31, 2016.

Matters as to Which an Estimate Can Be Made

For some loss contingency matters, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of December 31, 2016, the aggregate range of reasonably possible losses in excess of amounts accrued for these matters was not material for the Company.

Matters as to Which an Estimate Cannot Be Made

For other matters, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.

Unclaimed Property Litigation

On November 14, 2012, the West Virginia Treasurer filed an action against MetLife Investors USA Insurance Company in West Virginia state court (West Virginia ex rel. John D. Perdue v. MetLife Investors USA Insurance Company, Circuit Court of Putnam County, Civil Action No. 12-C-363) alleging that MetLife Investors USA Insurance Company violated the West Virginia Uniform Unclaimed Property Act (the “Act”), seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On December 28, 2012, the Treasurer filed a substantially identical suit against MetLife Insurance Company of Connecticut (West Virginia ex rel. John D. Perdue v. MetLife Insurance Company of Connecticut, Circuit Court of Putnam County, Civil Action No. 12-C-430). On January 31, 2017, the parties entered into a settlement agreement resolving these actions.

Other Litigation

Thrivent Financial for Lutherans v. MetLife Insurance Company USA, (E.D. Wis., filed September 12, 2016)

Plaintiff filed a complaint against MetLife USA contending that its use of the Brighthouse Financial trademark and logo will infringe on its trademarks. Alleging violations of federal and state law, plaintiff sought preliminary and permanent injunctions, compensatory damages, and other relief. On December 23, 2016, plaintiff filed an amended complaint adding Brighthouse Financial, Inc. as an additional defendant. The parties have resolved this matter, and the action was voluntarily dismissed on February 15, 2017.

Sales Practices Claims

Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made on its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters.

Summary

Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for on the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods.

Insolvency Assessments

Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets.

Assets and liabilities held for insolvency assessments were as follows:

	December 31,
	2016		2015
	(In millions)
Other Assets:
Premium tax offset for future discounted and undiscounted assessments	$	13	$	13
Premium tax offsets currently available for paid assessments	8		14
Total	$	21	$	27
Other Liabilities:
Insolvency assessments	$	17	$	18

Commitments

Mortgage Loan Commitments

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $335 million and $128 million at December 31, 2016 and 2015, respectively.

Commitments to Fund Partnership Investments and Private Corporate Bond Investments

The Company commits to fund partnership investments and to lend funds under private corporate bond investments. The amounts of these unfunded commitments were $1.3 billion and $1.0 billion at December 31, 2016 and 2015, respectively.

Other Commitments

The Company has entered into collateral arrangements with affiliates, which require the transfer of collateral in connection with secured demand notes. At both December 31, 2016 and 2015, the Company had agreed to fund up to $20 million of cash upon the request by these affiliates and had transferred collateral consisting of various securities with a fair market value of $25 million to custody accounts to secure the demand notes. Each of these affiliates is permitted by contract to sell or re-pledge this collateral

Guarantees

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from $6 million to $222 million, with a cumulative maximum of $228 million, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company’s recorded liabilities were $2 million at both December 31, 2016 and 2015, for indemnities, guarantees and commitments.

XML

Related Party Transactions

12 Months Ended

Dec. 31, 2016

Related Party Transactions [Abstract]

Related Party Transactions

17. Related Party Transactions

The Company has various existing relationships with MetLife for services necessary to conduct its activities.

Non-Broker-Dealer Transactions

The following table summarizes income and expense from transactions with MetLife (excluding broker-dealer transactions) for the years indicated:

	Years Ended December 31,								Years Ended December 31,
	2016			2015		2014			2016		2015		2014
	Income								Expense
	(In millions)
MetLife	$	(45	)	$	36	$	(68	)	$	370	$	855	$	974

The following table summarizes assets and liabilities from transactions with MetLife (excluding broker-dealer transactions) at:

	At December 31,				At December 31,
	2016		2015		2016		2015
	Assets				Liabilities
	(In millions)
MetLife	$	4,288	$	9,720	$	5,125	$	5,933

The material arrangements between the Company and MetLife are as follows:

Reinsurance Agreements

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by certain affiliates. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

The Company has reinsurance agreements with its affiliate NELICO and certain of MetLife, Inc subsidiaries, all of which are related parties. See Note 7 for further discussion of the affiliated reinsurance agreements.

Financing Arrangements

The Company has financing arrangements with MetLife that are used to support reinsurance obligations arising under affiliated reinsurance agreements. The Company recognized interest expense for affiliated debt of $125 million, $125 million and $130 million, for the years ended December 31, 2016, 2015 and 2014, respectively. See Note 12 for further discussion of the related party financing arrangements.

Investment Transactions

The Company has extended loans to certain subsidiaries of MetLife, Inc. Additionally, in the ordinary course of business, the Company transfers invested assets, primarily consisting of fixed maturity securities, to and from MetLife affiliates. See Note 8 for further discussion of the related party investment transactions.

Shared Services and Overhead Allocations

MetLife provides the Company certain services, which include, but are not limited to, executive oversight, treasury, finance, legal, human resources, tax planning, internal audit, financial reporting, information technology, distribution services and investor relations. The Company is charged for these services based on direct and indirect costs. When specific identification is not practicable, an allocation methodology is used, primarily based on sales, in-force liabilities, or headcount. For certain agreements, charges are based on various performance measures or activity-based costing, such as sales, new policies/contracts issued, reserves, and in-force policy counts. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Management believes that the methods used to allocate expenses under these arrangements are reasonable. Expenses incurred with MetLife related to these arrangements, recorded in other operating expenses, were $847 million, $1.1 billion and $1.1 billion for the years ended December 31, 2016, 2015 and 2014, respectively.

Sales Distribution Services

In July 2016, MetLife, Inc. completed the sale to MassMutual of MetLife’s retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MSI. MassMutual assumed all of the liabilities related to such assets and that arise or occur after the closing of the sale.

Broker-Dealer Transactions

The Company accrues related party revenues and expenses arising from transactions with MetLife’s broker-dealers whereby the MetLife broker-dealers sell the Company’s variable annuity and life products. The affiliated revenue for the Company is fee income from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. The affiliated expense for the Company is commissions collected on the sale of variable products by the Company and passed through to the broker-dealer.

The following table summarizes income and expense from transactions with related broker-dealers for the years indicated:

	Years Ended December 31,						Years Ended December 31,
	2016		2015		2014		2016		2015		2014
	Fee Income						Commission Expense
	(In millions)
MetLife broker-dealers	$	202	$	218	$	212	$	638	$	643	$	602

The following table summarizes assets and liabilities from transactions with affiliated broker-dealers as follows:

	At December 31,				At December 31,
	2016		2015		2016		2015
	Fee Income Receivables				Secured Demand Notes
	(In millions)
MetLife broker-dealers	$	19	$	19	$	20	$	20

XML

Subsequent Events

12 Months Ended

Dec. 31, 2016

Subsequent Events [Abstract]

Subsequent Events

18. Subsequent Events

Reinsurance Transactions

Effective May 2017, the Company and Brighthouse NY recaptured from MLIC risks related to multiple life products ceded under yearly renewable term and coinsurance agreements. This recapture resulted in an increase in cash and cash equivalents of $214 million and a decrease in premiums, reinsurance and other receivables of $189 million. The Company recognized a gain of $17 million, net of income tax, as a result of reinsurance termination.

Effective January 2017, the Company executed a novation and assignment agreement whereby it replaced MLIC as the reinsurer of certain variable annuities, including guaranteed minimum benefits, issued by NELICO. This novation and assignment resulted in an increase in cash and cash equivalents of $184 million, an increase in future policy benefits of $34 million, an increase in policyholder account balances of $219 million and a decrease in other liabilities of $68 million. The Company recognized no gain or loss as a result of this transaction.

EffectiveJanuary 2017, MLIC recaptured risks related to certain variable annuities, including guaranteed minimum benefits, issued by Brighthouse NY. This recapture resulted in a decrease in cash and cash equivalents of $150 million, an increase in future policy benefits of $45 million, an increase in policyholder account balances of $168 million and a decrease in other liabilities of $359 million. The Company recognized no gain or loss as a result of this transaction.

Effective January 2017, MLIC recaptured risks related to guaranteed minimum benefit guarantees on certain variable annuities being reinsured by Brighthouse Life Insurance Company. This recapture resulted in a decrease in investments and cash and cash equivalents of $568 million, a decrease in future policy benefits of $106 million, and a decrease in policyholder account balances of $460 million. In June 2017, there was an adjustment to the recapture amounts of this transaction, which resulted in an increase in premiums, reinsurance and other receivables of $140 million. The Company recognized a gain of $89 million, net of income tax, as a result of this transaction.

Committed Facilities and Reinsurance Financing Arrangement

On April 28, 2017, MetLife, Inc. and MetLife Reinsurance of Vermont terminated the $4.3 billion committed facility, and MetLife, Inc. and MRSC terminated the $3.5 billion committed facility.

On April 28, 2017, BRCD entered into a new financing arrangement with a pool of highly rated third party reinsurers and a total capacity of $10.0 billion. This financing arrangement consists of credit-linked notes that each have a term of 20 years. At September 14, 2017, there were no drawdowns on such notes and there was $8.1 billion of funding available under this arrangement.

Surplus Notes - Affiliated

On June 16, 2017, MetLife, Inc. forgave Brighthouse Life Insurance Company’s obligation to pay the principal under the $750 million aggregate principal amount, 8.595% surplus notes. The forgiveness of the surplus notes was treated as a capital transaction and recorded as an increase to additional paid-in-capital.

On April 28, 2017, the surplus note obligations with MetLife, Inc. totaling $1.1 billion, which were due on September 30, 2032 and December 31, 2033 and bore interest at 5.13% and 6.00%, respectively, were satisfied in a noncash exchange for $1.1 billion of loans outstanding from MetLife, Inc.

Capital Transactions

On September 8, 2017, Brighthouse Life Insurance Company received a capital contribution of $100 million in cash from Brighthouse Holdings, LLC.

On August 10, 2017, Brighthouse Life Insurance Company received a capital contribution of $400 million in cash from Brighthouse Holdings, LLC.

On June 30, 2017, Brighthouse Life Insurance Company received a capital contribution of $600 million in cash from Brighthouse Holdings, LLC.

On April 28, 2017, the Contribution Transactions discussed in Note 3 included a net cash return of capital of $2.7 billion.

XML

Consolidated Summary of Investments - Other Than Investments in Related Parties

12 Months Ended

Dec. 31, 2016

Summary of Investments, Other than Investments in Related Parties [Abstract]

Summary of Investments, Other than Investments in Related Parties [Text Block]

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Schedule I

Consolidated Summary of Investments —

Other Than Investments in Related Parties

December 31, 2016

(In millions)

Types of Investments	Cost or Amortized Cost (1)		Estimated Fair Value		Amount at Which Shown on Balance Sheet
Fixed maturity securities:
Bonds:
U.S. government and agency securities	$	11,872	$	12,916	$	12,916
State and political subdivision securities	3,520		3,858		3,858
Public utilities	2,067		2,268		2,268
Foreign government securities	1,000		1,103		1,103
All other corporate bonds	24,419		25,181		25,181
Total bonds	42,878		45,326		45,326
Mortgage-backed and asset-backed securities	14,163		14,234		14,234
Redeemable preferred stock	248		339		339
Total fixed maturity securities	57,289		59,899		59,899
Equity securities:
Common stock:
Industrial, miscellaneous and all other	98		116		116
Public utilities	—		2		2
Banks, trust and insurance companies	2		5		5
Non-redeemable preferred stock	180		177		177
Total equity securities	280		300		300
Mortgage loans	9,290				9,290
Policy loans	1,093				1,093
Real estate and real estate joint ventures	215				215
Other limited partnership interests	1,639				1,639
Short-term investments	1,272				1,272
Other invested assets	5,029				5,029
Total investments	$	76,107			$	78,737

______________

(1) Cost or amortized cost for fixed maturity securities and mortgage loans represents original cost reduced by repayments, valuation allowances and impairments from other-than-temporary declines in estimated fair value that are charged to earnings and adjusted for amortization of premiums or accretion of discounts; for equity securities, cost represents original cost reduced by impairments from other-than-temporary declines in estimated fair value; for real estate, cost represents original cost reduced by impairments and adjusted for valuation allowances and depreciation; for real estate joint ventures and other limited partnership interests, cost represents original cost reduced for impairments or original cost adjusted for equity in earnings and distributions.

XML

Condensed Financial Information

12 Months Ended

Dec. 31, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Financial Information of Parent Company Only Disclosure [Text Block]

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information

(Parent Company Only)

December 31, 2016 and 2015

(In millions, except share and per share data)

	2016				2015
Condensed Balance Sheets
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $49,356 and $50,206, respectively)	$	51,880			$	52,514
Equity securities available-for-sale, at estimated fair value (cost: $280 and $384, respectively)	300				409
Mortgage loans (net of valuation allowances of $38 and $35, respectively)	8,746				7,088
Policy loans	1,093				1,266
Real estate and real estate joint ventures	200				575
Other limited partnership interests	1,632				1,836
Short-term investments, principally at estimated fair value	926				1,730
Investment in subsidiaries	7,338				7,326
Other invested assets, at estimated fair value	3,712				4,746
Total investments	75,827				77,490
Cash and cash equivalents	1,881				1,379
Accrued investment income	591				506
Premium, reinsurance and other receivable	10,397			—	9,239
Receivable from subsidiaries	9,703				13,011
Deferred policy acquisition costs and value of business acquired	5,274				4,809
Current income tax recoverable	454				—
Deferred income tax receivable	1,016				—
Goodwill	—				381
Other assets, principally at estimated fair value	667				838
Separate account assets	100,588				101,735
Total assets	$	206,398			$	209,388
Liabilities and Stockholder’s Equity
Liabilities
Future policy benefits	$	31,684			$	29,894
Policyholder account balances	35,588				35,661
Other policy-related balances	3,384				3,549
Payables for collateral under securities loaned and other transactions	7,362				10,619
Long-term debt	744				750
Current income tax payable	—				20
Deferred income tax liability	—				807
Other liabilities	10,183				7,717
Separate account liabilities	100,588				101,735
Total liabilities	189,533				190,752
Stockholder’s Equity
Common stock, par value $25,000 per share; 4,000 shares authorized; 3,000 shares issued and outstanding	75				75
Additional paid-in capital	18,461				16,850
Retained earnings (deficit)	(2,919		)		117
Accumulated other comprehensive income (loss)	1,248				1,594
Total stockholder’s equity	16,865				18,636
Total liabilities and stockholder’s equity	$	206,398			$	209,388

See accompanying notes to the condensed financial information.

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information — (continued)

(Parent Company Only)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Condensed Statements of Operations
Revenues
Premiums	$	921		$	1,433		$	1,126
Universal life and investment-type product policy fees	2,696			2,940			3,193
Equity in earnings of subsidiaries	157			144			(102		)
Net investment income	2,680			2,550			2,530
Other revenues	760			504			524
Net investment gains (losses)	(2		)	20			(52		)
Net derivative gains (losses)	(5,878		)	(424		)	(261		)
Total revenues	1,334			7,167			6,958
Expenses
Policyholder benefits and claims	2,984			2,696			2,621
Interest credited to policyholder account balances	957			1,037			1,062
Goodwill impairment	381			—			33
Amortization of deferred policy acquisition costs and value of business acquired	(172		)	595			384
Other expenses	1,733			1,710			1,707
Total expenses	5,883			6,038			5,807
Income (loss) before provision for income tax	(4,549		)	1,129			1,151
Provision for income tax expense (benefit)	(1,774		)	211			344
Net income (loss)	$	(2,775	)	$	918		$	807
Comprehensive income (loss)	$	(3,121	)	$	(110	)	$	2,459

See accompanying notes to the condensed financial information.

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information — (continued)

(Parent Company Only)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016			2015			2014
Condensed Statements of Cash Flows
Net cash provided by operating activities	$	3,256		$	4,196		$	4,547
Cash flows from investing activities
Sales, maturities, and repayments of:
Fixed maturity securities	39,104			35,728			20,197
Equity securities	175			308			98
Mortgage loans	1,484			958			1,049
Real estate and real estate joint ventures	441			368			27
Other limited partnership interests	413			422			254
Purchases of:
Fixed maturity securities	(34,906		)	(39,298		)	(24,524		)
Equity securities	(58		)	(273		)	(41		)
Mortgage loans	(2,803		)	(2,515		)	(343		)
Real estate and real estate joint ventures	(75		)	(105		)	(204		)
Other limited partnership interests	(203		)	(233		)	(345		)
Cash received in connection with freestanding derivatives	707			223			366
Cash paid in connection with freestanding derivatives	(2,764		)	(868		)	(1,784		)
Cash received under repurchase agreements	—			199			—
Cash paid under repurchase agreements	—			(199		)	—
Cash received under reverse repurchase agreements	—			199			—
Cash paid under reverse repurchase agreements	—			(199		)	—
Sales of loans to affiliates	—			—			520
Returns of capital from subsidiaries	32			169			818
Capital contributions to subsidiaries	(1		)	(2		)	(2		)
Net change in policy loans	109			(72		)	52
Net change in short-term investments	876			(495		)	3,645
Net change in other invested assets	5			(59		)	(151		)
Net cash provided by (used in) investing activities	2,536			(5,744		)	(368		)
Cash flows from financing activities
Policyholder account balances:
Deposits	9,672			19,970			18,602
Withdrawals	(12,001		)	(20,797		)	(21,584		)
Net change in payables for collateral under securities loaned and other transactions	(3,257		)	3,118			680
Long-term debt issued	—			175			—
Long-term debt repaid	—			(148		)	(75		)
Financing element on certain derivative instruments and other derivative related transactions, net	(1,011		)	(97		)	(414		)
Redemption of common stock	—			—			(906		)
Common stock redemption premium	—			—			(484		)
Dividends on common stock	(261		)	(500		)	(155		)
Capital contributions	1,568			11			231
Net cash provided by (used in) financing activities	(5,290		)	1,732			(4,105		)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	—			(2		)	(45		)
Change in cash and cash equivalents	502			182			29
Cash and cash equivalents, beginning of year	1,379			1,197			1,168
Cash and cash equivalents, end of year	$	1,881		$	1,379		$	1,197

Brighthouse Life Insurance Company

Schedule II

Condensed Financial Information — (continued)

(Parent Company Only)

For the Years Ended December 31, 2016, 2015 and 2014

(In millions)

	2016		2015			2014
Supplemental disclosures of cash flow information
Net cash paid (received) for:
Interest	$	64	$	65		$	70
Income tax	$	428	$	(267	)	$	(231	)
Non-cash transactions:
Capital contributions	$	43	$	141		$	703
Transfer of fixed maturity securities from affiliates	$	3,565	$	—		$	—
Transfer of mortgage loans from affiliates	$	395	$	—		$	—
Transfer of short-term investments from affiliates	$	94	$	—		$	—
Transfer of fixed maturity securities to affiliates	$	346	$	—		$	804
Transfer of mortgage loans to affiliates	$	—	$	—		$	94
Transfer of policyholder account balances to affiliates	$	—	$	—		$	528
Reduction of other invested assets in connection with reinsurance transactions	$	676	$	—		$	863

Brighthouse Life Insurance Company

Schedule II

Notes to the Condensed Financial Information

(Parent Company Only)

1. Basis of Presentation

The condensed financial information of Brighthouse Life Insurance Company (the “Parent Company”) should be read in conjunction with the consolidated financial statements of Brighthouse Life Insurance Company and its subsidiaries and the notes thereto (the “Consolidated Financial Statements”). These condensed unconsolidated financial statements reflect the results of operations, financial position and cash flows for the Parent Company. Investments in subsidiaries are accounted for using the equity method of accounting.

The preparation of these condensed unconsolidated financial statements in conformity with GAAP requires management to adopt accounting policies and make certain estimates and assumptions. The most important of these estimates and assumptions relate to the fair value measurements, the accounting for goodwill and identifiable intangible assets and the provision for potential losses that may arise from litigation and regulatory proceedings and tax audits, which may affect the amounts reported in the condensed unconsolidated financial statements and accompanying notes. Actual results could differ from these estimates.

XML

Consolidated Supplementary Insurance Information

12 Months Ended

Dec. 31, 2016

Supplementary Insurance Information [Abstract]

Consolidated Supplementary Insurance Information

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Schedule III

Consolidated Supplementary Insurance Information

December 31, 2016, 2015 and 2014

(In millions)

Segment	DAC and VOBA		Future Policy Benefits and Other Policy-Related Balances		Policyholder Account Balances		Unearned Premiums (1), (2)		Unearned Revenue (1)
2016
Annuities	$	4,820	$	7,560	$	25,233	$	—	$	86
Life	787		4,094		2,838		13		53
Run-off	584		16,381		8,506		—		79
Corporate & Other	148		7,429		2		6		—
Total	$	6,339	$	35,464	$	36,579	$	19	$	218
2015
Annuities	$	3,724	$	6,659	$	22,014	$	—	$	96
Life	969		4,618		2,691		13		52
Run-off	974		14,867		12,018		—		60
Corporate & Other	110		7,166		2		5		—
Total	$	5,777	$	33,310	$	36,725	$	18	$	208
2014
Annuities	$	3,829	$	5,431	$	21,246	$	—	$	101
Life	942		4,124		2,673		10		48
Run-off	1,026		15,201		12,665		—		75
Corporate & Other	63		6,771		1		5		—
Total	$	5,860	$	31,527	$	36,585	$	15	$	224

______________

(1) Amounts are included within the future policy benefits and other policy-related balances column.

(2) Includes premiums received in advance.

Brighthouse Life Insurance Company

(A Wholly-Owned Subsidiary of MetLife, Inc.)

Schedule III

Consolidated Supplementary Insurance Information — (continued)

December 31, 2016, 2015 and 2014

(In millions)

Segment	Premiums and Universal Life and Investment-Type Product Policy Fees		Net Investment Income (1)		Policyholder Benefits and Claims and Interest Credited to Policyholder   Account Balances		Amortization of DAC and VOBA			Other Operating Expenses
2016
Annuities	$	2,714	$	1,324	$	2,340	$	(908	)	$	903
Life	546		330		541		261			242
Run-off	878		1,311		1,901		399			275
Corporate & Other	139		146		87		23			280
Total	$	4,277	$	3,111	$	4,869	$	(225	)	$	1,700
2015
Annuities	$	3,282	$	1,141	$	2,285	$	432		$	938
Life	555		295		507		150			259
Run-off	793		1,461		1,301		67			285
Corporate & Other	300		104		218		24			241
Total	$	4,930	$	3,001	$	4,311	$	673		$	1,723
2014
Annuities	$	3,511	$	1,056	$	2,641	$	759		$	976
Life	545		345		469		173			282
Run-off	757		1,492		1,251		115			236
Corporate & Other	248		91		82		22			263
Total	$	5,061	$	2,984	$	4,443	$	1,069		$	1,757

______________

(1) See Note 2 of the Notes to the Consolidated Financial Statements for information on certain segment reporting changes which were retrospectively applied.

XML

Consolidated Reinsurance

12 Months Ended

Dec. 31, 2016

Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Abstract]

Consolidated Reinsurance

Brighthouse Life Insurance Company

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Schedule IV

Consolidated Reinsurance

December 31, 2016, 2015 and 2014

(Dollars in millions)

	Gross Amount		Ceded		Assumed		Net Amount		% Amount Assumed to Net
2016
Life insurance in-force	$	610,206	$	450,000	$	7,006	$	167,212	4.2	%
Insurance premium
Life insurance (1)	$	1,850	$	909	$	67	$	1,008	6.6	%
Accident & health insurance	376		218		14		172		8.1	%
Total insurance premium	$	2,226	$	1,127	$	81	$	1,180	6.9	%
2015
Life insurance in-force	$	591,105	$	466,406	$	94,863	$	219,562	43.2	%
Insurance premium
Life insurance (1)	$	2,172	$	824	$	84	$	1,432	5.9	%
Accident & health insurance	232		239		212		205		103.4	%
Total insurance premium	$	2,404	$	1,063	$	296	$	1,637	18.1	%
2014
Life insurance in-force	$	544,635	$	450,615	$	55,381	$	149,401	37.1	%
Insurance premium
Life insurance (1)	$	2,064	$	689	$	65	$	1,440	4.5	%
Accident & health insurance	295		314		30		11		272.7	%
Total insurance premium	$	2,359	$	1,003	$	95	$	1,451	6.5	%

______________

(1) Includes annuities with life contingencies.

For the year ended December 31, 2016, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $266.3 billion and $7.0 billion, respectively, and life insurance premiums of $766 million and $35 million, respectively. For the year ended December 31, 2015, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $278.4 billion and $86.4 billion, respectively, and life insurance premiums of $687 million and $227 million, respectively. For the year ended December 31, 2014, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $279.7 billion and $52.9 billion, respectively, and life insurance premiums of $652 million and $56 million, respectively.

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.

Consolidation of Subsidiaries

The accompanying consolidated financial statements include the accounts of Brighthouse Life Insurance Company and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.

Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.

Discontinued Operations

Discontinued Operations

The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. Effective January 1, 2014, the Company adopted new guidance regarding reporting of discontinued operations for disposals or classifications as held-for-sale that have not been previously reported on the consolidated financial statements. A disposal of a component is reported in discontinued operations if the disposal represents a strategic shift that has or will have a major effect on the Company’s operations and financial results. See “— Adoption of New Accounting Pronouncements.”

Separate Accounts

Separate Accounts

Separate accounts are established in conformity with insurance laws. Generally, the assets of the separate accounts cannot be used to settle the liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if:

• such separate accounts are legally recognized;

• assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities;

• investments are directed by the contractholder; and

• all investment performance, net of contract fees and assessments, is passed through to the contractholder.

The Company reports separate account assets at their fair value, which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line on the statements of operations. Separate accounts credited with a contractual investment return are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses and the accounting for these investments is consistent with the methodologies described herein for similar financial instruments held within the general account.

The Company’s revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees on the statements of operations.

Future Policy Benefit Liabilities and Policyholder Account Balances

Future Policy Benefit Liabilities and Policyholder Account Balances

The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid, reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions that are in accordance with GAAP and applicable actuarial standards. The principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, policy renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. These assumptions are established at the time the policy is issued and locked in and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality, morbidity and interest rates are locked in upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation. To assess whether or not a premium deficiency exists, the Company groups insurance contracts based on the manner acquired, serviced, and the measurement of profitability. In applying the profitability criteria, groupings are limited by segment.

Liabilities for universal and variable life secondary guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the contract period based on total expected assessments. The assumptions used in estimating the secondary guarantee liabilities are consistent with those used for amortizing deferred policy acquisition costs (“DAC”), and are therefore subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of the appropriate underlying equity indices, such as the Standard & Poor’s Global Ratings (“S&P”) 500 Index. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios.

The Company regularly reviews its assumptions supporting its estimates of actuarial liabilities for future policy benefits. For universal life and annuity product guarantees, assumptions are updated periodically, whereas for traditional life products, such as term life and non-participating whole life insurance, assumptions are established and locked in at inception but reviewed periodically to determine whether a premium deficiency exists that would trigger an unlocking of assumptions. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur.

Policyholder account balances relate to contracts or contract features where the Company has no significant insurance risk.

Policyholder account balances are equal to: (i) policy account values, which consist of an accumulation of gross premium payments; (ii) credited interest, ranging from less than 1% to 8%, less expenses, mortality charges and withdrawals; and (iii) fair value adjustments relating to business combinations.

Future policy benefits are measured as follows:

Product Type:	Measurement Assumptions:
Participating life	Aggregate of (i) net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate of 4%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends.
Nonparticipating life	Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities range from 3% to 8%.
Individual and group traditional fixed annuities after annuitization	Present value of expected future payments. Interest rate assumptions used in establishing such liabilities range from 3% to 8%.
Non-medical health insurance	The net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rate assumptions used in establishing such liabilities range from 4% to 7%.
Disabled lives	Present value of benefits method and experience assumptions as to claim terminations, expenses and interest. Interest rate assumptions used in establishing such liabilities range from 3% to 7%.

Variable Annuity Guaranteed Minimum Benefits

Variable Annuity Guarantees

The Company issues directly and assumes from an affiliate through reinsurance certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. In some cases, the benefit base may be increased by additional deposits, bonus amounts, accruals or optional market value step-ups.

Certain of the Company’s variable annuity guarantee features are accounted for as insurance liabilities and recorded in future policy benefits while others are accounted for at fair value as embedded derivatives and recorded in policyholder account balances. Generally speaking, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. Alternatively, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize, that is, the policyholder can receive the guarantee on a net basis. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. Further, changes in assumptions, principally involving behavior, can result in a change of expected future cash outflows of a guarantee between portions accounted for as insurance liabilities and portions accounted for as embedded derivatives.

Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits (“GMDBs”), the life contingent portion of the GMWBs and the portion of the GMIBs that require annuitization, as well as the life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value.

These insurance liabilities are accrued over the accumulation phase of the contract in proportion to actual and future expected policy assessments based on the level of guaranteed minimum benefits generated using multiple scenarios of separate account returns. The scenarios are based on best estimate assumptions consistent with those used to amortize DAC. When current estimates of future benefits exceed those previously projected or when current estimates of future assessments are lower than those previously projected, liabilities will increase, resulting in a current period charge to net income. The opposite result occurs when the current estimates of future benefits are lower than those previously projected or when current estimates of future assessments exceed those previously projected. At each reporting period, we update the actual amount of business remaining in-force, which impacts expected future assessments and the projection of estimated future benefits resulting in a current period charge or increase to earnings.SeeNote 5for additional details of guarantees accounted for as insurance liabilities.

Guarantees accounted for as embedded derivatives in policyholder account balances include the non-life contingent portion of GMWBs,GMABs,and for GMIBs the non-life contingent portion of the expected annuitization when the policyholder is forced into an annuitization upon depletion of their account value, as well as the Guaranteed Principal Option.

The estimated fair values of guarantees accounted for as embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees. At policy inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees. In valuing the embedded derivative, the percentage of fees included in the fair value measurement is locked-in at inception.

The projections of future benefits and future fees require capital market and actuarial assumptions including expectations concerning policyholder behavior. A risk neutral valuation methodology is used to project the cash flows from the guarantees under multiple capital market scenarios to determine an economic liability. The reported estimated fair value is then determined by taking the present value of these risk-free generated cash flows using a discount rate that incorporates a spread over the risk-free rate to reflect our nonperformance risk and adding a risk margin. For more information on the determination of estimated fair value,seeNote 10Fair Value.

See “— Variable Annuity Guarantees” for additional information on the Company’s variable annuity guarantee features that are accounted for as insurance liabilities and recorded in future policy benefits, as well as the guarantee features that are accounted for at fair value as embedded derivatives and recorded in policyholder account balances.

The Company issues variable annuity products with guaranteed minimum benefits. GMABs, the non-life contingent portion of GMWBs and the portion of certain GMIBs that do not require annuitization are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 9. Guarantees accounted for as insurance liabilities include:

Guarantee:			Measurement Assumptions:
GMDBs	•	A return of purchase payment upon death even if the account value is reduced to zero.	•	Present value of expected death benefits in excess of the projected account balance recognizing the excess ratably over the accumulation period based on the present value of total expected assessments.
	•	An enhanced death benefit may be available for an additional fee.	•	Assumptions are consistent with those used for amortizing DAC, and are thus subject to the same variability and risk.
			•	Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index.
			•	Benefit assumptions are based on the average benefits payable over a range of scenarios.
GMIBs	•	After a specified period of time determined at the time of issuance of the variable annuity contract, a minimum accumulation of purchase payments, even if the account value is reduced to zero, that can be annuitized to receive a monthly income stream that is not less than a specified amount.	•	Present value of expected income benefits in excess of the projected account balance at any future date of annuitization and recognizing the excess ratably over the accumulation period based on present value of total expected assessments.
	•	Certain contracts also provide for a guaranteed lump sum return of purchase premium in lieu of the annuitization benefit.	•	Assumptions are consistent with those used for estimating GMDB liabilities.
			•	Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder.
GMWBs	•	A return of purchase payment via partial withdrawals, even if the account value is reduced to zero, provided that cumulative withdrawals in a contract year do not exceed a certain limit.	•	Expected value of the life contingent payments and expected assessments using assumptions consistent with those used for estimating the GMDB liabilities.
	•	Certain contracts include guaranteed withdrawals that are life contingent.

Embedded Derivatives

Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees, equity or bond indexed crediting rates within certain annuity contracts, and those related to funds withheld on ceded reinsurance agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

The Company’s actuarial department calculates the fair value of these embedded derivatives, which are estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries as compared to MetLife, Inc.

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.

The Company assumed from an affiliated insurance company the risk associated with certain GMIBs. These embedded derivatives are included in policyholder account balances on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on these assumed risks is determined using a methodology consistent with that described previously for the guarantees directly written by the Company.

The Company ceded to an affiliate the risk associated with certain of the GMIBs, GMABs and GMWBs described above that are also accounted for as embedded derivatives. In addition to ceding risks associated with guarantees that are accounted for as embedded derivatives, the Company also cedes, to an affiliated company, certain directly written GMIBs that are accounted for as insurance (i.e., not as embedded derivatives), but where the reinsurance agreement contains an embedded derivative. These embedded derivatives are included within premiums, reinsurance and other receivables on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.

Other Policy-Related Balances

Other Policy-Related Balances

Other policy-related balances primarily include assumed affiliated reinsurance payables, affiliated deferred experience refunds, policy and contract claims and unearned revenue liabilities.

The assumed affiliated reinsurance payable relates primarily to reinsurance for certain universal life business assumed from an affiliate, net of other reinsurance. 

The affiliated deferred experience refunds relate to the repayment of acquisition costs under an affiliated reinsurance agreement and represent part of the net cost of reinsurance for the business reinsured. The deferred experience refund is being amortized consistent with the DAC methodology on the underlying contracts.

The liability for policy and contract claims generally relates to incurred but not reported death, disability and long-term care claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company’s estimated ultimate cost of settling all claims. The Company derives estimates for the development of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made.

The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product’s estimated gross profits, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees.

Recognition of Insurance Revenues and Deposits

Recognition of Insurance Revenues and Deposits

Premiums related to traditional life and annuity contracts with life contingencies are recognized as revenues when due from policyholders. When premiums are due over a significantly shorter period than the period over which policyholder benefits are incurred, any excess profit is deferred and recognized into earnings in proportion to insurance in-force or, for annuities, the amount of expected future policy benefit payments.

Premiums related to non-medical health and disability contracts are recognized on a pro rata basis over the applicable contract term.

Deposits related to universal life-type and investment-type products are credited to policyholder account balances. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which policyholder benefits and expenses are incurred. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related policyholder account balances.

Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance.

Deferred Policy Acquisition Costs and Value of Business Acquired

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles

The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include:

• incremental direct costs of contract acquisition, such as commissions;

• the portion of an employee’s total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed;

• other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and

• the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits.

All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred.

Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections.

DAC and VOBA are amortized as follows:

Products:		In proportion to the following over estimated lives of the contracts:
•	Nonparticipating and non-dividend-paying traditional contracts (primarily term insurance)		Actual and expected future gross premiums.
•	Participating, dividend-paying traditional contracts		Actual and expected future gross margins.
•	Fixed and variable universal life contracts		Actual and expected future gross profits.
•	Fixed and variable deferred annuity contracts

See Note 6 for additional information on DAC and VOBA amortization.

The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated on the financial statements for reporting purposes.

Nonparticipating and Non-Dividend-Paying Traditional Contracts

The Company amortizes DAC and VOBA related to these contracts (primarily term insurance) over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes.

Participating, Dividend-Paying Traditional Contracts

The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales, are reasonably likely to significantly impact the rate of DAC amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC balances.

Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts

The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, benefit elections and withdrawals, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and benefit elections and withdrawals are reasonably likely to significantly impact the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances.

Factors Impacting Amortization

Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company’s long-term expectation produce higher account balances, which increases the Company’s future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company’s long-term expectation. The Company’s practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.

The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency, benefit elections and withdrawals and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will generally decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease.

Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.

Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized.

Deferred Policy Acquisition Costs and Value of Business Acquired

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles

The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include:

• incremental direct costs of contract acquisition, such as commissions;

• the portion of an employee’s total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed;

• other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and

• the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits.

All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred.

Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections.

DAC and VOBA are amortized as follows:

Products:		In proportion to the following over estimated lives of the contracts:
•	Nonparticipating and non-dividend-paying traditional contracts (primarily term insurance)		Actual and expected future gross premiums.
•	Participating, dividend-paying traditional contracts		Actual and expected future gross margins.
•	Fixed and variable universal life contracts		Actual and expected future gross profits.
•	Fixed and variable deferred annuity contracts

See Note 6 for additional information on DAC and VOBA amortization.

The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated on the financial statements for reporting purposes.

Nonparticipating and Non-Dividend-Paying Traditional Contracts

The Company amortizes DAC and VOBA related to these contracts (primarily term insurance) over the appropriate premium paying period in proportion to the actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policy benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes.

Participating, Dividend-Paying Traditional Contracts

The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales, are reasonably likely to significantly impact the rate of DAC amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC balances.

Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts

The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, benefit elections and withdrawals, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and benefit elections and withdrawals are reasonably likely to significantly impact the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances.

Factors Impacting Amortization

Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company’s long-term expectation produce higher account balances, which increases the Company’s future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company’s long-term expectation. The Company’s practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.

The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency, benefit elections and withdrawals and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will generally decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease.

Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.

Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized.

Deferred Sales Inducements

The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a specified percentage of the customer’s deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements (“DSI”) to determine the recoverability of the asset.

Value of Distribution Agreements and Customer Relationships Acquired

Value of distribution agreements acquired (“VODA”) is reported in other assets and represents the present value of expected future profits associated with the expected future business derived from the distribution agreements acquired as part of a business combination. Value of customer relationships acquired (“VOCRA”) is also reported in other assets and represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business. The VODA and VOCRA associated with past business combinations are amortized over useful lives ranging from 10 to 40 years and such amortization is included in other expenses. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews VODA and VOCRA to determine whether the asset is impaired.

Reinsurance

Reinsurance

For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims.

For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC when there is a gain at inception on the ceding entity and to other liabilities when there is a loss at inception. The net cost of reinsurance is recognized as a component of other expenses when there is a gain at inception and as policyholder benefits and claims when there is a loss and is subsequently amortized on a basis consistent with the methodology used for amortizing DAC related to the underlying reinsured contracts. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums and ceded (assumed) premiums, reinsurance and other receivables (future policy benefits) are established.

Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance.

The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. The Company withholds the funds rather than transferring the underlying investments and, as a result, records funds withheld liability within other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio.

Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to guaranteed minimum income benefits (“GMIBs”), a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in net derivative gains (losses).

If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. Certain assumed non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”), guaranteed minimum accumulation benefits (“GMABs”) and GMIBs are also accounted for as embedded derivatives with changes in estimated fair value reported in net derivative gains (losses).

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by affiliated and unaffiliated companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 8.

Investments

Investments

Net Investment Income and Net Investment Gains (Losses)

Income from investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein.

Fixed Maturity and Equity Securities

The Company’s fixed maturity and equity securities are classified as available-for-sale (“AFS”) and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) (“OCI”), net of policy-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis.

Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for mortgage-backed and asset-backed securities (“ABS”) considers the estimated timing and amount of prepayments of the underlying loans. See Note 8 “Investments — Fixed Maturity and Equity Securities AFS — Methodology for Amortization of Premium and Accretion of Discount on Structured Securities”. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Dividends on equity securities are recognized when declared.

The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 8 “— Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities.”

For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment (“OTTI”) is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in OCI.

With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security’s cost and its estimated fair value.

Mortgage Loans

The Company disaggregates its mortgage loan investments into three portfolio segments: commercial, agricultural and residential. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 8.

Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts.

Also included in mortgage loans are commercial mortgage loans held by consolidated securitization entities (“CSEs”) for which the fair value option (“FVO”) was elected, which are stated at estimated fair value. Changes in estimated fair value are recognized in net investment gains (losses) for commercial mortgage loans held by CSEs.

Policy Loans

Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy.

Real Estate

Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Rental income is recognized on a straight-line basis over the term of the respective leases. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable and exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, which is generally computed using the present value of expected future cash flows discounted at a rate commensurate with the underlying risks.

Real estate for which the Company commits to a plan to sell within one year and actively markets in its current condition for a reasonable price in comparison to its estimated fair value is classified as held-for-sale. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated.

Real Estate Joint Ventures and Other Limited Partnership Interests

The Company uses the equity method of accounting for investments (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, while the cost method is used when the Company has virtually no influence over the investee’s operations. The Company generally recognizes its share of the equity method investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period; while distributions on cost method investments are recognized as earned or received.

The Company routinely evaluates such investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value (“NAV”). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired.

Short-term Investments

Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value. Short-term investments also include investments in affiliated money market pools.

Other Invested Assets

Other invested assets consist principally of the following:

• Freestanding derivatives with positive estimated fair values which are described in “— Derivatives” below.

• Tax credit and renewable energy partnerships which derive a significant source of investment return in the form of income tax credits or other tax incentives. Where tax credits are guaranteed by a creditworthy third party, the investment is accounted for under the effective yield method. Otherwise, the investment is accounted for under the equity method.

• Leveraged leases which are recorded net of non-recourse debt. Income is recognized by applying the leveraged lease’s estimated rate of return to the net investment in the lease. The Company regularly reviews residual values for impairment.

• Investments in an operating joint venture that engages in insurance underwriting activities which are accounted for under the equity method.

• Funds withheld which represent a receivable for amounts contractually withheld by ceding companies in accordance with reinsurance agreements. The Company recognizes interest on funds withheld at rates defined by the terms of the agreement which may be contractually specified or directly related to the underlying investments.

Securities Lending Program

Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with securities lending transactions may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the Company’s financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary throughout the duration of the loan. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income.

Maturities of Fixed Maturity Securities

Investment Risks and Uncertainties

Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of VIEs. The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented on the consolidated financial statements.

The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available.

The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, ABS and certain structured investment transactions) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned.

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Evaluation and Measurement Methodologies

Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.

The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows: 

• The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment.

• When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management’s best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security’s position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies.

• Additional considerations are made when assessing the unique features that apply to certain Structured Securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security.

• When determining the amount of the credit loss for U.S. and foreign corporate securities, state and political subdivision securities and foreign government securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities.

With respect to securities that have attributes of debt and equity (“perpetual hybrid securities”), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security’s cost and its estimated fair value with a corresponding charge to earnings.

The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value.

In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows.

Valuation Allowance Methodology

Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for all three portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for all loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

Commercial and Agricultural Mortgage Loan Portfolio Segments

The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans.

All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio.

For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property’s net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio and the values utilized in calculating the ratio are updated annually on a rolling basis, with a portion of the portfolio updated each quarter. In addition, the loan-to-value ratio is routinely updated for all but the lowest risk loans as part of the Company’s ongoing review of its commercial mortgage loan portfolio.

For agricultural mortgage loans, the Company’s primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated.

Residential Mortgage Loan Portfolio Segment

The Company’s residential mortgage loan portfolio is comprised primarily of closed end, amortizing residential mortgage loans. For evaluations of residential mortgage loans, the key inputs of expected frequency and expected loss reflect current market conditions, with expected frequency adjusted, when appropriate, for differences from market conditions and historical experience. In contrast to the commercial and agricultural mortgage loan portfolios, residential mortgage loans are smaller-balance homogeneous loans that are collectively evaluated for impairment. Non-specific valuation allowances are established using the evaluation framework described above for pools of loans with similar risk characteristics from inputs that are unique to the residential segment of the loan portfolio. Loan specific valuation allowances are only established on residential mortgage loans when they have been restructured and are established using the methodology described above for all loan portfolio segments.

For residential mortgage loans, the Company’s primary credit quality indicator is whether the loan is performing or nonperforming. The Company generally defines nonperforming residential mortgage loans as those that are 60 or more days past due and/or in nonaccrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.

The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days.

Past Due and Nonaccrual Mortgage Loans

Mortgage Loans Modified in a Troubled Debt Restructuring

The Company may grant concessions related to borrowers experiencing financial difficulties, which are classified as troubled debt restructurings. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concessions granted are considered in determining any impairment or changes in the specific valuation allowance.

For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. The Company generally defines nonperforming rental receivables as those that are 90 days or more past due.

Leveraged Leases

Purchased Credit Impaired Investments

Investments acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments are classified as purchased credit impaired (“PCI”) investments. For each investment, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI.

Variable Interest Entities

The Company has invested in certain entities (including CSEs) that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity.

Derivatives

Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:

Statement of Operations Presentation:	Derivative:
Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
Net investment income	•	Economic hedges of equity method investments in joint ventures

Hedge Accounting

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:

• Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in estimated fair value of the hedged item attributable to the designated risk being hedged.

• Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).

The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported on the statement of operations within interest income or interest expense to match the location of the hedged item.

In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:

• the combined instrument is not accounted for in its entirety at estimated fair value with changes in estimated fair value recorded in earnings;

• the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and

• a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.

See “Variable Annuity Guarantees” for additional information on the accounting policy for embedded derivatives bifurcated from variable annuity host contracts.

Such embedded derivatives are carried on the balance sheet at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses), except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps to synthetically replicate investment risks and returns which are not readily available in the cash markets.

The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; and (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments.

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

Fair Value

Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition.

Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities.

When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows:

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities.

Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company’s ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities.

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

Goodwill

Goodwill

Goodwill represents the future economic benefits arising from net assets acquired in a business combination that are not individually identified and recognized. Goodwill is calculated as the excess of cost over the estimated fair value of such net assets acquired, is not amortized, and is tested for impairment based on a fair value approach at least annually or more frequently if events or circumstances indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event.

The impairment test is performed at the reporting unit level, which is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income.

On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company’s reporting units to assess whether any goodwill impairment exists.

Employee Benefit Plans

Employee Benefit Plans

Through December 31, 2016, Metropolitan Life Insurance Company (“MLIC”) provided and the Company contributed to defined benefit pension and postemployment plans for its employees and retirees. MLIC also provides and the Company contributes to a postretirement medical and life insurance benefit plan for certain retired employees. The Company accounts for these plans as multiemployer benefit plans and as a result the assets, obligations and other comprehensive gains and losses of these benefit plans are not included on the consolidated balance sheet. Within its consolidated statement of operations, the Company has included expense associated with its participants in these plans. These plans also include participants from other affiliates of MLIC. The Company’s participation in these plans ceased December 31, 2016.

Defined Contribution Plans

Through December 31, 2016, MLIC provides and the Company contributes to a defined contribution plan sponsored by MLIC for substantially all employees under which a portion of employee contributions are matched. The Company’s participation in this plan ceased on December 31, 2016.

Income Tax

Income Tax

Brighthouse Life Insurance Company and its includable subsidiaries join with MetLife, Inc. and its includable subsidiaries in filing a consolidated U.S. life and non-life federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended. Current taxes (and the benefits of tax attributes such as losses) are allocated to Brighthouse Life Insurance Company and its subsidiaries under the consolidated tax return regulations and a tax sharing agreement. Under the consolidated tax return regulations, MetLife, Inc. has elected the “percentage method” (and 100% under such method) of reimbursing companies for tax attributes e.g. net operating losses. As a result, 100% of tax attributes are reimbursed by MetLife, Inc. to the extent that consolidated federal income tax of the consolidated federal tax return group is reduced in a year by tax attributes. On an annual basis, each of the profitable subsidiaries pays to MetLife, Inc. the federal income tax which it would have paid based upon that year’s taxable income. If Brighthouse Life Insurance Company or its includable subsidiaries has current or prior deductions and credits (including but not limited to losses) which reduce the consolidated tax liability of the consolidated federal tax return group, the deductions and credits are characterized as realized (or realizable) by Brighthouse Life Insurance Company and its includable subsidiaries when those tax attributes are realized (or realizable) by the consolidated federal tax return group, even if Brighthouse Life Insurance Company or its includable subsidiaries would not have realized the attributes on a stand-alone basis under a “wait and see” method.

The Company’s accounting for income taxes represents management’s best estimate of various events and transactions.

Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse.

The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established against deferred tax assets when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination the Company considers many factors, including:

• the nature, frequency, and amount of cumulative financial reporting income and losses in recent years;

• the jurisdiction in which the deferred tax asset was generated;

• the length of time that carryforward can be utilized in the various taxing jurisdiction;

• future taxable income exclusive of reversing temporary differences and carryforwards;

• future reversals of existing taxable temporary differences;

• taxable income in prior carryback years; and

• tax planning strategies.

The Company may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, the effect of changes in tax laws, tax regulations, or interpretations of such laws or regulations, is recognized in net income tax expense (benefit) in the period of change.

The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded on the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made.

The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax expense.

Litigation Contingencies

Litigation Contingencies

The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company’s financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected on the Company’s financial statements.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value.

Property, Equipment, Leasehold Improvements and Computer Software

Property, Equipment, Leasehold Improvements and Computer Software

Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, as appropriate. Estimated lives generally range from five to 10 years for leasehold improvements, and from three to seven years for all other property and equipment. The net book value of the property, equipment and leasehold improvements was insignificant at both December 31, 2016 and 2015.

Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $248 million and $266 million at December 31, 2016 and 2015, respectively. Accumulated amortization of capitalized software was $142 million and $110 million at December 31, 2016 and 2015, respectively. Related amortization expense was $39 million, less than $1 million and $3 million for the years ended December 31, 2016, 2015 and 2014, respectively.

Other Revenues

Other Revenues

Other revenues primarily include, in addition to items described elsewhere herein, fee income on financial reinsurance agreements and broker-dealer fees.

Foreign Currency

Foreign Currency

Assets, liabilities and operations of a foreign affiliate (owned in 2014) are recorded based on functional currency. The determination of the functional currency is made based on the appropriate economic and management indicators. The local currencies of foreign operations are the functional currencies. Assets and liabilities of this foreign affiliate are translated from the functional currency to U.S. dollars at the exchange rates in effect at each year-end and revenues and expenses are translated at the average exchange rates during the year. The resulting translation adjustments are charged or credited directly to OCI, net of applicable taxes. Gains and losses from foreign currency transactions, including the effect of re-measurement of monetary assets and liabilities to the appropriate functional currency, are reported as part of net investment gains (losses) in the period in which they occur.

XML

Segment Information (Tables)

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Revenue from External Customers by Products and Services [Table Text Block]

The following table presents total premiums, universal life and investment-type product policy fees and other revenues by major product groups of the Company’s segments, as well as Corporate & Other:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Annuity products	$	3,411	$	3,701	$	4,110
Life insurance products	1,552		1,529		1,466
Other products	23		133		5
Total	$	4,986	$	5,363	$	5,581

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

Reconciliation of Company operating revenues to total revenues:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Annuities	$	4,423		$	4,665		$	4,790
Life	1,036			881			897
Run-off	2,313			2,366			2,319
Total segment	7,772			7,912			8,006
Corporate & Other	338			398			314
Net investment gains (losses)	(67		)	5			(489		)
Net derivative gains (losses)	(5,770		)	(497		)	294
Other adjustments	(13		)	54			245
Total	$	2,260		$	7,872		$	8,370

Segment Reporting Information, by Segment

	Operating Results
Year Ended December 31, 2016	Annuities		Life			Run-off			Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,494	$	6		$	(249	)	$	23		$	1,274
Provision for income tax expense (benefit)	441		—			(90		)	(10		)	341
Operating earnings	$	1,053	$	6		$	(159	)	$	33		933
Adjustments for:
Net investment gains (losses)												(67		)
Net derivative gains (losses)												(5,770		)
Other adjustments to net income												98
Provision for income tax (expense) benefit												2,031
Net income (loss)												$	(2,775	)
Inter-segment revenues	$	716	$	(722	)	$	135		$	20
Interest revenue	$	1,446	$	351		$	1,411		$	197
Interest expense	$	—	$	—		$	60		$	67

At December 31, 2016	Annuities		Life		Run-off		Corporate & Other		Total
	(In millions)
Total assets	$	146,224	$	12,296	$	40,575	$	12,330	$	211,425
Separate account assets	$	100,209	$	1,671	$	3,466	$	—	$	105,346
Separate account liabilities	$	100,209	$	1,671	$	3,466	$	—	$	105,346

	Operating Results
Year Ended December 31, 2015	Annuities		Life			Run-off		Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,339	$	(56	)	$	713	$	(77	)	$	1,919
Provision for income tax expense (benefit)	329		(21		)	247		(43		)	512
Operating earnings	$	1,010	$	(35	)	$	466	$	(34	)	1,407
Adjustments for:
Net investment gains (losses)											5
Net derivative gains (losses)											(497		)
Other adjustments to net income											(262		)
Provision for income tax (expense) benefit											265
Net income (loss)											$	918
Inter-segment revenues	$	595	$	(695	)	$	118	$	215
Interest revenue	$	1,266	$	313		$	1,551	$	97
Interest expense	$	—	$	—		$	60	$	69

At December 31, 2015	Annuities		Life		Run-off		Corporate & Other		Total
	(In millions)
Total assets	$	142,646	$	13,242	$	44,176	$	15,552	$	215,616
Separate account assets	$	101,714	$	1,580	$	3,233	$	—	$	106,527
Separate account liabilities	$	101,714	$	1,580	$	3,233	$	—	$	106,527

	Operating Results
Year Ended December 31, 2014	Annuities		Life			Run-off		Corporate & Other			Total
	(In millions)
Pre-tax operating earnings	$	1,182	$	(7	)	$	824	$	(16	)	$	1,983
Provision for income tax expense (benefit)	281		(4		)	283		(21		)	539
Operating earnings	$	901	$	(3	)	$	541	$	5		1,444
Adjustments for:
Net investment gains (losses)											(489		)
Net derivative gains (losses)											294
Other adjustments to net income											(720		)
Provision for income tax (expense) benefit											278
Net income (loss)											$	807
Inter-segment revenues	$	849	$	(575	)	$	23	$	36
Interest revenue	$	1,119	$	359		$	1,518	$	66
Interest expense	$	—	$	5		$	60	$	68

XML

Insurance (Tables)

12 Months Ended

Dec. 31, 2016

Insurance [Abstract]

Insurance Liabilities

Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:

	December 31,
	2016		2015
	(In millions)
Annuities	$	32,793	$	28,673
Life	6,932		7,309
Run-off	24,887		26,885
Corporate & Other	7,431		7,168
Total	$	72,043	$	70,035

Liabilities for Guarantees

Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity and universal and variable life contracts was as follows:

	Annuity Contracts						Universal and Variable Life Contracts
	GMDBs			GMIBs			Secondary Guarantees		Total
	(In millions)
Direct
Balance at January 1, 2014	$	409		$	1,231		$	1,784	$	3,424
Incurred guaranteed benefits (1)	233			304			590		1,127
Paid guaranteed benefits	(23		)	—			—		(23		)
Balance at December 31, 2014	619			1,535			2,374		4,528
Incurred guaranteed benefits	248			337			413		998
Paid guaranteed benefits	(36		)	—			—		(36		)
Balance at December 31, 2015	831			1,872			2,787		5,490
Incurred guaranteed benefits	335			334			753		1,422
Paid guaranteed benefits	(60		)	—			—		(60		)
Balance at December 31, 2016	$	1,106		$	2,206		$	3,540	$	6,852
Net Ceded/(Assumed)
Balance at January 1, 2014	$	(200	)	$	(130	)	$	683	$	353
Incurred guaranteed benefits (1)	177			104			163		444
Paid guaranteed benefits	2			—			—		2
Balance at December 31, 2014	(21		)	(26		)	846		799
Incurred guaranteed benefits	20			(2		)	161		179
Paid guaranteed benefits	(33		)	—			—		(33		)
Balance at December 31, 2015	(34		)	(28		)	1,007		945
Incurred guaranteed benefits	44			9			98		151
Paid guaranteed benefits	(55		)	—			—		(55		)
Balance at December 31, 2016	$	(45	)	$	(19	)	$	1,105	$	1,041
Net
Balance at January 1, 2014	$	609		$	1,361		$	1,101	$	3,071
Incurred guaranteed benefits (1)	56			200			427		683
Paid guaranteed benefits	(25		)	—			—		(25		)
Balance at December 31, 2014	640			1,561			1,528		3,729
Incurred guaranteed benefits	228			339			252		819
Paid guaranteed benefits	(3		)	—			—		(3		)
Balance at December 31, 2015	865			1,900			1,780		4,545
Incurred guaranteed benefits	291			325			655		1,271
Paid guaranteed benefits	(5		)	—			—		(5		)
Balance at December 31, 2016	$	1,151		$	2,225		$	2,435	$	5,811

______________

(1) See Note 7.

Fund Groupings

Account balances of contracts with guarantees were invested in separate account asset classes as follows at: 

	December 31,
	2016		2015
	(In millions)
Fund Groupings:
Balanced	$	52,170	$	52,837
Equity	41,152		42,723
Bond	6,086		5,119
Money Market	703		820
Total	$	100,111	$	101,499

Guarantees related to Annuity, Universal and Variable Life Contracts

Information regarding the Company’s guarantee exposure was as follows at:

	December 31,
	2016						2015
	In the Event of Death			At Annuitization			In the Event of Death			At Annuitization
	(Dollars in millions)
Annuity Contracts (1), (2)
Variable Annuity Guarantees
Total account value (3)	$	106,590		$	61,340		$	108,625		$	62,645
Separate account value	$	101,991		$	60,016		$	103,685		$	61,311
Net amount at risk	$	6,763	(4)	$	3,116	(5)	$	8,296	(4)	$	2,241	(5)
Average attained age of contractholders	67 years			67 years			66 years			66 years

	December 31,
	2016		2015
	Secondary Guarantees
	(Dollars in millions)
Universal and Variable Life Contracts
Total account value (3)	$	7,176	$	6,919
Net amount at risk (6)	$	90,973	$	90,940
Average attained age of policyholders	60 years		59 years

______________

(1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, the NARs presented reflect the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. See Note 7 for a discussion of GMxBs which have been reinsured.

(3) Includes the contractholder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved.

(6) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.

Schedule of Federal Home Loan Bank, common stock holdings, by branch of FHLB Bank

The Company is a member of the Federal Home Loan Bank (“FHLB”) of Pittsburgh and holds common stock in certain regional banks in the FHLB system (“FHLBanks”). Holdings of common stock of FHLBanks, included in equity securities, were as follows as of:

	December 31,
	2016		2015
	(In millions)
FHLB of Pittsburgh	$	44	$	85
FHLB of Boston	$	27	$	36
FHLB of Des Moines	$	4	$	4

Schedule of liability recorded and collateral pledged for funding agreements

The Company has also entered into funding agreements with FHLBanks. The liability for such funding agreements is included in policyholder account balances. Information related to such funding agreements was as follows as of:

	Liability				Collateral
	December 31,
	2016		2015		2016			2015
	(In millions)
FHLB of Pittsburgh (1)	$	500	$	1,570	$	3,765	(2)	$	1,789	(2)
FHLB of Boston (1)	$	50	$	250	$	144	(2)	$	311	(2)
FHLB of Des Moines (1)	$	95	$	95	$	266	(2)	$	147	(2)

______________

(1) Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities (“RMBS”), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank’s recovery on the collateral is limited to the amount of the Company’s liability to such FHLBank.

(2) Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value.

Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes at:

	December 31,
	2016		2015
	(In millions)
Invested assets on deposit (regulatory deposits)	$	7,644	$	7,247
Invested assets held in trust (reinsurance agreements) (1)	9,054		8,083
Invested assets pledged as collateral (2)	3,548		2,801
Total invested assets on deposit, held in trust, and pledged as collateral	$	20,246	$	18,131

______________

(1) The Company has held in trust certain investments in connection with certain reinsurance transactions.

(2) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 5) and derivative transactions (see Note 9).

Liabilities for Unpaid Claims and Claim Expenses

Information regarding the liabilities for unpaid claims and claim expense was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at December 31 of prior period	$	1,693		$	1,483		$	1,325
Less: Reinsurance recoverables	1,545			1,400			1,235
Net balance at December 31 of prior period	148			83			90
Cumulative adjustment (1)	68			—			—
Net balance at January 1,	216			83			90
Incurred related to:
Current year	651			105			3
Prior years (2)	(20		)	—			2
Total incurred	631			105			5
Paid related to:
Current year	(626		)	(30		)	—
Prior years	(63		)	(10		)	(12		)
Total paid	(689		)	(40		)	(12		)
Net balance at December 31,	158			148			83
Add: Reinsurance recoverables	1,811			1,545			1,400
Balance at December 31,	$	1,969		$	1,693		$	1,483

______________

(1) Reflects the accumulated adjustment, net of reinsurance, upon implementation of the new guidance related to short-duration contracts. Prior periods have not been restated. See Note 1.

(2) During 2016, 2015 and 2014, claims and claims adjustment expenses associated with prior years changed due to differences between the actual benefits paid and the expected benefits owed during those periods.

XML

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Tables)

12 Months Ended

Dec. 31, 2016

Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]

Schedule of Deferred Policy Acquisition Costs and Value of Business Acquired

Information regarding DAC and VOBA was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DAC
Balance at January 1,	$	5,066		$	5,097		$	5,712
Capitalizations	330			399			376
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	1,371			163			(184		)
Other expenses	(1,076		)	(690		)	(745		)
Total amortization	295			(527		)	(929		)
Unrealized investment gains (losses)	(24		)	97			(64		)
Other	—			—			2
Balance at December 31,	5,667			5,066			5,097
VOBA
Balance at January 1,	711			763			932
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	2			(19		)	(1		)
Other expenses	(72		)	(127		)	(139		)
Total amortization	(70		)	(146		)	(140		)
Unrealized investment gains (losses)	31			94			(29		)
Balance at December 31,	672			711			763
Total DAC and VOBA
Balance at December 31,	$	6,339		$	5,777		$	5,860

Deferred Policy Acquisition Costs

Information regarding DAC and VOBA was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DAC
Balance at January 1,	$	5,066		$	5,097		$	5,712
Capitalizations	330			399			376
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	1,371			163			(184		)
Other expenses	(1,076		)	(690		)	(745		)
Total amortization	295			(527		)	(929		)
Unrealized investment gains (losses)	(24		)	97			(64		)
Other	—			—			2
Balance at December 31,	5,667			5,066			5,097
VOBA
Balance at January 1,	711			763			932
Amortization related to:
Net investment gains (losses) and net derivative gains (losses)	2			(19		)	(1		)
Other expenses	(72		)	(127		)	(139		)
Total amortization	(70		)	(146		)	(140		)
Unrealized investment gains (losses)	31			94			(29		)
Balance at December 31,	672			711			763
Total DAC and VOBA
Balance at December 31,	$	6,339		$	5,777		$	5,860

Information Regarding Deferred Policy Acquisition Costs and Value of Business Acquired by Segment

Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:

	December 31,
	2016		2015
	(In millions)
Annuities	$	4,820	$	3,724
Life	787		969
Run-off	584		974
Corporate & Other	148		110
Total	$	6,339	$	5,777

Deferred Sales Inducements

Information regarding other intangibles was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DSI
Balance at January 1,	$	515		$	566		$	669
Capitalization	3			3			5
Amortization	(83		)	(72		)	(80		)
Unrealized investment gains (losses)	(3		)	18			(28		)
Balance at December 31,	$	432		$	515		$	566
VODA and VOCRA
Balance at January 1,	$	136		$	155		$	173
Amortization	(16		)	(19		)	(18		)
Balance at December 31,	$	120		$	136		$	155
Accumulated amortization	$	140		$	124		$	105

Value of Distribution Agreements and Customer Relationships Acquired

Information regarding other intangibles was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
DSI
Balance at January 1,	$	515		$	566		$	669
Capitalization	3			3			5
Amortization	(83		)	(72		)	(80		)
Unrealized investment gains (losses)	(3		)	18			(28		)
Balance at December 31,	$	432		$	515		$	566
VODA and VOCRA
Balance at January 1,	$	136		$	155		$	173
Amortization	(16		)	(19		)	(18		)
Balance at December 31,	$	120		$	136		$	155
Accumulated amortization	$	140		$	124		$	105

Estimated Future Amortization Expense

The estimated future amortization expense to be reported in other expenses for the next five years is as follows:

	VOBA		VODA and VOCRA
	(In millions)
2017	$	110	$	15
2018	$	94	$	14
2019	$	80	$	13
2020	$	60	$	12
2021	$	52	$	10

XML

Reinsurance (Tables)

12 Months Ended

Dec. 31, 2016

Reinsurance Disclosure [Line Items]

Effects of reinsurance

The amounts on the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at:

	December 31,
	2016									2015
	Direct		Assumed		Ceded			Total Balance Sheet		Direct		Assumed		Ceded			Total Balance Sheet
	(In millions)
Assets
Premiums, reinsurance and other receivables	$	1,161	$	23	$	12,669		$	13,853	$	765	$	161	$	17,178		$	18,104
Deferred policy acquisition costs and value of business acquired	6,638		71		(370		)	6,339		6,013		218		(454		)	5,777
Total assets	$	7,799	$	94	$	12,299		$	20,192	$	6,778	$	379	$	16,724		$	23,881
Liabilities
Future policy benefits	$	32,520	$	232	$	—		$	32,752	$	29,214	$	1,294	$	—		$	30,508
Policyholder account balances	35,838		741		—			36,579		36,013		712		—			36,725
Other policy-related balances	1,035		1,677		—			2,712		999		1,804		(1		)	2,802
Other liabilities	4,525		13		907			5,445		2,620		87		1,218			3,925
Total liabilities	$	73,918	$	2,663	$	907		$	77,488	$	68,846	$	3,897	$	1,217		$	73,960

The amounts on the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Premiums
Direct premiums	$	2,226		$	2,404		$	2,359
Reinsurance assumed	81			296			95
Reinsurance ceded	(1,127		)	(1,063		)	(1,003		)
Net premiums	$	1,180		$	1,637		$	1,451
Universal life and investment-type product policy fees
Direct universal life and investment-type product policy fees	$	3,582		$	3,722		$	3,729
Reinsurance assumed	126			139			383
Reinsurance ceded	(611		)	(568		)	(502		)
Net universal life and investment-type product policy fees	$	3,097		$	3,293		$	3,610
Other revenues
Direct other revenues	$	271		$	271		$	270
Reinsurance assumed	89			2			30
Reinsurance ceded	349			160			220
Net other revenues	$	709		$	433		$	520
Policyholder benefits and claims
Direct policyholder benefits and claims	$	6,101		$	4,944		$	4,924
Reinsurance assumed	127			302			254
Reinsurance ceded	(2,490		)	(2,159		)	(1,980		)
Net policyholder benefits and claims	$	3,738		$	3,087		$	3,198
Interest credited to policyholder account balances
Direct interest credited to policyholder account balances	$	1,067		$	1,156		$	1,180
Reinsurance assumed	75			78			76
Reinsurance ceded	(11		)	(10		)	(11		)
Net interest credited to policyholder account balances	$	1,131		$	1,224		$	1,245
Amortization of deferred policy acquisition costs and value of business acquired
Direct amortization of deferred policy acquisition costs and value of business acquired	$	(182	)	$	727		$	1,018
Reinsurance assumed	148			8			99
Reinsurance ceded	(191		)	(62		)	(48		)
Net amortization of deferred policy acquisition costs and value of business acquired	$	(225	)	$	673		$	1,069
Other expenses
Direct other expenses	$	1,700		$	1,723		$	1,797
Reinsurance assumed	36			47			3
Reinsurance ceded	(36		)	(47		)	(43		)
Net other expenses	$	1,700		$	1,723		$	1,757

Affiliated Entity [Member]

Reinsurance Disclosure [Line Items]

Effects of reinsurance

Information regarding the significant effects of affiliated reinsurance included on the consolidated statements of operations was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Premiums
Reinsurance assumed	$	35		$	227		$	56
Reinsurance ceded	(766		)	(687		)	(652		)
Net premiums	$	(731	)	$	(460	)	$	(596	)
Universal life and investment-type product policy fees
Reinsurance assumed	$	126		$	139		$	276
Reinsurance ceded	(60		)	(58		)	(47		)
Net universal life and investment-type product policy fees	$	66		$	81		$	229
Other revenues
Reinsurance assumed	$	59		$	2		$	30
Reinsurance ceded	348			160			220
Net other revenues	$	407		$	162		$	250
Policyholder benefits and claims
Reinsurance assumed	$	90		$	252		$	220
Reinsurance ceded	(737		)	(656		)	(622		)
Net policyholder benefits and claims	$	(647	)	$	(404	)	$	(402	)
Interest credited to policyholder account balances
Reinsurance assumed	$	75		$	78		$	76
Reinsurance ceded	(11		)	(10		)	(11		)
Net interest credited to policyholder account balances	$	64		$	68		$	65
Amortization of deferred policy acquisition costs and value of business acquired
Reinsurance assumed	$	49		$	24		$	90
Reinsurance ceded	(175		)	(59		)	(42		)
Net amortization of deferred policy acquisition costs and value of business acquired	$	(126	)	$	(35	)	$	48
Other expenses
Reinsurance assumed	$	19		$	41		$	(2	)
Reinsurance ceded	(21		)	(31		)	(23		)
Net other expenses	$	(2	)	$	10		$	(25	)

Information regarding the significant effects of affiliated reinsurance included on the consolidated balance sheets was as follows at:

	December 31,
	2016					2015
	Assumed		Ceded			Assumed		Ceded
	(In millions)
Assets
Premiums, reinsurance and other receivables	$	23	$	3,382		$	128	$	8,452
Deferred policy acquisition costs and value of business acquired	71		(356		)	120		(439		)
Total assets	$	94	$	3,026		$	248	$	8,013
Liabilities
Future policy benefits	$	211	$	—		$	630	$	—
Policyholder account balances	741		—			712		—
Other policy-related balances	1,677		—			1,785		(1		)
Other liabilities	11		578			28		876
Total liabilities	$	2,640	$	578		$	3,155	$	875

XML

Investments (Tables)

12 Months Ended

Dec. 31, 2016

Investments, Debt and Equity Securities [Abstract]

Fixed Maturity and Equity Securities Available-for-Sale

The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, commercial mortgage-backed securities (“CMBS”) and ABS (collectively, “Structured Securities”).

	December 31, 2016											December 31, 2015
	Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value		Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses							Gains		Temporary Losses		OTTI Losses
										(In millions)
Fixed maturity securities:
U.S. corporate	$	20,663	$	1,287	$	285	$	—		$	21,665	$	19,930	$	1,077	$	532	$	—		$	20,475
U.S. government and agency	11,872		1,281		237		—			12,916		13,145		1,362		66		—			14,441
RMBS	7,876		203		139		—			7,940		9,803		219		127		22			9,873
Foreign corporate	6,071		220		168		—			6,123		5,536		165		217		1			5,483
State and political subdivision	3,520		376		38		—			3,858		3,184		387		24		1			3,546
CMBS (1)	3,687		40		32		(1		)	3,696		3,286		28		34		(1		)	3,281
ABS	2,600		11		13		—			2,598		4,303		19		59		—			4,263
Foreign government	1,000		114		11		—			1,103		665		105		11		—			759
Total fixed maturity securities	$	57,289	$	3,532	$	923	$	(1	)	$	59,899	$	59,852	$	3,362	$	1,070	$	23		$	62,121
Equity securities:
Non-redeemable preferred stock	$	180	$	6	$	9	$	—		$	177	$	265	$	15	$	9	$	—		$	272
Common stock	100		23		—		—			123		167		23		5		—			185
Total equity securities	$	280	$	29	$	9	$	—		$	300	$	432	$	38	$	14	$	—		$	457

______________

(1) The noncredit loss component of OTTI losses for CMBS was in an unrealized gain position of $1 million at both December 31, 2016and 2015, due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”

Available-for-sale fixed maturity securities by contractual maturity date

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at December 31, 2016:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In millions)
Amortized cost	$	1,824	$	9,020	$	9,814	$	22,468	$	14,163	$	57,289
Estimated fair value	$	1,829	$	9,408	$	9,931	$	24,497	$	14,234	$	59,899

Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale

The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	December 31, 2016								December 31, 2015
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in millions)
Fixed maturity securities:
U.S. corporate	$	4,632	$	187	$	699	$	98	$	6,365	$	383	$	832	$	149
U.S. government and agency	4,396		237		—		—		4,256		66		—		—
RMBS	3,457		107		818		32		5,172		105		520		44
Foreign corporate	1,443		64		573		104		1,896		107		680		111
State and political subdivision	887		35		29		3		624		22		43		3
CMBS	1,553		26		171		5		1,864		30		97		3
ABS	450		5		461		8		2,651		42		547		17
Foreign government	242		10		6		1		133		10		6		1
Total fixed maturity securities	$	17,060	$	671	$	2,757	$	251	$	22,961	$	765	$	2,725	$	328
Equity securities:
Non-redeemable preferred stock	$	57	$	2	$	40	$	7	$	24	$	1	$	40	$	8
Common stock	—		—		—		—		7		5		1		—
Total equity securities	$	57	$	2	$	40	$	7	$	31	$	6	$	41	$	8
Total number of securities in an unrealized loss position	1,711				475				2,224				452

Disclosure of Mortgage Loans Net of Valuation Allowance

Mortgage loans are summarized as follows at:

	December 31,
	2016					2015
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in millions)
Mortgage loans
Commercial	$	6,497		69.9	%	$	5,452		73.7	%
Agricultural	1,830			19.7		1,481			20.0
Residential	867			9.3		335			4.5
Subtotal	9,194			98.9		7,268			98.2
Valuation allowances	(40		)	(0.4	)	(36		)	(0.5	)
Subtotal mortgage loans, net	9,154			98.5		7,232			97.7
Commercial mortgage loans held by CSEs — FVO	136			1.5		172			2.3
Total mortgage loans, net	$	9,290		100.0	%	$	7,404		100.0	%

Disclosure of mortgage loans held-for-investment and valuation allowances by method of evaluation for credit loss

Mortgage loans by portfolio segment, by method of evaluation of credit loss, impaired mortgage loans including those modified in a troubled debt restructuring, and the related valuation allowances, were as follows at and for the years ended:

	Evaluated Individually for Credit Losses										Evaluated Collectively for Credit Losses				Impaired Loans
	Impaired Loans with a Valuation  Allowance						Impaired Loans without a Valuation Allowance
	Unpaid Principal Balance		Recorded Investment		Valuation Allowances		Unpaid Principal Balance		Recorded Investment		Recorded Investment		Valuation Allowances		Carrying Value		Average Recorded Investment
	(In millions)
December 31, 2016
Commercial	$	—	$	—	$	—	$	—	$	—	$	6,497	$	32	$	—	$	—
Agricultural	4		3		—		—		—		1,827		5		3		3
Residential	—		—		—		1		1		866		3		1		—
Total	$	4	$	3	$	—	$	1	$	1	$	9,190	$	40	$	4	$	3
December 31, 2015
Commercial	$	—	$	—	$	—	$	—	$	—	$	5,452	$	28	$	—	$	—
Agricultural	4		3		—		—		—		1,478		5		3		3
Residential	—		—		—		—		—		335		3		—		—
Total	$	4	$	3	$	—	$	—	$	—	$	7,265	$	36	$	3	$	3

Allowance for Credit Losses on Financing Receivables

The changes in the valuation allowance, by portfolio segment, were as follows:

	Commercial			Agricultural		Residential		Total
	(In millions)
Balance at January 1, 2014	$	31		$	4	$	—	$	35
Provision (release)	(10		)	—		—		(10		)
Balance at December 31, 2014	21			4		—		25
Provision (release)	7			1		3		11
Balance at December 31, 2015	28			5		3		36
Provision (release)	4			—		—		4
Balance at December 31, 2016	$	32		$	5	$	3	$	40

Investment in leveraged leases

Investment in leveraged leases consisted of the following at:

	December 31,
	2016			2015
	(In millions)
Rental receivables, net	$	87		$	90
Estimated residual values	14			14
Subtotal	101			104
Unearned income	(32		)	(33		)
Investment in leveraged leases, net of non-recourse debt	$	69		$	71

Components of net unrealized investment gains (losses) included in accumulated other comprehensive income (loss)

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Fixed maturity securities	$	2,600		$	2,283		$	4,729
Fixed maturity securities with noncredit OTTI losses included in AOCI	1			(23		)	(38		)
Total fixed maturity securities	2,601			2,260			4,691
Equity securities	32			54			69
Derivatives	397			370			281
Short-term investments	(42		)	—			—
Other	59			79			10
Subtotal	3,047			2,763			5,051
Amounts allocated from:
Future policy benefits	(922		)	(126		)	(613		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)	(1		)	(2		)
DAC, VOBA and DSI	(193		)	(198		)	(406		)
Subtotal	(1,117		)	(325		)	(1,021		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	—			9			14
Deferred income tax benefit (expense)	(653		)	(827		)	(1,416		)
Net unrealized investment gains (losses)	$	1,277		$	1,620		$	2,628

The changes in net unrealized investment gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at January 1,	$	1,620		$	2,628		$	930
Fixed maturity securities on which noncredit OTTI losses have been recognized	24			15			15
Unrealized investment gains (losses) during the year	260			(2,303		)	3,234
Unrealized investment gains (losses) relating to:
Future policy benefits	(796		)	487			(613		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(1		)	1			(2		)
DAC, VOBA and DSI	5			208			(119		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(9		)	(5		)	(4		)
Deferred income tax benefit (expense)	174			589			(813		)
Balance at December 31,	$	1,277		$	1,620		$	2,628
Change in net unrealized investment gains (losses)	$	(343	)	$	(1,008	)	$	1,698

Other than temporary impairment, losses recongnized in earnings

The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:

	Years Ended December 31,
	2016			2015
	(In millions)
Balance at January 1,	$	(23	)	$	(38	)
Noncredit OTTI losses and subsequent changes recognized	3			8
Securities sold with previous noncredit OTTI loss	18			19
Subsequent changes in estimated fair value	3			(12		)
Balance at December 31,	$	1		$	(23	)

Securities Lending

Elements of the securities lending program are presented below at:

	December 31,
	2016		2015
	(In millions)
Securities on loan: (1)
Amortized cost	$	5,895	$	8,047
Estimated fair value	$	6,555	$	8,830
Cash collateral on deposit from counterparties (2)	$	6,642	$	8,981
Security collateral on deposit from counterparties (3)	$	27	$	23
Reinvestment portfolio — estimated fair value	$	6,571	$	8,938

______________

(1) Included within fixed maturity securities and short-term investments.

(2) Included within payables for collateral under securities loaned and other transactions.

(3) Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the consolidated financial statements.

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	December 31, 2016								December 31, 2015
	Remaining Tenor of Securities Lending Agreements								Remaining Tenor of Securities Lending Agreements
	Open (1)		1 Month or Less		1 to 6 Months		Total		Open (1)		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
U.S. government and agency	$	2,129	$	1,906	$	1,743	$	5,778	$	2,631	$	3,140	$	1,338	$	7,109
U.S. corporate	—		480		—		480		9		302		—		311
Agency RMBS	—		—		274		274		—		939		579		1,518
Foreign corporate	—		58		—		58		—		—		—		—
Foreign government	—		52		—		52		1		42		—		43
Total	$	2,129	$	2,496	$	2,017	$	6,642	$	2,641	$	4,423	$	1,917	$	8,981

_____________

(1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral.

Invested Assets on Deposit, Held in Trust and Pledged as Collateral

The Company has also entered into funding agreements with FHLBanks. The liability for such funding agreements is included in policyholder account balances. Information related to such funding agreements was as follows as of:

	Liability				Collateral
	December 31,
	2016		2015		2016			2015
	(In millions)
FHLB of Pittsburgh (1)	$	500	$	1,570	$	3,765	(2)	$	1,789	(2)
FHLB of Boston (1)	$	50	$	250	$	144	(2)	$	311	(2)
FHLB of Des Moines (1)	$	95	$	95	$	266	(2)	$	147	(2)

______________

(1) Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities (“RMBS”), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank’s recovery on the collateral is limited to the amount of the Company’s liability to such FHLBank.

(2) Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value.

Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes at:

	December 31,
	2016		2015
	(In millions)
Invested assets on deposit (regulatory deposits)	$	7,644	$	7,247
Invested assets held in trust (reinsurance agreements) (1)	9,054		8,083
Invested assets pledged as collateral (2)	3,548		2,801
Total invested assets on deposit, held in trust, and pledged as collateral	$	20,246	$	18,131

______________

(1) The Company has held in trust certain investments in connection with certain reinsurance transactions.

(2) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 5) and derivative transactions (see Note 9).

Purchased credit impaired investments, by invested asset class, held

The following table presents information about PCI fixed maturity securities acquired during the periods indicated:

	Years Ended December 31,
	2016		2015
	(In millions)
Contractually required payments (including interest)	$	558	$	797
Cash flows expected to be collected (1)	$	483	$	709
Fair value of investments acquired	$	341	$	520

______________

(1) Represents undiscounted principal and interest cash flow expectations, at the date of acquisition.

The Company’s PCI fixed maturity securities were as follows at:

	December 31,
	2016		2015
	(In millions)
Outstanding principal and interest balance (1)	$	1,458	$	1,219
Carrying value (2)	$	1,113	$	907

______________

(1) Represents the contractually required payments, which is the sum of contractual principal, whether or not currently due, and accrued interest.

(2) Estimated fair value plus accrued interest.

The following table presents activity for the accretable yield on PCI fixed maturity securities for:

	Years Ended December 31,
	2016			2015
	(In millions)
Accretable yield, January 1,	$	400		$	244
Investments purchased	142			189
Accretion recognized in earnings	(66		)	(47		)
Disposals	(8		)	(8		)
Reclassification (to) from nonaccretable difference	(49		)	22
Accretable yield, December 31,	$	419		$	400

The Components of Net Investment Income

The components of net investment income were as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Investment income:
Fixed maturity securities	$	2,567	$	2,398	$	2,269
Equity securities	19		19		17
Mortgage loans	393		367		344
Policy loans	54		54		59
Real estate and real estate joint ventures	32		108		80
Other limited partnership interests	163		134		266
Cash, cash equivalents and short-term investments	20		9		5
Operating joint venture	11		11		2
Other	14		11		4
Subtotal	3,273		3,111		3,046
Less: Investment expenses	173		126		111
Subtotal, net	3,100		2,985		2,935
FVO CSEs — interest income — commercial mortgage loans	11		16		49
Net investment income	$	3,111	$	3,001	$	2,984

The components of net investment gains (losses)

The components of net investment gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Total gains (losses) on fixed maturity securities:
Total OTTI losses recognized — by sector and industry:
U.S. and foreign corporate securities — by industry:
Industrial	$	(16	)	$	(3	)	$	—
Consumer	—			(8		)	(2		)
Utility	—			(6		)	—
Transportation	—			—			(2		)
Total U.S. and foreign corporate securities	(16		)	(17		)	(4		)
RMBS	(6		)	(14		)	(10		)
OTTI losses on fixed maturity securities recognized in earnings	(22		)	(31		)	(14		)
Fixed maturity securities — net gains (losses) on sales and disposals	(28		)	(60		)	10
Total gains (losses) on fixed maturity securities	(50		)	(91		)	(4		)
Total gains (losses) on equity securities:
Total OTTI losses recognized — by sector:
Common stock	(1		)	(3		)	(7		)
Non-redeemable preferred stock	(1		)	—			(8		)
OTTI losses on equity securities recognized in earnings	(2		)	(3		)	(15		)
Equity securities — net gains (losses) on sales and disposals	10			18			14
Total gains (losses) on equity securities	8			15			(1		)
Mortgage loans	5			(11		)	18
Real estate and real estate joint ventures	(34		)	98			(4		)
Other limited partnership interests	(7		)	(1		)	(9		)
Other	11			(2		)	43
Subtotal	(67		)	8			43
FVO CSEs:
Commercial mortgage loans	(2		)	(7		)	(13		)
Long-term debt — related to commercial mortgage loans	1			4			19
Non-investment portfolio gains (losses) (1)	1			—			(538		)
Subtotal	—			(3		)	(532		)
Total net investment gains (losses)	$	(67	)	$	5		$	(489	)

______________

(1) Non-investment portfolio gains (losses) for the year ended December 31, 2014 includes a loss of $608 million related to the disposition of MAL as more fully described in Note 4.

Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains and losses

Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) were as shown in the table below.

	Years Ended December 31,
	2016			2015			2014			2016			2015			2014
	Fixed Maturity Securities									Equity Securities
	(In millions)
Proceeds	$	39,210		$	32,085		$	16,943		$	48		$	80		$	57
Gross investment gains	$	253		$	184		$	95		$	10		$	26		$	15
Gross investment losses	(281		)	(244		)	(85		)	—			(8		)	(1		)
OTTI losses	(22		)	(31		)	(14		)	(2		)	(3		)	(15		)
Net investment gains (losses)	$	(50	)	$	(91	)	$	(4	)	$	8		$	15		$	(1	)

Rollforward of the Cumulative Credit Loss Component of OTTI income (loss)

The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI:

	Years Ended December 31,
	2016			2015
	(In millions)
Balance at January 1,	$	66		$	67
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	—			6
Additional impairments — credit loss OTTI on securities previously impaired	5			11
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(42		)	(16		)
Increase in cash flows — accretion of previous credit loss OTTI	(1		)	(2		)
Balance at December 31,	$	28		$	66

Schedule of Invested Assets Transferred To and From Affiliates

The Company transfers invested assets, primarily consisting of fixed maturity securities, to and from affiliates. Invested assets transferred to and from affiliates were as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Estimated fair value of invested assets transferred to affiliates	$	1,495	$	185	$	1,441
Amortized cost of invested assets transferred to affiliates	$	1,400	$	169	$	1,362
Net investment gains (losses) recognized on transfers	$	27	$	16	$	79
Change in additional paid-in-capital recognized on transfers	$	68	$	—	$	—
Estimated fair value of invested assets transferred from affiliates	$	5,582	$	928	$	132

Variable Interest Entity, Primary Beneficiary [Member]

Variable Interest Entity [Line Items]

Variable Interest Entities

The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2016 and 2015.

	December 31,
	2016		2015
	(In millions)
MRSC (collateral financing arrangement ) (1)	$	3,422	$	3,374
CSEs: (2)
Assets:
Mortgage loans (commercial mortgage loans)	136		172
Accrued investment income	1		1
Total assets	$	137	$	173
Liabilities:
Long-term debt	$	23	$	48
Other liabilities	1		1
Total liabilities	$	24	$	49

______________

(1) See Note 3 for additional information on MRSC collateral financing arrangement.

(2) The Company consolidates entities that are structured as CMBS. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $95 million and $105 million at estimated fair value at December 31, 2016 and 2015, respectively.

Variable Interest Entity, Not Primary Beneficiary [Member]

Variable Interest Entity [Line Items]

Variable Interest Entities

The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:

	December 31,
	2016				2015
	Carrying Amount		Maximum Exposure to Loss (1)		Carrying Amount		Maximum Exposure to Loss (1)
	(In millions)
Fixed maturity securities AFS:
Structured Securities (2)	$	12,809	$	12,809	$	16,454	$	16,454
U.S. and foreign corporate	536		536		625		625
Other limited partnership interests	1,491		2,287		1,367		1,646
Real estate joint ventures	17		22		35		38
Other investments (3)	60		66		58		62
Total	$	14,913	$	15,720	$	18,539	$	18,825

______________

(1) The maximum exposure to loss relating to fixed maturity and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties. There were no income tax credits and less than $1 million at December 31, 2016 and 2015, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.

(2) For these variable interests, the Company’s involvement is limited to that of a passive investor in mortgage-backed or asset-backed securities issued by trusts that do not have substantial equity.

(3) Other investments is comprised of other invested assets and non-redeemable preferred stock.

Commercial

Mortgage Loans on Real Estate [Line Items]

Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment										Estimated Fair Value		% of Total
	Debt Service Coverage Ratios						Total		% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x
	(Dollars in millions)
December 31, 2016
Loan-to-value ratios
Less than 65%	$	5,718	$	230	$	167	$	6,115	94.1	%	$	6,197	94.3	%
65% to 75%	291		—		19		310		4.8		303		4.6
76% to 80%	34		—		—		34		0.5		33		0.5
Greater than 80%	24		14		—		38		0.6		37		0.6
Total	$	6,067	$	244	$	186	$	6,497	100.0	%	$	6,570	100.0	%
December 31, 2015
Loan-to-value ratios
Less than 65%	$	4,771	$	153	$	105	$	5,029	92.2	%	$	5,250	92.7	%
65% to 75%	330		—		10		340		6.2		332		5.9
76% to 80%	—		—		—		—		—		—		—
Greater than 80%	44		25		14		83		1.6		80		1.4
Total	$	5,145	$	178	$	129	$	5,452	100.0	%	$	5,662	100.0	%

Agricultural

Mortgage Loans on Real Estate [Line Items]

Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories

The credit quality of agricultural mortgage loans was as follows at:

	December 31,
	2016				2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Loan-to-value ratios
Less than 65%	$	1,789	97.8	%	$	1,386	93.6	%
65% to 75%	41		2.2		95		6.4
Total	$	1,830	100.0	%	$	1,481	100.0	%

Residential

Mortgage Loans on Real Estate [Line Items]

Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories

The credit quality of residential mortgage loans was as follows at:

	December 31,
	2016				2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Performance indicators:
Performing	$	856	98.7	%	$	331	98.8	%
Nonperforming	11		1.3		4		1.2
Total	$	867	100.0	%	$	335	100.0	%

XML

Derivatives (Tables)

12 Months Ended

Dec. 31, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location

The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:

	Primary Underlying Risk Exposure	December 31,
		2016						2015
				Estimated Fair Value						Estimated Fair Value
		Gross Notional Amount		Assets		Liabilities		Gross Notional Amount		Assets		Liabilities
		(In millions)
Derivatives Designated as Hedging Instruments
Fair value hedges:
Interest rate swaps	Interest rate	$	310	$	41	$	—	$	420	$	38	$	1
Cash flow hedges:
Interest rate swaps	Interest rate	45		7		—		230		60		—
Interest rate forwards	Interest rate	—		—		—		35		8		—
Foreign currency swaps	Foreign currency exchange rate	1,420		186		10		969		129		3
Subtotal		1,465		193		10		1,234		197		3
Total qualifying hedges		1,775		234		10		1,654		235		4
Derivatives Not Designated or Not Qualifying as Hedging Instruments
Interest rate swaps	Interest rate	28,175		1,928		1,688		23,086		1,802		638
Interest rate floors	Interest rate	2,100		5		2		7,036		33		24
Interest rate caps	Interest rate	12,042		25		—		13,792		38		—
Interest rate futures	Interest rate	1,288		9		—		630		2		—
Interest rate options	Interest rate	15,520		136		—		18,620		472		5
Interest rate total return swaps	Interest rate	3,876		—		611		48		2		—
Foreign currency swaps	Foreign currency exchange rate	1,250		153		4		673		77		—
Foreign currency forwards	Foreign currency exchange rate	158		9		—		185		4		1
Credit default swaps — purchased	Credit	34		—		—		21		—		—
Credit default swaps — written	Credit	1,891		28		—		2,093		13		1
Equity futures	Equity market	8,037		38		—		3,669		37		—
Equity index options	Equity market	37,501		897		934		44,035		1,032		626
Equity variance swaps	Equity market	14,894		140		517		14,866		120		434
Equity total return swaps	Equity market	2,855		1		117		2,814		31		49
Total non-designated or nonqualifying derivatives		129,621		3,369		3,873		131,568		3,663		1,778
Total		$	131,396	$	3,603	$	3,883	$	133,222	$	3,898	$	1,782

Earned Income On Derivatives And Income Statement Location

The following table presents earned income on derivatives:

	Years Ended December 31,
	2016		2015			2014
	(In millions)
Qualifying hedges:
Net investment income	$	19	$	11		$	4
Interest credited to policyholder account balances	—		(2		)	(1		)
Nonqualifying hedges:
Net derivative gains (losses)	460		361			273
Policyholder benefits and claims	16		14			32
Total	$	495	$	384		$	308

Amount and location of gains (losses) recognized in income for derivatives that are not designated or qualifying as hedging instruments

The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments:

	Net Derivative Gains (Losses)			Net Investment Income (1)			Policyholder Benefits and Claims (2)
	(In millions)
Year Ended December 31, 2016
Interest rate derivatives	$	(2,873	)	$	—		$	(4	)
Foreign currency exchange rate derivatives	76			—			—
Credit derivatives — purchased	—			—			—
Credit derivatives — written	10			—			—
Equity derivatives	(1,724		)	(6		)	(320		)
Total	$	(4,511	)	$	(6	)	$	(324	)
Year Ended December 31, 2015
Interest rate derivatives	$	(67	)	$	—		$	5
Foreign currency exchange rate derivatives	44			—			—
Credit derivatives — purchased	—			—			—
Credit derivatives — written	(14		)	—			—
Equity derivatives	(476		)	(4		)	(25		)
Total	$	(513	)	$	(4	)	$	(20	)
Year Ended December 31, 2014
Interest rate derivatives	$	1,174		$	—		$	43
Foreign currency exchange rate derivatives	6			—			—
Credit derivatives — purchased	(22		)	—			—
Credit derivatives — written	18			—			—
Equity derivatives	(591		)	(8		)	(279		)
Total	$	585		$	(8	)	$	(236	)

______________

(1) Changes in estimated fair value related to economic hedges of equity method investments in joint ventures.

(2) Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.

Net derivatives gains (losses) recognized on fair value derivatives and the related hedged items

The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):

Derivatives in Fair Value Hedging Relationships	Hedged Items in Fair Value Hedging Relationships	Net Derivative Gains (Losses) Recognized for Derivatives		Net Derivative Gains (Losses) Recognized for Hedged Items			Ineffectiveness Recognized in Net Derivative Gains (Losses)
		(In millions)
Year Ended December 31, 2016
Interest rate swaps:	Fixed maturity securities	$	1	$	(1	)	$	—
	Policyholder liabilities (1)	—		—			—
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	1	$	(1	)	$	—
Year Ended December 31, 2015
Interest rate swaps:	Fixed maturity securities	$	1	$	1		$	2
	Policyholder liabilities (1)	2		(2		)	—
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	3	$	(1	)	$	2
Year Ended December 31, 2014
Interest rate swaps:	Fixed maturity securities	$	1	$	(1	)	$	—
	Policyholder liabilities (1)	32		(31		)	1
Foreign currency swaps:	Foreign-denominated policyholder account balances (2)	—		—			—
Total		$	33	$	(32	)	$	1

______________

(1) Fixed rate liabilities reported in policyholder account balances or future policy benefits.

(2) Fixed rate or floating rate liabilities.

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of stockholder’s equity:

Derivatives in Cash Flow Hedging Relationships	Amount of Gains (Losses) Deferred in AOCI on Derivatives		Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)					Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives
	(Effective Portion)		(Effective Portion)					(Ineffective Portion)
			Net Derivative Gains (Losses)			Net Investment Income		Net Derivative Gains (Losses)
	(In millions)
Year Ended December 31, 2016
Interest rate swaps	$	24	$	33		$	3	$	—
Interest rate forwards	4		2			2		—
Foreign currency swaps	42		3			—		—
Credit forwards	—		—			—		—
Total	$	70	$	38		$	5	$	—
Year Ended December 31, 2015
Interest rate swaps	$	15	$	1		$	1	$	1
Interest rate forwards	1		2			2		—
Foreign currency swaps	79		—			—		—
Credit forwards	—		—			—		—
Total	$	95	$	3		$	3	$	1
Year Ended December 31, 2014
Interest rate swaps	$	131	$	1		$	1	$	—
Interest rate forwards	55		1			1		—
Foreign currency swaps	57		(6		)	—		—
Credit forwards	—		—			—		—
Total	$	243	$	(4	)	$	2	$	—

Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:

	December 31,
	2016					2015
Rating Agency Designation of Referenced Credit Obligations (1)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)
	(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (3)	$	1	$	45	2.2	$	1	$	207	1.5
Credit default swaps referencing indices	8		433		3.7	1		219		4.0
Subtotal	9		478		3.6	2		426		2.8
Baa
Single name credit default swaps (3)	1		180		1.6	2		409		1.6
Credit default swaps referencing indices	18		1,213		4.8	8		1,222		4.8
Subtotal	19		1,393		4.4	10		1,631		4.0
Ba
Single name credit default swaps (3)	—		20		2.7	—		—		—
Credit default swaps referencing indices	—		—		—	—		—		—
Subtotal	—		20		2.7	—		—		—
B
Single name credit default swaps (3)	—		—		—	—		—		—
Credit default swaps referencing indices	—		—		—	—		36		5.0
Subtotal	—		—		—	—		36		5.0
Total	$	28	$	1,891	4.2	$	12	$	2,093	3.8

______________

(1) The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.

(2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.

(3) Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or state and political subdivisions.

Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	December 31,
	2016						2015
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	3,394		$	2,929		$	3,875		$	1,725
OTC-cleared (1)	267			905			78			78
Exchange-traded	46			—			39			—
Total gross estimated fair value of derivatives (1)	3,707			3,834			3,992			1,803
Amounts offset on the consolidated balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the consolidated balance sheets (1)	3,707			3,834			3,992			1,803
Gross amounts not offset on the consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(2,231		)	(2,231		)	(1,577		)	(1,577		)
OTC-cleared	(165		)	(165		)	(70		)	(70		)
Exchange-traded	—			—			—			—
Cash collateral: (3), (4)
OTC-bilateral	(634		)	—			(1,608		)	—
OTC-cleared	(91		)	(740		)	(8		)	(8		)
Exchange-traded	—			—			—			—
Securities collateral: (5)
OTC-bilateral	(429		)	(698		)	(553		)	(148		)
OTC-cleared	—			—			—			—
Exchange-traded	—			—			—			—
Net amount after application of master netting agreements and collateral	$	157		$	—		$	176		$	—

______________

(1) At December 31, 2016 and 2015, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $104 million and $94 million, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($49) million and $21 million, respectively.

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.

(4) The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2016 and 2015, the Company received excess cash collateral of $3 million and $1 million, respectively, and provided excess cash collateral of $25 million and $62 million, respectively, which is not included in the table above due to the foregoing limitation.

(5) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at December 31, 2016none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2016 and 2015, the Company received excess securities collateral with an estimated fair value of $135 million and $0, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At December 31, 2016 and 2015, the Company provided excess securities collateral with an estimated fair value of $108 million and $36 million, respectively, for its OTC-bilateral derivatives, $630 million and $34 million, respectively, for its OTC-cleared derivatives, and $453 million and $156 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.

Derivative Instruments, Gain (Loss) [Line Items]

Components of Net Derivatives Gains (Losses)

The components of net derivative gains (losses) were as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Freestanding derivatives and hedging gains (losses) (1)	$	(4,029	)	$	(153	)	$	870
Embedded derivatives gains (losses)	(1,741		)	(344		)	(576		)
Total net derivative gains (losses)	$	(5,770	)	$	(497	)	$	294

______________

(1) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships, which are not presented elsewhere in this note.

Schedule of Derivative Instruments

	December 31,
	2016		2015
	(In millions)
Estimated fair value of derivatives in a net liability position (1)	$	698	$	148
Estimated Fair Value of Collateral Provided
Fixed maturity securities	$	777	$	179
Cash	$	—	$	—
Fair Value of Incremental Collateral Provided Upon
One-notch downgrade in financial strength rating	$	—	$	—
Downgrade in financial strength rating to a level that triggers full overnight collateralization or termination of the derivative position	$	—	$	—

______________

(1) After taking into consideration the existence of netting agreements.

Embedded Derivative Financial Instruments [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Components of Net Derivatives Gains (Losses)

The following table presents changes in estimated fair value related to embedded derivatives:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Net derivative gains (losses) (1), (2)	$	(1,741	)	$	(344	)	$	(576	)
Policyholder benefits and claims	$	(4	)	$	21		$	87

______________

(1) The valuation of direct and assumed guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were $244 million, $26 million and $69 million for the years ended December 31, 2016, 2015 and 2014, respectively.

(2) See Note 7 for discussion of affiliated net derivative gains (losses).

Schedule of Derivative Instruments

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

		December 31,
	Balance Sheet Location	2016			2015
		(In millions)
Embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	409		$	363
Funds withheld on assumed reinsurance	Other invested assets	—			35
Options embedded in debt or equity securities	Investments	(49		)	(62		)
Embedded derivatives within asset host contracts		$	360		$	336
Embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances	$	2,237		$	122
Assumed guaranteed minimum benefits	Policyholder account balances	741			712
Funds withheld on ceded reinsurance	Other liabilities	—			—
Fixed annuities with equity indexed returns	Policyholder account balances	192			6
Embedded derivatives within liability host contracts		$	3,170		$	840

XML

Fair Value (Tables)

12 Months Ended

Dec. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					December 31, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)					(65)	-	240	49	Decrease
			•	Offered quotes (5)	18	-	138	104	96	-	100	98	Increase
	•	Market pricing	•	Quoted prices (5)	13	-	700	99	13	-	780	282	Increase
	•	Consensus pricing	•	Offered quotes (5)	37	-	109	85	68	-	100	86	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	38	-	111	91	29	-	292	93	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	94	-	106	100	97	-	103	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	100	99	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	—	-	—		317	-	317		Increase (8)
			•	Repurchase rates (9)	(44)	-	18						Decrease (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	98		—	-	—		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	14%	-	32%		17%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.09%		0%	-	0.09%		Decrease (14)
				Ages 41 - 60	0.04%	-	0.65%		0.04%	-	0.65%		Decrease (14)
				Ages 61 - 115	0.26%	-	100%		0.26%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		3%	-	100%		Decrease (15)
				Durations 21 - 116	2%	-	100%		3%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0.25%	-	10%		0.25%	-	10%		(17)
			•	Long-term equity volatilities	17.40%	-	25%		17.40%	-	25%		Increase (18)
			•	Nonperformance risk spread	0.04%	-	0.57%		0.04%	-	0.52%		Decrease (19)

______________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) As of December 31, 2016 and 2015, independent non-binding broker quotations were used in the determination of 3% and less than 1% of the total net derivative estimated fair value, respectively.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contractholders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below at:

	December 31, 2016
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	20,221	$	1,444	$	21,665
U.S. government and agency	6,110		6,806		—		12,916
RMBS	—		6,627		1,313		7,940
Foreign corporate	—		5,257		866		6,123
State and political subdivision	—		3,841		17		3,858
CMBS	—		3,529		167		3,696
ABS	—		2,383		215		2,598
Foreign government	—		1,103		—		1,103
Total fixed maturity securities	6,110		49,767		4,022		59,899
Equity securities	39		124		137		300
Short-term investments	702		568		2		1,272
Commercial mortgage loans held by CSEs — FVO	—		136		—		136
Derivative assets: (1)
Interest rate	9		2,142		—		2,151
Foreign currency exchange rate	—		348		—		348
Credit	—		20		8		28
Equity market	37		860		179		1,076
Total derivative assets	46		3,370		187		3,603
Embedded derivatives within asset host contracts (2)	—		—		409		409
Separate account assets (3)	720		104,616		10		105,346
Total assets	$	7,617	$	158,581	$	4,767	$	170,965
Liabilities
Derivative liabilities: (1)
Interest rate	$	—	$	1,690	$	611	$	2,301
Foreign currency exchange rate	—		14		—		14
Equity market	—		1,038		530		1,568
Total derivative liabilities	—		2,742		1,141		3,883
Embedded derivatives within liability host contracts (2)	—		—		3,170		3,170
Long-term debt of CSEs — FVO	—		23		—		23
Total liabilities	$	—	$	2,765	$	4,311	$	7,076

	December 31, 2015
	Fair Value Hierarchy						Total Estimated Fair Value
	Level 1		Level 2		Level 3
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	18,787	$	1,688	$	20,475
U.S. government and agency	8,150		6,291		—		14,441
RMBS	—		8,522		1,351		9,873
Foreign corporate	—		4,761		722		5,483
State and political subdivision	—		3,533		13		3,546
CMBS	—		3,066		215		3,281
ABS	—		3,833		430		4,263
Foreign government	—		732		27		759
Total fixed maturity securities	8,150		49,525		4,446		62,121
Equity securities	44		316		97		457
Short-term investments (4)	74		1,666		47		1,787
Commercial mortgage loans held by CSEs — FVO	—		172		—		172
Derivative assets: (1)
Interest rate	2		2,445		8		2,455
Foreign currency exchange rate	—		210		—		210
Credit	—		12		1		13
Equity market	37		968		215		1,220
Total derivative assets	39		3,635		224		3,898
Embedded derivatives within asset host contracts (2)	—		—		398		398
Separate account assets (3)	624		105,757		146		106,527
Total assets	$	8,931	$	161,071	$	5,358	$	175,360
Liabilities
Derivative liabilities: (1)
Interest rate	$	—	$	668	$	—	$	668
Foreign currency exchange rate	—		4		—		4
Credit	—		1		—		1
Equity market	—		653		456		1,109
Total derivative liabilities	—		1,326		456		1,782
Embedded derivatives within liability host contracts (2)	—		—		840		840
Long-term debt of CSEs — FVO	—		48		—		48
Total liabilities	$	—	$	1,374	$	1,296	$	2,670

______________

(1) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the roll-forward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.

(2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances and other liabilities on the consolidated balance sheets. At December 31, 2016 and 2015, debt and equity securities also included embedded derivatives of ($49) million and ($62) million, respectively.

(3) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.

(4) Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.

Fair Value Inputs, Quantitative Information

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					December 31, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)					(65)	-	240	49	Decrease
			•	Offered quotes (5)	18	-	138	104	96	-	100	98	Increase
	•	Market pricing	•	Quoted prices (5)	13	-	700	99	13	-	780	282	Increase
	•	Consensus pricing	•	Offered quotes (5)	37	-	109	85	68	-	100	86	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	38	-	111	91	29	-	292	93	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	94	-	106	100	97	-	103	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	100	99	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	—	-	—		317	-	317		Increase (8)
			•	Repurchase rates (9)	(44)	-	18						Decrease (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	98		—	-	—		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	14%	-	32%		17%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.09%		0%	-	0.09%		Decrease (14)
				Ages 41 - 60	0.04%	-	0.65%		0.04%	-	0.65%		Decrease (14)
				Ages 61 - 115	0.26%	-	100%		0.26%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		3%	-	100%		Decrease (15)
				Durations 21 - 116	2%	-	100%		3%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0.25%	-	10%		0.25%	-	10%		(17)
			•	Long-term equity volatilities	17.40%	-	25%		17.40%	-	25%		Increase (18)
			•	Nonperformance risk spread	0.04%	-	0.57%		0.04%	-	0.52%		Decrease (19)

______________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) As of December 31, 2016 and 2015, independent non-binding broker quotations were used in the determination of 3% and less than 1% of the total net derivative estimated fair value, respectively.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contractholders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			State and Political Subdivision			Foreign Government			Equity Securities			Short-term Investments			Net Derivatives (2)			Net Embedded Derivatives (3)			Separate Account Assets (4)
	(In millions)
Balance, January 1, 2015	$	2,403		$	1,212		$	—		$	—		$	100		$	71		$	(196	)	$	354		$	158
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	16			21			—			—			11			—			(74		)	(303		)	(6		)
Total realized/unrealized gains (losses) included in AOCI	(120		)	(14		)	—			(2		)	(10		)	—			2			—			—
Purchases (7)	406			1,342			13			29			—			47			22			—			3
Sales (7)	(191		)	(364		)	—			—			(16		)	—			—			—			(5		)
Issuances (7)	—			—			—			—			—			—			—			—			—
Settlements (7)	—			—			—			—			—			—			14			(493		)	—
Transfers into Level 3 (8)	202			31			—			—			19			—			—			—			—
Transfers out of Level 3 (8)	(306		)	(232		)	—			—			(7		)	(71		)	—			—			(4		)
Balance, December 31, 2015	$	2,410		$	1,996		$	13		$	27		$	97		$	47		$	(232	)	$	(442	)	$	146
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	(11		)	30			—			—			—			—			(703		)	(1,760		)	—
Total realized/unrealized gains (losses) included in AOCI	(24		)	21			—			—			(11		)	—			4			—			—
Purchases (7)	584			600			—			—			—			3			10			—			2
Sales (7)	(443		)	(598		)	—			—			(26		)	(1		)	—			—			(134		)
Issuances (7)	—			—			—			—			—			—			—			—			—
Settlements (7)	—			—			—			—			—			—			(33		)	(559		)	—
Transfers into Level 3 (8)	119			12			9			—			131			—			—			—			—
Transfers out of Level 3 (8)	(325		)	(366		)	(5		)	(27		)	(54		)	(47		)	—			—			(4		)
Balance, December 31, 2016	$	2,310		$	1,695		$	17		$	—		$	137		$	2		$	(954	)	$	(2,761	)	$	10
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2014 (9)	$	2		$	6		$	—		$	—		$	(1	)	$	—		$	(7	)	$	(565	)	$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2015(9)	$	11		$	21		$	—		$	—		$	—		$	—		$	(64	)	$	(310	)	$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at December 31, 2016 (9)	$	2		$	28		$	—		$	—		$	—		$	—		$	(687	)	$	(1,772	)	$	—
Gains (Losses) Data for the year ended December 31, 2014
Total realized/unrealized gains (losses) included in net income (loss) (5) (6)	$	3		$	10		$	—		$	—		$	(2	)	$	—		$	(4	)	$	(468	)	$	(1	)
Total realized/unrealized gains (losses) included in AOCI	$	72		$	13		$	—		$	—		$	7		$	—		$	57		$	107		$	—

____________

(1) Comprised of U.S. and foreign corporate securities.

(2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses).

(5) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and embedded derivatives are reported in net derivatives gains (losses).

(6) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.

(7) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(8) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(9) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and embedded derivatives are reported in net derivative gains (losses).

Fair Value Option

The following table presents information for certain assets and liabilities of CSEs, which are accounted for under the FVO. These assets and liabilities were initially measured at fair value. 

	December 31,
	2016		2015
	(In millions)
Assets (1)
Unpaid principal balance	$	88	$	121
Difference between estimated fair value and unpaid principal balance	48		51
Carrying value at estimated fair value	$	136	$	172
Liabilities (1)
Contractual principal balance	$	22	$	46
Difference between estimated fair value and contractual principal balance	1		2
Carrying value at estimated fair value	$	23	$	48

______________

(1) These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.

Nonrecurring Fair Value Measurements

The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).

	At December 31,						Years Ended December 31,
	2016		2015		2014		2016			2015			2014
	Carrying Value After Measurement						Gains (Losses)
	(In millions)
Mortgage loans (1)	$	3	$	3	$	3	$	—		$	—		$	—
Other limited partnership interests (2)	$	3	$	2	$	38	$	(2	)	$	(1	)	$	(6	)
Other assets (3)	$	—	$	—	$	—	$	(11	)	$	—		$	—
Goodwill (4)	$	—	$	—	$	—	$	(381	)	$	—		$	(33	)

______________ 

(1) Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.

(2) For these cost method investments, estimated fair value is determined from information provided on the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both December 31, 2016 and 2015 were not significant.

(3) During the year ended December 31, 2016, the Company recognized an impairment of computer software in connection with the sale to Massachusetts Mutual Life Insurance Company (“MassMutual”) of MetLife, Inc.’s U.S. retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MetLife’s affiliated broker-dealer, MetLife Securities, Inc. (“MSI”), a wholly-owned subsidiary of MetLife, Inc. See Note 17.

(4) As discussed in Note 11, for the year ended December 31, 2016, the Company recorded an impairment of goodwill associated with the Run-off reporting unit.

Fair Value of Financial Instruments Carried at Other Than Fair Value

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	December 31, 2016
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	9,154	$	—	$	—	$	9,298	$	9,298
Policy loans	$	1,093	$	—	$	746	$	431	$	1,177
Real estate joint ventures	$	12	$	—	$	—	$	44	$	44
Other limited partnership interests	$	44	$	—	$	—	$	42	$	42
Loans to affiliates	$	1,100	$	—	$	1,090	$	—	$	1,090
Premiums, reinsurance and other receivables	$	2,363	$	—	$	834	$	1,981	$	2,815
Liabilities
Policyholder account balances	$	16,043	$	—	$	—	$	17,259	$	17,259
Long-term debt	$	1,881	$	—	$	2,117	$	—	$	2,117
Other liabilities	$	256	$	—	$	90	$	166	$	256
Separate account liabilities	$	1,110	$	—	$	1,110	$	—	$	1,110

	December 31, 2015
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	7,232	$	—	$	—	$	7,535	$	7,535
Policy loans	$	1,266	$	—	$	917	$	430	$	1,347
Real estate joint ventures	$	23	$	—	$	—	$	65	$	65
Other limited partnership interests	$	52	$	—	$	—	$	57	$	57
Loans to affiliates	$	1,150	$	—	$	1,178	$	—	$	1,178
Premiums, reinsurance and other receivables	$	6,639	$	—	$	83	$	7,511	$	7,594
Liabilities
Policyholder account balances	$	20,260	$	—	$	—	$	21,726	$	21,726
Long-term debt	$	1,888	$	—	$	2,320	$	—	$	2,320
Other liabilities	$	255	$	—	$	81	$	174	$	255
Separate account liabilities	$	1,275	$	—	$	1,275	$	—	$	1,275

XML

Goodwill (Tables)

12 Months Ended

Dec. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill Rollforward and by Segment

Information regarding goodwill by segment was as follows:

	Annuities			Life			Run-off			Total
	(In millions)
Balance at January 1, 2014
Goodwill	$	427		$	66		$	493		$	986
Accumulated impairment	(394		)	(66		)	—			(460		)
Total goodwill, net	33			—			493			526
Dispositions (1)	—			—			(112		)	(112		)
Impairments	(33		)	—			—			(33		)
Balance at December 31, 2014
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	—			(493		)
Total goodwill, net	—			—			381			381
Balance at December 31, 2015
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	—			(493		)
Total goodwill, net	—			—			381			381
Impairments	—			—			(381		)	(381		)
Balance at December 31, 2016
Goodwill	427			66			381			874
Accumulated impairment	(427		)	(66		)	(381		)	(874		)
Total goodwill, net	$	—		$	—		$	—		$	—

______________

(1) In connection with the sale of MAL, goodwill in the Run-off reporting unit was reduced by $112 million during the year ended December 31, 2014. See Note 4. This goodwill was allocated to MAL based on the relative fair values of MAL and the remaining portion of the Run-off reporting unit.

XML

Debt (Tables)

12 Months Ended

Dec. 31, 2016

Debt Disclosure [Abstract]

Long-term debt outstanding

Long-term debt outstanding was as follows:

	Interest Rate	Maturity	December 31,
			2016		2015
			(In millions)
Surplus note — affiliated with MetLife, Inc. (1), (2)	8.60%	2038	$	744	$	750
Surplus note — affiliated with MetLife, Inc. (3)	5.13%	2032	750		750
Surplus note — affiliated with MetLife, Inc. (3)	6.00%	2033	350		350
Long-term debt — unaffiliated (4)	7.03%	2030	37		38
Total long-term debt (5)			$	1,881	$	1,888

______________  

(1) Payments of interest and principal on the affiliated surplus note, which is subordinate to all other obligations, may be made only with the prior approval of the Delaware Commissioner of Insurance (the “Delaware Commissioner”). See Note 18 for information regarding subsequent forgiveness of this surplus note.

(2) Includes $6 million of debt issuance costs at December 31, 2016. Debt issuance costs were reported in other assets at December 31, 2015.

(3) Interest is paid semi-annually. See Note 18 for information regarding subsequent settlement of these surplus notes.

(4) Principal and interest is paid quarterly.

(5) Excludes $23 million and $48 million of long-term debt relating to CSEs at December 31, 2016 and 2015, respectively. See Note 8.

Letter of credit outstanding and remaining availability

At December 31, 2016, the Company had $3.3 billion in letters of credit outstanding and the remaining availability was $5.2 billion.

Account Party/Borrower(s)	Expiration	Maximum Capacity		Letters of Credit Used by the Company		Letters of Credit Used by Affiliates		Drawdowns by Affiliates		Unused Commitments
		(In millions)
MetLife, Inc. and MetLife Funding, Inc.	May 2019 (1)	$	4,000	$	90	$	640	$	—	$	3,270
MetLife, Inc.	June 2018 (1)	425		170		255		—		—
MRSC and MetLife, Inc.	June 2037 (2)	3,500		—		—		2,797		703
MRV Cell and MetLife, Inc.	September 2038 (2)	4,250		3,000		—		—		1,250
Total		$	12,175	$	3,260	$	895	$	2,797	$	5,223

______________

(1) The letters of credit used by the Company under these facilities were cancelled in connection with a new financing arrangement described in Note 18.

(2) See Note 18 for information regarding subsequent termination of these facilities, as well as information regarding a new financing arrangement.

XML

Equity (Tables)

12 Months Ended

Dec. 31, 2016

Equity [Abstract]

Schedule of Dividend Payment Restrictions [Table Text Block]

The table below sets forth the dividends permitted to be paid by the Company’s without insurance regulatory approval and dividends paid:

	2017		2016		2015
Company	Permitted Without Approval (1)		Paid (2)		Paid (2)
	(In millions)
Brighthouse Life Insurance Company	$	473	$	261	$	500
Brighthouse Life Insurance Company of NY	$	—	$	—	$	—

______________ 

(1) Reflects dividend amounts that may be paid during 2017 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2017, some or all of such dividends may require regulatory approval.

(2) Reflects all amounts paid, including those requiring regulatory approval.

Schedules of statutory net income, capital and surplus and reserve strengthening by subsidiary

Statutory capital and surplus was as follows at:

	December 31,
Company	2016		2015
	(In millions)
Brighthouse Life Insurance Company	$	4,374	$	5,942
Brighthouse Life Insurance Company of NY	$	196	$	321

Statutory net income (loss) was as follows:

		Years Ended December 31,
Company	State of Domicile	2016			2015			2014
		(In millions)
Brighthouse Life Insurance Company	Delaware	$	1,186		$	(1,022	)	$	1,543
Brighthouse Life Insurance Company of NY	New York	$	(87	)	$	17		$	11

Components of Accumulated Other Comprehensive Income (Loss)

Information regarding changes on the balances of each component of AOCI was as follows:

	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Total
	(In millions)
Balance at January 1, 2014	$	906		$	24		$	40		$	970
OCI before reclassifications	2,601			243			(56		)	2,788
Deferred income tax benefit (expense)	(815		)	(85		)	4			(896		)
AOCI before reclassifications, net of income tax	2,692			182			(12		)	2,862
Amounts reclassified from AOCI	(11		)	2			—			(9		)
Deferred income tax benefit (expense)	4			(1		)	—			3
Amounts reclassified from AOCI, net of income tax	(7		)	1			—			(6		)
Sale of subsidiary (2)	(320		)	—			6			(314		)
Deferred income tax benefit (expense)	80			—			—			80
Sale of subsidiary, net of income tax	(240		)	—			6			(234		)
Balance at December 31, 2014	2,445			183			(6		)	2,622
OCI before reclassifications	(1,759		)	95			(29		)	(1,693		)
Deferred income tax benefit (expense)	643			(33		)	9			619
AOCI before reclassifications, net of income tax	1,329			245			(26		)	1,548
Amounts reclassified from AOCI	78			(6		)	—			72
Deferred income tax benefit (expense)	(28		)	2			—			(26		)
Amounts reclassified from AOCI, net of income tax	50			(4		)	—			46
Balance at December 31, 2015	1,379			241			(26		)	1,594
OCI before reclassifications	(565		)	70			(3		)	(498		)
Deferred income tax benefit (expense)	185			(25		)	—			160
AOCI before reclassifications, net of income tax	999			286			(29		)	1,256
Amounts reclassified from AOCI	30			(43		)	—			(13		)
Deferred income tax benefit (expense)	(10		)	15			—			5
Amounts reclassified from AOCI, net of income tax	20			(28		)	—			(8		)
Balance at December 31, 2016	$	1,019		$	258		$	(29	)	$	1,248

__________________

(1) See Note 8 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI.

(2) See Note 4.

Reclassification out of Accumulated Other Comprehensive Income (Loss)

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI									Consolidated Statements of Operations and Comprehensive Income (Loss) Locations
	Years Ended December 31,
	2016			2015			2014
	(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains(losses)	$	(39	)	$	(81	)	$	(6	)	Net investment gains (losses)
Net unrealized investment gains (losses)	3			13			13			Net investment income
Net unrealized investment gains (losses)	6			(10		)	4			Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	(30		)	(78		)	11
Income tax (expense) benefit	10			28			(4		)
Net unrealized investment gains (losses), net of income tax	$	(20	)	$	(50	)	$	7
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate swaps	$	33		$	1		$	1		Net derivative gains (losses)
Interest rate swaps	3			1			1			Net investment income
Interest rate forwards	2			2			1			Net derivative gains (losses)
Interest rate forwards	2			2			1			Net investment income
Foreign currency swaps	3			—			(6		)	Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax	43			6			(2		)
Income tax (expense) benefit	(15		)	(2		)	1
Gains (losses) on cash flow hedges, net of income tax	$	28		$	4		$	(1	)
Total reclassifications, net of income tax	$	8		$	(46	)	$	6

XML

Other Expenses (Tables)

12 Months Ended

Dec. 31, 2016

Other Income and Expenses [Abstract]

Other Expenses

Information on other expenses was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Compensation	$	356		$	487		$	360
Commissions	641			722			634
Volume-related costs	279			231			263
Affiliated expenses on ceded and assumed reinsurance	22			17			39
Capitalization of DAC	(330		)	(399		)	(376		)
Interest expense on debt	130			137			170
Premium taxes, licenses and fees	59			71			56
Professional services	85			22			60
Rent and related expenses	46			54			43
Other	412			381			508
Total other expenses	$	1,700		$	1,723		$	1,757

XML

Income Tax (Tables)

12 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Abstract]

Provision for income tax from continuing operations

The provision for income tax was as follows:

	Years Ended December 31,
	2016			2015		2014
	(In millions)
Current:
Federal	$	(374	)	$	35	$	(592	)
Foreign	4			—		6
Subtotal	(370		)	35		(586		)
Deferred:
Federal	(1,320		)	212		847
Foreign	—			—		—
Subtotal	(1,320		)	212		847
Provision for income tax expense (benefit)	$	(1,690	)	$	247	$	261

Income (loss) from continuing operations before income tax expense (benefit) from domestic and foreign operations

The Company’s income (loss) before income tax expense (benefit) from domestic and foreign operations were as follows:

	Years Ended December 31,
	2016			2015		2014
	(In millions)
Income (loss):
Domestic	$	(4,477	)	$	1,152	$	604
Foreign	12			13		464
Total	$	(4,465	)	$	1,165	$	1,068

Income tax for continuing operations effective rate reconciliation

The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Tax provision at U.S. statutory rate	$	(1,563	)	$	408		$	374
Tax effect of:
Dividend received deduction	(110		)	(132		)	(119		)
Prior year tax	24			(5		)	(20		)
Tax credits	(22		)	(16		)	(14		)
Foreign tax rate differential	2			(5		)	4
Goodwill impairment	(20		)	—			12
Sale of subsidiary	(6		)	—			24
Other, net	5			(3		)	—
Provision for income tax expense (benefit)	$	(1,690	)	$	247		$	261

Components of deferred tax assets and liabilities

Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at:

	December 31,
	2016			2015
	(In millions)
Deferred income tax assets:
Investments, including derivatives	$	357		$	—
Tax credit carryforwards	184			172
Other	55			39
Total deferred income tax assets	596			211
Deferred income tax liabilities:
Policyholder liabilities and receivables	536			1,419
Investments, including derivatives	—			125
Intangibles	293			394
Net unrealized investment gains	653			818
DAC	1,565			1,390
Total deferred income tax liabilities	3,047			4,146
Net deferred income tax asset (liability)	$	(2,451	)	$	(3,935	)

Summary of Tax Credit Carryforwards

The following table sets forth the general business credits, foreign tax credits, and other credit carryforwards for tax purposes as of December 31, 2016.

	Tax Credit Carryforwards
	General Business Credits		Foreign Tax Credits		Other
	(In millions)
Expiration
2017-2021	$	—	$	—	$	—
2022-2026	—		35		—
2027-2031	—		—		—
2032-2036	7		—		—
Indefinite	—		—		145
	$	7	$	35	$	145

Reconciliation of unrecognized tax benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:

	Years Ended December 31,
	2016			2015			2014
	(In millions)
Balance at January 1,	$	43		$	39		$	27
Additions for tax positions of prior years	1			5			15
Reductions for tax positions of prior years	(9		)	—			(5		)
Additions for tax positions of current year	5			3			2
Settlements with tax authorities	(2		)	(4		)	—
Balance at December 31,	$	38		$	43		$	39
Unrecognized tax benefits that, if recognized would impact the effective rate	$	38		$	33		$	29

Interest was as follows:

	Years Ended December 31,
	2016		2015		2014
	(In millions)
Interest recognized on the consolidated statements of operations	$	1	$	—	$	—
			December 31,
			2016		2015
			(In millions)
Interest included in other liabilities on the consolidated balance sheets			$	1	$	2

XML

Contingencies, Commitments and Guarantees (Tables)

12 Months Ended

Dec. 31, 2016

Insurance-related Assessments

Loss Contingencies [Line Items]

Schedule of Loss Contingencies by Contingency

Assets and liabilities held for insolvency assessments were as follows:

	December 31,
	2016		2015
	(In millions)
Other Assets:
Premium tax offset for future discounted and undiscounted assessments	$	13	$	13
Premium tax offsets currently available for paid assessments	8		14
Total	$	21	$	27
Other Liabilities:
Insolvency assessments	$	17	$	18

XML

Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2016

Related Party Transactions [Abstract]

Schedule of Related Party Transactions [Table Text Block]

The following table summarizes income and expense from transactions with related broker-dealers for the years indicated:

	Years Ended December 31,						Years Ended December 31,
	2016		2015		2014		2016		2015		2014
	Fee Income						Commission Expense
	(In millions)
MetLife broker-dealers	$	202	$	218	$	212	$	638	$	643	$	602

The following table summarizes assets and liabilities from transactions with MetLife (excluding broker-dealer transactions) at:

	At December 31,				At December 31,
	2016		2015		2016		2015
	Assets				Liabilities
	(In millions)
MetLife	$	4,288	$	9,720	$	5,125	$	5,933

The following table summarizes assets and liabilities from transactions with affiliated broker-dealers as follows:

	At December 31,				At December 31,
	2016		2015		2016		2015
	Fee Income Receivables				Secured Demand Notes
	(In millions)
MetLife broker-dealers	$	19	$	19	$	20	$	20

The following table summarizes income and expense from transactions with MetLife (excluding broker-dealer transactions) for the years indicated:

	Years Ended December 31,								Years Ended December 31,
	2016			2015		2014			2016		2015		2014
	Income								Expense
	(In millions)
MetLife	$	(45	)	$	36	$	(68	)	$	370	$	855	$	974

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016 Segment	Dec. 31, 2016 USD ($) shares	Dec. 31, 2016 USD ($) Segment shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2015 USD ($) shares	Dec. 31, 2014 USD ($)	Aug. 04, 2017 shares	Jun. 30, 2017	Nov. 30, 2014 shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of segments	3		3	3
Restructuring Cost and Reserve [Line Items]
Common Stock, Shares, Issued | shares		3,000	3,000	3,000	3,000	3,000				3,000
Property, Equipment, Leasehold Improvements and Computer Software [Abstract]
Cost basis of computer software | $		$ 248	$ 248	$ 248	$ 248	$ 266
Accumulated amortization of computer software | $		$ 142	$ 142	$ 142	142	110
Amortization expense related to computer software | $					$ 39	$ 1	$ 3
Maximum
Real Estate Held-for-investment And Accumulated Depreciation [Line Items]
Real Estate Held-for-investment And Accumulated Depreciation Life Used For Depreciation		55 years
Minimum
Real Estate Held-for-investment And Accumulated Depreciation [Line Items]
Real Estate Held-for-investment And Accumulated Depreciation Life Used For Depreciation		20 years
Spinoff [Member] | Subsequent Event [Member]
Restructuring Cost and Reserve [Line Items]
Common Stock, Shares, Issued | shares								119,773,106
Spinoff [Member] | Parent shareholders' percentage [Member] | Subsequent Event [Member]
Restructuring Cost and Reserve [Line Items]
Common Stock, Shares, Issued | shares								96,776,670
Common stock distribution by parent									80.80%
Spinoff [Member] | Minimum | Subsequent Event [Member]
Restructuring Cost and Reserve [Line Items]
Common stock distribution by parent									80.10%
Other Capitalized Property Plant and Equipment [Member] | Maximum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life		7 years
Other Capitalized Property Plant and Equipment [Member] | Minimum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life		3 years
Leasehold Improvements [Member] | Maximum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life		10 years
Leasehold Improvements [Member] | Minimum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life		5 years
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization period		4 years
VODA and VOCRA [Member] | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization period		40 years
VODA and VOCRA [Member] | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization period		10 years

XML

Segment Information (Earnings) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ (4,465)	$ 1,165	$ 1,068
Income Tax Expense (Benefit)	(1,690)	247	261
Expenses
Gain (Loss) on Investments	(67)	5	(489)
Gain (Loss) on Derivative Instruments, Net, Pretax	(5,770)	(497)	294
Other Income	709	433	520
Net income (loss)	(2,775)	918	807
Revenues	2,260	7,872	8,370
Annuities
Expenses
Interest Revenue (Expense), Net	1,446	1,266	1,119
Interest Expense	0	0	0
Life
Expenses
Interest Revenue (Expense), Net	351	313	359
Interest Expense	0	0	5
Run-off
Expenses
Interest Revenue (Expense), Net	1,411	1,551	1,518
Interest Expense	60	60	60
Corporate & Other
Expenses
Interest Revenue (Expense), Net	197	97	66
Interest Expense	67	69	68
Operating Segments
Revenues
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	1,274	1,919	1,983
Income Tax Expense (Benefit)	341	512	539
Operating Income (Loss)	933	1,407	1,444
Expenses
Revenues	7,772	7,912	8,006
Operating Segments | Annuities
Revenues
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	1,494	1,339	1,182
Income Tax Expense (Benefit)	441	329	281
Operating Income (Loss)	1,053	1,010	901
Expenses
Revenues	4,423	4,665	4,790
Operating Segments | Life
Revenues
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	6	(56)	(7)
Income Tax Expense (Benefit)	0	(21)	(4)
Operating Income (Loss)	6	(35)	(3)
Expenses
Revenues	1,036	881	897
Operating Segments | Run-off
Revenues
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(249)	713	824
Income Tax Expense (Benefit)	(90)	247	283
Operating Income (Loss)	(159)	466	541
Expenses
Revenues	2,313	2,366	2,319
Operating Segments | Corporate & Other
Revenues
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	23	(77)	(16)
Income Tax Expense (Benefit)	(10)	(43)	(21)
Operating Income (Loss)	33	(34)	5
Expenses
Revenues	338	398	314
Significant Reconciling Items
Revenues
Income Tax Expense (Benefit)	2,031	265	278
Expenses
Gain (Loss) on Investments	(67)	5	(489)
Gain (Loss) on Derivative Instruments, Net, Pretax	(5,770)	(497)	294
Other Income	98	(262)	(720)
Revenues	(13)	54	245
Intersegment Eliminations [Member] | Annuities
Expenses
Revenues	716	595	849
Intersegment Eliminations [Member] | Life
Expenses
Revenues	(722)	(695)	(575)
Intersegment Eliminations [Member] | Run-off
Expenses
Revenues	135	118	23
Intersegment Eliminations [Member] | Corporate & Other
Expenses
Revenues	$ 20	$ 215	$ 36

XML

Segment Information (Total Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Segment Reporting Information [Line Items]
Total assets	$ 211,425	$ 215,616
Separate account assets	105,346	106,527
Separate account liabilities	105,346	106,527
Annuities
Segment Reporting Information [Line Items]
Total assets	146,224	142,646
Separate account assets	100,209	101,714
Separate account liabilities	100,209	101,714
Life
Segment Reporting Information [Line Items]
Total assets	12,296	13,242
Separate account assets	1,671	1,580
Separate account liabilities	1,671	1,580
Run-off
Segment Reporting Information [Line Items]
Total assets	40,575	44,176
Separate account assets	3,466	3,233
Separate account liabilities	3,466	3,233
Corporate & Other
Segment Reporting Information [Line Items]
Total assets	12,330	15,552
Separate account assets	0	0
Separate account liabilities	$ 0	$ 0

XML

Segment Information Segment Information (Reconciliation of Operating Revenues to Total Revenues) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 2,260	$ 7,872	$ 8,370
Gain (Loss) on Investments	(67)	5	(489)
Gain (Loss) on Derivative Instruments, Net, Pretax	(5,770)	(497)	294
Operating Segments
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	7,772	7,912	8,006
Operating Segments | Annuities
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	4,423	4,665	4,790
Operating Segments | Life
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	1,036	881	897
Operating Segments | Run-off [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	2,313	2,366	2,319
Operating Segments | Corporate & Other
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	338	398	314
Significant Reconciling Items
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	(13)	54	245
Gain (Loss) on Investments	(67)	5	(489)
Gain (Loss) on Derivative Instruments, Net, Pretax	$ (5,770)	$ (497)	$ 294

XML

Segment Information (Premiums, Universal Life and Investment-Type Policy Fees and Other Revenues by Major Product Groups) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
Total premiums, universal life and investment-type product policy fees and other revenues	$ 4,986	$ 5,363	$ 5,581
Annuity products
Segment Reporting Information [Line Items]
Total premiums, universal life and investment-type product policy fees and other revenues	3,411	3,701	4,110
Life insurance (1)
Segment Reporting Information [Line Items]
Total premiums, universal life and investment-type product policy fees and other revenues	1,552	1,529	1,466
Other products
Segment Reporting Information [Line Items]
Total premiums, universal life and investment-type product policy fees and other revenues	$ 23	$ 133	$ 5

XML

Segment Information (Narrative) (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2016 Segment	Dec. 31, 2016 Segment	Dec. 31, 2016
Segment Reporting [Abstract]
Number of segments	3	3	3

XML

Organizational Changes (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital		$ 26	$ 50	$ 40
Income Tax Expense (Benefit)		(1,690)	247	261
Net income (loss)		(2,775)	918	807
Spinoff [Member]
Restructuring Cost and Reserve [Line Items]
Net income (loss)		162	79	512
Other Comprehensive Income, Other, Net of Tax		$ (120)	$ (230)	$ 206
Subsequent Event [Member]
Restructuring Cost and Reserve [Line Items]
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital	$ 2,700
Subsequent Event [Member] | Spinoff [Member]
Restructuring Cost and Reserve [Line Items]
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital	3,400
Capital contribution	703
Income Tax Expense (Benefit)	$ 643

XML

Mergers (Details Narrative) (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2016	Dec. 31, 2015	Nov. 30, 2014
Related Party Transaction [Line Items]
Common Stock, Shares Authorized	40,000,000	4,000	4,000	4,000
Common Stock, Shares, Issued		3,000	3,000	3,000
Met Life Insurance Company Of Connecticut
Related Party Transaction [Line Items]
Common Stock, Shares, Issued	30,000,000
Metropolitan Life Insurance Company
Related Party Transaction [Line Items]
Estimated fair value of invested assets transferred to affiliates	$ 6.3

XML

Dispositions (Details Narrative) £ in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2014 GBP (£)	Dec. 31, 2014 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Non-investment portfolio gains (losses)	$ 11	$ (2)	$ 43
Goodwill Disposition			112
MetLife Assurance Limited
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net consideration				£ 418	$ 702
Non-investment portfolio gains (losses)			(608)
Non-investment portfolio gains (losses), net of tax			(436)
Goodwill Disposition			112
Goodwill Disposition, net of tax			94
Disposal Group, Including Discontinued Operation, Operating Income (Loss)			$ 77

XML

Insurance (Insurance Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	$ 72,043	$ 70,035
Annuities
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	32,793	28,673
Life
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	6,932	7,309
Run-off
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	24,887	26,885
Corporate & Other
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	$ 7,431	$ 7,168

XML

Insurance (Liabilities for Guarantees) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	$ 5,490	$ 4,528	$ 3,424
Incurred guaranteed benefits	1,422	998	1,127
Paid guaranteed benefits	(60)	(36)	(23)
Balance at December 31,	6,852	5,490	4,528
Variable Annuity Guarantees | Guaranteed Minimum Death Benefit
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	831	619	409
Incurred guaranteed benefits	335	248	233
Paid guaranteed benefits	(60)	(36)	(23)
Balance at December 31,	1,106	831	619
Variable Annuity Guarantees | Guaranteed Minimum Income Benefit
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	1,872	1,535	1,231
Incurred guaranteed benefits	334	337	304
Paid guaranteed benefits	0	0	0
Balance at December 31,	2,206	1,872	1,535
Universal and Variable Life Contracts | Secondary Guarantees
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	2,787	2,374	1,784
Incurred guaranteed benefits	753	413	590
Paid guaranteed benefits	0	0	0
Balance at December 31,	3,540	2,787	2,374
Net Ceded/(Assumed)
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	945	799	353
Incurred guaranteed benefits	151	179	444
Paid guaranteed benefits	(55)	(33)	2
Balance at December 31,	1,041	945	799
Net Ceded/(Assumed) | Secondary Guarantees
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	1,007	846	683
Incurred guaranteed benefits	98	161	163
Paid guaranteed benefits	0	0	0
Balance at December 31,	1,105	1,007	846
Net Ceded/(Assumed) | Guaranteed Minimum Death Benefit
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	(34)	(21)	(200)
Incurred guaranteed benefits	44	20	177
Paid guaranteed benefits	(55)	(33)	2
Balance at December 31,	(45)	(34)	(21)
Net Ceded/(Assumed) | Guaranteed Minimum Income Benefit
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	(28)	(26)	(130)
Incurred guaranteed benefits	9	(2)	104
Paid guaranteed benefits	0	0	0
Balance at December 31,	(19)	(28)	(26)
Net
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	4,545	3,729	3,071
Incurred guaranteed benefits	1,271	819	683
Paid guaranteed benefits	(5)	(3)	(25)
Balance at December 31,	5,811	4,545	3,729
Net | Secondary Guarantees
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	1,780	1,528	1,101
Incurred guaranteed benefits	655	252	427
Paid guaranteed benefits	0	0	0
Balance at December 31,	2,435	1,780	1,528
Net | Guaranteed Minimum Death Benefit
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	865	640	609
Incurred guaranteed benefits	291	228	56
Paid guaranteed benefits	(5)	(3)	(25)
Balance at December 31,	1,151	865	640
Net | Guaranteed Minimum Income Benefit
Movement In Guaranteed Benefit Liability Gross Rollforward
Balance at January 1,	1,900	1,561	1,361
Incurred guaranteed benefits	325	339	200
Paid guaranteed benefits	0	0	0
Balance at December 31,	$ 2,225	$ 1,900	$ 1,561

XML

Insurance (Fund Groupings) (Details) - Variable Annuity and Variable Life - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fund Groupings	$ 100,111	$ 101,499
Balanced
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fund Groupings	52,170	52,837
Equity
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fund Groupings	41,152	42,723
Bond
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fund Groupings	6,086	5,119
Money Market
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fund Groupings	$ 703	$ 820

XML

Insurance (Guarantees Related to Annuity Contracts) (Details) - Variable Annuity Guarantees - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Guaranteed Death Benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value (3)	$ 106,590	$ 108,625
Separate account value	101,991	103,685
Net amount at risk	$ 6,763	$ 8,296
Average attained age of contractholders	67 years	66 years
Guaranteed Annuitization Benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value (3)	$ 61,340	$ 62,645
Separate account value	60,016	61,311
Net amount at risk	$ 3,116	$ 2,241
Average attained age of contractholders	67 years	66 years

XML

Insurance (Guarantees Related to Universal and Variable Life Contracts) (Details) - Universal and Variable Life Contracts - Secondary Guarantees - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value (3)	$ 7,176	$ 6,919
Net amount at risk (6)	$ 90,973	$ 90,940
Average attained age of policyholders	60 years	59 years

XML

Insurance (Obligations Under Funding Agreements - FHLB Common Stock) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Federal Home Loan Bank of Boston
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank Stock	$ 27	$ 36
Federal Home Loan Bank of Des Moines
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank Stock	4	4
Federal Home Loan Bank of Pittsburgh
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank Stock	$ 44	$ 85

XML

Insurance (Obligations Under Funding Agreements - Liability and Collateral) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Fixed and Floating Rate Funding Agreements by Type [Line Items]
Outstanding funding agreements to certain SPEs	$ 127	$ 2,200
Invested Assets Pledged As Collateral	3,548	2,801
Federal Home Loan Bank of Boston
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank amount of advances by branch for funding agreements	50	250
Collateral pledged relating to obligations under funding agreements	144	311
Federal Home Loan Bank of Des Moines
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank amount of advances by branch for funding agreements	95	95
Collateral pledged relating to obligations under funding agreements	266	147
Federal Home Loan Bank of Pittsburgh
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal Home Loan Bank amount of advances by branch for funding agreements	500	1,570
Collateral pledged relating to obligations under funding agreements	$ 3,765	$ 1,789

XML

Insurance (Liabilities for Unpaid Claims and Claim Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Balance at December 31 of prior period	$ 1,693	$ 1,483	$ 1,325
Less: Reinsurance recoverables	1,545	1,400	1,235
Net balance at December 31 of prior period	148	83	90
Incurred related to:
Current year	651	105	3
Prior years	(20)	0	2
Total incurred	631	105	5
Paid related to:
Current year	(626)	(30)	0
Prior years	(63)	(10)	(12)
Total paid	(689)	(40)	(12)
Net balance at December 31,	158	148	83
Add: Reinsurance recoverables	1,811	1,545	1,400
Balance at December 31,	1,969	1,693	1,483
Scenario, Previously Reported [Member]
Net balance at December 31 of prior period	216	83	90
Paid related to:
Net balance at December 31,		216	83
Scenario, Adjustment [Member]
Net balance at December 31 of prior period	$ 68	0	0
Paid related to:
Net balance at December 31,		$ 68	$ 0

XML

Insurance (Insurance Liabilities Assumptions and Ratios - Narrative) (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Liability for Future Policy Benefits and Policyholder Account Balances [Abstract]
Participating business as a percentage of gross life insurance policies in-force	4.00%	3.00%
Participating business as a percentage of the gross life insurance premiums	42.00%	39.00%	35.00%
Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumptions for the aggregate future policy benefit liabilities for individual and group traditional fixed annuities after annuitization	3.00%
Interest rate assumptions for the aggregate future policy benefit liabilities for non-medical health insurance	4.00%
Interest rate assumptions for the aggregate future policy benefit liabilities for disabled lives	3.00%
Interest rate range credited to policyholder account balances	1.00%
Maximum [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumptions for the aggregate future policy benefit liabilities for individual and group traditional fixed annuities after annuitization	8.00%
Interest rate assumptions for the aggregate future policy benefit liabilities for non-medical health insurance	7.00%
Interest rate assumptions for the aggregate future policy benefit liabilities for disabled lives	7.00%
Interest rate range credited to policyholder account balances	8.00%
Participating Life Insurance Policies | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies	.04
Nonparticipating Life Insurance Policies | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies	.03
Nonparticipating Life Insurance Policies | Maximum [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies	.08

XML

Insurance (Obligations Under Funding Agreements - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Insurance [Abstract]
Funding agreements issued to certain SPEs	$ 1,400	$ 13,000	$ 12,200
Funding agreements repaid to certain SPEs	3,400	14,400	$ 13,900
Outstanding funding agreements to certain SPEs	$ 127	$ 2,200

XML

Insurance (Separate Accounts - Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule Separate Accounts [Line Items]
Separate account assets	$ 105,346,000,000	$ 106,527,000,000
Gain (losses) on transfers of assets from the general account to the separate accounts	$ 0	$ 0	$ 0
Funding Agreements and Participating Close Out Contracts Included in Separate Accounts with a Guaranteed Minimum Return or Account Value
Schedule Separate Accounts [Line Items]
Average interest rate credited on separate accounts with a guaranteed minimum return or account value	2.63%	2.56%
Pass Through Separate Accounts
Schedule Separate Accounts [Line Items]
Separate account assets	$ 105,300,000,000	$ 106,300,000,000
Separate Accounts With A Guaranteed Minimum Return Or Account Value
Schedule Separate Accounts [Line Items]
Separate account assets	$ 33,000,000	$ 189,000,000

XML

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (DAC and VOBA) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]
Beginning Balance of DAC	$ 5,066	$ 5,097	$ 5,712
Capitalizations of DAC	330	399	376
Net investment gains (losses) of DAC and net derivative gains (losses) of DAC	1,371	163	(184)
Other expenses of DAC	(1,076)	(690)	(745)
Total amortization of DAC	295	(527)	(929)
Unrealized investment gains (losses) of DAC	(24)	97	(64)
Ending Balance of DAC	5,667	5,066	5,097
Beginning Balance of VOBA	711	763	932
Net investment gains (losses) of VOBA and net derivative gains (losses) of VOBA	2	(19)	(1)
Other expenses of VOBA	(72)	(127)	(139)
Total amortization of VOBA	(70)	(146)	(140)
Unrealized investment gains (losses) of VOBA	31	94	(29)
Ending Balance of VOBA	672	711	763
Balance at December 31,	6,339	5,777	5,860
Deferred Policy Acquisition Cost, Foreign Currency Translation Adjustment and Other	$ 0	$ 0	$ 2

XML

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (DAC and VOBA by Segment) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
DAC and VOBA	$ 6,339	$ 5,777	$ 5,860
Annuities
Segment Reporting Information [Line Items]
DAC and VOBA	4,820	3,724	3,829
Life
Segment Reporting Information [Line Items]
DAC and VOBA	787	969	942
Run-off
Segment Reporting Information [Line Items]
DAC and VOBA	584	974	1,026
Corporate & Other
Segment Reporting Information [Line Items]
DAC and VOBA	$ 148	$ 110	$ 63

XML

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Deferred Sales Inducements) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
DSI
Balance at January 1,	$ 515	$ 566	$ 669
Capitalization	3	3	5
Amortization	(83)	(72)	(80)
Unrealized investment gains (losses)	(3)	18	(28)
Balance at December 31,	$ 432	$ 515	$ 566

XML

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (VODA and VOCRA) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Insurance [Abstract]
Balance at January 1,	$ 136	$ 155	$ 173
Amortization	(16)	(19)	(18)
Balance at December 31,	120	136	155
Accumulated amortization	$ 140	$ 124	$ 105

XML

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Estimated Future Amortization) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016 USD ($)
Estimated future amortization expense allocated to other expenses for VOBA [Abstract]
VOBA 2017	$ 110
VOBA 2018	94
VOBA 2019	80
VOBA 2020	60
VOBA 2021	52
Value of Distribution Agreements and Customer Relationships Acquired [Abstract]
VODA and VOCRA 2017	15
VODA and VOCRA 2018	14
VODA and VOCRA 2019	13
VODA and VOCRA 2020	12
VODA and VOCRA 2021	$ 10

XML

Reinsurance (Effects of Reinsurance on Earnings) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Premiums:
Direct premiums	$ 2,226	$ 2,404	$ 2,359
Reinsurance assumed	81	296	95
Reinsurance ceded	(1,127)	(1,063)	(1,003)
Net premiums	1,180	1,637	1,451
Universal life and investment-type product policy fees:
Direct universal life and investment-type product policy fees	3,582	3,722	3,729
Reinsurance assumed	126	139	383
Reinsurance ceded	(611)	(568)	(502)
Net universal life and investment-type product policy fees	3,097	3,293	3,610
Other revenues:
Direct other revenues	271	271	270
Reinsurance assumed	89	2	30
Reinsurance ceded	349	160	220
Net other revenues	709	433	520
Policyholder benefits and claims:
Direct policyholder benefits and claims	6,101	4,944	4,924
Reinsurance assumed	127	302	254
Reinsurance ceded	(2,490)	(2,159)	(1,980)
Net policyholder benefits and claims	3,738	3,087	3,198
Interest credited to policyholder account balances:
Direct interest credited to policyholder account balances	1,067	1,156	1,180
Reinsurance assumed	75	78	76
Reinsurance ceded	11	10	11
Net interest credited to policyholder account balances	1,131	1,224	1,245
Amortization of deferred policy acquisition costs and value of business acquired
Direct amortization of deferred policy acquisition costs and value of business acquired	(182)	727	1,018
Reinsurance assumed	148	8	99
Reinsurance ceded	(191)	(62)	(48)
Direct amortization of deferred policy acquisition costs and value of business acquired	(225)	673	1,069
Other expenses:
Direct other expenses	1,700	1,723	1,797
Reinsurance assumed	36	47	3
Reinsurance ceded	(36)	(47)	(43)
Total other expenses	$ 1,700	$ 1,723	$ 1,757

XML

Reinsurance (Effects of Reinsurance on Balance Sheet) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Assets:
Premiums, reinsurance and other receivables	$ 13,853	$ 18,104
Deferred policy acquisition costs and value of business acquired	6,339	5,777	$ 5,860
Total assets	20,192	23,881
Liabilities:
Future policy benefits	32,752	30,508
Policyholder Account Balances	36,579	36,725	$ 36,585
Other policy-related balances	2,712	2,802
Other Liabilities	5,445	3,925
Total liabilities	77,488	73,960
Direct
Assets:
Premiums, reinsurance and other receivables	1,161	765
Deferred policy acquisition costs and value of business acquired	6,638	6,013
Total assets	7,799	6,778
Liabilities:
Future policy benefits	32,520	29,214
Policyholder Account Balances	35,838	36,013
Other policy-related balances	1,035	999
Other Liabilities	4,525	2,620
Total liabilities	73,918	68,846
Assumed
Assets:
Premiums, reinsurance and other receivables	23	161
Deferred policy acquisition costs and value of business acquired	71	218
Total assets	94	379
Liabilities:
Future policy benefits	232	1,294
Policyholder Account Balances	741	712
Other policy-related balances	1,677	1,804
Other Liabilities	13	87
Total liabilities	2,663	3,897
Ceded
Assets:
Premiums, reinsurance and other receivables	12,669	17,178
Deferred policy acquisition costs and value of business acquired	(370)	(454)
Total assets	12,299	16,724
Liabilities:
Future policy benefits	0	0
Policyholder Account Balances	0	0
Other policy-related balances	0	(1)
Other Liabilities	907	1,218
Total liabilities	$ 907	$ 1,217

XML

Reinsurance (Effects of Affiliated Reinsurance on Statements of Operations) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Premiums:
Reinsurance assumed	$ 81	$ 296	$ 95
Reinsurance ceded	(1,127)	(1,063)	(1,003)
Net premiums	1,180	1,637	1,451
Universal life and investment-type product policy fees:
Reinsurance assumed	126	139	383
Reinsurance ceded	(611)	(568)	(502)
Net universal life and investment-type product policy fees	3,097	3,293	3,610
Other revenues:
Reinsurance assumed	89	2	30
Reinsurance ceded	349	160	220
Net other revenues	709	433	520
Policyholder benefits and claims:
Reinsurance assumed	127	302	254
Reinsurance ceded	(2,490)	(2,159)	(1,980)
Net policyholder benefits and claims	3,738	3,087	3,198
Interest credited to policyholder account balances:
Reinsurance assumed	75	78	76
Reinsurance ceded	(11)	(10)	(11)
Net interest credited to policyholder account balances	1,131	1,224	1,245
Reinsurance assumed	148	8	99
Reinsurance ceded	(191)	(62)	(48)
Direct amortization of deferred policy acquisition costs and value of business acquired	(225)	673	1,069
Other expenses:
Reinsurance assumed	36	47	3
Reinsurance ceded	(36)	(47)	(43)
Net other expenses	1,700	1,723	1,757
Affiliated Entity [Member]
Other expenses:
Net other expenses	847	1,100	1,100
Affiliated Entity [Member] | Assumed
Premiums:
Reinsurance assumed	35	227	56
Universal life and investment-type product policy fees:
Reinsurance assumed	126	139	276
Other revenues:
Reinsurance assumed	59	2	30
Policyholder benefits and claims:
Reinsurance assumed	90	252	220
Interest credited to policyholder account balances:
Reinsurance assumed	75	78	76
Reinsurance assumed	49	24	90
Other expenses:
Reinsurance assumed	19	41	(2)
Affiliated Entity [Member] | Ceded
Premiums:
Reinsurance ceded	(766)	(687)	(652)
Universal life and investment-type product policy fees:
Reinsurance ceded	(60)	(58)	(47)
Other revenues:
Reinsurance ceded	348	160	220
Policyholder benefits and claims:
Reinsurance ceded	(737)	(656)	(622)
Interest credited to policyholder account balances:
Reinsurance ceded	(11)	(10)	(11)
Reinsurance ceded	(175)	(59)	(42)
Other expenses:
Reinsurance ceded	(21)	(31)	(23)
Affiliated Entity [Member] | Reinsurance [Member]
Premiums:
Net premiums	(731)	(460)	(596)
Universal life and investment-type product policy fees:
Net universal life and investment-type product policy fees	66	81	229
Other revenues:
Net other revenues	407	162	250
Policyholder benefits and claims:
Net policyholder benefits and claims	(647)	(404)	(402)
Interest credited to policyholder account balances:
Net interest credited to policyholder account balances	64	68	65
Direct amortization of deferred policy acquisition costs and value of business acquired	(126)	(35)	48
Other expenses:
Net other expenses	$ (2)	$ 10	$ (25)

XML

Reinsurance (Effects of Affiliated Reinsurance on Balance Sheets) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Assets:
Premiums, reinsurance and other receivables	$ 13,853	$ 18,104
Deferred policy acquisition costs and value of business acquired	6,339	5,777	$ 5,860
Total assets	20,192	23,881
Liabilities:
Future policy benefits	32,752	30,508
Policyholder account balances	36,579	36,725	$ 36,585
Other policy-related balances	2,712	2,802
Other Liabilities	5,445	3,925
Total liabilities	77,488	73,960
Assumed
Assets:
Premiums, reinsurance and other receivables	23	161
Deferred policy acquisition costs and value of business acquired	71	218
Total assets	94	379
Liabilities:
Future policy benefits	232	1,294
Policyholder account balances	741	712
Other policy-related balances	1,677	1,804
Other Liabilities	13	87
Total liabilities	2,663	3,897
Assumed | Affiliated Entity [Member]
Assets:
Premiums, reinsurance and other receivables	23	128
Deferred policy acquisition costs and value of business acquired	71	120
Total assets	94	248
Liabilities:
Future policy benefits	211	630
Policyholder account balances	741	712
Other policy-related balances	1,677	1,785
Other Liabilities	11	28
Total liabilities	2,640	3,155
Ceded
Assets:
Premiums, reinsurance and other receivables	12,669	17,178
Deferred policy acquisition costs and value of business acquired	(370)	(454)
Total assets	12,299	16,724
Liabilities:
Future policy benefits	0	0
Policyholder account balances	0	0
Other policy-related balances	0	(1)
Other Liabilities	907	1,218
Total liabilities	907	1,217
Ceded | Affiliated Entity [Member]
Assets:
Premiums, reinsurance and other receivables	3,382	8,452
Deferred policy acquisition costs and value of business acquired	(356)	(439)
Total assets	3,026	8,013
Liabilities:
Future policy benefits	0	0
Policyholder account balances	0	0
Other policy-related balances	0	(1)
Other Liabilities	578	876
Total liabilities	$ 578	$ 875

XML

Reinsurance (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reinsurance Disclosures [Abstract]
Deposit assets in premiums, reinsurance, and other receivables or secondary guarantee risk for reinsurance	$ 1,500.0	$ 6,600.0
Deposit liabilities in other liabilities for reinsurance	1.0	1.0
Ceded Credit Risk [Line Items]
Reinsurance recoverables	9,100.0	8,600.0
Reinsurance Recoverables, Allowance	0.0	0.0
Future policy benefits	32,752.0	30,508.0
Other policy-related balances	2,712.0	2,802.0
Other assets, principally at estimated fair value	689.0	862.0
Other Investments	5,029.0	6,129.0
Deferred Policy Acquisition Costs and Value of Business Acquired	6,339.0	5,777.0	$ 5,860.0
Other Liabilities	5,445.0	3,925.0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ (4,465.0)	1,165.0	$ 1,068.0
PWL [Member]
Ceded Credit Risk [Line Items]
Percentage Of Participating Whole Life Insurance Policies	90.00%
Future policy benefits	$ (654.0)
Other Investments	(713.0)
Deferred Policy Acquisition Costs and Value of Business Acquired	(95.0)
Other Liabilities	(43.0)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(72.0)
Five Largest Ceded Reinsurers [Member]
Ceded Credit Risk [Line Items]
Five largest reinsurers, reinsurance recoverables amount	$ 7,800.0	$ 7,400.0
Five largest reinsurers, reinsurance recoverables percentage	86.00%	86.00%
Mortality Risk [Member]
Reinsurance Retention Policy [Line Items]
Percentage of reinsured risk in excess of stated amount	90.00%
Retention amount	$ 2.0
Mortality Risk on Case by Case Basis [Member]
Reinsurance Retention Policy [Line Items]
Percentage of reinsured risk in excess of stated amount	100.00%
Retention amount	$ 20.0
Quota Share Reinsurance for Certain Disability Business [Member]
Reinsurance Retention Policy [Line Items]
Reinsured risk percentage	100.00%
Living And Death Benefit Guarantees [Member]
Reinsurance Retention Policy [Line Items]
Reinsured risk percentage	100.00%
Ceded Credit Risk, Unsecured [Member]
Ceded Credit Risk [Line Items]
Reinsurance recoverables	$ 2,600.0	$ 2,500.0
Ceded Credit Risk, Unsecured [Member] | Five Largest Ceded Reinsurers [Member]
Ceded Credit Risk [Line Items]
Five largest reinsurers, reinsurance recoverables amount	$ 1,500.0	$ 1,500.0

XML

Reinsurance (Related Party Narrative) (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jan. 01, 2017	Apr. 01, 2016
Reinsurance Disclosures [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Liability			$ 3,170,000,000	$ 840,000,000
Other Liabilities			5,445,000,000	3,925,000,000
Net derivatives gains (losses)			(1,741,000,000)	(344,000,000)	$ (576,000,000)
Premiums, reinsurance and other receivables			13,853,000,000	18,104,000,000
Deferred Policy Acquisition Costs and Value of Business Acquired			6,339,000,000	5,777,000,000	5,860,000,000
Other Assets			689,000,000	862,000,000
Future policy benefits			32,752,000,000	30,508,000,000
Other Policy-Related Balances			2,712,000,000	2,802,000,000
Embedded Derivative, Fair Value of Embedded Derivative Asset			360,000,000	336,000,000
Reinsurance recoverables			9,100,000,000	8,600,000,000
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest			(4,465,000,000)	1,165,000,000	1,068,000,000
Deposit Contracts, Assets			1,500,000,000	6,600,000,000
Deposit Contracts, Liabilities			1,000,000	1,000,000
Affiliated Entity [Member]
Reinsurance Disclosures [Abstract]
Reinsurance recoverables			2,600,000,000	7,500,000,000
Deposit Contracts, Assets			1,400,000,000	6,400,000,000
Deposit Contracts, Liabilities			0	0
Affiliated Entity [Member] | Assumed guaranteed minimum benefits
Reinsurance Disclosures [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Liability			741,000,000	712,000,000
Net derivatives gains (losses)			(21,000,000)	(47,000,000)	(453,000,000)
Affiliated Entity [Member] | Ceded guaranteed minimum benefits
Reinsurance Disclosures [Abstract]
Net derivatives gains (losses)			46,000,000	54,000,000	$ 42,000,000
Embedded Derivative, Fair Value of Embedded Derivative Asset			171,000,000	126,000,000
Affiliated Entity [Member] | Recapture MLUS [Member]
Reinsurance Disclosures [Abstract]
Other Liabilities							$ 4,000,000,000
Cash, Cash Equivalents, and Short-term Investments							4,300,000,000
Deferred Policy Acquisition Costs and Value of Business Acquired							$ 87,000,000
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ 246,000,000
Subsequent Event [Member] | Affiliated Entity [Member] | MLUS Recapture GMIB [Member]
Reinsurance Disclosures [Abstract]
Cash, Cash Equivalents, and Short-term Investments						$ 568,000,000
Premiums, reinsurance and other receivables						140,000,000
Future policy benefits						$ 106,000,000
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest		$ 89,000,000
Ceded Reinsurance [Member]
Reinsurance Disclosures [Abstract]
Other Liabilities			907,000,000	1,218,000,000
Premiums, reinsurance and other receivables			12,669,000,000	17,178,000,000
Deferred Policy Acquisition Costs and Value of Business Acquired			(370,000,000)	(454,000,000)
Future policy benefits			0	0
Other Policy-Related Balances			0	(1,000,000)
Ceded Reinsurance [Member] | Affiliated Entity [Member]
Reinsurance Disclosures [Abstract]
Other Liabilities			578,000,000	876,000,000
Premiums, reinsurance and other receivables			3,382,000,000	8,452,000,000
Deferred Policy Acquisition Costs and Value of Business Acquired			(356,000,000)	(439,000,000)
Future policy benefits			0	0
Other Policy-Related Balances			$ 0	$ (1,000,000)

XML

Investments (Fixed Maturity and Equity Securities Available-For-Sale by Sector) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	$ 57,289	$ 59,852
Cost or Amortized Cost	280	432
Gross Unrealized OTTI Loss	1	(23)	$ (38)
Available-for-sale Securities, Debt Securities	59,899	62,121
Equity securities	300	457
Fixed Maturity Securities
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	57,289	59,852
Gross Unrealized Gain	3,532	3,362
Gross Unrealized Temporary Loss	923	1,070
Gross Unrealized OTTI Loss	(1)	23
Available-for-sale Securities, Debt Securities	59,899	62,121
U.S. corporate
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	20,663	19,930
Gross Unrealized Gain	1,287	1,077
Gross Unrealized Temporary Loss	285	532
Gross Unrealized OTTI Loss	0	0
Available-for-sale Securities, Debt Securities	21,665	20,475
U.S. government and agency
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	11,872	13,145
Gross Unrealized Gain	1,281	1,362
Gross Unrealized Temporary Loss	237	66
Gross Unrealized OTTI Loss	0	0
Available-for-sale Securities, Debt Securities	12,916	14,441
RMBS
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	7,876	9,803
Gross Unrealized Gain	203	219
Gross Unrealized Temporary Loss	139	127
Gross Unrealized OTTI Loss	0	22
Available-for-sale Securities, Debt Securities	7,940	9,873
Foreign corporate
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	6,071	5,536
Gross Unrealized Gain	220	165
Gross Unrealized Temporary Loss	168	217
Gross Unrealized OTTI Loss	0	1
Available-for-sale Securities, Debt Securities	6,123	5,483
State and political subdivision
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	3,520	3,184
Gross Unrealized Gain	376	387
Gross Unrealized Temporary Loss	38	24
Gross Unrealized OTTI Loss	0	1
Available-for-sale Securities, Debt Securities	3,858	3,546
CMBS
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	3,687	3,286
Gross Unrealized Gain	40	28
Gross Unrealized Temporary Loss	32	34
Gross Unrealized OTTI Loss	(1)	(1)
Available-for-sale Securities, Debt Securities	3,696	3,281
ABS
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	2,600	4,303
Gross Unrealized Gain	11	19
Gross Unrealized Temporary Loss	13	59
Gross Unrealized OTTI Loss	0	0
Available-for-sale Securities, Debt Securities	2,598	4,263
Foreign government
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	1,000	665
Gross Unrealized Gain	114	105
Gross Unrealized Temporary Loss	11	11
Gross Unrealized OTTI Loss	0	0
Available-for-sale Securities, Debt Securities	1,103	759
Equity securities
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	280	432
Gross Unrealized Gain	29	38
Gross Unrealized Temporary Loss	9	14
Gross Unrealized OTTI Loss	0	0
Equity securities	300	457
Non-redeemable preferred stock
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	180	265
Gross Unrealized Gain	6	15
Gross Unrealized Temporary Loss	9	9
Gross Unrealized OTTI Loss	0	0
Equity securities	177	272
Common Stock
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	100	167
Gross Unrealized Gain	23	23
Gross Unrealized Temporary Loss	0	5
Gross Unrealized OTTI Loss	0	0
Equity securities	$ 123	$ 185

XML

Investments (Maturities of Fixed Maturity Securities) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Available-for-sale Securities, Debt Maturities [Abstract]
Amortized Cost, Due in one year or less	$ 1,824
Amortized Cost, Due after one year through five years	9,020
Amortized Cost, Due after five years through ten years	9,814
Amortized Cost, Due after ten years	22,468
Amortized Cost, Structured Securities	14,163
Amortized Cost, Subtotal	57,289	$ 59,852
Estimated Fair Value, Due in one year or less	1,829
Estimated Fair Value, Due after one year through five years	9,408
Estimated Fair Value, Due after five years through ten years	9,931
Estimated Fair Value, Due after ten years	24,497
Estimated Fair Value, Structured Securities	14,234
Available-for-sale Securities, Debt Securities	$ 59,899	$ 62,121

XML

Investments (Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities Available-For-Sale) (Details) $ in Millions	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Total number of securities in an unrealized loss position less than 12 months	1,711	2,224
Total number of securities in an unrealized loss position equal to or greater than 12 months	475	452
Fixed maturity securities
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	$ 17,060	$ 22,961
Less than 12 Months Gross Unrealized Loss	671	765
Equal to or Greater than 12 Months Estimated Fair Value	2,757	2,725
Equal to or Greater than 12 Months Gross Unrealized Loss	251	328
U.S. corporate
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	4,632	6,365
Less than 12 Months Gross Unrealized Loss	187	383
Equal to or Greater than 12 Months Estimated Fair Value	699	832
Equal to or Greater than 12 Months Gross Unrealized Loss	98	149
Foreign corporate
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	1,443	1,896
Less than 12 Months Gross Unrealized Loss	64	107
Equal to or Greater than 12 Months Estimated Fair Value	573	680
Equal to or Greater than 12 Months Gross Unrealized Loss	104	111
U.S. government and agency
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	4,396	4,256
Less than 12 Months Gross Unrealized Loss	237	66
Equal to or Greater than 12 Months Estimated Fair Value	0	0
Equal to or Greater than 12 Months Gross Unrealized Loss	0	0
RMBS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	3,457	5,172
Less than 12 Months Gross Unrealized Loss	107	105
Equal to or Greater than 12 Months Estimated Fair Value	818	520
Equal to or Greater than 12 Months Gross Unrealized Loss	32	44
State and political subdivision
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	887	624
Less than 12 Months Gross Unrealized Loss	35	22
Equal to or Greater than 12 Months Estimated Fair Value	29	43
Equal to or Greater than 12 Months Gross Unrealized Loss	3	3
ABS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	450	2,651
Less than 12 Months Gross Unrealized Loss	5	42
Equal to or Greater than 12 Months Estimated Fair Value	461	547
Equal to or Greater than 12 Months Gross Unrealized Loss	8	17
CMBS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	1,553	1,864
Less than 12 Months Gross Unrealized Loss	26	30
Equal to or Greater than 12 Months Estimated Fair Value	171	97
Equal to or Greater than 12 Months Gross Unrealized Loss	5	3
Foreign government
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	242	133
Less than 12 Months Gross Unrealized Loss	10	10
Equal to or Greater than 12 Months Estimated Fair Value	6	6
Equal to or Greater than 12 Months Gross Unrealized Loss	1	1
Equity securities
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	57	31
Less than 12 Months Gross Unrealized Loss	2	6
Equal to or Greater than 12 Months Estimated Fair Value	40	41
Equal to or Greater than 12 Months Gross Unrealized Loss	7	8
Non-redeemable preferred stock
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	57	24
Less than 12 Months Gross Unrealized Loss	2	1
Equal to or Greater than 12 Months Estimated Fair Value	40	40
Equal to or Greater than 12 Months Gross Unrealized Loss	7	8
Common stock
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	0	7
Less than 12 Months Gross Unrealized Loss	0	5
Equal to or Greater than 12 Months Estimated Fair Value	0	1
Equal to or Greater than 12 Months Gross Unrealized Loss	$ 0	$ 0

XML

Investments (Mortgage Loans by Portfolio Segment) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Company-held mortgage loans held-for-investment, net
Commercial mortgage loans	$ 6,497	$ 5,452
Percentage of loans receivable on commercial mortgage loans	69.90%	73.70%
Agricultural mortgage loans	$ 1,830	$ 1,481
Percentage of loans receivable on agricultural mortgage loans	19.70%	20.00%
Residential	$ 867	$ 335
Percentage Of Loans And Leases Receivable Consumer Mortgage To Mortgage Loans On Real Estate Commercial And Consumer Net	9.30%	4.50%
Subtotal	$ 9,194	$ 7,268
Percentage of loans receivable on subtotal	98.90%	98.20%
Valuation allowances	$ (40)	$ (36)	$ (25)	$ (35)
Percentage of loans receivable on valuation allowances	(0.40%)	(0.50%)
Subtotal mortgage loans, net	$ 9,154	$ 7,232
Percentage of loans receivable on subtotal mortgage loans held-for-investment, net	98.50%	97.70%
Percentage of loans receivable on commercial mortgage loans held by consolidated securitization entities - fair value option	1.50%	2.30%
Mortgage Loans on Real Estate	$ 9,290	$ 7,404
Percentage of total mortgage loans, net	100.00%	100.00%
Variable Interest Entity, Primary Beneficiary, Consolidated Securitization Entities
Company-held mortgage loans held-for-investment, net
Mortgage Loans on Real Estate	$ 136	$ 172

XML

Investments (Mortgage Loans and Valuation Allowance by Portfolio Segment) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	$ 4	$ 4
Recorded Investment	3	3
Valuation Allowances	0	0
Unpaid Principal Balance	1	0
Recorded Investment	1	0
Recorded Investment	9,190	7,265
Valuation Allowances	40	36
Carrying Value	4	3
Average Recorded Investment	3	3
Commercial
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	0	0
Recorded Investment	0	0
Valuation Allowances	0	0
Unpaid Principal Balance	0	0
Recorded Investment	0	0
Recorded Investment	6,497	5,452
Valuation Allowances	32	28
Carrying Value	0	0
Average Recorded Investment	0	0	$ 43
Agricultural
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	4	4
Recorded Investment	3	3
Valuation Allowances	0	0
Unpaid Principal Balance	0	0
Recorded Investment	0	0
Recorded Investment	1,827	1,478
Valuation Allowances	5	5
Carrying Value	3	3
Average Recorded Investment	3	3	3
Residential
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	0	0
Recorded Investment	0	0
Valuation Allowances	0	0
Unpaid Principal Balance	1	0
Recorded Investment	1	0
Recorded Investment	866	335
Valuation Allowances	3	3
Carrying Value	1	0
Average Recorded Investment	$ 0	$ 0	$ 0

XML

Investments (Valuation Allowance Rollforward by Portfolio Segment) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Mortgage Loans on Real Estate [Line Items]
Beginning Balance	$ 36	$ 25	$ 35
Provision (release)	4	11	(10)
Ending Balance	40	36	25
Commercial
Mortgage Loans on Real Estate [Line Items]
Beginning Balance	28	21	31
Provision (release)	4	7	(10)
Ending Balance	32	28	21
Agricultural
Mortgage Loans on Real Estate [Line Items]
Beginning Balance	5	4	4
Provision (release)	0	1	0
Ending Balance	5	5	4
Residential
Mortgage Loans on Real Estate [Line Items]
Beginning Balance	3	0	0
Provision (release)	0	3	0
Ending Balance	$ 3	$ 3	$ 0

XML

Investments (Credit Quality of Commercial Mortgage Loans) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 6,497	$ 5,452
% of Total	100.00%	100.00%
Estimated Fair Value	$ 6,570	$ 5,662
% of Total	100.00%	100.00%
Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 6,115	$ 5,029
% of Total	94.10%	92.20%
Estimated Fair Value	$ 6,197	$ 5,250
% of Total	94.30%	92.70%
65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 310	$ 340
% of Total	4.80%	6.20%
Estimated Fair Value	$ 303	$ 332
% of Total	4.60%	5.90%
76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 34	$ 0
% of Total	0.50%	0.00%
Estimated Fair Value	$ 33	$ 0
% of Total	0.50%	0.00%
Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 38	$ 83
% of Total	0.60%	1.60%
Estimated Fair Value	$ 37	$ 80
% of Total	0.60%	1.40%
Greater than 1.20x
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 6,067	$ 5,145
Greater than 1.20x | Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	5,718	4,771
Greater than 1.20x | 65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	291	330
Greater than 1.20x | 76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	34	0
Greater than 1.20x | Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	24	44
1.00x - 1.20x
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	244	178
1.00x - 1.20x | Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	230	153
1.00x - 1.20x | 65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	0	0
1.00x - 1.20x | 76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	0	0
1.00x - 1.20x | Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	14	25
Less than 1.00x
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	186	129
Less than 1.00x | Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	167	105
Less than 1.00x | 65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	19	10
Less than 1.00x | 76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	0	0
Less than 1.00x | Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 0	$ 14

XML

Investments (Credit Quality of Agricultural and Residential Mortgage Loans) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded investment in Mortgage Loan	$ 1,830	$ 1,481
% of Total	100.00%	100.00%
Residential Mortgage Loans By Credit Quality Indicator [Abstract]
Recorded Investment	$ 867	$ 335
% of Total	100.00%	100.00%
Less than 65%
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded investment in Mortgage Loan	$ 1,789	$ 1,386
% of Total	97.80%	93.60%
65% to 75%
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded investment in Mortgage Loan	$ 41	$ 95
% of Total	2.20%	6.40%
Performing
Residential Mortgage Loans By Credit Quality Indicator [Abstract]
Recorded Investment	$ 856	$ 331
% of Total	98.70%	98.80%
Nonperforming
Residential Mortgage Loans By Credit Quality Indicator [Abstract]
Recorded Investment	$ 11	$ 4
% of Total	1.30%	1.20%

XML

Investments (Investment in Leverage Leases) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Investment in leveraged leases
Rental receivables, net	$ 87	$ 90
Estimated residual values	14	14
Subtotal	101	104
Unearned income	(32)	(33)
Investment in leveraged leases, net of non-recourse debt	$ 69	$ 71

XML

Investments (Net Unrealized Investment Gains Losses) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Components of net unrealized investment gains (losses) included in accumulated other comprehensive loss
Fixed maturity securities	$ 2,600	$ 2,283	$ 4,729
Fixed maturity securities with noncredit OTTI losses included in AOCI	1	(23)	(38)
Total fixed maturity securities	2,601	2,260	4,691
Equity securities	32	54	69
Derivatives	397	370	281
Short-term investments	(42)	0	0
Other	59	79	10
Subtotal	3,047	2,763	5,051
Future policy benefits	(922)	(126)	(613)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2)	(1)	(2)
DAC, VOBA and DSI	(193)	(198)	(406)
Subtotal	(1,117)	(325)	(1,021)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	0	9	14
Deferred income tax benefit (expense)	(653)	(827)	(1,416)
Net unrealized investment gains (losses)	$ 1,277	$ 1,620	$ 2,628

XML

Investments (Changes in Fixed Maturity Securities with Noncredit OTTI Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Changes in fixed maturity securities with noncredit OTTI losses in accumulated other comprehensive income (loss)
Balance at January 1,	$ (23)	$ (38)
Noncredit OTTI losses and subsequent changes recognized	3	8
Securities sold with previous noncredit OTTI loss	18	19
Subsequent changes in estimated fair value	3	(12)
Balance at December 31,	$ 1	$ (23)

XML

Investments (Changes in Net Unrealized Investment Gains Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Changes In Net Unrealized Investment Gains Losses Included In Accumulated Other Comprehensive Loss [Abstract]
Balance at January 1,	$ 1,620	$ 2,628	$ 930
Fixed maturity securities on which noncredit OTTI losses have been recognized	24	15	15
Unrealized investment gains (losses) during the year	260	(2,303)	3,234
Unrealized investment gains (losses) relating to
Future policy benefits	(796)	487	(613)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(1)	1	(2)
DAC, VOBA and DSI	5	208	(119)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(9)	(5)	(4)
Deferred income tax benefit (expense)	174	589	(813)
Balance at December 31,	1,277	1,620	2,628
Change in net unrealized investment gains (losses)	$ (343)	$ (1,008)	$ 1,698

XML

Investments (Securities Lending) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Securities Financing Transaction [Line Items]
Cash collateral on deposit from counterparties	$ 6,642	$ 8,981
Security collateral on deposit from counterparties	27	23
Reinvestment portfolio — estimated fair value	6,571	8,938
Amortized cost
Securities Financing Transaction [Line Items]
Securities loaned	5,895	8,047
Estimated fair value
Securities Financing Transaction [Line Items]
Securities loaned	$ 6,555	$ 8,830

XML

Investments (Securities Lending Remaining Tenor) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Securities Financing Transaction [Line Items]
Total	$ 6,642	$ 8,981
Maturity Overnight
Securities Financing Transaction [Line Items]
Total	2,129	2,641
Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	2,496	4,423
Maturity 30 to 180 Days
Securities Financing Transaction [Line Items]
Total	2,017	1,917
U.S. government and agency
Securities Financing Transaction [Line Items]
Total	5,778	7,109
U.S. government and agency | Maturity Overnight
Securities Financing Transaction [Line Items]
Total	2,129	2,631
U.S. government and agency | Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	1,906	3,140
U.S. government and agency | Maturity 30 to 180 Days
Securities Financing Transaction [Line Items]
Total	1,743	1,338
U.S. corporate
Securities Financing Transaction [Line Items]
Total	480	311
U.S. corporate | Maturity Overnight
Securities Financing Transaction [Line Items]
Total	0	9
U.S. corporate | Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	480	302
U.S. corporate | Maturity 30 to 180 Days
Securities Financing Transaction [Line Items]
Total	0	0
Agency RMBS
Securities Financing Transaction [Line Items]
Total	274	1,518
Agency RMBS | Maturity Overnight
Securities Financing Transaction [Line Items]
Total	0	0
Agency RMBS | Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	0	939
Agency RMBS | Maturity 30 to 180 Days
Securities Financing Transaction [Line Items]
Total	274	579
Foreign corporate
Securities Financing Transaction [Line Items]
Total	58	0
Foreign corporate | Maturity Overnight
Securities Financing Transaction [Line Items]
Total	0	0
Foreign corporate | Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	58	0
Foreign corporate | Maturity 30 to 180 Days
Securities Financing Transaction [Line Items]
Total	0	0
Foreign government
Securities Financing Transaction [Line Items]
Total	52	43
Foreign government | Maturity Overnight
Securities Financing Transaction [Line Items]
Total	0	1
Foreign government | Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	52	42
Foreign government | Maturity 30 to 180 Days
Securities Financing Transaction [Line Items]
Total	$ 0	$ 0

XML

Investments (Invested Assets on Deposit, Held In Trust and Pledged as Collateral) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Investments, Debt and Equity Securities [Abstract]
Invested assets on deposit (regulatory deposits)	$ 7,644	$ 7,247
Invested assets held-in-trust (reinsurance agreements)	9,054	8,083
Invested assets pledged as collateral	3,548	2,801
Total invested assets on deposit, held in trust, and pledged as collateral	$ 20,246	$ 18,131

XML

Investments (PCI Investments by Invested Asset Class) (Details) - Fixed maturity securities - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Purchased credit impaired investments, by invested asset class, held:
Outstanding principal and interest balance	$ 1,458	$ 1,219
Carrying value	$ 1,113	$ 907

XML

Investments (PCI Investments Acquired) (Details) - Fixed maturity securities - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Purchased credit impaired investments as of their respective acquisition dates
Contractually required payments (including interest)	$ 558	$ 797
Cash flows expected to be collected	483	709
Fair value of investments acquired	$ 341	$ 520

XML

Investments (Activity For Accretable Yield on PCI Investments) (Details) - Fixed maturity securities - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Accretable yield on purchased distressed assets acquired
Accretable yield, January 1,	$ 400	$ 244
Accretion recognized in earnings	(66)	(47)
Disposals	(8)	(8)
Reclassification (to) from nonaccretable difference	(49)	22
Accretable yield, December 31,	419	400
Investments Purchased [Member]
Accretable yield on purchased distressed assets acquired
Additions	$ 142	$ 189

XML

Investments (Consolidated Variable Interest Entities) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Assets:
Accrued Investment Income Receivable	$ 668	$ 585
Liabilities
Long-term debt, at estimated fair value, relating to variable interest entities	1,904	1,936
Other liabilities relating to variable interest entities	5,445	3,925
Mrsc Collateral Financing Arrangement [Member]
Assets:
Total assets	3,422	3,374
Consolidated securitization entities
Assets:
Mortgage loans (commercial mortgage loans)	136	172
Accrued Investment Income Receivable	1	1
Total assets	137	173
Liabilities
Long-term debt, at estimated fair value, relating to variable interest entities	23	48
Other liabilities relating to variable interest entities	1	1
Total liabilities	$ 24	$ 49

XML

Investments (Unconsolidated Variable Interest Entities) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Variable Interest Entity [Line Items]
Carrying Amount Asset	$ 14,913	$ 18,539
Carrying Amount Liability	15,720	18,825
Other limited partnership interests
Variable Interest Entity [Line Items]
Carrying Amount Asset	1,491	1,367
Carrying Amount Liability	2,287	1,646
Real estate joint ventures
Variable Interest Entity [Line Items]
Carrying Amount Asset	17	35
Carrying Amount Liability	22	38
Other Investments [Member]
Variable Interest Entity [Line Items]
Carrying Amount Asset	60	58
Carrying Amount Liability	66	62
Structured securities
Variable Interest Entity [Line Items]
Carrying Amount Asset	12,809	16,454
Carrying Amount Liability	12,809	16,454
U.S. and foreign corporate
Variable Interest Entity [Line Items]
Carrying Amount Asset	536	625
Carrying Amount Liability	$ 536	$ 625

XML

Investments (Net Investment Income) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net Investment Income [Line Items]
Gross Investment Income, Operating	$ 3,100	$ 2,985	$ 2,935
Less: Investment expenses	173	126	111
Net investment income	3,111	3,001	2,984
Securities Investment
Net Investment Income [Line Items]
Gross Investment Income, Operating	3,273	3,111	3,046
Fixed maturity securities
Net Investment Income [Line Items]
Gross Investment Income, Operating	2,567	2,398	2,269
Equity securities
Net Investment Income [Line Items]
Gross Investment Income, Operating	19	19	17
Mortgage loans
Net Investment Income [Line Items]
Gross Investment Income, Operating	393	367	344
Policy loans
Net Investment Income [Line Items]
Gross Investment Income, Operating	54	54	59
Real estate and real estate joint ventures
Net Investment Income [Line Items]
Gross Investment Income, Operating	32	108	80
Other limited partnership interests
Net Investment Income [Line Items]
Gross Investment Income, Operating	163	134	266
Cash, cash equivalents and short-term investments
Net Investment Income [Line Items]
Gross Investment Income, Operating	20	9	5
Operating joint venture
Net Investment Income [Line Items]
Gross Investment Income, Operating	11	11	2
Other
Net Investment Income [Line Items]
Gross Investment Income, Operating	14	11	4
FVO CSEs — interest income — commercial mortgage loans | Variable Interest Entity, Primary Beneficiary, Consolidated Securitization Entities
Net Investment Income [Line Items]
Gross Investment Income, Operating	$ 11	$ 16	$ 49

XML

Investments (Components of Net Investment Gains Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Marketable Securities, Gain (Loss) [Abstract]
Fixed maturity securities — net gains (losses) on sales and disposals	$ (28)	$ (60)	$ 10
Equity securities — net gains (losses) on sales and disposals	10	18	14
Other net investment gains (losses):
Mortgage loans	5	(11)	18
Real estate and real estate joint ventures	(34)	98	(4)
Other limited partnership interests	(7)	(1)	(9)
Other	11	(2)	43
Subtotal	(67)	8	43
FVO CSEs - changes in estimated fair value:
Commercial mortgage loans	(2)	(7)	(13)
Long-term debt — related to commercial mortgage loans	1	4	19
Non-investment portfolio gains (losses)	1	0	(538)
Subtotal	0	(3)	(532)
Total net investment gains (losses)	(67)	5	(489)
Fixed maturity securities
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	(22)	(31)	(14)
Net investment gains (losses)	(50)	(91)	(4)
Industrial
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	(16)	(3)	0
Consumer
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	0	(8)	(2)
Public Utility, Bonds [Member]
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	0	(6)	0
Transportation
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	0	0	(2)
U.S. and foreign corporate
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	(16)	(17)	(4)
RMBS
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	(6)	(14)	(10)
Equity securities
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	(2)	(3)	(15)
Net investment gains (losses)	8	15	(1)
Common Stock
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	(1)	(3)	(7)
Non-redeemable preferred stock
Gain (Loss) on Investments [Line Items]
Total OTTI losses recognized in earnings	$ (1)	$ 0	$ (8)

XML

Investments (Sales or Disposals and Impairments of Fixed Maturity and Equity Securities) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Fixed maturity securities
Components of Sales or Disposals of Fixed Maturity and Equity Securities
Proceeds	$ 39,210	$ 32,085	$ 16,943
Gross investment gains	253	184	95
Gross investment losses	(281)	(244)	(85)
Total OTTI losses recognized in earnings:
Total OTTI losses recognized in earnings	(22)	(31)	(14)
Net investment gains (losses)	(50)	(91)	(4)
Equity securities
Components of Sales or Disposals of Fixed Maturity and Equity Securities
Proceeds	48	80	57
Gross investment gains	10	26	15
Gross investment losses	0	(8)	(1)
Total OTTI losses recognized in earnings:
Total OTTI losses recognized in earnings	(2)	(3)	(15)
Net investment gains (losses)	$ 8	$ 15	$ (1)

XML

Investments (Credit Loss Rollforward) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance at January 1,	$ 66	$ 67
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	0	6
Additional impairments — credit loss OTTI on securities previously impaired	5	11
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(42)	(16)
Increase in cash flows — accretion of previous credit loss OTTI	(1)	(2)
Balance at December 31,	$ 28	$ 66

XML

Investments (Related Party Investment Transactions) (Details) - Affiliated Entity [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Invested Assets Transferred To and From Affiliates
Estimated fair value of invested assets transferred to affiliates	$ 1,495	$ 185	$ 1,441
Amortized cost of invested assets transferred to affiliates	1,400	169	1,362
Net investment gains (losses) recognized on transfers	27	16	79
Change Additional Paid In Capital Recognized On Transfers	68	0	0
Estimated fair value of invested assets transferred from affiliates	$ 5,582	$ 928	$ 132

XML

Investments (Fixed Maturity and Equity Securities Available-For-Sale - Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Gross Unrealized OTTI Loss	$ (1)	$ 23	$ 38
Summary of Certain Fixed Maturity Securities
Available-for-sale Securities, Debt Securities	59,899	62,121
CMBS
Schedule of Available-for-sale Securities [Line Items]
Gross Unrealized OTTI Loss	1	1
Summary of Certain Fixed Maturity Securities
Available-for-sale Securities, Debt Securities	3,696	3,281
Non-Income Producing Debt Securities [Member]
Summary of Certain Fixed Maturity Securities
Available-for-sale Securities, Debt Securities	5	11
Gross Unrealized Gain (Loss)		$ 1
Maximum | Non-Income Producing Debt Securities [Member]
Summary of Certain Fixed Maturity Securities
Gross Unrealized Gain (Loss)	$ 1

XML

Investments (Evaluation of Available-For-Sale Securities for OTTI and Evaluating Temporarily Impaired AFS Securities - Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016 USD ($) Contracts
Schedule of Available-for-sale Securities [Line Items]
Fixed securities available-for-sale with gross unrealized loss of equal to or greater than stated percentage	20.00%
Fixed maturity securities
Schedule of Available-for-sale Securities [Line Items]
Change in Gross Unrealized Temporary Loss	$ (171)
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	922
Twenty Percent Or More | Six months or greater | Fixed maturity securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ 57
Number of Securities | Contracts	15
Twenty Percent Or More | Six months or greater | Fixed maturity securities | External Credit Rating, Investment Grade
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ 53
Number of Securities	6
Percentage of gross unrealized loss	93.00%
Twenty Percent Or More | Six months or greater | Fixed maturity securities | External Credit Rating, Non Investment Grade
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ 4
Number of Securities	9
Percentage of gross unrealized loss	7.00%

XML

Investments (Mortgage Loans - Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016 USD ($) Contracts	Dec. 31, 2015 USD ($) Contracts	Dec. 31, 2014 USD ($)
Financing Receivable, Recorded Investment [Line Items]
Average Recorded Investment	$ 3	$ 3
Financing Receivable, Significant Purchases	$ 619	$ 346
Percentage of Mortgage Loans Classified as Performing	99.00%	99.00%
Financing Receivable, Modifications, Subsequent Default, Number of Contracts | Contracts	0	0
Agricultural Portfolio Segment [Member]
Financing Receivable, Recorded Investment [Line Items]
Average Recorded Investment	$ 3	$ 3	$ 3
Estimated fair value of mortgage loans held-for-investment	$ 1,900	$ 1,500
Loans and Leases Receivable, Number of Contract, Nonperforming, Nonaccrual of Interest | Contracts	0	0
Financing Receivable Number of Contract of Recorded Investment Past Due | Contracts	0	0
Commercial
Financing Receivable, Recorded Investment [Line Items]
Average Recorded Investment	$ 0	$ 0	43
Loans and Leases Receivable, Number of Contract, Nonperforming, Nonaccrual of Interest | Contracts	0	0
Financing Receivable Number of Contract of Recorded Investment Past Due | Contracts	0	0
Residential
Financing Receivable, Recorded Investment [Line Items]
Average Recorded Investment	$ 0	$ 0	0
Estimated fair value of mortgage loans held-for-investment	867	345
Financing Receivable, Recorded Investment, Past Due	11	11
Loans and Leases Receivable, Nonperforming, Nonaccrual of Interest	4	4
Affiliated Entity [Member]
Financing Receivable, Recorded Investment [Line Items]
Financing Receivable, Significant Sales	2,400	2,000	370
Related Party Transaction, Amounts of Transaction	$ 1,600	$ 1,000	$ 1,000

XML

Investments (Investments in Tax Credit Partnerships - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]
Carrying value of Tax Credits	$ 41	$ 42
Losses From Tax Credits	$ (1)	$ (1)	$ 3

XML

Investments (Leverage Leases - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Gains (Losses) From Tax Credits Guaranteed By Third Parties	$ (1)	$ (1)	$ 3
Leveraged Leases [Abstract]
Deferred income tax liability related to leveraged leases	$ 74	$ 76
Percentage of rental receivables performing	100.00%	100.00%
Minimum
Lessor Leasing Arrangements, Operating Leases, Term of Contract	1 year
Maximum
Lessor Leasing Arrangements, Operating Leases, Term of Contract	16 years

XML

Investments (Cash Equivalents - Narrative) (Details) - USD ($) $ in Billions	Dec. 31, 2016	Dec. 31, 2015
Investments, Debt and Equity Securities [Abstract]
Cash equivalents	$ 4.7	$ 1.2

XML

Investments (Concentrations of Credit Risk - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Investments, Debt and Equity Securities [Abstract]
Securities holdings exposure in single issuer greater than stated percentage of Company's equity	10.00%
Investments in any counterparty that were greater than 10% of equity	$ 0	$ 0

XML

Investments (Securities Lending Remaining Tenor - Narrative) (Details) - Estimated fair value $ in Billions	Dec. 31, 2016 USD ($)
Securities Financing Transaction [Line Items]
Cash collateral on deposit from counterparties	$ 2.1
U.S. government and agency
Securities Financing Transaction [Line Items]
Percentage Of US Treasury And Agency Securities At Estimated Fair Value Of Securities On Loan Relating To Cash Collateral On Open	100.00%
Securities Investment
Securities Financing Transaction [Line Items]
Percentage of Reinvestment Portfolio in Fixed Maturity Securities	48.00%

XML

Investments (Collectively Significant Equity Method Investments - Narrative) (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Equity Method Investment, Summarized Financial Information, Gross Profit (Loss)
Carrying Value of investments accounted for under the equity method	$ 1.9
Unfunded commitments for investments accounted for under the equity method	1.1
Total assets for investments accounted for under the equity method	285.1	$ 294.3
Total liabilities for investments accounted for under the equity method	26.3	46.3
Net Income (loss) for investments accounted for under the equity method	$ 21.3	$ 13.7	$ 25.1
Aggregate Net income Exceeded Stated Percentage Of The Pre Tax Income (Loss) From Continuing Operations	10.00%	10.00%	10.00%

XML

Investments (Consolidated Variable Interest Entities - Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Consolidated Securitization Entities
Variable Interest Entity [Line Items]
Variable interest, maximum exposure to loss in consolidated securitization entities	$ 95	$ 105

XML

Investments (Unconsolidated Variable Interest Entities - Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Variable Interest Entity [Line Items]
Tax Credits Guaranteed By Third Parties Amount That Reduces Maximum Exposure To Loss Related To Other Invested Assets	$ 0
Financial or other support to investees designated as VIEs	$ 0	$ 0	$ 0
Maximum
Variable Interest Entity [Line Items]
Tax Credits Guaranteed By Third Parties Amount That Reduces Maximum Exposure To Loss Related To Other Invested Assets		$ 1,000,000

XML

Investments (Net Investment Gains Losses - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Other investment portfolio gains (losses)	$ (11)	$ 2	$ (43)
Gains (losses) from foreign currency transactions	$ 8	$ (5)	66
MetLife Assurance Limited
Schedule of Available-for-sale Securities [Line Items]
Other investment portfolio gains (losses)			$ 608

XML

Investments (Related Party Investment Transactions - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Apr. 01, 2016	Aug. 31, 2015	Nov. 30, 2014
Related Party Transaction [Line Items]
Related party net investment income	$ 31	$ 16
Related party investment administrative services	98	79	$ 70
Commercial
Related Party Transaction [Line Items]
Related party net investment income		8	34
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Assets Transferred From Affiliates, Estimated Fair Value	5,582	928	132
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale, Gain (Loss) on Sale	27	16	79
Carrying value of related party loans	1,100	0
Affiliated Entity [Member] | Commercial
Related Party Transaction [Line Items]
Carrying value of related party loans			242
Affiliated Entity [Member] | Other invested assets [Member]
Related Party Transaction [Line Items]
Related party net investment income			13
Carrying value of related party loans	$ 1,100	1,200
Related Party Loan One [Member] | Affiliated Entity [Member] | Commercial
Related Party Transaction [Line Items]
Carrying value of related party loans					$ 132
Related Party Loan One [Member] | Affiliated Entity [Member] | Other invested assets [Member]
Related Party Transaction [Line Items]
Interest Rate	4.21%
Debt Instrument, Maturity Date	Sep. 30, 2032
Related Party Loan Two [Member] | Affiliated Entity [Member] | Commercial
Related Party Transaction [Line Items]
Carrying value of related party loans						$ 120
Related Party Loan Two [Member] | Affiliated Entity [Member] | Other invested assets [Member]
Related Party Transaction [Line Items]
Interest Rate	5.10%
Debt Instrument, Maturity Date	Dec. 31, 2033
Related Party Loan Three [Member] | Affiliated Entity [Member] | Commercial
Related Party Transaction [Line Items]
Carrying value of related party loans		110
MetLife Investors USA Insurance Company [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Assets Transferred From Affiliates, Estimated Fair Value			520
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale, Gain (Loss) on Sale			45
Recapture MLUS [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Cash, Cash Equivalents, and Short-term Investments				$ 4,300
Contract Termination [Member] | Recapture MLIC [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Cash, Cash Equivalents, and Short-term Investments				$ 5,200
Spinoff [Member] | MRD Surplus Notes
Related Party Transaction [Line Items]
Surplus Notes	$ 1,100
Metropolitan Life Insurance Company [Member]
Related Party Transaction [Line Items]
Related party net investment income	$ 51	$ 52
Metropolitan Life Insurance Company [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Carrying value of related party loans			$ 50
Metropolitan Life Insurance Company [Member] | Minimum | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Interest Rate	1.55%
Debt Instrument, Maturity Date	Oct. 31, 2021
Metropolitan Life Insurance Company [Member] | Maximum | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Interest Rate	2.39%
Debt Instrument, Maturity Date	Jun. 30, 2022

XML

Derivatives (Primary Risks) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Gross Notional Amount	$ 131,396	$ 133,222
Estimated Fair Value Assets	3,603	3,898
Estimated Fair Value Liabilities	3,883	1,782
Derivatives Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,775	1,654
Estimated Fair Value Assets	234	235
Estimated Fair Value Liabilities	10	4
Derivatives Designated as Hedging Instruments | Fair Value Hedges [Member] | Interest rate swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	310	420
Estimated Fair Value Assets	41	38
Estimated Fair Value Liabilities	0	1
Derivatives Designated as Hedging Instruments | Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,465	1,234
Estimated Fair Value Assets	193	197
Estimated Fair Value Liabilities	10	3
Derivatives Designated as Hedging Instruments | Cash Flow Hedges [Member] | Interest rate swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	45	230
Estimated Fair Value Assets	7	60
Estimated Fair Value Liabilities	0	0
Derivatives Designated as Hedging Instruments | Cash Flow Hedges [Member] | Interest rate forwards
Derivatives, Fair Value [Line Items]
Gross Notional Amount	0	35
Estimated Fair Value Assets	0	8
Estimated Fair Value Liabilities	0	0
Derivatives Designated as Hedging Instruments | Cash Flow Hedges [Member] | Foreign currency swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,420	969
Estimated Fair Value Assets	186	129
Estimated Fair Value Liabilities	10	3
Derivatives Not Designated or Not Qualifying as Hedging Instruments
Derivatives, Fair Value [Line Items]
Gross Notional Amount	129,621	131,568
Estimated Fair Value Assets	3,369	3,663
Estimated Fair Value Liabilities	3,873	1,778
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	28,175	23,086
Estimated Fair Value Assets	1,928	1,802
Estimated Fair Value Liabilities	1,688	638
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate floors
Derivatives, Fair Value [Line Items]
Gross Notional Amount	2,100	7,036
Estimated Fair Value Assets	5	33
Estimated Fair Value Liabilities	2	24
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate caps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	12,042	13,792
Estimated Fair Value Assets	25	38
Estimated Fair Value Liabilities	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate futures
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,288	630
Estimated Fair Value Assets	9	2
Estimated Fair Value Liabilities	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest Rate Swaption [Member]
Derivatives, Fair Value [Line Items]
Gross Notional Amount	15,520	18,620
Estimated Fair Value Assets	136	472
Estimated Fair Value Liabilities	0	5
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Foreign currency swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,250	673
Estimated Fair Value Assets	153	77
Estimated Fair Value Liabilities	4	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Foreign currency forwards
Derivatives, Fair Value [Line Items]
Gross Notional Amount	158	185
Estimated Fair Value Assets	9	4
Estimated Fair Value Liabilities	0	1
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Credit default swaps — purchased
Derivatives, Fair Value [Line Items]
Gross Notional Amount	34	21
Estimated Fair Value Assets	0	0
Estimated Fair Value Liabilities	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Credit default swaps — written
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,891	2,093
Estimated Fair Value Assets	28	13
Estimated Fair Value Liabilities	0	1
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Equity futures
Derivatives, Fair Value [Line Items]
Gross Notional Amount	8,037	3,669
Estimated Fair Value Assets	38	37
Estimated Fair Value Liabilities	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Equity index options
Derivatives, Fair Value [Line Items]
Gross Notional Amount	37,501	44,035
Estimated Fair Value Assets	897	1,032
Estimated Fair Value Liabilities	934	626
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Equity variance swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	14,894	14,866
Estimated Fair Value Assets	140	120
Estimated Fair Value Liabilities	517	434
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Interest rate total return swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	3,876	48
Estimated Fair Value Assets	0	2
Estimated Fair Value Liabilities	611	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Equity total return swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	2,855	2,814
Estimated Fair Value Assets	1	31
Estimated Fair Value Liabilities	$ 117	$ 49

XML

Derivatives (Net Derivative Gains Losses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Components of Net Derivatives Gains (Losses)
Derivatives and hedging gains (losses)	$ (4,029)	$ (153)	$ 870
Embedded derivatives gains (losses)	(1,741)	(344)	(576)
Total net derivative gains (losses)	$ (5,770)	$ (497)	$ 294

XML

Derivatives (Earned Income On Derivatives) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Total earned income	$ 495	$ 384	$ 308
Derivatives Designated as Hedging Instruments | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Total earned income	19	11	4
Derivatives Designated as Hedging Instruments | Interest credited to policyholder account balances
Derivative Instruments, Gain (Loss) [Line Items]
Total earned income	0	(2)	(1)
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net derivative gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Total earned income	460	361	273
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Policyholder benefits and claims
Derivative Instruments, Gain (Loss) [Line Items]
Total earned income	$ 16	$ 14	$ 32

XML

Derivatives (Gains Losses Recognized in Income Not Designated or Qualifying) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	$ 1	$ 3	$ 33
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Derivative Gains (Losses)
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	(4,511)	(513)	585
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Derivative Gains (Losses) | Interest rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	(2,873)	(67)	1,174
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Derivative Gains (Losses) | Foreign currency exchange rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	76	44	6
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Derivative Gains (Losses) | Credit default swaps — purchased
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	(22)
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Derivative Gains (Losses) | Credit default swaps — written
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	10	(14)	18
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Derivative Gains (Losses) | Equity derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	(1,724)	(476)	(591)
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Investment Income
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	(6)	(4)	(8)
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Investment Income | Interest rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Investment Income | Foreign currency exchange rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Investment Income | Credit default swaps — purchased
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Investment Income | Credit default swaps — written
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Net Investment Income | Equity derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	(6)	(4)	(8)
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Policyholder benefits and claims
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	(324)	(20)	(236)
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Policyholder benefits and claims | Interest rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	(4)	5	43
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Policyholder benefits and claims | Foreign currency exchange rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Policyholder benefits and claims | Credit default swaps — purchased
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Policyholder benefits and claims | Credit default swaps — written
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments | Policyholder benefits and claims | Equity derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivatives Gains (Losses) Recognized for Derivatives	$ (320)	$ (25)	$ (279)

XML

Derivatives (Fair Value Hedges) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	$ (1)	$ (3)	$ (33)
Net Derivative Gains (Losses) Recognized for Hedged Items	1	1	32
Ineffectiveness Recognized in Net Derivative Gains (Losses)	0	2	1
Interest rate swaps | Fixed maturity securities
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	(1)	(1)	(1)
Net Derivative Gains (Losses) Recognized for Hedged Items	1	(1)	1
Ineffectiveness Recognized in Net Derivative Gains (Losses)	0	2	0
Interest rate swaps | Policyholder account balances
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	0	(2)	(32)
Net Derivative Gains (Losses) Recognized for Hedged Items	0	2	31
Ineffectiveness Recognized in Net Derivative Gains (Losses)	0	0	1
Foreign currency swaps | Foreign-denominated policyholder account balances [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	0	0	0
Net Derivative Gains (Losses) Recognized for Hedged Items	0	0	0
Ineffectiveness Recognized in Net Derivative Gains (Losses)	$ 0	$ 0	$ 0

XML

Derivatives (Cash Flow Hedges) (Details) - Cash Flow Hedges [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	$ 70	$ 95	$ 243
Interest rate swaps
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	24	15	131
Interest rate forwards
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	4	1	55
Foreign currency swaps
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	42	79	57
Credit forwards
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	0	0	0
Net Derivative Gains (Losses)
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	38	3	(4)
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	1	0
Net Derivative Gains (Losses) | Interest rate swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	33	1	1
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	1	0
Net Derivative Gains (Losses) | Interest rate forwards
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	2	2	1
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0
Net Derivative Gains (Losses) | Foreign currency swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	3	0	(6)
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0
Net Derivative Gains (Losses) | Credit forwards
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	0
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0
Net Investment Income
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	5	3	2
Net Investment Income | Interest rate swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	3	1	1
Net Investment Income | Interest rate forwards
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	2	2	1
Net Investment Income | Foreign currency swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	0
Net Investment Income | Credit forwards
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	$ 0	$ 0	$ 0

XML

Derivatives (Credit Derivatives) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 28	$ 12
Maximum Amount of Future Payments under Credit Default Swaps	$ 1,891	$ 2,093
Weighted Average Years to Maturity	4 years 2 months	3 years 9 months
Aaa/Aa/A
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 9	$ 2
Maximum Amount of Future Payments under Credit Default Swaps	$ 478	$ 426
Weighted Average Years to Maturity	3 years 7 months	2 years 9 months
Aaa/Aa/A | Single name credit default swaps (3)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 1	$ 1
Maximum Amount of Future Payments under Credit Default Swaps	$ 45	$ 207
Weighted Average Years to Maturity	2 years 2 months	1 year 6 months
Aaa/Aa/A | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 8	$ 1
Maximum Amount of Future Payments under Credit Default Swaps	$ 433	$ 219
Weighted Average Years to Maturity	3 years 8 months	4 years
Baa
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 19	$ 10
Maximum Amount of Future Payments under Credit Default Swaps	$ 1,393	$ 1,631
Weighted Average Years to Maturity	4 years 5 months	4 years
Baa | Single name credit default swaps (3)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 1	$ 2
Maximum Amount of Future Payments under Credit Default Swaps	$ 180	$ 409
Weighted Average Years to Maturity	1 year 7 months	1 year 7 months
Baa | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 18	$ 8
Maximum Amount of Future Payments under Credit Default Swaps	$ 1,213	$ 1,222
Weighted Average Years to Maturity	4 years 10 months	4 years 9 months
Ba
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 0	$ 0
Maximum Amount of Future Payments under Credit Default Swaps	$ 20	$ 0
Weighted Average Years to Maturity	2 years 8 months	0 years
Ba | Single name credit default swaps (3)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 0	$ 0
Maximum Amount of Future Payments under Credit Default Swaps	$ 20	$ 0
Weighted Average Years to Maturity	2 years 8 months	0 years
Ba | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 0	$ 0
Maximum Amount of Future Payments under Credit Default Swaps	$ 0	$ 0
Weighted Average Years to Maturity	0 years	0 years
B
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 0	$ 0
Maximum Amount of Future Payments under Credit Default Swaps	$ 0	$ 36
Weighted Average Years to Maturity	0 years	5 years
B | Single name credit default swaps (3)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 0	$ 0
Maximum Amount of Future Payments under Credit Default Swaps	$ 0	$ 0
Weighted Average Years to Maturity	0 years	0 years
B | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 0	$ 0
Maximum Amount of Future Payments under Credit Default Swaps	$ 0	$ 36
Weighted Average Years to Maturity	0 years	5 years

XML

Derivatives (Estimated Fair Value of Derivatives Assets and Liabilities after Master Netting Agreements and Cash) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset Excluding Accruals	$ 3,707	$ 3,992
Derivative Liability, Fair Value, Gross Liability Excluding Accruals	3,834	1,803
Amounts offset in the consolidated balance sheets, Assets	0	0
Amounts offset in the consolidated balance sheets, Liabilities	0	0
Net amount of derivative assets after application of master netting agreements and cash collateral	157	176
Net amount of derivative liabilities after application of master netting agreements and cash collateral	0	0
Estimated fair value of derivative assets presented in the consolidated balance sheets	3,707	3,992
Estimated fair value of derivative liabilities presented in the consolidated balance sheets	3,834	1,803
Over the Counter [Member]
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset Excluding Accruals	3,394	3,875
Derivative Liability, Fair Value, Gross Liability Excluding Accruals	2,929	1,725
Gross estimated fair value of derivative assets	(2,231)	(1,577)
Gross estimated fair value of derivative liabilities	(2,231)	(1,577)
Cash collateral on derivative assets	(634)	(1,608)
Cash collateral on derivative liabilities	0	0
Securities collateral on derivative assets	(429)	(553)
Securities collateral on derivative liabilities	(698)	(148)
Exchange-cleared [Member]
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset Excluding Accruals	267	78
Derivative Liability, Fair Value, Gross Liability Excluding Accruals	905	78
Gross estimated fair value of derivative assets	(165)	(70)
Gross estimated fair value of derivative liabilities	(165)	(70)
Cash collateral on derivative assets	(91)	(8)
Cash collateral on derivative liabilities	(740)	(8)
Securities collateral on derivative assets	0	0
Securities collateral on derivative liabilities	0	0
Exchange-traded [Member]
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset Excluding Accruals	46	39
Derivative Liability, Fair Value, Gross Liability Excluding Accruals	0	0
Gross estimated fair value of derivative assets	0	0
Gross estimated fair value of derivative liabilities	0	0
Cash collateral on derivative assets	0	0
Cash collateral on derivative liabilities	0	0
Securities collateral on derivative assets	0	0
Securities collateral on derivative liabilities	$ 0	$ 0

XML

Derivatives (Credit Risk on Freestanding Derivatives) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Credit Derivatives [Line Items]
Estimated Fair Value of Derivatives in Net Liability Position	$ 698	$ 148
Fair Value Of Incremental Collateral Provided Upon A One Notch Downgrade In The Company's Credit Rating	0	0
Fair Value Of Incremental Collateral Provided Upon A Downgrade In The Company's Credit Rating to a Level that Triggers Full Overnight Collateralization or Termination of the Derivative Position	0	0
Fixed Maturity Securities
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided	777	179
Cash
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided	$ 0	$ 0

XML

Derivatives (Embedded Derivatives) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Asset	$ 360	$ 336
Embedded Derivative, Fair Value of Embedded Derivative Liability	3,170	840
Ceded guaranteed minimum benefits | Premiums, reinsurance and other receivables
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Asset	409	363
Direct guaranteed minimum benefits | Policyholder account balances
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Liability	2,237	122
Assumed guaranteed minimum benefits | Policyholder account balances
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Liability	741	712
Funds withheld on ceded reinsurance | Other liabilities
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Liability	0	0
Other Embedded Derivatives [Member] | Policyholder account balances
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Liability	192	6
Options embedded in debt or equity securities [Member] | Other invested assets
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Asset	0	35
Options embedded in debt or equity securities [Member] | Other Investments [Member]
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded Derivative, Fair Value of Embedded Derivative Asset	$ (49)	$ (62)

XML

Derivatives (Changes in Estimated Fair Value Related to Embedded Derivatives) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	$ (1,741)	$ (344)	$ (576)
Net derivative gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	(1,741)	(344)	(576)
Policyholder Benefits And Claims Incurred Net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	$ (4)	$ 21	$ 87

XML

Derivatives (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 3,603	$ 3,898
Derivative Liability, Fair Value, Gross Liability	3,883	1,782
Maximum Amount of Future Payments under Credit Default Swaps	1,891	2,093
Estimated Fair Value of Credit Default Swaps	28	12
Cash collateral on derivative assets	3	1
Cash collateral on derivative liabilities	25	62
Derivative Instruments, Gain (Loss) [Line Items]
Embedded derivatives gains (losses)	(1,741)	(344)	$ (576)
Derivative Instrument Detail [Abstract]
Net amounts reclassified into net derivatives gains (losses) on discontinued cash flow hedges	$ 1	$ 3	0
Hedging exposure to variability in future cash flows for specific length of time	3 years	4 years
Accumulated Other Comprehensive Income (Loss)	$ 397	$ 370
Deferred net gains (losses) expected to be reclassified to earnings	40
Customer Securities for which Entity has Right to Sell or Repledge, Fair Value of Securities Sold or Repledged	0
Over the Counter [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Excess securities collateral received on derivatives	(135)	0
Excess securities collateral provided on derivatives	108	36
Exchange-cleared [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Excess securities collateral provided on derivatives	630	34
Exchange Traded [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Excess securities collateral provided on derivatives	453	156
Nonperformance Risk [Member] | Direct And Assumed Guaranteed Minimum Benefit [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Embedded derivatives gains (losses)	244	0	$ 100
Derivative [Member]
Derivatives, Fair Value [Line Items]
Assets Transferred To Affiliates, Estimated Fair Value	1,800
Liabilities Transferred To Affiliates Estimated Fair Value	1,200
Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	104	(49)
Derivative Liability, Fair Value, Gross Liability	$ 94	$ 21

XML

Fair Value (Recurring Fair Value Measurements) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Assets [Abstract]
Available-for-sale Securities, Debt Securities	$ 59,899	$ 62,121
Available-for-sale Securities, Equity Securities	300	457
Short-term Investments	1,272	1,796
Mortgage Loans on Real Estate	9,290	7,404
Derivative assets	3,603	3,898
Net embedded derivatives within asset host contracts	360	336
Separate account assets	105,346	106,527
Liabilities [Abstract]
Derivative liabilities	3,883	1,782
Net embedded derivatives within liability host contracts	3,170	840
Long-term debt, at estimated fair value, relating to variable interest entities	1,904	1,936
Consolidated Securitization Entities
Assets [Abstract]
Mortgage Loans on Real Estate	136	172
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	23	48
Recurring
Assets [Abstract]
Available-for-sale Securities, Debt Securities	59,899	62,121
Available-for-sale Securities, Equity Securities	300	457
Short-term Investments	1,272	1,787
Derivative assets	3,603	3,898
Net embedded derivatives within asset host contracts	409	398
Separate account assets	105,346	106,527
Total assets	170,965	175,360
Liabilities [Abstract]
Derivative liabilities	3,883	1,782
Net embedded derivatives within liability host contracts	3,170	840
Total liabilities	7,076	2,670
Recurring | Consolidated Securitization Entities
Assets [Abstract]
Mortgage Loans on Real Estate	136	172
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	23	48
Recurring | Interest rate
Assets [Abstract]
Derivative assets	2,151	2,455
Liabilities [Abstract]
Derivative liabilities	2,301	668
Recurring | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	348	210
Liabilities [Abstract]
Derivative liabilities	14	4
Recurring | Credit
Assets [Abstract]
Derivative assets	28	13
Liabilities [Abstract]
Derivative liabilities		1
Recurring | Equity market
Assets [Abstract]
Derivative assets	1,076	1,220
Liabilities [Abstract]
Derivative liabilities	1,568	1,109
Recurring | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	21,665	20,475
Recurring | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	12,916	14,441
Recurring | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	7,940	9,873
Recurring | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	6,123	5,483
Recurring | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	3,858	3,546
Recurring | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	2,598	4,263
Recurring | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	1,103	759
Recurring | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	3,696	3,281
Recurring | Level 1
Assets [Abstract]
Available-for-sale Securities, Debt Securities	6,110	8,150
Available-for-sale Securities, Equity Securities	39	44
Short-term Investments	702	74
Derivative assets	46	39
Net embedded derivatives within asset host contracts	0	0
Separate account assets	720	624
Total assets	7,617	8,931
Liabilities [Abstract]
Derivative liabilities	0	0
Net embedded derivatives within liability host contracts	0	0
Total liabilities	0	0
Recurring | Level 1 | Consolidated Securitization Entities
Assets [Abstract]
Mortgage Loans on Real Estate	0	0
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	0	0
Recurring | Level 1 | Interest rate
Assets [Abstract]
Derivative assets	9	2
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 1 | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 1 | Credit
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities		0
Recurring | Level 1 | Equity market
Assets [Abstract]
Derivative assets	37	37
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 1 | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	6,110	8,150
Recurring | Level 1 | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 2
Assets [Abstract]
Available-for-sale Securities, Debt Securities	49,767	49,525
Available-for-sale Securities, Equity Securities	124	316
Short-term Investments	568	1,666
Derivative assets	3,370	3,635
Net embedded derivatives within asset host contracts	0	0
Separate account assets	104,616	105,757
Total assets	158,581	161,071
Liabilities [Abstract]
Derivative liabilities	2,742	1,326
Net embedded derivatives within liability host contracts	0	0
Total liabilities	2,765	1,374
Recurring | Level 2 | Consolidated Securitization Entities
Assets [Abstract]
Mortgage Loans on Real Estate	136	172
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	23	48
Recurring | Level 2 | Interest rate
Assets [Abstract]
Derivative assets	2,142	2,445
Liabilities [Abstract]
Derivative liabilities	1,690	668
Recurring | Level 2 | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	348	210
Liabilities [Abstract]
Derivative liabilities	14	4
Recurring | Level 2 | Credit
Assets [Abstract]
Derivative assets	20	12
Liabilities [Abstract]
Derivative liabilities		1
Recurring | Level 2 | Equity market
Assets [Abstract]
Derivative assets	860	968
Liabilities [Abstract]
Derivative liabilities	1,038	653
Recurring | Level 2 | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	20,221	18,787
Recurring | Level 2 | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	6,806	6,291
Recurring | Level 2 | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	6,627	8,522
Recurring | Level 2 | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	5,257	4,761
Recurring | Level 2 | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	3,841	3,533
Recurring | Level 2 | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	2,383	3,833
Recurring | Level 2 | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	1,103	732
Recurring | Level 2 | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	3,529	3,066
Recurring | Level 3
Assets [Abstract]
Available-for-sale Securities, Debt Securities	4,022	4,446
Available-for-sale Securities, Equity Securities	137	97
Short-term Investments	2	47
Derivative assets	187	224
Net embedded derivatives within asset host contracts	409	398
Separate account assets	10	146
Total assets	4,767	5,358
Liabilities [Abstract]
Derivative liabilities	1,141	456
Net embedded derivatives within liability host contracts	3,170	840
Total liabilities	4,311	1,296
Recurring | Level 3 | Consolidated Securitization Entities
Assets [Abstract]
Mortgage Loans on Real Estate	0	0
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	0	0
Recurring | Level 3 | Interest rate
Assets [Abstract]
Derivative assets	0	8
Liabilities [Abstract]
Derivative liabilities	611	0
Recurring | Level 3 | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 3 | Credit
Assets [Abstract]
Derivative assets	8	1
Liabilities [Abstract]
Derivative liabilities		0
Recurring | Level 3 | Equity market
Assets [Abstract]
Derivative assets	179	215
Liabilities [Abstract]
Derivative liabilities	530	456
Recurring | Level 3 | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	1,444	1,688
Recurring | Level 3 | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 3 | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	1,313	1,351
Recurring | Level 3 | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	866	722
Recurring | Level 3 | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	17	13
Recurring | Level 3 | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	215	430
Recurring | Level 3 | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	27
Recurring | Level 3 | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	$ 167	$ 215

XML

Fair Value (Quantitative Information) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Interest rate contracts | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Swap yield	0.00%	317.00%
Fair Value Inputs, Repurchase Rate	(44.00%)
Interest rate contracts | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Swap yield	0.00%	317.00%
Fair Value Inputs, Repurchase Rate	18.00%
Credit contracts | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Credit spreads	97.00%	0.00%
Credit contracts | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Credit spreads	98.00%	0.00%
Equity market contracts | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Correlation	40.00%	70.00%
Volatility	14.00%	17.00%
Equity market contracts | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Correlation	40.00%	70.00%
Volatility	32.00%	36.00%
Embedded derivatives direct and ceded guaranteed minimum benefits | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Utilization rates	0.00%	0.00%
Withdrawal rates	0.25%	0.25%
Long-term equity volatilities	17.40%	17.40%
Nonperformance risk spread	0.04%	0.04%
Embedded derivatives direct and ceded guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Durations 1 - 10
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	0.25%	0.25%
Embedded derivatives direct and ceded guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Durations 11 - 20
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	2.00%	3.00%
Embedded derivatives direct and ceded guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Durations 21 - 116
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	2.00%	3.00%
Embedded derivatives direct and ceded guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Ages 0 - 40
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.00%	0.00%
Embedded derivatives direct and ceded guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Ages 41 - 60
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.04%	0.04%
Embedded derivatives direct and ceded guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Ages 61 – 115
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.26%	0.26%
Embedded derivatives direct and ceded guaranteed minimum benefits | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Utilization rates	25.00%	25.00%
Withdrawal rates	10.00%	10.00%
Long-term equity volatilities	25.00%	25.00%
Nonperformance risk spread	0.57%	0.52%
Embedded derivatives direct and ceded guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Durations 1 - 10
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	100.00%	100.00%
Embedded derivatives direct and ceded guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Durations 11 - 20
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	100.00%	100.00%
Embedded derivatives direct and ceded guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Durations 21 - 116
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	100.00%	100.00%
Embedded derivatives direct and ceded guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Ages 0 - 40
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.09%	0.09%
Embedded derivatives direct and ceded guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Ages 41 - 60
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.65%	0.65%
Embedded derivatives direct and ceded guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Ages 61 – 115
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	100.00%	100.00%
U.S. corporate and foreign corporate | Minimum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Delta spread adjustments		(0.65%)
Fair Value Inputs, Offered Quotes Matrix Pricing	$ 18	$ 96
Offered quotes	37	68
Quoted prices	13	$ 13
U.S. corporate and foreign corporate | Maximum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Delta spread adjustments		2.40%
Fair Value Inputs, Offered Quotes Matrix Pricing	138	$ 100
Offered quotes	109	100
Quoted prices	700	$ 780
U.S. corporate and foreign corporate | Weighted Average | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Delta spread adjustments		0.49%
Fair Value Inputs, Offered Quotes Matrix Pricing	104	$ 98
Offered quotes	85	86
Quoted prices	99	282
RMBS | Minimum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	38	29
RMBS | Maximum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	111	292
RMBS | Weighted Average | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	91	93
ABS | Minimum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Offered quotes	98	66
Quoted prices	94	97
ABS | Maximum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Offered quotes	100	105
Quoted prices	106	103
ABS | Weighted Average | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Offered quotes	99	99
Quoted prices	$ 100	$ 100

XML

Fair Value (Unobservable Input Reconciliation) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net Derivatives
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	$ (687)	$ (64)	$ (7)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at January 1,	(232)	(196)
Total realized/unrealized gains (losses) included in net income (loss)	(703)	(74)	(4)
Total realized/unrealized gains (losses) included in AOCI	4	2	57
Purchases	10	22
Sales	0	0
Issuances	0	0
Settlements	(33)	14
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Balance at December 31,	(954)	(232)	(196)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	(687)	(64)	(7)
Net Embedded Derivatives
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	(1,772)	(310)	(565)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at January 1,	(442)	354
Total realized/unrealized gains (losses) included in net income (loss)	(1,760)	(303)	(468)
Total realized/unrealized gains (losses) included in AOCI	0	0	107
Purchases	0	0
Sales	0	0
Issuances	0	0
Settlements	(559)	(493)
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Balance at December 31,	(2,761)	(442)	354
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	(1,772)	(310)	(565)
Corporate Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1,	2,410	2,403
Total realized/unrealized gains (losses) included in net income (loss)	(11)	16	3
Total realized/unrealized gains (losses) included in AOCI	(24)	(120)	72
Purchases	584	406
Sales	(443)	(191)
Issuances	0	0
Settlements	0	0
Transfers into Level 3	119	202
Transfers out of Level 3	(325)	(306)
Balance at December 31,	2,310	2,410	2,403
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	2	11	2
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	2	11	2
Structured Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1,	1,996	1,212
Total realized/unrealized gains (losses) included in net income (loss)	30	21	10
Total realized/unrealized gains (losses) included in AOCI	21	(14)	13
Purchases	600	1,342
Sales	(598)	(364)
Issuances	0	0
Settlements	0	0
Transfers into Level 3	12	31
Transfers out of Level 3	(366)	(232)
Balance at December 31,	1,695	1,996	1,212
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	28	21	6
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	28	21	6
State and political subdivision
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1,	13	0
Total realized/unrealized gains (losses) included in net income (loss)	0	0	0
Total realized/unrealized gains (losses) included in AOCI	0	0	0
Purchases	0	13
Sales	0	0
Issuances	0	0
Settlements	0	0
Transfers into Level 3	9	0
Transfers out of Level 3	(5)	0
Balance at December 31,	17	13	0
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0
Foreign government
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1,	27	0
Total realized/unrealized gains (losses) included in net income (loss)	0	0	0
Total realized/unrealized gains (losses) included in AOCI	0	(2)	0
Purchases	0	29
Sales	0	0
Issuances	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	(27)	0
Balance at December 31,	0	27	0
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1,	97	100
Total realized/unrealized gains (losses) included in net income (loss)	0	11	(2)
Total realized/unrealized gains (losses) included in AOCI	(11)	(10)	7
Purchases	0	0
Sales	(26)	(16)
Issuances	0	0
Settlements	0	0
Transfers into Level 3	131	19
Transfers out of Level 3	(54)	(7)
Balance at December 31,	137	97	100
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	(1)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	(1)
Short-term Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1,	47	71
Total realized/unrealized gains (losses) included in net income (loss)	0	0	0
Total realized/unrealized gains (losses) included in AOCI	0	0	0
Purchases	3	47
Sales	(1)	0
Issuances	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	(47)	(71)
Balance at December 31,	2	47	71
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0
Separate account assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1,	146	158
Total realized/unrealized gains (losses) included in net income (loss)	0	(6)	(1)
Total realized/unrealized gains (losses) included in AOCI	0	0	0
Purchases	2	3
Sales	(134)	(5)
Issuances	0	0
Settlements	0	0
Transfers into Level 3	0	0
Transfers out of Level 3	(4)	(4)
Balance at December 31,	10	146	158
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	$ 0	$ 0	$ 0

XML

Fair Value (Fair Value Option for Certain Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Option, Quantitative Disclosures [Line Items]
Carrying value at estimated fair value	$ 9,290	$ 7,404
Carrying value at estimated fair value	1,904	1,936
Consolidated Securitization Entities
Fair Value, Option, Quantitative Disclosures [Line Items]
Unpaid principal balance	88	121
Difference between estimated fair value and unpaid principal balance	48	51
Carrying value at estimated fair value	136	172
Contractual principal balance	22	46
Difference between estimated fair value and contractual principal balance	1	2
Carrying value at estimated fair value	$ 23	$ 48

XML

Fair Value (Nonrecurring Fair Value Measurements) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Level 3 | Goodwill
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	$ 0	$ 0	$ 0
Level 3 | Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	3	3	3
Level 3 | Other limited partnership interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	3	2	38
Level 3 | Computer Software, Intangible Asset [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	0	0	0
Nonrecurring | Goodwill
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	(381)	0	(33)
Nonrecurring | Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	0	0	0
Nonrecurring | Other limited partnership interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	(2)	(1)	(6)
Nonrecurring | Computer Software, Intangible Asset [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	$ (11)	$ 0	$ 0

XML

Fair Value (Financial Instruments Carried at Other Than Fair Value) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Assets
Policy loans	$ 1,093	$ 1,266
Liabilities
Separate account liabilities	105,346	106,527
Estimated Fair Value
Assets
Mortgage loans	9,298	7,535
Policy loans	1,177	1,347
Real estate joint ventures	44	65
Other limited partnership interests	42	57
Loans and Leases Receivable, Related Parties	1,090	1,178
Premiums, reinsurance and other receivables	2,815	7,594
Liabilities
Policyholder account balances	17,259	21,726
Long-term debt	2,117	2,320
Other liabilities	256	255
Separate account liabilities	1,110	1,275
Estimated Fair Value | Level 1
Assets
Mortgage loans	0	0
Policy loans	0	0
Real estate joint ventures	0	0
Other limited partnership interests	0	0
Loans and Leases Receivable, Related Parties	0	0
Premiums, reinsurance and other receivables	0	0
Liabilities
Policyholder account balances	0	0
Long-term debt	0	0
Other liabilities	0	0
Separate account liabilities	0	0
Estimated Fair Value | Level 2
Assets
Mortgage loans	0	0
Policy loans	746	917
Real estate joint ventures	0	0
Other limited partnership interests	0	0
Loans and Leases Receivable, Related Parties	1,090	1,178
Premiums, reinsurance and other receivables	834	83
Liabilities
Policyholder account balances	0	0
Long-term debt	2,117	2,320
Other liabilities	90	81
Separate account liabilities	1,110	1,275
Estimated Fair Value | Level 3
Assets
Mortgage loans	9,298	7,535
Policy loans	431	430
Real estate joint ventures	44	65
Other limited partnership interests	42	57
Loans and Leases Receivable, Related Parties	0	0
Premiums, reinsurance and other receivables	1,981	7,511
Liabilities
Policyholder account balances	17,259	21,726
Long-term debt	0	0
Other liabilities	166	174
Separate account liabilities	0	0
Carrying Value
Assets
Mortgage loans	9,154	7,232
Policy loans	1,093	1,266
Real estate joint ventures	12	23
Other limited partnership interests	44	52
Loans and Leases Receivable, Related Parties	1,100	1,150
Premiums, reinsurance and other receivables	2,363	6,639
Liabilities
Policyholder account balances	16,043	20,260
Long-term debt	1,881	1,888
Other liabilities	256	255
Separate account liabilities	$ 1,110	$ 1,275

XML

Fair Value (Recurring Fair Value Measurements) (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Net Embedded Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ (49)	$ (62)

XML

Fair Value (Nonrecurring Fair Value Measurements) (Narrative) (Details) - Private Equity And Debt Funds	12 Months Ended
	Dec. 31, 2016
Minimum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Liquidation period	2 years
Maximum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Liquidation period	10 years

XML

Goodwill (Goodwill) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Goodwill Rollforward and by Segment
Goodwill	$ 874	$ 874	$ 986
Accumulated impairment	(493)	(493)	(460)
Total goodwill, net	381	381	526
Dispositions (1)			(112)
Impairments	(381)	0	(33)
Goodwill	874	874	874
Accumulated impairment	(874)	(493)	(493)
Total goodwill, net	0	381	381
Annuities
Goodwill Rollforward and by Segment
Goodwill	427	427	427
Accumulated impairment	(427)	(427)	(394)
Total goodwill, net	0	0	33
Dispositions (1)			0
Impairments	0		(33)
Goodwill	427	427	427
Accumulated impairment	(427)	(427)	(427)
Total goodwill, net	0	0	0
Life
Goodwill Rollforward and by Segment
Goodwill	66	66	66
Accumulated impairment	(66)	(66)	(66)
Total goodwill, net	0	0	0
Dispositions (1)			0
Impairments	0		0
Goodwill	66	66	66
Accumulated impairment	(66)	(66)	(66)
Total goodwill, net	0	0	0
Run-off [Member]
Goodwill Rollforward and by Segment
Goodwill	381	381	493
Accumulated impairment	0	0	0
Total goodwill, net	381	381	493
Dispositions (1)			(112)
Impairments	(381)		0
Goodwill	381	381	381
Accumulated impairment	(381)	0	0
Total goodwill, net	$ 0	$ 381	$ 381

XML

Goodwill (Narrative) (Details) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016 Segment	Dec. 31, 2016 USD ($) Segment	Dec. 31, 2016 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Goodwill [Line Items]
Number of Reportable Segments	3	3	3
Goodwill		$ 0	$ 0	$ 0	$ 381	$ 381	$ 526
Impairments				381	0	33
Dispositions						112
MetLife Assurance Limited
Goodwill [Line Items]
Dispositions						112
Run-off [Member]
Goodwill [Line Items]
Goodwill impairment, net of income tax				305
Goodwill		$ 0	$ 0	0	$ 381	381	$ 493
Impairments				$ 381		0
Dispositions						112
Run-off [Member] | MetLife Assurance Limited
Goodwill [Line Items]
Dispositions						$ 112

XML

Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Long-term Debt	$ 1,904	$ 1,936
Debt Issuance Costs, Net	6
Long Term Debt Excluding Consolidated Securitization Entities	1,881	1,888
Consolidated Securitization Entities
Debt Instrument [Line Items]
Long-term Debt	$ 23	48
Surplus Notes | MLUSA Surplus Notes due 2038 | Affiliated Entity
Debt Instrument [Line Items]
Interest Rate	8.60%
Debt Instrument Maturity	Apr. 08, 2038
Long-term Debt	$ 744	750
Surplus Notes | MRD Surplus Notes due 2032 | Affiliated Entity
Debt Instrument [Line Items]
Interest Rate	5.13%
Debt Instrument Maturity	Sep. 30, 2032
Long-term Debt	$ 750	750
Surplus Notes | MRD Surplus Notes due to 2033 | Affiliated Entity
Debt Instrument [Line Items]
Interest Rate	6.00%
Debt Instrument Maturity	Dec. 31, 2033
Long-term Debt	$ 350	350
Long-term Debt
Debt Instrument [Line Items]
Interest Rate	7.03%
Debt Instrument Maturity	Nov. 30, 2030
Long-term Debt	$ 37	$ 38

XML

Debt (Long Term Debt - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Repayments of Long-term Debt	$ 26	$ 235	$ 1,379
Long Term Debt Aggregate Maturities, Year One	1
Long Term Debt Aggregate Maturities, Year Two	2
Long Term Debt Aggregate Maturities, Year Three	2
Long Term Debt Aggregate Maturities, Year Four	2
Long Term Debt Aggregate Maturities, Year Five	2
Long-term Debt, Maturities, Repayments of Principal after Year Five	1,900
Total interest expense	$ 128	$ 128	133
Affiliated Debt
Debt Instrument [Line Items]
Repayments of Long-term Debt			$ 75
Interest Rate			6.80%

XML

Debt (Letters of Credit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Line of Credit Facility [Line Items]
Line of Credit Facility, Commitment Fee Amount	$ 55	$ 61	$ 73
Letters of Credit Outstanding, Amount	3,300
Line of Credit Facility, Remaining Borrowing Capacity	5,200
Committed Credit Facility MRD (cell 2)
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	90
Line of Credit Facility, Remaining Borrowing Capacity	$ 3,270
Line of Credit Facility, Expiration Date	May 31, 2019
Line of Credit Facility, Maximum Borrowing Capacity	$ 4,000
Long-term Line of Credit	0
Committed Credit Facility MRD (cell 2) | Affiliated Entity
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	640
Committed Credit Facility MRD
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	170
Line of Credit Facility, Remaining Borrowing Capacity	$ 0
Line of Credit Facility, Expiration Date	Jun. 30, 2018
Line of Credit Facility, Maximum Borrowing Capacity	$ 425
Long-term Line of Credit	0
Committed Credit Facility MRD | Affiliated Entity
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	255
MRSC committed credit facility
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	0
Line of Credit Facility, Remaining Borrowing Capacity	$ 703
Line of Credit Facility, Expiration Date	Jun. 30, 2037
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,500
Long-term Line of Credit	2,797
MRSC committed credit facility | Affiliated Entity
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	0
MRV committed credit facility
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	3,000
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,250
Line of Credit Facility, Expiration Date	Sep. 30, 2038
Line of Credit Facility, Maximum Borrowing Capacity	$ 4,250
Long-term Line of Credit	0
MRV committed credit facility | Affiliated Entity
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	0
Committed Credit Facility
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	3,260
Line of Credit Facility, Remaining Borrowing Capacity	5,223
Line of Credit Facility, Maximum Borrowing Capacity	12,175
Long-term Line of Credit	2,797
Committed Credit Facility | Affiliated Entity
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount	$ 895

XML

Equity (Statutory Income) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Parent Company
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	$ 4,374	$ 5,942
Statutory net income (loss)	1,186	(1,022)	$ 1,543
Brighthouse Life Insurance Co of NY [Member]
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	196	321
Statutory net income (loss)	$ (87)	$ 17	$ 11

XML

Equity (Components of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period	$ 1,594	$ 2,622	$ 970
OCI before reclassifications	(498)	(1,693)	2,788
Deferred income tax benefit (expense)	160	619	(896)
AOCI before reclassifications, net of income tax	1,256	1,548	2,862
Amounts reclassified from AOCI	(13)	72	(9)
Deferred income tax benefit (expense)	5	(26)	3
Amounts reclassified from AOCI, net of income tax	(8)	46	(6)
Balance end of period	1,248	1,594	2,622
Unrealized Investment Gains (Losses), Net of Related Offsets
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period	1,379	2,445	906
OCI before reclassifications	(565)	(1,759)	2,601
Deferred income tax benefit (expense)	185	643	(815)
AOCI before reclassifications, net of income tax	999	1,329	2,692
Amounts reclassified from AOCI	30	78	(11)
Deferred income tax benefit (expense)	(10)	(28)	4
Amounts reclassified from AOCI, net of income tax	20	50	(7)
Balance end of period	1,019	1,379	2,445
Unrealized Gains (Losses) on Derivatives
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period	241	183	24
OCI before reclassifications	70	95	243
Deferred income tax benefit (expense)	(25)	(33)	(85)
AOCI before reclassifications, net of income tax	286	245	182
Amounts reclassified from AOCI	(43)	(6)	2
Deferred income tax benefit (expense)	15	2	(1)
Amounts reclassified from AOCI, net of income tax	(28)	(4)	1
Balance end of period	258	241	183
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance beginning of period	(26)	(6)	40
OCI before reclassifications	(3)	(29)	(56)
Deferred income tax benefit (expense)	0	9	4
AOCI before reclassifications, net of income tax	(29)	(26)	(12)
Amounts reclassified from AOCI	0	0	0
Deferred income tax benefit (expense)	0	0	0
Amounts reclassified from AOCI, net of income tax	0	0	0
Balance end of period	$ (29)	$ (26)	(6)
MetLife Assurance Limited
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from AOCI			(314)
Deferred income tax benefit (expense)			80
Amounts reclassified from AOCI, net of income tax			(234)
MetLife Assurance Limited | Unrealized Investment Gains (Losses), Net of Related Offsets
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from AOCI			(320)
Deferred income tax benefit (expense)			80
Amounts reclassified from AOCI, net of income tax			(240)
MetLife Assurance Limited | Unrealized Gains (Losses) on Derivatives
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from AOCI			0
Deferred income tax benefit (expense)			0
Amounts reclassified from AOCI, net of income tax			0
MetLife Assurance Limited | Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from AOCI			6
Deferred income tax benefit (expense)			0
Amounts reclassified from AOCI, net of income tax			$ 6

XML

Equity (Reclassifications Out of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Investments	$ (67)	$ 5	$ (489)
Net investment income	3,111	3,001	2,984
Net derivative gains (losses)	(5,770)	(497)	294
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(4,465)	1,165	1,068
Provision for income tax expense (benefit)	1,690	(247)	(261)
Net income (loss)	(2,775)	918	807
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income (loss)	8	(46)	6
Unrealized Investment Gains (Losses), Net of Related Offsets | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Investments	(39)	(81)	(6)
Net investment income	3	13	13
Net derivative gains (losses)	6	(10)	4
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(30)	(78)	11
Provision for income tax expense (benefit)	10	28	(4)
Net income (loss)	(20)	(50)	7
Unrealized Gains (Losses) on Derivatives | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	43	6	(2)
Provision for income tax expense (benefit)	(15)	(2)	1
Net income (loss)	28	4	(1)
Interest rate swaps | Unrealized Gains (Losses) on Derivatives | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment income	3	1	1
Net derivative gains (losses)	33	1	1
Interest rate forwards | Unrealized Gains (Losses) on Derivatives | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment income	2	2	1
Net derivative gains (losses)	2	2	1
Foreign currency swaps | Unrealized Gains (Losses) on Derivatives | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net derivative gains (losses)	$ 3	$ 0	$ (6)

XML

Equity (Common Stock - Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2014
Equity [Abstract]
Redemption of common stock	$ 1,400	$ 1,390
Stock Repurchased and Retired During Period, Shares	4,595,317

XML

Equity (Capital Contributions - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accrued Capital Contribution		$ 120	$ 385
Cash Capital Contribution
Capital contribution	$ 1,600	21	476
Non-cash Capital Contribution
Capital contribution	$ 69	$ 181	$ 457

XML

Equity (Statutory Equity & Income and Dividend Restrictions - Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2017
Parent Company
Statutory Accounting Practices [Line Items]
Total adjusted capital of MetLife USA	in excess of 400%	in excess of 400% Company Action RBC
Paid	$ 261	$ 500
Parent Company | Scenario, Forecast
Statutory Accounting Practices [Line Items]
Permitted w/o approval			$ 473
Brighthouse Life Insurance Co of NY [Member]
Statutory Accounting Practices [Line Items]
Paid	$ 0	$ 0
Brighthouse Life Insurance Co of NY [Member] | Scenario, Forecast
Statutory Accounting Practices [Line Items]
Permitted w/o approval			$ 0

XML

Other Expenses (Other Expenses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Other Income and Expenses [Abstract]
Compensation	$ 356	$ 487	$ 360
Commissions	641	722	634
Volume-related costs	279	231	263
Affiliated expenses on ceded and assumed reinsurance	22	17	39
Capitalization of DAC	(330)	(399)	(376)
Interest expense on debt	130	137	170
Premium taxes, licenses and fees	59	71	56
Professional services	85	22	60
Rent and related expenses	46	54	43
Other	412	381	508
Total other expenses	$ 1,700	$ 1,723	$ 1,757

XML

Income Tax (Provision for Income Tax from Continuing Operations) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Current:
Federal	$ (374)	$ 35	$ (592)
Foreign	4	0	6
Subtotal	(370)	35	(586)
Deferred:
Federal	(1,320)	212	847
Foreign	0	0	0
Subtotal	(1,320)	212	847
Current and Deferred
Provision for income tax expense (benefit)	$ (1,690)	$ 247	$ 261

XML

Income Tax (Income Loss from Continuing Operations Before Income Tax Expense from Domestic and Foreign Operations) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income (loss) from continuing operations:
Domestic	$ (4,477)	$ 1,152	$ 604
Foreign	12	13	464
Income (loss) before provision for income tax	$ (4,465)	$ 1,165	$ 1,068

XML

Income Tax (Reconciliation of Income Tax Provision between US Statutory Rate and As Reported for Continuing Operations) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income tax expense benefit continuing operations income tax reconciliation
Tax provision at U.S. statutory rate	$ (1,563)	$ 408	$ 374
Dividend received deduction	(110)	(132)	(119)
Prior year tax	24	(5)	(20)
Tax credits	(22)	(16)	(14)
Foreign tax rate differential	2	(5)	4
Goodwill impairment	(20)	0	12
Sale of subsidiary	(6)	0	24
Other, net	5	(3)	0
Provision for income tax expense (benefit)	$ (1,690)	$ 247	$ 261

XML

Income Tax (Net Deferred Income Tax Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Deferred income tax assets:
Investments, including derivatives	$ 357	$ 0
Tax credit carryforwards	184	172
Other	55	39
Total deferred income tax assets	596	211
Deferred income tax liabilities:
Policyholder liabilities and receivables	536	1,419
Investments, including derivatives	0	125
Intangibles	293	394
Net unrealized investment gains	653	818
DAC	1,565	1,390
Total deferred income tax liabilities	3,047	4,146
Deferred tax assets and liabilities [Abstract]
Net deferred income tax asset (liability)	$ (2,451)	$ (3,935)

XML

Income Tax (Reconciliation of Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of Unrecognized Tax Benefits
Balance at January 1,	$ 43	$ 39	$ 27
Additions for tax positions of prior years	1	5	15
Reductions for tax positions of prior years	(9)	0	(5)
Additions for tax positions of current year	5	3	2
Settlements with tax authorities	(2)	(4)	0
Balance at December 31,	38	43	39
Unrecognized tax benefits that, if recognized would impact the effective rate	$ 38	$ 33	$ 29

XML

Income Tax (Tax Credit Carryforwards) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 184	$ 172
Foreign Tax Authority
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	35
Foreign Tax Authority | 2016-2020
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Foreign Tax Authority | 2021-2025
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	35
Foreign Tax Authority | 2026-2030
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Foreign Tax Authority | 2031-2035
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Foreign Tax Authority | Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
General business tax credit carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	7
General business tax credit carryforward | 2016-2020
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
General business tax credit carryforward | 2021-2025
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
General business tax credit carryforward | 2026-2030
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
General business tax credit carryforward | 2031-2035
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	7
General business tax credit carryforward | Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Other tax credit carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	145
Other tax credit carryforward | 2016-2020
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Other tax credit carryforward | 2021-2025
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Other tax credit carryforward | 2026-2030
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Other tax credit carryforward | 2031-2035
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
Other tax credit carryforward | Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 145

XML

Income Tax (Interest Accrued Related to Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Interest recognized on the consolidated statements of operations	$ 1	$ 0	$ 0
Interest included in other liabilities on the consolidated balance sheets	$ 1	$ 2

XML

Income Tax (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Examination, Penalties Expense	$ 0	$ 0	$ 0
Federal statutory tax rate	35.00%
Income tax benefit related to the separate account dividends received deduction	$ 88,000	143,000	141,000
Amounts due from affiliates per tax sharing agreement	(775,000)	(259,000)
Maximum
True-up of the prior year tax return included in current year benefit related to the separate account dividends received deduction	$ (22,000)	$ 13,000	$ 22,000

XML

Contingencies, Commitments and Guarantees (Insolvency Assessments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Other Assets:
Premium tax offset for future discounted and undiscounted assessments	$ 13	$ 13
Premium tax offsets currently available for paid assessments	8	14
Other Liabilities:
Insolvency assessments	17	18
Insurance-related Assessments
Loss Contingencies [Line Items]
Total assets held for insolvency assessments	$ 21	$ 27

XML

Contingencies, Commitments and Guarantees (Commitments - Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Commitments to Fund Partnership Investments and Private Corporate Bond Investments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	$ 1,300	$ 1,000
Mortgage Loan Commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	335	128
Secured Demand Notes | Affiliated Entity
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	20	20
Securities Pledged as Collateral, at Fair Value	$ 25	$ 25

XML

Contingencies, Commitments and Guarantees (Guarantees - Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Contingencies, Commitments and Guarantees (Textuals) [Abstract]
Guarantor Obligations, Maximum Exposure, Undiscounted	$ 228
Guarantor Obligations, Current Carrying Value	2	$ 2
Minimum
Contingencies, Commitments and Guarantees (Textuals) [Abstract]
Indemnities and guarantees contractual limitation range	6
Maximum
Contingencies, Commitments and Guarantees (Textuals) [Abstract]
Indemnities and guarantees contractual limitation range	$ 222

XML

Related Party Transactions (Related Party Transactions) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Related Party Transaction [Line Items]
Other expenses	$ 1,700	$ 1,723	$ 1,757
Universal life and investment-type product policy fees	3,097	3,293	3,610
Other revenues	709	433	520
Assets	211,425	215,616
Liabilities	194,560	196,980
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Other expenses	847	1,100	1,100
All Services and Transactions Except Broker Dealer Activities [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties	(45)	36	(68)
Related Party Transaction, Expenses from Transactions with Related Party	370	855	974
Assets	4,288	9,720
Liabilities	5,125	5,933
Broker Dealer Activities [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties	202	218	212
Related Party Transaction, Expenses from Transactions with Related Party	638	643	$ 602
Assets	19	19
Liabilities	$ 20	$ 20

XML

Related Party Transaction (Related Party Transaction - Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	May 01, 2017
Related Party Transaction [Line Items]
Premiums and Other Receivables, Net		$ 13,853	$ 18,104
Interest Expense, Debt		128	128	$ 133
Operating Expenses		1,700	1,723	1,757
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest		(4,465)	1,165	1,068
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Interest Expense, Debt		125	125	130
Operating Expenses		847	1,100	$ 1,100
Group Life Term [Member] | Metropolitan Life Insurance Company [Member] | Subsequent Event [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Cash, Cash Equivalents, and Short-term Investments					$ 214
Premiums and Other Receivables, Net					$ 189
Ceded Reinsurance [Member]
Related Party Transaction [Line Items]
Premiums and Other Receivables, Net		12,669	17,178
Ceded Reinsurance [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Premiums and Other Receivables, Net		$ 3,382	$ 8,452
Ceded Reinsurance [Member] | Group Life Term [Member] | Metropolitan Life Insurance Company [Member] | Subsequent Event [Member] | Affiliated Entity [Member]
Related Party Transaction [Line Items]
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ 17
Mortality Risk on Case by Case Basis [Member]
Related Party Transaction [Line Items]
Reinsurance Retention Policy, Excess Retention, Percentage		100.00%
Mortality Risk on Case by Case Basis [Member] | Life Insurance Product Line [Member]
Related Party Transaction [Line Items]
Reinsurance Retention Policy, Excess Retention, Percentage		90.00%
Mortality Risk [Member]
Related Party Transaction [Line Items]
Reinsurance Retention Policy, Excess Retention, Percentage		90.00%

XML

Subsequent Events (Reinsurance Subsequent Events) (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	May 01, 2017	Jan. 01, 2017
Subsequent Event [Line Items]
Premiums and Other Receivables, Net			$ 13,853	$ 18,104
Liability for Future Policy Benefits			32,752	30,508
Policyholder account balances			36,579	36,725	$ 36,585
Other Liabilities			5,445	3,925
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest			(4,465)	1,165	$ 1,068
Subsequent Event [Member] | Affiliated Entity [Member] | MLUS Recapture GMIB [Member]
Subsequent Event [Line Items]
Premiums and Other Receivables, Net							$ 140
Cash, Cash Equivalents, and Short-term Investments							568
Liability for Future Policy Benefits							106
Policyholder account balances							460
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest		$ 89
Ceded Reinsurance [Member]
Subsequent Event [Line Items]
Premiums and Other Receivables, Net			12,669	17,178
Liability for Future Policy Benefits			0	0
Policyholder account balances			0	0
Other Liabilities			907	1,218
Ceded Reinsurance [Member] | Affiliated Entity [Member]
Subsequent Event [Line Items]
Premiums and Other Receivables, Net			3,382	8,452
Liability for Future Policy Benefits			0	0
Policyholder account balances			0	0
Other Liabilities			$ 578	$ 876
New England Life Insurance Company [Member] | Subsequent Event [Member] | Affiliated Entity [Member] | Affiliate Recapture Variable Annuities [Member]
Subsequent Event [Line Items]
Cash, Cash Equivalents, and Short-term Investments							184
Liability for Future Policy Benefits							34
Policyholder account balances							219
Other Liabilities							68
Brighthouse Life Insurance Co of NY [Member] | Subsequent Event [Member] | Affiliated Entity [Member] | Affiliate Recapture Variable Annuities [Member]
Subsequent Event [Line Items]
Cash, Cash Equivalents, and Short-term Investments							150
Liability for Future Policy Benefits							45
Policyholder account balances							168
Other Liabilities							$ 359
Metropolitan Life Insurance Company [Member] | Subsequent Event [Member] | Affiliated Entity [Member] | Group Life Term [Member]
Subsequent Event [Line Items]
Premiums and Other Receivables, Net						$ 189
Cash, Cash Equivalents, and Short-term Investments						$ 214
Metropolitan Life Insurance Company [Member] | Ceded Reinsurance [Member] | Subsequent Event [Member] | Affiliated Entity [Member] | Group Life Term [Member]
Subsequent Event [Line Items]
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ 17

XML

Subsequent Events (Committed Facilities and Reinsurance Financing Arrangement) (Detail - Narrative) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Subsequent Event [Line Items]
Letters of Credit Outstanding, Amount		$ 3,300
MRV committed credit facility
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		4,250
Letters of Credit Outstanding, Amount		3,000
MRSC committed credit facility
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		3,500
Letters of Credit Outstanding, Amount		$ 0
Subsequent Event | MRV committed credit facility | Spinoff
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 4,300
Subsequent Event | MRSC committed credit facility | Spinoff
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	3,500
Subsequent Event | BRCD | Spinoff
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	10,000
Subsequent Event | BRCD | Spinoff | Credit-linked Note
Subsequent Event [Line Items]
Letters of Credit Outstanding, Amount	$ 8,100

XML

Subsequent Events (Surplus Notes - Affiliated) (Detail - Narrative) - Spinoff - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
MRD Surplus Notes
Subsequent Event [Line Items]
Surplus Notes		$ 1,100
Subsequent Event | Affiliated Entity
Subsequent Event [Line Items]
Notes Receivable, Related Parties	$ 1,100
Subsequent Event | MRD Surplus Notes | Affiliated Entity
Subsequent Event [Line Items]
Surplus Notes	$ 1,100
Subsequent Event | MRD Surplus Notes due 2032 | Affiliated Entity
Subsequent Event [Line Items]
Interest Rate	5.13%
Subsequent Event | MRD Surplus Notes due to 2033 | Affiliated Entity
Subsequent Event [Line Items]
Interest Rate	6.00%
Subsequent Event | MLUSA Surplus Notes due 2038 | Affiliated Entity
Subsequent Event [Line Items]
Surplus Notes	$ 750
Interest Rate	8.595%

XML

Subsequent Events (Capital Transactions) (Detail - Narrative) - USD ($) $ in Millions			3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 08, 2017	Aug. 10, 2017	Jun. 30, 2017	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Subsequent Event [Line Items]
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital					$ 26	$ 50	$ 40
Cash Capital Contribution
Subsequent Event [Line Items]
Capital contribution					$ 1,600	$ 21	$ 476
Subsequent Event
Subsequent Event [Line Items]
Amount of other increase (decrease) in additional paid in capital (APIC) due to a return of capital				$ 2,700
Subsequent Event | Cash Capital Contribution
Subsequent Event [Line Items]
Capital contribution	$ 100	$ 400	$ 600

XML

Consolidated Summary of Investments - Other Than Investments in Related Parties (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	$ 76,107
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	78,737
Loans, Gross, Insurance Policy	1,093	$ 1,266
Real Estate Investments, Net	215	628
Other Investments	5,029	6,129
Other Limited Partnership Interests	1,639	1,846
Mortgage Loans on Real Estate	9,290	7,404
Short-term Investments	1,272	$ 1,796
Fixed Maturities [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	57,289
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	59,899
Summary of Investments, Other than Investments in Related Parties, Fair Value	59,899
U.S. government and agency
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	11,872
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	12,916
Summary of Investments, Other than Investments in Related Parties, Fair Value	12,916
US States and Political Subdivisions Debt Securities [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	3,520
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	3,858
Summary of Investments, Other than Investments in Related Parties, Fair Value	3,858
Public Utility, Bonds [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	2,067
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	2,268
Summary of Investments, Other than Investments in Related Parties, Fair Value	2,268
Foreign government
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	1,000
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	1,103
Summary of Investments, Other than Investments in Related Parties, Fair Value	1,103
Other Corporate Bonds [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	24,419
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	25,181
Summary of Investments, Other than Investments in Related Parties, Fair Value	25,181
Bonds [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	42,878
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	45,326
Summary of Investments, Other than Investments in Related Parties, Fair Value	45,326
Mortgage Backed And Asset Backed Securities [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	14,163
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	14,234
Summary of Investments, Other than Investments in Related Parties, Fair Value	14,234
Redeemable Preferred Stock [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	248
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	339
Summary of Investments, Other than Investments in Related Parties, Fair Value	339
Equity Securities, Investment Summary [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	280
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	300
Summary of Investments, Other than Investments in Related Parties, Fair Value	300
Industrial, Miscellaneous, and All Others [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	98
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	116
Summary of Investments, Other than Investments in Related Parties, Fair Value	116
Public Utility, Equities [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	0
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	2
Summary of Investments, Other than Investments in Related Parties, Fair Value	2
Banks, Trust and Insurance, Equities [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	2
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	5
Summary of Investments, Other than Investments in Related Parties, Fair Value	5
Nonredeemable Preferred Stock [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Cost	180
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	177
Summary of Investments, Other than Investments in Related Parties, Fair Value	177
Mortgage loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	9,290
Policy loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	1,093
Real estate and real estate joint ventures
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	215
Other limited partnership interests
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	1,639
Short-term Investments [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	1,272
Other invested assets [Member]
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	$ 5,029

XML

Condensed Financial Information Condensed Financial Information (Parent Company) (Condensed Balance Sheet) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Investments [Abstract]
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $57,289 and $59,852, respectively, includes $0 and $3,194, respectively, relating to variable interest entities)	$ 59,899	$ 62,121
Equity securities	300	457
Mortgage loans (net of valuation allowances of $40 and $36, respectively; includes $136 and $172, respectively, at estimated fair value, relating to variable interest entities)	9,290	7,404
Loans, Gross, Insurance Policy	1,093	1,266
Real estate and real estate joint ventures	215	628
Other Limited Partnership Interests	1,639	1,846
Short-term Investments	1,272	1,796
Other Investments	5,029	6,129
Investments	78,737	81,647
Cash and Cash Equivalents, at Carrying Value	5,057	1,507
Accrued Investment Income Receivable	668	585
Premiums, reinsurance and other receivables	13,853	18,104
Deferred Policy Acquisition Costs and Value of Business Acquired	6,339	5,777	$ 5,860
Current income tax recoverable	736	226
Other Assets	689	862
Separate Account Assets	105,346	106,527
Assets	211,425	215,616
Liabilities
Future policy benefits	32,752	30,508
Policyholder Account Balances	36,579	36,725	36,585
Other Policy-Related Balances	2,712	2,802
Payables For Collateral Under Securities Loaned And Other Transactions	7,371	10,622
Deferred income tax liability	2,451	3,935
Other liabilities (includes $1 and $1, respectively, relating to variable interest entities)	5,445	3,925
Separate Accounts, Liability	105,346	106,527
Liabilities	194,560	196,980
Stockholders' Equity Attributable to Parent [Abstract]
Common Stock, Value, Issued	75	75
Additional Paid in Capital	18,461	16,850
Retained Earnings (Accumulated Deficit)	(2,919)	117
Accumulated Other Comprehensive Income (Loss), Net of Tax	1,248	1,594	2,622	$ 970
Stockholders' Equity Attributable to Parent	16,865	18,636	$ 19,094	$ 17,287
Liabilities and Equity	211,425	215,616
Parent Company
Investments [Abstract]
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $57,289 and $59,852, respectively, includes $0 and $3,194, respectively, relating to variable interest entities)	51,880	52,514
Equity securities	300	409
Mortgage loans (net of valuation allowances of $40 and $36, respectively; includes $136 and $172, respectively, at estimated fair value, relating to variable interest entities)	8,746	7,088
Loans, Gross, Insurance Policy	1,093	1,266
Real estate and real estate joint ventures	200	575
Other Limited Partnership Interests	1,632	1,836
Short-term Investments	926	1,730
Investments in and Advances to Affiliates, at Fair Value	7,338	7,326
Other Investments	3,712	4,746
Investments	75,827	77,490
Cash and Cash Equivalents, at Carrying Value	1,881	1,379
Accrued Investment Income Receivable	591	506
Premiums, reinsurance and other receivables	10,397	9,239
Due from Affiliates	9,703	13,011
Deferred Policy Acquisition Costs and Value of Business Acquired	5,274	4,809
Current income tax recoverable	454	0
Deferred Tax Assets, Net, Noncurrent	1,016	0
Advances to Affiliate	0	381
Other Assets	667	838
Separate Account Assets	100,588	101,735
Assets	206,398	209,388
Liabilities
Future policy benefits	31,684	29,894
Policyholder Account Balances	35,588	35,661
Other Policy-Related Balances	3,384	3,549
Payables For Collateral Under Securities Loaned And Other Transactions	7,362	10,619
Notes Payable, Related Parties	744	750
Deferred Tax Liabilities, Net, Current	0	20
Deferred income tax liability	0	807
Other liabilities (includes $1 and $1, respectively, relating to variable interest entities)	10,183	7,717
Separate Accounts, Liability	100,588	101,735
Liabilities	189,533	190,752
Stockholders' Equity Attributable to Parent [Abstract]
Common Stock, Value, Issued	75	75
Additional Paid in Capital	18,461	16,850
Retained Earnings (Accumulated Deficit)	(2,919)	117
Accumulated Other Comprehensive Income (Loss), Net of Tax	1,248	1,594
Stockholders' Equity Attributable to Parent	16,865	18,636
Liabilities and Equity	$ 206,398	$ 209,388

XML

Condensed Financial Information Condensed Financial Information (Parent Company) (Condensed Balance Sheet - Parenthetical) (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Nov. 30, 2014	Dec. 31, 2013
Condensed Balance Sheet Statements, Captions [Line Items]
Amortized cost of fixed maturity securities available-for-sale	$ 57,289	$ 59,852
Cost of equity securities available-for-sale	280	432
Allowance for Loan and Lease Losses, Real Estate	$ 40	$ 36	$ 25		$ 35
Common Stock, Par or Stated Value Per Share	$ 25,000	$ 25,000
Common Stock, Shares Authorized	4,000	4,000	40,000,000	4,000
Common Stock, Shares, Issued	3,000	3,000		3,000
Common Stock, Shares, Outstanding	3,000	3,000
Parent Company
Condensed Balance Sheet Statements, Captions [Line Items]
Amortized cost of fixed maturity securities available-for-sale	$ 0	$ 0
Cost of equity securities available-for-sale	0	0
Allowance for Loan and Lease Losses, Real Estate	$ 0	$ 0
Common Stock, Par or Stated Value Per Share	$ 25,000	$ 25,000
Common Stock, Shares Authorized	4,000	4,000
Common Stock, Shares, Issued	3,000	3,000
Common Stock, Shares, Outstanding	3,000	3,000

XML

Condensed Financial Information (Parent Company) (Condensed Statements of Operations) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Income Statements, Captions [Line Items]
Premiums	$ 1,180	$ 1,637	$ 1,451
Universal life and investment-type product policy fees	3,097	3,293	3,610
Net investment income	3,111	3,001	2,984
Other revenues	709	433	520
Gain (Loss) on Investments	(67)	5	(489)
Gain (Loss) on Derivative Instruments, Net, Pretax	(5,770)	(497)	294
Revenues	2,260	7,872	8,370
Net policyholder benefits and claims	3,738	3,087	3,198
Interest credited to policyholder account balances	1,131	1,224	1,245
Goodwill impairment	381	0	33
Amortization of DAC and VOBA Charged to Other Expenses	(225)	673	1,069
Operating Expenses	1,700	1,723	1,757
Benefits, Losses and Expenses	6,725	6,707	7,302
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(4,465)	1,165	1,068
Income Tax Expense (Benefit)	(1,690)	247	261
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	(3,121)	(110)	2,459
Parent Company
Condensed Income Statements, Captions [Line Items]
Premiums	921	1,433	1,126
Universal life and investment-type product policy fees	2,696	2,940	3,193
Income (Loss) from Subsidiaries, before Tax	157	144	(102)
Net investment income	2,680	2,550	2,530
Other revenues	760	504	524
Gain (Loss) on Investments	(2)	20	(52)
Gain (Loss) on Derivative Instruments, Net, Pretax	(5,878)	(424)	(261)
Revenues	1,334	7,167	6,958
Net policyholder benefits and claims	2,984	2,696	2,621
Interest credited to policyholder account balances	957	1,037	1,062
Goodwill impairment	381	0	33
Amortization of DAC and VOBA Charged to Other Expenses	(172)	595	384
Operating Expenses	1,733	1,710	1,707
Benefits, Losses and Expenses	5,883	6,038	5,807
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(4,549)	1,129	1,151
Income Tax Expense (Benefit)	(1,774)	211	344
Net Income (Loss) Attributable to Parent	(2,775)	918	807
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ (3,121)	$ (110)	$ 2,459

XML

Condensed Financial Information Condensed Financial Information (Parent Company) (Condensed Statements of Cash Flows) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net Cash Provided by (Used in) Operating Activities	$ 4,131	$ 4,992	$ 5,761
Net Cash Provided by (Used in) Investing Activities [Abstract]
Sales, maturities and repayments of fixed maturity securities	45,460	38,341	22,990
Sales, maturities and repayments of equity securities	224	308	98
Sales, maturities and repayments of mortgage loans	1,560	1,083	2,456
Sales, maturities and repayments of real estate and real estate joint ventures	446	512	28
Sales, maturities and repayments of other limited partnership interests	417	425	255
Purchases of fixed maturity securities	(39,097)	(43,502)	(28,056)
Purchases of equity securities	(58)	(273)	(89)
Purchases of mortgage loans	(2,847)	(2,560)	(353)
Purchases of real estate and real estate joint ventures	(75)	(109)	(209)
Purchases of other limited partnership interests	(203)	(233)	(345)
Cash received in connection with freestanding derivatives	707	224	788
Cash paid in connection with freestanding derivatives	(2,764)	(869)	(1,991)
Cash received under repurchase agreements	0	199	0
Cash paid under repurchase agreements	0	(199)	0
Cash received under reverse repurchase agreements	0	199	0
Cash paid under reverse repurchase agreements	0	(199)	0
Sales of loans to affiliates	0	26	520
Net change in policy loans	109	(72)	52
Net change in short-term investments	596	(343)	3,491
Net change in other invested assets	7	(55)	(598)
Net cash provided by (used in) investing activities	4,532	(7,097)	(512)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Policyholder account balances: Deposits	10,040	20,269	18,947
Policyholder account balances: Withdrawals	(12,292)	(21,078)	(21,853)
Net change in payables for collateral under securities loaned and other transactions	(3,251)	3,121	704
Long-term debt issued	0	175	0
Long-term debt repaid	(26)	(235)	(1,379)
Financing element on certain derivative instruments and other derivative related transactions, net	(1,011)	(97)	(414)
Redemption of common stock	0	0	(906)
Common stock redemption premium	0	0	(484)
Dividends on common stock	(261)	(500)	(155)
Capital contributions	1,688	406	476
Net cash provided by (used in) financing activities	(5,113)	2,061	(5,064)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	0	(2)	(45)
Change in cash and cash equivalents	3,550	(46)	140
Cash and cash equivalents, beginning of year	1,507	1,553	1,413
Cash and cash equivalents, end of year	5,057	1,507	1,553
Supplemental Cash Flow Information [Abstract]
Interest	130	137	171
Income tax	150	(463)	(471)
Non-cash transactions:
Capital contributions	69	181	457
Transfer of fixed maturity securities from affiliates	4,030	0	0
Transfer of mortgage loans from affiliates	662	0	0
Transfer of short-term investments from affiliates	94	0	0
Transfer of fixed maturity securities to affiliates	346	0	804
Transfer of mortgage loans to affiliates	0	0	94
Transfer of policyholder account balances to affiliate	0	0	528
Reduction of other invested assets in connection with reinsurance transactions	676	0	863
Parent Company
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net Cash Provided by (Used in) Operating Activities	3,256	4,196	4,547
Net Cash Provided by (Used in) Investing Activities [Abstract]
Sales, maturities and repayments of fixed maturity securities	39,104	35,728	20,197
Sales, maturities and repayments of equity securities	175	308	98
Sales, maturities and repayments of mortgage loans	1,484	958	1,049
Sales, maturities and repayments of real estate and real estate joint ventures	441	368	27
Sales, maturities and repayments of other limited partnership interests	413	422	254
Purchases of fixed maturity securities	(34,906)	(39,298)	(24,524)
Purchases of equity securities	(58)	(273)	(41)
Purchases of mortgage loans	(2,803)	(2,515)	(343)
Purchases of real estate and real estate joint ventures	(75)	(105)	(204)
Purchases of other limited partnership interests	(203)	(233)	(345)
Cash received in connection with freestanding derivatives	707	223	366
Cash paid in connection with freestanding derivatives	(2,764)	(868)	(1,784)
Cash received under repurchase agreements	0	199	0
Cash paid under repurchase agreements	0	(199)	0
Cash received under reverse repurchase agreements	0	199	0
Cash paid under reverse repurchase agreements	0	(199)	0
Sales of loans to affiliates	0	0	520
Returns of capital from subsidiaries	32	169	818
Capital contributions to subsidiaries	(1)	(2)	(2)
Net change in policy loans	109	(72)	52
Net change in short-term investments	876	(495)	3,645
Net change in other invested assets	5	(59)	(151)
Net cash provided by (used in) investing activities	2,536	(5,744)	(368)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Policyholder account balances: Deposits	9,672	19,970	18,602
Policyholder account balances: Withdrawals	(12,001)	(20,797)	(21,584)
Net change in payables for collateral under securities loaned and other transactions	(3,257)	3,118	680
Long-term debt issued	0	175	0
Long-term debt repaid	0	(148)	(75)
Financing element on certain derivative instruments and other derivative related transactions, net	(1,011)	(97)	(414)
Redemption of common stock	0	0	(906)
Common stock redemption premium	0	0	(484)
Dividends on common stock	(261)	(500)	(155)
Capital contributions	1,568	11	231
Net cash provided by (used in) financing activities	(5,290)	1,732	(4,105)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	0	(2)	(45)
Change in cash and cash equivalents	502	182	29
Cash and cash equivalents, beginning of year	1,379	1,197	1,168
Cash and cash equivalents, end of year	1,881	1,379	1,197
Supplemental Cash Flow Information [Abstract]
Interest	64	65	70
Income tax	428	(267)	(231)
Non-cash transactions:
Capital contributions	43	141	703
Transfer of fixed maturity securities from affiliates	3,565	0	0
Transfer of mortgage loans from affiliates	395	0	0
Transfer of short-term investments from affiliates	94	0	0
Transfer of fixed maturity securities to affiliates	346	0	804
Transfer of mortgage loans to affiliates	0	0	94
Transfer of policyholder account balances to affiliate	0	0	528
Reduction of other invested assets in connection with reinsurance transactions	$ 676	$ 0	$ 863

XML

Consolidated Supplementary Insurance Information (Balance Sheet Items) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Supplementary Insurance Information, by Segment [Line Items]
DAC and VOBA	$ 6,339	$ 5,777	$ 5,860
Future Policy Benefits and Other Policy-Related Balances	35,464	33,310	31,527
Policyholder Account Balances	36,579	36,725	36,585
Unearned Premiums	19	18	15
Unearned Revenue	218	208	224
Annuities
Supplementary Insurance Information, by Segment [Line Items]
DAC and VOBA	4,820	3,724	3,829
Future Policy Benefits and Other Policy-Related Balances	7,560	6,659	5,431
Policyholder Account Balances	25,233	22,014	21,246
Unearned Premiums	0	0	0
Unearned Revenue	86	96	101
Life
Supplementary Insurance Information, by Segment [Line Items]
DAC and VOBA	787	969	942
Future Policy Benefits and Other Policy-Related Balances	4,094	4,618	4,124
Policyholder Account Balances	2,838	2,691	2,673
Unearned Premiums	13	13	10
Unearned Revenue	53	52	48
Run-off
Supplementary Insurance Information, by Segment [Line Items]
DAC and VOBA	584	974	1,026
Future Policy Benefits and Other Policy-Related Balances	16,381	14,867	15,201
Policyholder Account Balances	8,506	12,018	12,665
Unearned Premiums	0	0	0
Unearned Revenue	79	60	75
Corporate & Other
Supplementary Insurance Information, by Segment [Line Items]
DAC and VOBA	148	110	63
Future Policy Benefits and Other Policy-Related Balances	7,429	7,166	6,771
Policyholder Account Balances	2	2	1
Unearned Premiums	6	5	5
Unearned Revenue	$ 0	$ 0	$ 0

XML

Consolidated Supplementary Insurance Information (Income Statement Items) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Supplementary Insurance Information, by Segment [Line Items]
Premiums and Universal Life and Investment-Type Product Policy Fees	$ 4,277	$ 4,930	$ 5,061
Net Investment Income	3,111	3,001	2,984
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	4,869	4,311	4,443
Amortization of DAC and VOBA Charged to Other Expenses	(225)	673	1,069
Other Operating Expenses	1,700	1,723	1,757
Annuities
Supplementary Insurance Information, by Segment [Line Items]
Premiums and Universal Life and Investment-Type Product Policy Fees	2,714	3,282	3,511
Net Investment Income	1,324	1,141	1,056
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	2,340	2,285	2,641
Amortization of DAC and VOBA Charged to Other Expenses	(908)	432	759
Other Operating Expenses	903	938	976
Life
Supplementary Insurance Information, by Segment [Line Items]
Premiums and Universal Life and Investment-Type Product Policy Fees	546	555	545
Net Investment Income	330	295	345
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	541	507	469
Amortization of DAC and VOBA Charged to Other Expenses	261	150	173
Other Operating Expenses	242	259	282
Run-off [Member]
Supplementary Insurance Information, by Segment [Line Items]
Premiums and Universal Life and Investment-Type Product Policy Fees	878	793	757
Net Investment Income	1,311	1,461	1,492
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	1,901	1,301	1,251
Amortization of DAC and VOBA Charged to Other Expenses	399	67	115
Other Operating Expenses	275	285	236
Corporate & Other
Supplementary Insurance Information, by Segment [Line Items]
Premiums and Universal Life and Investment-Type Product Policy Fees	139	300	248
Net Investment Income	146	104	91
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	87	218	82
Amortization of DAC and VOBA Charged to Other Expenses	23	24	22
Other Operating Expenses	$ 280	$ 241	$ 263

XML

Consolidated Reinsurance (Consolidated Reinsurance) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Consolidated Reinsurance
Life Insurance in Force, Gross Amounts	$ 610,206	$ 591,105	$ 544,635
Life Insurance in Force, Ceded Amounts	450,000	466,406	450,615
Life Insurance in Force, Assumed Amounts	7,006	94,863	55,381
Life Insurance in Force, Net Amounts	$ 167,212	$ 219,562	$ 149,401
Life Insurance in Force, Percentage Assumed to Net	4.20%	43.20%	37.10%
Direct Premiums Earned	$ 2,226	$ 2,404	$ 2,359
Ceded Premiums Earned	1,127	1,063	1,003
Assumed Premiums Earned	81	296	95
Premiums Earned, Net	$ 1,180	$ 1,637	$ 1,451
Premiums, Percentage Assumed to Net	6.90%	18.10%	6.50%
Life insurance (1)
Consolidated Reinsurance
Direct Premiums Earned	$ 1,850	$ 2,172	$ 2,064
Ceded Premiums Earned	909	824	689
Assumed Premiums Earned	67	84	65
Premiums Earned, Net	$ 1,008	$ 1,432	$ 1,440
Premiums, Percentage Assumed to Net	6.60%	5.90%	4.50%
Accident & health insurance
Consolidated Reinsurance
Direct Premiums Earned	$ 376	$ 232	$ 295
Ceded Premiums Earned	218	239	314
Assumed Premiums Earned	14	212	30
Premiums Earned, Net	$ 172	$ 205	$ 11
Premiums, Percentage Assumed to Net	8.10%	103.40%	272.70%

XML

Consolidated Reinsurance (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Consolidated Reinsurance
Reinsurance ceded	$ 1,127	$ 1,063	$ 1,003
Reinsurance assumed	81	296	95
Assumed Premiums, Life Insurance in Force	7,006	94,863	55,381
Ceded Premiums, Life Insurance in Force	450,000	466,406	450,615
Affiliated Entity [Member]
Consolidated Reinsurance
Assumed Premiums, Life Insurance in Force	7,000	86,400	52,900
Ceded Premiums, Life Insurance in Force	266,300	278,400	279,700
Life insurance (1)
Consolidated Reinsurance
Reinsurance ceded	909	824	689
Reinsurance assumed	67	84	65
Life insurance (1) | Affiliated Entity [Member]
Consolidated Reinsurance
Reinsurance ceded	766	687	652
Reinsurance assumed	$ 35	$ 227	$ 56